
<html lang="en"     class="pb-page"  data-request-id="b8880e36-ffd3-4d1b-8807-993e548577c0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm300343m;issue:issue:10.1021/jmcmar.2012.55.issue-13;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Mitigating Heterocycle Metabolism in Drug Discovery" /></meta><meta name="dc.Creator" content="David J.  St. Jean,Jr." /></meta><meta name="dc.Creator" content="Christopher  Fotsch" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 7, 2012" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300343m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300343m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300343m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300343m" /></link>
        
    
    

<title>Mitigating Heterocycle Metabolism in Drug Discovery | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300343m" /></meta><meta property="og:title" content="Mitigating Heterocycle Metabolism in Drug Discovery" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300343m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300343m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300343m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300343m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300343m&amp;href=/doi/10.1021/jm300343m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6002-6020</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm300288g" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm300253q" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm301579v"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Mitigating Heterocycle Metabolism in Drug Discovery</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++St.+Jean%2C+Jr.">David J. St. Jean, Jr.</a></span></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Fotsch">Christopher Fotsch</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Therapeutic Discovery, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div><div class="corresp-info"><strong>*</strong>Telephone: 805-447-7746. Fax: 805-480-1337. E-mail: <a href="/cdn-cgi/l/email-protection#c1a2a7aeb5b2a2a981a0aca6a4afefa2aeac"><span class="__cf_email__" data-cfemail="5231343d2621313a12333f35373c7c313d3f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300343m&amp;href=/doi/10.1021%2Fjm300343m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6002–6020</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 25, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 March 2012</li><li><span class="item_label"><b>Published</b> online</span>7 May 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 July 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300343m" title="DOI URL">https://doi.org/10.1021/jm300343m</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6002%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDavid%2BJ.%2BSt.%2BJean%252C%2BChristopher%2BFotsch%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D13%26contentID%3Djm300343m%26title%3DMitigating%2BHeterocycle%2BMetabolism%2Bin%2BDrug%2BDiscovery%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6020%26publicationDate%3DJuly%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300343m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">17221</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">122</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300343m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Mitigating Heterocycle Metabolism in Drug Discovery&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. St. Jean&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Fotsch&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;6002-6020&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300343m&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300343m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300343m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300343m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300343m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300343m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300343m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300343m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300343m&amp;href=/doi/10.1021/jm300343m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300343m" /></input><a href="/doi/pdf/10.1021/jm300343m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300343m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300343m%26sid%3Dliteratum%253Aachs%26pmid%3D22533875%26genre%3Darticle%26aulast%3DSt.%2BJean%26date%3D2012%26atitle%3DMitigating%2BHeterocycle%2BMetabolism%2Bin%2BDrug%2BDiscovery%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D13%26spage%3D6002%26epage%3D6020%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=290921" title="Heterocyclic compounds">Heterocyclic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jmcmar.2012.55.issue-13/production/jmcmar.2012.55.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04154" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04154" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the past few decades, drug metabolism research has played an ever increasing role in the design of drugs.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> In vitro metabolism assays<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> have become an integral part of the routine profiling of compounds made in drug discovery.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The data from these assays have allowed medicinal chemists to focus their efforts on compounds with improved metabolic stability.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Detailed metabolite identification studies are also done more routinely, which provide information on how to strategically replace or block metabolically labile sites.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Additionally, in vivo PK studies are regularly conducted in drug discovery, which helps to build in vitro–in vivo PK relationships.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The positive influence that these advances in PKDM sciences have had on drug discovery is reflected in the fact that fewer drug candidates fail in the clinic for PKDM related issues.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> This suggests that medicinal chemists are successfully integrating the data generated by their PKDM colleagues into the design of compounds with fewer metabolic liabilities.</div><div class="NLM_p">Extensive data from metabolism studies have allowed medicinal chemists to develop general principles for reducing compound metabolism. These methods include, but are not limited to, reducing lipophilicity, altering sterics and electronics, introducing a conformational constraint, and altering the stereochemistry of their compounds. While no single method is able to solve every metabolic problem, these principles do give medicinal chemists guidance on how to improve the metabolic liabilities of their compounds. If the specific site of metabolism is known, medicinal chemists block the site, typically with a fluorine, or replace the metabolically labile group with a bioisostere.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> While several authors have reviewed these techniques for reducing metabolism,<a onclick="showRef(event, 'ref5 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref5 ref10 ref11">(5, 10, 11)</a> there is no review that summarizes different approaches to improving the metabolic stability of heterocycles. In this review, we summarize examples where changes were made at or near the heterocycle to improve metabolic stability. By summarizing these examples, we hope to provide a useful guide to medicinal chemists as they attempt to improve the metabolic profile of their own heterocyclic compounds.</div><div class="NLM_p">The majority of the examples that are included in this review came from searching the online open access database CHEMBL.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In addition to having pharmacology data on compounds from the medicinal chemistry literature, CHEMBL has over 120 000 points of data on the ADMET properties of compounds. With the help of the visualization software Spotfire, we were able to cull examples from the CHEMBL ADMET data that focused on heterocycles. We also identified examples from papers that cite leading reviews in the drug metabolism field<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17 ref18">(13-18)</a> and were present in other recent reviews on drug metabolism.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19-22)</a> The main criteria that we placed on the examples selected for this review was that the change made to improve metabolism had to occur at or near the heterocycle and nowhere else on the molecule. This allowed us to eliminate examples where a change made to a compound away from the heterocycle may have influenced the metabolism.</div><div class="NLM_p last">The data that we included in this review is predominantly from in vitro microsomal stability studies. However, we have included some data from bioactivation studies and in vivo PK studies to provide additional information about the overall metabolic profile. In several instances, the compound with the improved metabolic profile also became the lead compound in the paper, so we felt that including the data on the intended target was informative even though this is not a discussion point for the review. Of course, in some examples when the heterocycle was modified to improve metabolic stability, the activity at the intended biological target diminished. However, we felt that these examples of improved metabolic stability would still be of value to the reader. In the discussion below, we have organized the review by first discussing saturated heterocycles and then heteroaromatic compounds. Within each section we have organized the discussion by ring size.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Saturated Heterocycles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Saturated heterocycles are most prone to metabolism at the position adjacent to or directly on the heteroatom.<a onclick="showRef(event, 'ref16 ref23'); return false;" href="javascript:void(0);" class="ref ref16 ref23">(16, 23)</a> Therefore, strategies used to reduce metabolism of these rings involve techniques to block the site of metabolism, change the electronics of the ring, or reduce the hydrophobicity of the ring. Since lipophilicity and charge influence metabolism, we have tabulated the cLogP, cLogD<sub>7.4</sub>,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and p<i>K</i><sub>a</sub><a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> for some of the more common saturated heterocycles (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. cLogP, cLogD<sub>7.4</sub>, and p<i>K</i><sub>a</sub> Values for More Common Saturated Heterocycles<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0045.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">See ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>. </p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">See ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">26</a>.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">p<i>K</i><sub>a</sub> refers to the Het ⇆ HetH<sup>+</sup> equilibrium.</p></div></div><div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Saturated Four-Membered Rings</h3><div class="NLM_p">Of the saturated heterocycles containing one heteroatom, azetidine and oxetane are among the least lipophilic, so one would expect these rings to be least likely to undergo metabolism when compared to their larger ring counterparts. In fact, in some of the examples show below, the azetidine and oxetane ring analogues were more metabolically stable than analogues containing a larger ring (see Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>, and <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>). However, there are some reports where the four-membered saturated heterocycle was modified to improve metabolic stability. For example, in their work on histamine receptor 3 (H<sub>3</sub>R) inverse agonists for the treatment of obesity, Pierson et al. found that the derivative containing the oxetane <b>1</b> was less metabolically stable in rat liver microsomes (RLM) than the cyclobutyl analogue (<b>2</b>) (see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> While the oxetane analogue <b>1</b> was less lipophilic than cyclobutyl analogue <b>2</b>, the p<i>K</i><sub>a</sub> of the adjacent piperidine ring was >9 for analogue <b>2</b>, while the oxetane analogue <b>1</b> had a p<i>K</i><sub>a</sub> = 6.4. This p<i>K</i><sub>a</sub> difference may explain why the cyclobutyl analogue <b>2</b> is more stable, since at physiological pH, this compound would be fully protonated and more polar than the oxetane analogue.</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. In vitro potency and PK properties of selected H<sub>3</sub>R inverse antagonists. The log <i>D</i><sub>7.4</sub> and p<i>K</i><sub>a</sub> values were experimentally determined by Pierson et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example where the oxetane was removed to improve the metabolic stability of the compound was found in the aldosterone synthase inhibitors from Adams et al. (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Analogue <b>3</b> had IC<sub>50</sub> < 10 nM, but the isobutyl group was heavily metabolized. To mitigate this metabolism, the isobutyl group was replaced with a substituted oxetane (<b>4</b>), a compound with a more than 10-fold increase in metabolic stability. However, the metabolic stability was improved even further by replacing the oxetane ring with a <i>tert</i>-hydroxyl group (<b>5</b>). The decrease in cLogD<sub>7.4</sub> correlates with the improvement in metabolic stability for these three analogues.</div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. In vitro potency and PK properties of selected aldosterone synthase inhibitors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Saturated Five-Membered Rings</h3><div class="NLM_p">In their factor Xa (FXa) program, Zbinden et al. added either a fluorine or hydroxyl group to a pyrrolidine ring in an attempt to improve metabolism (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The RLM clearance of pyrrolidine analogue <b>6</b> was only slightly improved by adding a fluorine to the ring (analogue <b>7</b>). However, when a hydroxyl group was added (<b>8</b>), the metabolic stability in RLM significantly improved probably because this compound was more polar than the other two. Unfortunately, analogue <b>8</b> had high rat in vivo clearance. After additional in vivo PK studies, Zbinden et al. found that 50% of <b>8</b> was cleared by the kidney unchanged.</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vitro potency and PK properties of selected FXa inhibitors.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dragovich et al. also provided an example where replacing a pyrrolidine with a more polar ring improved metabolism. In their work on hepatitis C virus (HCV) NS5B inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> pyrrolidine analogue <b>9</b>, while potent against the intended target, had a short half-life of 10 min in human liver microsomes (HLM). Replacement of the pyrrolidine with the morpholine ring (<b>10</b>) lowered the cLogD<sub>7.4</sub> and significantly improved the metabolic stability.</div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vitro potency and in vitro PKDM profile for selected HCV NS5B polymerase inhibitors.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Other groups have demonstrated that changing the ring size of the pyrrolidine can reduce metabolism. For example, in their serotonin receptor subtype 2C (5-HT<sub>2C</sub>) agonist program, Fish et al. changed the pyrrolidine in one of their analogues to a piperidine and an azetidine (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The piperidine analogue <b>12</b> showed a slight improvement in HLM stability over the pyrrolidine <b>11</b>, while the azetidine analogue <b>13</b> was the most stable. The position of the chloride on the phenyl ring was also modified on azetidine analogue <b>13</b> so that change may have also influenced the metabolic stability.</div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro potency and in vitro PKDM profile for selected 5-HT<sub>2C</sub> agonists. The log <i>D</i><sub>7.4</sub> values were experimental determined by Fish et al.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Pescatore et al. also prepared six-membered ring analogues of their pyrrolidine containing compound to improve metabolism (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In their anticancer program on histone deacetylase 1 (HDAC1) inhibitors, the analogue that contained a pyrrolidine ring, <b>14</b>, had a RLM intrinsic clearance (CL<sub>int</sub>) of >500 μL min<sup>–1</sup> mg<sup>–1</sup>. By replacing this group with various piperidine analogues, they identified a compound with a greater than 7-fold improvement in RLM stability (see compound <b>17</b>). Interestingly, the most stable piperidine analogue <b>17</b> had a higher cLogD<sub>7.4</sub> than <b>14</b>, suggesting that clearance was not driven entirely by the lipophilicity of the compound.</div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vitro potency and RLM data for selected HDAC1 inhibitors.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Saturated Six-Membered Ring Heterocycles</h3><div class="NLM_p">To improve the metabolism of their piperidine analogues, Wan et al. employed a strategy of substituting the piperidine with a fluorine or adding polar groups to the ring (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In their 11β-hydroxysteroid dehydrogenase type I (11β-HSD1) program, they found that their compound containing the unsubstituted piperidine, <b>18</b>, had a <i>t</i><sub>1/2</sub> of 6 min in mouse liver microsomes (MLM). The analogues with polar groups added to the ring were all more stable in MLM, with 4-fluoro analogue (<b>20</b>), thiomorpholine 1,1-dioxide (<b>22</b>), 4-carboxyl (<b>23)</b> having MLM <i>t</i><sub>1/2</sub> > 30 min. Analogues <b>22</b> and <b>23</b> are the least lipophilic of this set of compounds, which may explain why they have better metabolic stability than analogues <b>18</b>, <b>19</b>, and <b>21</b>. The improved metabolic stability of the 4-fluoropiperidine analogue <b>20</b> suggests that the fluorine atom may have blocked a site of metabolism that was present on parent compound <b>18</b>. Carboxyl analogue <b>23</b> was also efficacious in an in vivo PD model that measured 11β-HSD1 inhibition in epididymal fat (40% inhibition at 10 mg/kg, po).</div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vitro potency and PK properties of selected 11β-HSD1 inhibitors. PK experiments were conducted with C57B6 mice at 2 mg/kg (iv) and at 10 mg/kg (for <b>23</b>) or 30 mg/kg (for <b>19</b>) (po).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In their anticancer program on aurora kinase inhibitors, Kerekes and co-workers improved the PK profile of their analogues containing piperidine by adding fluorine atoms and altering the ring size (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> One of their more advanced compounds in the paper contained a 4-fluoropiperidine (<b>24</b>), which had a rat oral AUC of 2.2 μM·h. To further improve the PK, the 4,4-difluoro analogue (<b>25</b>) was prepared, but it had a lower rat oral AUC. The five- and four-membered ring difluoro analogues <b>26</b> and <b>27</b>, respectively, had higher oral AUC than the six-membered ring analogue <b>25</b>. The four-membered ring analogue <b>27</b> had the highest oral AUC, but Kerekes et al. discovered that the azetidine ring was prone to nucleophilic ring-opening. Turning to the five-membered ring analogue <b>26</b>, Kerekes et al. discovered that a major route of metabolism in human and monkey hepatocytes was oxidation of the benzylic position adjacent to the isothiazole ring. To circumvent this problem, they deuterated the benzylic position of the 3,3-difluoropyrrolidine, which led to a compound (<b>28</b>) that had superior rat iv clearance, oral AUC, and bioavailability. This compound was advanced into a mouse tumor xenograft PD assay, where it reduced the phosphorylation of histone H3 (HH3) in the tumor by ∼80% after being dosed orally at 100 mg/kg. The addition of deuterium atoms to mitigate metabolism takes advantage of the kinetic isotope effect, which increase the energy required to fragment the carbon–deuterium bond.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This approach of incorporating deuterium to improve metabolism has gained renewed interest among medicinal chemists in the past few years.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Rat PK of selected aurora kinase inhibitors.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> All compounds had IC<sub>50</sub> at Aurora A and Aurora B of ≤4 and ≤13 nM, respectively. The po AUC was determined in SD rats from 0–6 h after a 10 mg/kg oral dose. The iv PK was run at 10 mg/kg and % <i>F</i> determined from 30 mg/kg po.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example where fluorine atoms were added to the piperidine ring was reported by Gleave et al. (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In their cannabinoid receptor 2 (CB2) agonist program, they had tested the metabolic stability in RLM for a piperidine containing analogue (<b>29</b>) and its 4,4-difluoro derivative (<b>30</b>). There was very little improvement in the RLM metabolic stability for the 4,4-difluoro analogue. However, when the piperidine ring was replaced with the more polar morpholine ring (<b>31</b>), the metabolic stability improved by 10-fold in RLM. This trend in improved metabolic stability followed the reduction in cLogD<sub>7.4</sub>.</div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. In vitro potency and metabolic stability of selected CB2 agonists.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Peglion and co-workers were able to improve the metabolic stability of their analogue containing a piperidine by adding a nitrogen (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In their 5-HT<sub>1A</sub> agonist program for the treatment of anxiety and depression, the 1,2,3,6-tetrahydropyridine analogue (<b>32</b>) and the piperidine analogue (<b>33</b>) both had poor metabolic stability (MF% of 8 and 7, respectively). However, the corresponding piperazine (<b>34</b>) was nearly 10-fold more metabolically stable than the piperidine analogue. The difference in cLogD<sub>7.4</sub> of compounds <b>33</b> and <b>34</b> is small, so the improved metabolic stability observed with compound <b>34</b> cannot be explained by a reduction in lipophilicity. Perhaps the C-4 position of the piperidine in compound <b>33</b> is a site for metabolism, which would be blocked by the piperazine nitrogen in analogue <b>34</b>. This piperazine analogue was active in a rodent ultrasonic vocalization test, which is an animal model for anxiety.</div><figure id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. In vitro potency and metabolic stability for selected 5-HT<sub>1A</sub> receptor agonists.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The metabolic bioavailability prediction (MF%) was determined from the stability of test compound (concentration of 0.1 μM) in human liver microsomes where MF% = 100% is equal to no metabolism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The piperidine analogues reported by Qiao et al. from their erythropoietin-producing hepatocellular carcinoma receptor type B3 (EphB3) inhibitor program illustrate how the position of the nitrogen atom can affect metabolism (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Their 1-substituted piperidine analogue <b>35</b> was significantly less stable in MLM than the analogue with the 4-substituted piperidine (<b>36</b>). This change in the position of the nitrogen lowered the cLogD<sub>7.4</sub> and produced an analogue with a more basic nitrogen, which may have contributed to the improvement in metabolic stability. This compound, named LDN-211904<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (<b>36</b>), was one of their lead compounds for their EphB3 inhibitor program.</div><figure id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. In vitro potency and metabolic stability of selected EphB3 inhibitors. Half-life and CL<sub>int</sub> were determined in MLM.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example where a piperazine ring was modified to improve metabolism was found in the report from Cramp et al. on their H4R antagonists (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a><i>N</i>-Methylpiperazine analogue <b>37</b> was found to undergo rapid N-dealkylation in RLM, so a number of analogues were prepared to circumvent this problem. The bridged piperazine analogue <b>38</b> had a similar cLogD<sub>7.4</sub>, but the RLM was significantly improved, suggesting that the increase in sterics surrounding the site of metabolism may have been responsible for the lower turnover. Another bridged piperazine analogue (<b>39</b>) had similar stability to <b>38</b>, but the analogue containing the 5,6-ring (<b>40</b>) was completely eliminated by RLM. Interestingly, the analogues containing the exocyclic aminomethyl group, pyrrolidine <b>41</b> and azetidine <b>42</b>, were the most metabolically stable in this set. The large reduction in cLogD<sub>7.4</sub> may explain why these two analogues were more stable than the other compounds in this series.</div><figure id="fig12" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. In vitro potency and RLM stability for selected human H4R inverse agonists. The percent remaining in RLM was measured after a 10 min incubation.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Turning to examples with a THP ring, Omura and co-workers were able to improve the metabolic stability of their CB2 agonist by adding a hydroxyl group to the 4-position of the THP ring (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The hydroxylated THP analogue <b>44</b> was nearly 6-fold more metabolically stable in HLM than the unsubstituted THP analogue <b>43</b>. While <b>44</b> was less potent than the parent THP analogue, the principle of having a tertiary alcohol at that position to improve metabolic stability was applied to the lead compound in their paper (<b>45)</b>, which had an HLM <i>t</i><sub>1/2</sub> of >120 min and was nearly as potent as <b>43</b>.</div><figure id="fig13" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. In vitro potency and metabolic stability of selected CB2 agonists.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example with THP rings was illustrated in the γ-secretase inhibitor program from Stepan et al. (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In this paper they showed that decreasing the ring size of the THP in their inhibitors improved the metabolic stability. Stability in HLM improved going from the THP (<b>46</b>) to THF (<b>47</b>) to the oxetane analogue (<b>48</b>). The authors point out that the increased metabolic stability was most likely a result of the reduction in log <i>D</i><sub>7.4</sub>. However, they also suggest that the reduced C–H bond reactivity of the oxetane ring compared to the THP and THF rings may have also contributed to the improved metabolic stability.</div><figure id="fig14" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. In vitro potency and metabolic stability of selected γ-secretase inhibitors.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The log <i>D</i><sub>7.4</sub> was determined experimentally by Stepan et al. using the method of Lombardo et al.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The position of the oxygen atom in the ring can also affect the metabolism of a THP ring. In their work on C–C chemokine receptor type 5 (CCR5) receptor antagonists containing THP rings (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>), Rotstein et al. found that the 4-substituted-THP analogue was 4-fold more stable in HLM than the 2-substituted-THP derivative (cf., <b>49</b> vs <b>50</b>).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> These two regiochemical isomers share nearly identical properties except for the position of the oxygen in the THP ring, so the metabolic differences cannot be explained by large difference in physical properties. The 4-THP analogue <b>50</b> was advanced into rat, dog, and monkey PK and also had IC<sub>50</sub> = 0.18 nM in a PBMC (peripheral blood mononuclear cell) viral replication assay.</div><figure id="fig15" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. In vitro potency and metabolic stability of selected CCR5 receptor antagonists.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Saturated Seven-Membered Ring Heterocycles</h3><div class="NLM_p">Seven-membered ring heterocycles are generally more lipophilic than their smaller ring counterparts, so methods for improving the metabolic stability of these rings typically involve reducing the ring size. For example, in the H<sub>3</sub>R inverse agonists work from Pierson et al., they found that their analogue containing an azepane ring (<b>51</b>) had a RLM clearance (CL) of 55 μL min<sup>–1</sup> mg<sup>–1</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>).<a onclick="showRef(event, 'ref27 ref45'); return false;" href="javascript:void(0);" class="ref ref27 ref45">(27, 45)</a> Replacing the ring with difluoropiperidine rings (<b>52</b>, <b>54</b>) or morpholine (<b>53</b>) produced analogues with improved metabolic stability. In this case, a combination of reducing ring size and adding fluorine atoms or polarity was used to reduce the metabolism.</div><figure id="fig16" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. In vitro potency and PK properties of selected H<sub>3</sub>R inverse agonists. In vivo PK experiments were run with Wistar rats at 1 mL/kg (iv) and 4 mL/kg (po). The log <i>D</i><sub>7.4</sub> values were experimentally determined by Pierson et al.<a onclick="showRef(event, 'ref27 ref45'); return false;" href="javascript:void(0);" class="ref ref27 ref45">(27, 45)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Zhang and co-workers gave an example of improving the metabolic stability of a seven-membered 1,4-oxazepane ring (Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>). In their adenosine type 2A (A<sub>2A</sub>) receptor antagonist program for Parkinson’s disease, they found that reducing the ring size of the 1,4-oxazepane in analogue <b>55</b> with either a morpholine (<b>56</b>) or an <i>N</i>-methylpiperazine ring (<b>57</b>) greatly improved metabolic stability.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig17" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. In vitro potency and metabolic stability for selected human A<sub>2A</sub> receptor antagonists.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Ward et al. showed how the metabolic stability of a 1,4-diazepane was improved by reducing the ring size (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In their 5-HT<sub>1</sub> receptor ligand program, the metabolism of the analogue containing the 1,4-diazepane (<b>58</b>) was greatly improved by replacing the ring with piperidine rings (<b>59</b>, <b>61</b>) or a piperazine ring (<b>60</b>). While the <i>N</i>-methylpiperazine derivative (<b>60</b>) and <i>N</i>-methylpiperidine derivative (<b>61</b>) had similar stability in RLM, <b>61</b> had lower in vivo rat clearance. In this set of compounds there is no correlation of cLogD<sub>7.4</sub> with metabolic stability, suggesting the ring size had more of an influence on metabolism.</div><figure id="fig18" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. In vitro potency and metabolic profile for selected 5-HT<sub>1A,B,D</sub> receptor ligands.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Rat in vivo PK was determined after 1 mg/kg dosing iv.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In their work on FXa inhibitors for the treatment of thrombotic disease, Fujimoto et al. had an analogue that contained the seven-membered ring caprolactam (<b>62</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The metabolic stability was progressively improved by replacing this ring with the six- and five-membered ring lactams (<b>63</b> and <b>64</b>). The six-membered ring cyclic urea analogue <b>65</b> had the best metabolic stability of this set and was advanced into the clinic as TAK-422.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The reduction in metabolism follows the trend of reduced lipophilicity for this set of compounds as noted by the reduction in cLogD<sub>7.4</sub>.</div><figure id="fig19" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. In vitro potency and metabolic stability for selected FXa inhibitors. The percent eliminated data were determined after 20 min incubations with NADPH and LM. The log <i>D</i><sub>7.4</sub> data were determined experimentally by Fujimoto et al.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (MoLM = monkey liver microsomes).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In their anticancer program, Tsou et al. prepared a mammalian target of rapamycin (mTOR) inhibitor containing an aza-bicyclo seven-membered ring (<b>66</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> This compound was rapidly metabolized by both phase I and phase II metabolism in MLM. However, reducing the ring size of the seven-membered ring with either a morpholine or <i>N</i>-methylpiperazine ring led to analogues (<b>67</b> and <b>68</b>) with greatly improved metabolic stability. Since in vivo studies for mTOR inhibitors typically involve the use of nude mice, the MLM studies were conducted with microsomes from this strain, although a recent report from Martignoni et al.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> showed that there are no significant metabolic differences between MLM from normal (CD-1) mice and nude mice.</div><figure id="fig20" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0021.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. In vitro potency and metabolic stability for selected mTOR inhibitors. MLM studies were conducted with MLM from nude mice. Phase I metabolism studies were conducted with NADPH, while phase I/II studies were conducted with both NADPH and uridine 5′-diphosphoglucuronic acid (UDPGA).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Mastalerz et al., in their work on human epidermal growth factor receptor 2/epidermal growth factor receptor (HER2/EGFR) dual inhibitors for the treatment of cancer, tried to improve the metabolic stability of their analogue containing a 1,4-diazepane (<b>69</b>) by adding polar groups to the ring (Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> However, adding a hydroxyl or carbonyl to the 1,4-diazepane (<b>70</b> and <b>71</b>) ring gave analogues that were both metabolically less stable than the parent analogue <b>69</b>. Ultimately, the analogue with the best microsomal stability was the six-membered piperazine analogue <b>72</b>. Here again, reducing the ring size improved metabolic stability.</div><figure id="fig21" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0022.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. In vitro potency and metabolic stability of selected dual EGFR/HER2 inhibitors.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Heteroaromatic Compounds</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Five-Membered Heteroarenes</h3><div class="NLM_p">Five-membered heteroarenes are commonly used in medicinal chemistry programs and are used as bioisosteres for carboxamides, esters, and carboxylic acids.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> However, because of the electron-rich nature of the ring, they are prone to undergo oxidative metabolism, which leads to electrophilic species.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The inherent electrophilicity of these metabolites is thought to be in part responsible for the idiosyncratic toxicity of some drugs containing five-membered heteroarenes.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> That being said, medicinal chemists have identified methods for reducing the metabolism of these rings by adding another nitrogen to the ring, blocking a potential site of metabolism with a fluorine, or replacing the ring with another heterocycle. Examples of each of these methods as well as others are summarized below. As with the saturated heterocycles, we have tabulated some of the calculated and measured physical properties for some of the more common five-membered ring heterocycles (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In addition to cLogP, cLogD<sub>7.4</sub>, and p<i>K</i><sub>a</sub>, we have included the ionization potential (IP) as a measure of the electron-rich nature of the ring. As elegantly summarized in the review by Dalvie et al.,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> all of these properties can influence the metabolic stability of five-membered heteroarenes.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. cLogP, cLogD<sub>7.4</sub>, p<i>K</i><sub>a</sub>, and Ionization Potentials for Some Common Five-Membered Ring Heteroaromatics<a class="ref internalNav" href="#tbl2-fn1" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0046.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">See ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>.</p></div><div class="footnote" id="tbl2-fn1"><sup>Table c</sup><p class="last">p<i>K</i><sub>a</sub> refers to the Het ⇆ HetH<sup>+</sup> equilibrium. For the triazoles and tetrazole, the second p<i>K</i><sub>a</sub> refers to the HetH ⇆ Het<sup>–</sup> equilibrium.</p></div></div><div></div></div><div class="NLM_p">Geng et al. in their work on glutamate racemase (MurI) inhibitors for <i>H. pylori</i> found that adding nitrogen atoms to the electron-rich thiophene and furan rings significantly improved metabolic stability (Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The high intrinsic clearance in both HLM and MLM of their thiophene analogue <b>73</b> was mitigated by replacing the ring with either a thiazole (<b>74</b>) or isothiazole (<b>75</b>), and the metabolic stability was improved when the furan on analogue <b>76</b> was replaced with an oxazole (<b>77</b>). The more metabolic stable analogues were all more polar than the analogue <b>73</b>.</div><figure id="fig22" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0023.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. In vitro potency, HLM, and MLM data for selected MurI inhibitors.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In their CB2 agonist program, Riether et al. improved the metabolic stability of their compound that contained a thiazole ring (analogue <b>78</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>),<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> by replacing it with isoxazole rings (analogues <b>79</b> and <b>80</b>). A decrease in lipophilicity cannot explain why isoxazole analogues <b>79</b> and <b>80</b> were more metabolically stable than thiazole analogue <b>78</b>, since the cLogD<sub>7.4</sub> is higher for analogues <b>79</b> and <b>80</b>. If metabolism occurs on the five-membered heteroarene, the improved metabolic stability of <b>79</b> and <b>80</b> might be explained by the fact that the isoxazole ring is less electron-rich than the thiazole ring, as noted by the higher ionization potential for isoxazole.</div><figure id="fig23" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0024.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. In vitro potency and HLM data for select CB2 agonists.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> All compounds displayed weak activity against CB1 (EC<sub>50</sub> > 20 μM). Rat in vivo PK experiments were performed using Wistar rats at 1 μmol/kg (iv) and 10 μmol/kg (po).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In their antithrombocytopenia program, Kalgutkar et al. found that their thrombopoietin (Tpo) receptor agonist containing a thiazole (<b>81</b>) underwent amide hydrolysis to form an intermediate (<b>84</b>), which was prone to bioactivation and attack of nucleophiles at the C-5 position (Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> However, incorporation of a fluorine (<b>82</b>) or nitrogen (<b>83</b>) at the C-5 position of the thiazole prevented the bioactivation pathway from occurring. The rat in vivo PK for these two new analogues was also better than the parent compound. Interestingly, the cLogD<sub>7.4</sub> of the two new compounds was higher than the parent compound. Nevertheless, the strategic blocking of the site of bioactivation mitigated the formation of the reactive intermediates.</div><figure id="fig24" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0025.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. In vivo PK data for selected Tpo receptor antagonists. NuH is protein nucleophile or glutathione (GSH). In vivo PK was measured in male SD rats (1 mg/kg iv, 5 mg/kg po).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a recent report from Obach et al., they found that the metabolic profile of a thiazole ring dramatically changed when the ring was substituted with a methyl group (Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a>).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The cyclooxygenase (COX-1/2) inhibitors sudoxicam (<b>86</b>) and meloxicam (<b>87</b>) have the same structure except that meloxicam has a methyl group at the C-5 position of the thiazole ring. P450 mediated oxidation of sudoxicam occurred to form a reactive epoxide <b>88</b>, which after hydrolysis produced the protoxin acylthiourea <b>89</b>. In contrast, the major route of metabolism for meloxicam involved oxidation of the methyl group to give metabolites <b>90</b> and <b>91</b>, which did not form reactive species. The protoxin acylthiourea <b>89</b>, formed during the metabolism of sudoxicam, may in part be responsible for the hepatotoxicity observed with sudoxicam.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Meloxicam, on the other hand, is not metabolized to a protoxin and has not been associated with hepatotoxicity.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> As pointed out in the previous example, the C-5 position is a “soft spot” for bioactivation of the thiazole ring, so the methyl group on meloxicam serves the purpose of blocking this site as well as providing an alternative site for metabolism.</div><figure id="fig25" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0026.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Metabolism of sudoxicam and meloxicam.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the work by Ioannidis and co-workers on Janus kinase 2 (JAK2) inhibitors, they showed that the metabolic stability was better for their analogue containing a pyrazole (<b>93</b>) rather than a thiazole ring (<b>92</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a>).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> While the difference in cLogD<sub>7.4</sub> between these two rings cannot explain the improvement in metabolism, pyrazole rings are known to be relatively stable to metabolism compared to other five-membered ring heteroaromatic compounds.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig26" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0027.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. In vitro potency and RLM stability for selected JAK2 inhibitors.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example where the pyrazole ring was employed to improve metabolic stability was illustrated in the work from Tremblay et al. in their Hedgehog (Hh) pathway antagonists for the treatment of cancer (Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Compound <b>94</b> was one of the initial leads in their program, but in monkey PK studies, the α,β-unsaturated ketone present in <b>94</b> underwent metabolism to give the corresponding saturated alcohol. Part of the strategy to circumvent this problem was to reduce the double bond and replace the ketone with five-membered heteroarenes. The pyrazole containing analogue <b>97</b> showed a dramatic improvement in metabolic stability (HLM <i>t</i><sub>1/2</sub> = 120 min), but the isoxazole analogue <b>95</b> and 1,2,5-oxadiazole analogue <b>96</b> were less metabolically stable. A decrease in lipophilicity cannot explain the improvement in metabolic stability, since the most metabolically stable compound <b>97</b> had the highest cLogD<sub>7.4</sub>. If metabolism occurred on the isoxazole ring of analogue <b>95</b>, the decrease in metabolic stability might be explained by the potential for this ring to undergo metabolically mediated ring cleavage, which is precedented in the literature.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The poor metabolic stability of analogue <b>96</b> is less easily explained, since little has been reported on the metabolism of 1,2,5-oxadiazole rings.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><figure id="fig27" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0028.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. In vitro potency and HLM data for selected orally active Hh pathway antagonists. In vivo PK experiments were conducted with SD rats (iv dose of 1 mg/kg, po dose of 5 mg/kg).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example of a compound containing a pyrazole was found in the work on glycine transporter 1 (GlyT1) inhibitors from Thomson and co-workers (Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The pyrazole ring analogue <b>98</b> was replaced with a 1,2,3-triazole ring (<b>99</b>), which had little effect on improving dog liver microsomes (DLM) and HLM stability, but it had improved RLM stability. The improved RLM stability might be explained by the lower lipophilicity of analogue <b>99</b>.</div><figure id="fig28" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0029.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. In vitro potency and LM data for selected GlyT1 receptor antagonists<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> (%TO = percent turnover).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Nietz and co-workers, in their work on c-Jun N-terminal kinase 3 (JNK3) inhibitors, also compared the microsomal stability of analogues containing a pyrazole with various triazoles (Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The pyrazole analogue <b>100</b> had poor metabolic stability in MLM. Replacing the pyrazole central core with a triazole had differing effects on metabolism, depending on which regioisomer of the triazole ring was used. Two analogues containing the 1,2,3-triazole (<b>101</b>, <b>102</b>) showed an improvement in MLM stability, but the 1,2,4-triazole analogue <b>103</b> was the most metabolically stable. Why the 1,2,4-triazole analogue <b>103</b> was more stable than 1,2,3-triazole analogues is difficult to explain, especially since there was little difference in the lipophilicity between analogues <b>100</b> and <b>103</b>. Since some triazoles are CYP P450 inhibitors,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> the improved metabolic stability of <b>101</b>–<b>103</b> might be explained by their ability to inhibit these metabolizing enzymes. Unfortunately, CYP P450 inhibition data were not disclosed for this set of compounds. Triazole containing compounds are also known to undergo elimination through glucuronidation,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> but analogues <b>101</b> and <b>102</b> were both relatively stable in a glucuronidation assay.</div><figure id="fig29" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0030.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. In vitro potency, MLM, and glucuronidation data for select JNK inhibitors.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example where the position of three heteroatoms in the ring had a significant effect on metabolism was reported by Barber et al. on the CCR5 program for HIV (Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Their analogue with the 1,2,4-oxadiazole <b>104</b> was less metabolically stable than the 1,3,4-oxadiazole analogue <b>105</b> in HLM. Compound <b>105</b> is more polar than analogue <b>104</b>, which may explain the improvement in metabolic stability. Also, if the five-membered ring on compound <b>104</b> is the site of metabolism, the 1,2,4-oxadiazole ring may undergo metabolic N–O ring-opening, which is precedented in the literature.<a onclick="showRef(event, 'ref13 ref66'); return false;" href="javascript:void(0);" class="ref ref13 ref66">(13, 66)</a> Without an N–O bond, the 1,3,4-oxadiazole ring on <b>105</b> would not undergo this route of metabolism.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="fig30" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0031.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. In vitro potency and HLM data for selected CCR5 antagonists. The log <i>D</i><sub>7.4</sub> values were experimentally determined by Barber et al.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In their work on dipeptidyl peptidase IV (DPP-4) inhibitors for the treatment of type 2 diabetes, Nordhoff et al. determined the metabolic stability of a number of three-heteroatom five-membered heterocycles (Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The orientations of the heteroatoms within these rings were important factors for metabolic stability. The lower lipophilicity of the 1,3,4-oxadiazole analogue <b>108</b> might explain why it was more metabolically stable than the 1,2,4-oxadiazole analogues <b>106</b> and <b>107</b>. Also, as pointed out in the previous example,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> if the five-membered heteroarene is the site of metabolism, the 1,2,4-oxadiazole analogues might be susceptible to metabolic ring-opening. The improvement in metabolic stability of the 1,2,4-triazole analogue <b>110</b> over the 1,2,3-triazole analogue <b>109</b> might in part be explained by the slight decrease in lipophilicity of analogue <b>110</b>.</div><figure id="fig31" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0032.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. In vitro potency and LM data for selected DPP-4 inhibitors.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">All of the previous examples involved replacing one five-membered heteroarene for another. However, another strategy for reducing the metabolism of a five-membered heteroarene is to replace it with a six-membered heteroaromatic ring, which tends to be more electron poor than a five-membered heteroarene. Eastwood et al. illustrated this method in their A<sub>2B</sub> receptor antagonists program where they replaced a furan ring for a pyridine ring (Figure <a data-tab="pane-pcw-Figures" href="#fig32" id="" class=" internalNav">32</a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The metabolic stability of the furan analogue <b>111</b> was improved in RLM when the ring was replaced with a pyridine to give analogue <b>112</b>. While the improvement in metabolic stability was modest, it eliminated the potential for bioactivation that might have occurred with the furan.</div><figure id="fig32" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0033.jpeg" id="gr32" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. In vitro potency and microsomal stability for selected A<sub>2B</sub> receptor antagonists.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Six-Membered Heteroarenes</h3><div class="NLM_p">Six-membered heteroaryl groups are often used to replace aryl groups to improve the physical properties and metabolic stability of a drug.<a onclick="showRef(event, 'ref9 ref21'); return false;" href="javascript:void(0);" class="ref ref9 ref21">(9, 21)</a> However, six-membered heteroaryl groups may also be metabolized at either the carbon or heteroatom. Strategies for improving the metabolic stability of these rings often involve substituting or replacing the site of metabolism on the ring. Also, adding an additional nitrogen to the ring can serve to replace the site of metabolism, lower the LogD<sub>7.4</sub>, and decrease the basicity of the ring. Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> summarizes some of the physical properties for common six-membered ring heteroarenes.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. cLogP, cLogD<sub>7.4</sub>, and p<i>K</i><sub>a</sub> for Some Common Six-Membered Ring Heteroaromatics<a class="ref internalNav" href="#tbl3-fn1" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0001.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">See ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">See ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>.</p></div><div class="footnote" id="tbl3-fn1"><sup>Table c</sup><p class="last">p<i>K</i><sub>a</sub> refers to the Het ⇆ HetH<sup>+</sup> equilibrium.</p></div></div><div></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Six-Membered Heteroarenes. One Nitrogen</h3><div class="NLM_p">In their anticancer program on FMS-like receptor tyrosine kinase 3 (FLT3) inhibitors, Ishida showed how the metabolism of an analogue containing a pyridine was improved by blocking the site of metabolism or adding a nitrogen to the ring (Figure <a data-tab="pane-pcw-Figures" href="#fig33" id="" class=" internalNav">33</a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Metabolism studies on a related analogue suggested that the 2-position of the pyridine ring on analogue <b>113</b> was a major site of metabolism. To circumvent this problem, they blocked the 2-position with a methyl group (<b>114</b>), but it showed no improvement in metabolic stability. However, the 2-pyridone and pyridine <i>N</i>-oxide analogues <b>115</b> and <b>116</b>, respectively, had better metabolic stability than <b>113</b>. In addition, the analogue that contained a pyrimidine (<b>117</b>) had improved metabolic stability. Analogues <b>115</b>–<b>117</b> increased the polarity of the ring and decreased the electron density at the C-2 position as a means for improving metabolic stability.</div><figure id="fig33" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0034.jpeg" id="gr33" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. In vitro potency and metabolic stability of selected FLT3 inhibitors<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> (MOLM-13 cells are from the human acute myeloid leukemia cell line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Bailey and co-workers employed the strategy of reducing the polarity of the pyridine ring to improve the metabolic stability of their acid pump antagonist (APA) <b>118</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig34" id="" class=" internalNav">34</a>).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The metabolic stability of <b>118</b> was improved by over 5-fold when the pyridine was replaced with the more polar pyrimidinone (<b>119</b>) or a pyridin-4-one (<b>120</b>) ring. Analogue <b>120</b> had the best overall profile with respect to potency and metabolic stability, so it was advanced into a rat acid secretion model where it was efficacious at 1 mg/kg, po.</div><figure id="fig34" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0035.jpeg" id="gr34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. In vitro potency and metabolic stability for selected APAs.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The report by Gao et al. on matrix metalloproteinase 13 (MMP-13) inhibitors for rheumatoid and osteoarthritis provided another example where a pyrimidine analogue was more metabolically stable than its pyridine congener (Figure <a data-tab="pane-pcw-Figures" href="#fig35" id="" class=" internalNav">35</a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The pyrimidine analogue <b>125</b> was marginally more metabolically stable than the corresponding pyridine analogue <b>123</b>. However, for the analogues where R<sub>1</sub> = C(OH)Me<sub>2</sub>, the metabolic stability of the pyrimidine analogue <b>126</b> was significantly better than the pyridine analogue <b>124</b>. The increased polarity that the pyrimidine ring provides may account for the improved metabolic stability of these analogues.</div><figure id="fig35" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0036.jpeg" id="gr35" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. In vitro potency and metabolic stability of selected MMP-13 inhibitors.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> %QH is the percent of hepatic clearance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another approach that has been used to improve the metabolic stability of compounds containing pyridines is to saturate the ring. In the Rho-associated coiled-coil containing serine/threonine protein kinase type 2 (ROCK2) inhibitors reported by Morwick et al. their initial lead compound contained a pyridine (<b>127</b>), but it had poor metabolic stability (Figure <a data-tab="pane-pcw-Figures" href="#fig36" id="" class=" internalNav">36</a>).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Through SAR (structure–activity relationship) studies, Morwick et al. found that the 4- and 3-piperidinyl analogues <b>128</b> and <b>129</b> had a significant increase in HLM stability compared to the parent pyridine analogue. The added polarity of the more basic piperidine rings may explain the improvement in metabolic stability.</div><figure id="fig36" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0037.jpeg" id="gr36" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. In vitro potency and metabolic stability of selected ROCK2 inhibitors.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example of how metabolite identification studies can be used to design around metabolism issues on pyridines was illustrated by Ceccarelli and co-workers (Figure <a data-tab="pane-pcw-Figures" href="#fig37" id="" class=" internalNav">37</a>).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Compound <b>130</b> was a lead in their metabotropic glutamate receptor type 5 (mGlu5) antagonist program, but it was readily metabolized by microsomes. Metabolite identification studies revealed that the oxidation products on the upper ring were the major metabolites (analogues <b>131</b> and <b>132</b>), whereas metabolism on the lower ring was minor. Ceccarelli et al. prepared the two major metabolites and found that the added polarity of the hydroxyl groups improved the metabolic stability of these compounds, but the activity at mGlu5 suffered, so they focused on preparing analogues that were designed to block the sites of metabolism. Analogue <b>133</b> had a nitrogen at the site where metabolism was occurring on the upper ring of the parent compound, which led to an improvement in RLM. Compound <b>134</b> had the lower pyridine ring replaced with a pyrimidine, which also led to an improvement in RLM. They also removed the methyl group on the upper ring that was being metabolized and added a fluorine atom at another site of metabolism. This led to compound <b>135</b>, which was slightly less stable in RLM than parent compound <b>130</b>. However, by replacing the lower pyridine ring on <b>135</b> for a pyrimidine ring, they obtained analogue <b>136</b>, which had virtually no RLM turnover and was orally active in their in vivo model for anxiety (MED = 3 mg/kg, po).</div><figure id="fig37" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0038.jpeg" id="gr37" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. In vitro potency and metabolic stability of selected mGlu5 antagonists.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Arrows indicate sites of oxidation observed on metabolites generated with HLM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Six-Membered Heteroarenes: Two Nitrogens</h3><div class="NLM_p">While the strategy of adding a nitrogen to a pyridine ring can be a useful for reducing metabolism, there are examples when the heterocycle with two nitrogens has to be modified to improve metabolism. For example, in their anti-diabetes program on G-protein-coupled receptor 119 (GPR119) agonists, Kalgutkar et al. observed that the pyrimidine compound <b>137</b> underwent metabolic activation and GSH conjugation to give two major metabolites <b>138</b> and <b>139</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig38" id="" class=" internalNav">38</a>).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The authors proposed that the GSH adducts formed through a nucleophilic aromatic substitution reaction onto the pyrimidine. The negatively charged Meisenheimer complex that forms in the proposed mechanism would be stabilized by the 5-cyano group on the pyrimidine ring. Kalgutkar et al. reasoned that if they added a group to the pyrimidine ring that destabilized the Meisenheimer complex, they should reduce the formation of GSH adducts. To that end, they prepared the 5-methylpyrimidine derivative <b>140</b> that, upon incubation with HLM, GSH, and NADPH, did not form GSH adducts. Presumably, the 5-methyl group destabilizes the buildup of charge on the pyrimidine that would be necessary for the Meisenheimer complex to form. While the biological activity of the 5-cyano analogue was not disclosed, the 5-methylpyrimidine was reported in another paper to be an important analogue for understanding the conformational preferences of GPR119 agonism.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><figure id="fig38" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0039.jpeg" id="gr38" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 38. GPR119 agonists containing 5-substituted pyrimidines: propensity for GSH adduct formation.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75, 76)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig38"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example of how GSH conjugation was reduced on a six-membered heterocycle containing two nitrogens was illustrated in a report on corticotropin-releasing factor-1 receptor (CRF<sub>1</sub>) antagonists containing a pyrazin-2(1<i>H</i>)-one (Figure <a data-tab="pane-pcw-Figures" href="#fig39" id="" class=" internalNav">39</a>). Hartz et al. initially reported on lead compound <b>141</b>, which was orally efficacious in a rodent model of anxiety but displayed high rat iv clearance.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Metabolite identification studies indicated that the peripheral methoxy groups were the main sites of metabolism, and oxidation on the pyrazin-2(1<i>H</i>)-one was negligible. Further SAR studies on this series, directed at replacing or removing the metabolically labile methoxy groups, led them to BMS-665053<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> (<b>142</b>), a compound that had a 10-fold improvement in rat iv clearance.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Additional metabolite ID studies on <b>142</b> revealed that the pyrazin-2(1<i>H</i>)-one was susceptible to oxidation and GSH conjugation.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The suggested intermediate that led to pyrazin-2(1<i>H</i>)-one metabolism was the chloroepoxide <b>146</b>, which after hydrolysis or reaction with GSH led to the observed oxidized metabolites <b>149</b> and <b>150</b> and GSH adducts <b>147</b> and <b>148</b>. Metabolism was also observed on the arylamine portion of <b>142</b> but to a lesser extent. Replacing the chloride on the pyrazin-2(1<i>H</i>)-one ring with a bromide gave compound <b>143</b>, which in metabolism studies with RLM showed slightly less oxidation and GSH conjugation. The 5-methyl analogue <b>144</b> showed a significant increase in GSH adduct formation on the pyrazin-2(1<i>H</i>)-one ring over the 5-chloro analogue, while the 5-cyano analogue <b>145</b> had negligible metabolism at the pyrazin-2(1<i>H</i>)-one ring. The trend in the amount of metabolism observed on the pyrazin-2(1<i>H</i>)-one ring can in part be explained by the inductive effects of the substituents at the 5-positon. The electron withdrawing 5-cyano group makes the double bond less prone to oxidation, while the electron rich 5-methyl group makes it more susceptible to oxidation. Bromide and chloride are considered to be less electron withdrawing than the cyano group,<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80, 81)</a> which might explain why the 5-bromo and 5-chloro analogues show more metabolism on the pyrazin-2(1<i>H</i>)-one ring than <b>145</b>. Analogues <b>142</b> and <b>143</b> differ from <b>144</b> and <b>145</b> by the stereochemistry of the α-methyl group. How this subtle change influenced the metabolism cannot be determined, since analogues with the same α-methyl stereochemistry were not reported. Nevertheless, the trend in GSH conjugation of the pyrazinone ring for analogues <b>142</b>–<b>145</b> is consistent with the electronic withdrawing properties of the substituent on the 5-position. From the standpoint of potency, metabolism, and rat PK, the 5-cyano analogue (<b>145</b>, BMS-721709<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a>) was the most promising lead in this report, but further development of this compound has not yet been disclosed.</div><figure id="fig39" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Figure 39</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0040.jpeg" id="gr39" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 39. CRF<sub>1</sub> antagonists containing pyrazin-2(1<i>H</i>)-ones: propensity for ring oxidation and GSH adduct formation.<a onclick="showRef(event, 'ref77 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref79">(77-79)</a> A single bracket on the structure of the metabolites indicates that the regiochemistry has not been assigned. Arrows indicate sites of metabolism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig39"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Fused Bicyclic Heteroaromatics</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76277" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76277" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As with the heteroaromatic rings discussed above, the strategies for reducing the metabolism of fused bicyclic heteroaromatics involve blocking the sites of metabolism and reducing the electron density of the ring by attaching polar groups or adding heteroatoms to the ring. For example, in their work on therapies for major depressive disorder, Bannwart et al. described the optimization of novel triple reuptake inhibitors (TRI) that contained a benzothiophene (<b>151</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig40" id="" class=" internalNav">40</a>).<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> The metabolic stability of analogue <b>151</b> was improved by replacing the ring with either an azaindole ring (<b>152</b>) or indazole ring (<b>153</b>). Both changes led to analogues that were less lipophilic than analogue <b>151</b>, which may explain the improved metabolic stability. In addition, if the benzothiophene ring on compound <b>151</b> is the site of metabolism, it may be prone to oxidation on the phenyl ring and/or sulfur atom, which is precedented in the literature.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Analogues <b>152</b> and <b>153</b> may have better stability than <b>151</b>, since the metabolically labile benzothiophene was replaced with an azaindole and indazole, respectively. While the indazole containing analogue <b>153</b> had the best metabolic stability in this set of compounds, it had the undesired attribute of being a CYP2D6 inhibitor.</div><figure id="fig40" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Figure 40</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0041.jpeg" id="gr40" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 40. Monoamine reuptake <i>K</i><sub>i</sub> values and in vitro metabolism data for selected TRI.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> SERT, NET, DAT are the serotonin transporter, norepinephrine transporter, and dopamine transporter, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig40"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another report containing examples of fused 5,6 heteroaromatic rings was published by Wishka et al. in their work on agonists for the α7 neuronal nicotinic acetylcholine receptor (α7 nAChR) (Figure <a data-tab="pane-pcw-Figures" href="#fig41" id="" class=" internalNav">41</a>).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The indole ring on analogue <b>154</b> was replaced with a benzofuran ring (<b>155</b>), which improved metabolic stability. However, benzofuran analogue <b>155</b> was positive in the reactive metabolite assay, indicating that an electrophilic metabolite was being formed. Additional metabolite identification studies with analogue <b>155</b> suggested that a glutathione ethyl ester (GSH-EE) adduct had formed on the phenyl ring of the benzofuran. The authors mentioned that the position of the carboxamide on the phenyl ring of <b>155</b> may have had an influence on bioactivation, since the regioisomeric benzofuran analogue <b>156</b>, which had a para-substituted carboxamide, was negative in the reactive metabolite assay. The related furopyridine analogue <b>157</b> was also negative in the reactive metabolite assay, but the added polarity of the pyridyl group did not improve the metabolic stability of the compound.</div><figure id="fig41" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Figure 41</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0042.jpeg" id="gr41" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 41. In vitro activity and rat liver microsomal profiles for selected α7 nAChR agonists. RLM data are expressed as percent parent remaining after 1 h.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The reactive metabolite assay (RMA) was conducted in the presence of HLM and GSH-EE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig41"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A paper containing the 5,6-heteroaromatic ring system, imidazopyrimidine, was published by Linton et al. from their androgen receptor (AR) antagonist program for prostate cancer (Figure <a data-tab="pane-pcw-Figures" href="#fig42" id="" class=" internalNav">42</a>).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Although the lead compound <b>158</b> had desirable rat PK, this compound was metabolized on the imidazopyrimidine ring by aldehyde oxidase (AO). Unlike CYP P450s, AO delivers an oxygen atom as a nucleophile and is known to add to electron-deficient carbons in N-heterocycles.<a onclick="showRef(event, 'ref20 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref20 ref85 ref86">(20, 85, 86)</a> To decrease the amount of metabolism by AO, Linton et al. prepared an analogue with one less nitrogen in the ring to increase the electron density of the ring, which resulted in analogue <b>159</b> that was no longer a substrate for AO. While the oxidation through AO was minimized, CYP P450-mediated metabolism increased, which was thought to be due to the higher lipophilicity of <b>159</b>. To modify the electronics of the imidazopyrimidine ring, they also prepared analogues with various substituents at the 6-position (<b>160</b>–<b>162</b>). However, these compounds were all substrates of AO, even though their electronic properties and lipophilicity differed significantly. On the other hand, AO oxidation was eliminated when the 7-position was substituted with either a methoxy (<b>163</b>) or morpholine group (<b>164</b>), suggesting that this was the site of AO oxidation on compound <b>158</b>. This last example illustrates that, in some cases, making a N-heterocycle too electron deficient to avoid CYP P450 mediated oxidation may make it more prone to AO oxidation.</div><figure id="fig42" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Figure 42</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0043.jpeg" id="gr42" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 42. SAR of selected AR antagonists toward oxidation by AO. A “yes” indicates that qualitative formation was observed in human S9 fraction (HS9) without NADPH which suggests AO oxidation. HLM is measured as extraction ratio (ER). cLogP values in this figure are those reported by Linton et al.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig42"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example of a 6,6-heteroaromatic system was reported by Lunniss et al. in their phosphodiesterase 4 (PDE4) inhibitor program (Figure <a data-tab="pane-pcw-Figures" href="#fig43" id="" class=" internalNav">43</a>).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The compound containing a quinoline (<b>165</b>) had acceptable PK parameters in rat and dog, but they discovered that an oxidized analogue <b>166</b> was formed in monkey hepatocytes. This metabolite was synthetically prepared and was found to be more stable than the parent compound in monkey PK studies. To further improve the metabolic stability of compound <b>165</b>, the quinoline ring was replaced with a cinnoline to give analogue <b>167</b>. The added nitrogen in the cinnoline ring blocked the metabolic site of the quinoline and lowered the electron density of the ring.</div><figure id="fig43" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Figure 43</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0044.jpeg" id="gr43" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 43. In vitro activity and in vivo PK parameters for selected PDE4 inhibitors.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The potency data are reported as the inhibition of LPS induced TNF-α production in human whole blood (hWB).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig43"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70840" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70840" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this review, we have given specific examples where the metabolic profile of the compound was improved by modifying the molecule at or near the heterocycle. In several of the examples discussed above, metabolite identification studies pointed to the heterocycle as the site of metabolism, and direct modification of the heterocycle led to an increase in metabolic stability. However, in the many of the other examples, the site of metabolism was not elucidated and may have occurred away from the heterocycle. So the effect that changing the heterocycle had on improving metabolism may have been indirect. Nonetheless, whether the change made to the heterocycle had a direct or indirect effect on metabolism, there is still value in examining the general trends used for improving the metabolism that emerge from this review.</div><div class="NLM_p">For saturated heterocyclic rings, adding fluorine atoms, polar groups, or reducing the ring size helps to reduce metabolism. Fluorine atoms served to lower the electron density of the ring as well as block potential sites of metabolism. Polar groups were either appended to the ring or incorporated into the ring to give compounds with lower lipophilicity. In some cases adding a polar group had a detrimental effect on metabolism, as was illustrated by the example from Mastalerz et al., where the hydroxyl and lactam diazepane analogues were less metabolically stable than the unsubstituted diazepane derivative.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Reducing the ring size generally improved metabolic stability. However, there were some exceptions in examples with pyrrolidine rings where the larger piperidine analogue was found to be more metabolically stable.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a></div><div class="NLM_p">For five-membered heteroarenes, adding one or more heteroatoms usually results in an increase in polarity and a ring with lower electron density, which helps to reduce metabolism. For example, we found several examples where the more reactive thiophene, furan, and thiazole rings were replaced with less electron rich rings like isoxazoles, thiadiazole, oxadiazoles, pyrazoles, and triazoles that led to analogues with lower metabolism.</div><div class="NLM_p">The position of the heteroatoms in five-membered heteroarenes also influences metabolism. In two examples,<a onclick="showRef(event, 'ref65 ref68'); return false;" href="javascript:void(0);" class="ref ref65 ref68">(65, 68)</a> analogues containing the 1,2,4-oxadiazole were less stable than their 1,3,4-oxadiazole congeners. A recent review comparing the HLM CL of 1,2,4- and 1,3,4-oxadiazole congeners confirms the fact that 1,3,4-oxadiazoles tend to be more metabolically stable.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Also, in the case of the triazole, there were two examples where the 1,2,4-triazole analogues were more stable than their 1,2,3-triazole congeners.<a onclick="showRef(event, 'ref64 ref68'); return false;" href="javascript:void(0);" class="ref ref64 ref68">(64, 68)</a></div><div class="NLM_p">Another method used to improve the metabolic profile of a five-membered heteroarene was to install a group that served as an alternative site for metabolism. This was illustrated in the work by Obach where they showed that on meloxicam the main site of metabolism was the methyl group which spared the thiazole ring from oxidative ring-opening that was seen with sudoxicam.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> This was discovered retrospectively, but adding a decoy group to prevent the formation of reactive metabolites could be a useful strategy for preventing the bioactivation of other compounds containing a five-membered heteroarene.</div><div class="NLM_p">For six-membered ring heteroarenes adding polar groups, fluorine atoms, or inserting nitrogens into the ring helps to decrease metabolism. Attaching electron withdrawing groups and adding nitrogen atoms to the ring generally had the beneficial effect of making these compounds less prone to metabolism. However, in some instances, an electron deficient ring was more prone to nucleophilic attack by GSH as demonstrated by Kalgutkar et al. in their work with the GPR119 agonist containing a 4-cyanopyrimidine.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Also, Linton et al. found that the electron deficient imidazopyrimidine, while relatively stable to CYPs, was susceptible to nucleophilic oxygen attack mediated by AO.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><div class="NLM_p last">Heterocycles are a broad class of compounds, covering a diverse set of ring systems with various types of heteroatoms. The heterocyclic compounds illustrated in this review cover only a small subset of this broad class of compounds, but the general principles of lowering lipophilicity and blocking sites of metabolism should serve as a useful starting point for solving metabolic issues on other heterocycles. Changing the ring size or the arrangement of the heteroatoms has also been used to improve metabolism, but the generality of these trends is less clear and their applicability to other heterocycles deserves further investigation. In the end, a certain amount of experimentation is necessary to understand the best way to improve the metabolism of any particular heterocycle. Knowing the identity of the metabolites can greatly facilitate this endeavor. The examples in this review should provide medicinal chemists with a foundation for understanding techniques used to solve the issues of heterocycle metabolism.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm300343m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Fotsch</span> - <span class="hlFld-Affiliation affiliation">Department of Therapeutic Discovery, Amgen,
Inc., One Amgen Center Drive, Thousand Oaks, California
91320, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#90f3f6ffe4e3f3f8d0f1fdf7f5febef3fffd"><span class="__cf_email__" data-cfemail="1370757c6760707b53727e74767d3d707c7e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. St. Jean</span> - <span class="hlFld-Affiliation affiliation">Department of Therapeutic Discovery, Amgen,
Inc., One Amgen Center Drive, Thousand Oaks, California
91320, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="43" class="article__inlineFigure"><h2 class="fig-label">David J. St. Jean,Jr.</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=BIO-d917e2224-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>David J. St. Jean, Jr.</b> received his BA from Goucher College, MD, working under the direction of Prof. David Horn. In 1999, he matriculated to the University of Pennsylvania where he received his Ph.D. in Organic Chemistry under the supervision of Prof. Gary Molander. David’s research focused on the development of novel methods utilizing samarium(II) iodide as well as the total synthesis of deacetoxyalcyonin acetate. Since 2004, he has been a medicinal chemist at Amgen where he currently holds the title of Principal Scientist.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Christopher Fotsch</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=BIO-d917e2229-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Christopher Fotsch</b> is a Director of Research in the Department of Therapeutic Discovery at Amgen, Inc. He received his Ph.D. in Organic Chemistry from the University of California, Irvine under the direction of Professor A. Richard Chamberlin, and he was a NIH Postdoctoral Fellow in the laboratory of Professor Chi-Huey Wong at The Scripps Research Institute, CA. At Amgen, he has led medicinal chemistry programs in the fields of oncology, neurosciences, and metabolic disorders. His research interests include the discovery of novel therapies for unmet medical needs, structure-based drug design, and enzyme-catalyzed organic synthesis.</p></figure></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i19" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i19"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i20" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i20"> Abbreviations Used</h2><tr><td class="NLM_term">%QH</td><td class="NLM_def"><p class="first last">percent of hepatic clearance</p></td></tr><tr><td class="NLM_term">%TO</td><td class="NLM_def"><p class="first last">percent turnover</p></td></tr><tr><td class="NLM_term">11β-HSD1</td><td class="NLM_def"><p class="first last">11β-hydroxysteroid dehydrogenase type I</p></td></tr><tr><td class="NLM_term">5-HT1A, -1B, -2C, -1D</td><td class="NLM_def"><p class="first last">serotonin receptor subtypes 1A, 1B, 2C, and 1D</p></td></tr><tr><td class="NLM_term">A<sub>2A</sub> and A<sub>2B</sub></td><td class="NLM_def"><p class="first last">adenosine receptor types 1 and 2A</p></td></tr><tr><td class="NLM_term">α7 nAChR</td><td class="NLM_def"><p class="first last">α7 neuronal nicotinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">AO</td><td class="NLM_def"><p class="first last">aldehyde oxidase</p></td></tr><tr><td class="NLM_term">APA</td><td class="NLM_def"><p class="first last">acid pump agonist</p></td></tr><tr><td class="NLM_term">AR</td><td class="NLM_def"><p class="first last">androgen receptor</p></td></tr><tr><td class="NLM_term">CB1 and CB2</td><td class="NLM_def"><p class="first last">cannabinoid receptors 1 and 2</p></td></tr><tr><td class="NLM_term">CCR5</td><td class="NLM_def"><p class="first last">C–C chemokine receptor type 5</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">COX</td><td class="NLM_def"><p class="first last">cyclooxygenase</p></td></tr><tr><td class="NLM_term">CRF1</td><td class="NLM_def"><p class="first last">corticotropin-releasing factor-1 receptor</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">DLM</td><td class="NLM_def"><p class="first last">dog liver microsomes</p></td></tr><tr><td class="NLM_term">DPP-4</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase IV</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">EphB3</td><td class="NLM_def"><p class="first last">erythropoietin-producing hepatocellular carcinoma receptor type B3</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">extraction ratio</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">FMS-like receptor tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">FXa</td><td class="NLM_def"><p class="first last">factor Xa</p></td></tr><tr><td class="NLM_term">GPR119</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor 119</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">GSH-EE</td><td class="NLM_def"><p class="first last">glutathione ethyl ester</p></td></tr><tr><td class="NLM_term">GlyT1</td><td class="NLM_def"><p class="first last">human glycine transporter 1</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">HDAC1</td><td class="NLM_def"><p class="first last">histone deacetylase 1</p></td></tr><tr><td class="NLM_term">HER2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2</p></td></tr><tr><td class="NLM_term">Hh</td><td class="NLM_def"><p class="first last">Hedgehog</p></td></tr><tr><td class="NLM_term">HH3</td><td class="NLM_def"><p class="first last">histone H3</p></td></tr><tr><td class="NLM_term">H<sub>3</sub>R and H<sub>4</sub>R</td><td class="NLM_def"><p class="first last">human histamine receptor subtypes 3 and 4</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">HS9</td><td class="NLM_def"><p class="first last">human S9 fraction</p></td></tr><tr><td class="NLM_term">hWB</td><td class="NLM_def"><p class="first last">human whole blood</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">Janus kinase 2</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">MF%</td><td class="NLM_def"><p class="first last">metabolic bioavailability prediction (assumes 100% total absorption)</p></td></tr><tr><td class="NLM_term">mGlu5</td><td class="NLM_def"><p class="first last">metabotropic glutamate receptor type 5</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsomes</p></td></tr><tr><td class="NLM_term">MMP-13</td><td class="NLM_def"><p class="first last">matrix metalloproteinase 13</p></td></tr><tr><td class="NLM_term">MoLM</td><td class="NLM_def"><p class="first last">monkey liver microsomes</p></td></tr><tr><td class="NLM_term">MOLM-13</td><td class="NLM_def"><p class="first last">human acute myeloid leukemia cell line</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">MurI</td><td class="NLM_def"><p class="first last">glutamate racemase</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">Norepinephrine transporter</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">PDE4</td><td class="NLM_def"><p class="first last">phosphodiesterase 4</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">RMA</td><td class="NLM_def"><p class="first last">reactive metabolite assay</p></td></tr><tr><td class="NLM_term">ROCK2</td><td class="NLM_def"><p class="first last">Rho-associated coiled-coil containing serine/threonine protein kinase type 2</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">Sprague-Dawley rat</p></td></tr><tr><td class="NLM_term">SERT</td><td class="NLM_def"><p class="first last">serotonin transporter</p></td></tr><tr><td class="NLM_term">Tpo</td><td class="NLM_def"><p class="first last">thrombopoietin</p></td></tr><tr><td class="NLM_term">TRI</td><td class="NLM_def"><p class="first last">triple reuptake inhibitor</p></td></tr><tr><td class="NLM_term">UDPGA</td><td class="NLM_def"><p class="first last">uridine 5′-diphosphoglucuronic acid</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub> and <i>V</i><sub>dss</sub></td><td class="NLM_def"><p class="first last">volume of distribution, under steady state</p></td></tr><tr><td class="NLM_term"><i>V</i><sub><i>z</i></sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 88 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A. Y. H.</span><span> </span><span class="NLM_article-title">Role of pharmacokinetics and metabolism in drug discovery and development</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=9443165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADyaK1cXjslSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1997&pages=403-449&author=J.+H.+Linauthor=A.+Y.+H.+Lu&title=Role+of+pharmacokinetics+and+metabolism+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Role of pharmacokinetics and metabolism in drug discovery and development</span></div><div class="casAuthors">Lin, Jiunn H.; Lu, Anthony Y. H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-449</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with approx. 500 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVCGyQIHSc8rVg90H21EOLACvtfcHk0ljqkuOouNUtkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslSrtQ%253D%253D&md5=6478056298f03045d8be510faa053221</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DLu%26aufirst%3DA.%2BY.%2BH.%26atitle%3DRole%2520of%2520pharmacokinetics%2520and%2520metabolism%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DPharmacol.%2520Rev.%26date%3D1997%26volume%3D49%26spage%3D403%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kumar, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surapaneni, S.</span><span> </span><span class="NLM_article-title">Role of drug metabolism in drug discovery and development</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1002%2Fmed.1016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=11579440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=397-411&author=G.+N.+Kumarauthor=S.+Surapaneni&title=Role+of+drug+metabolism+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Role of drug metabolism in drug discovery and development</span></div><div class="casAuthors">Kumar, Gondi N.; Surapaneni, Sekhar</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">397-411</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  This article reviews the role of drug metab. in drug discovery and development.  Metab. by the host organism is 1 of the most important determinants of the pharmacokinetic profile of a drug.  High metabolic lability usually leads to poor bioavailability and high clearance.  Formation of active or toxic metabolites will have an impact on the pharmacol. and toxicol. outcomes.  There is also potential for drug-drug interactions with coadministered drugs due to inhibition and/or induction of drug metab. pathways.  Hence, optimization of the metabolic liability and drug-drug interaction potential of the new chem. entities are some of the most important steps during the drug discovery process.  The rate and site(s) of metab. of new chem. entities by drug metabolizing enzymes is amenable to modulation by appropriate structural changes.  Similarly, the potential for drug-drug interactions can also be minimized by appropriate structural modifications to the drug candidate.  However, the optimization of the metabolic stability and drug-drug interaction potential during drug discovery stage was largely by empirical methods and by trial and error.  Recently, a lot of effort was applied to develop predictive methods to aid the optimization process during drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnXC3CBCcCZbVg90H21EOLACvtfcHk0ljqkuOouNUtkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbg%253D&md5=1ec2b0c0cb720ffd2be45f59145f9b70</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fmed.1016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.1016%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DG.%2BN.%26aulast%3DSurapaneni%26aufirst%3DS.%26atitle%3DRole%2520of%2520drug%2520metabolism%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2001%26volume%3D21%26spage%3D397%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. K.</span><span> </span><span class="NLM_article-title">Property-based design: optimization of drug absorption and pharmacokinetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000407e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1313-1333&author=H.+van+de+Waterbeemdauthor=D.+A.+Smithauthor=K.+Beaumontauthor=D.+K.+Walker&title=Property-based+design%3A+optimization+of+drug+absorption+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Property-based design: optimization of drug absorption and pharmacokinetics</span></div><div class="casAuthors">van de Waterbeemd, Han; Smith, Dennis A.; Beaumont, Kevin; Walker, Don K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1313-1333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 223 refs.  The authors discuss some aspects of the properties of biol. barriers.  In different sections the estn. of drug absorption via important barriers including gastrointestinal tract, blood-brain barrier, and skin are reviewed.  Various approaches for the measurement and computation of physicochem. and mol. properties currently used in the optimization of absorption as well as the use of physicochem. properties in the design of optimal pharmacokinetic profiles are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQwsmoX0-mbVg90H21EOLACvtfcHk0ljqkuOouNUtkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D&md5=3183baedca70020f4ce27f306ba0997e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm000407e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000407e%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DProperty-based%2520design%253A%2520optimization%2520of%2520drug%2520absorption%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1313%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Jang, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, D. T.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and its role in small molecule drug discovery research</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1002%2Fmed.1015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=11579439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=382-396&author=G.+R.+Jangauthor=R.+Z.+Harrisauthor=D.+T.+Lau&title=Pharmacokinetics+and+its+role+in+small+molecule+drug+discovery+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and its role in small molecule drug discovery research</span></div><div class="casAuthors">Jang, Graham R.; Harris, Robert Z.; Lau, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">382-396</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Pharmacokinetics (PK), which describes the disposition of a drug in the body, should be a primary consideration in the selection of a drug candidate, ultimately contributing to its eventual clin. success or failure.  Accordingly, a sound understanding of PK concepts and an appreciation of the judicious use of PK and related (e.g., metab., transporter) data in drug discovery can be beneficial to those involved in the process.  This review defines important PK parameters (e.g., clearance, vol. of distribution, half-life), describes methods of PK data anal. (noncompartmental vs. compartmental) and provides an overview of addnl. concepts such as allometric scaling, PK/pharmacodynamic modeling, and nonlinear PK.  Furthermore, the role and strategic use of PK screens in drug discovery are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6ZQgdKuejILVg90H21EOLACvtfcHk0lgVNa0bqXfg1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbs%253D&md5=b976d2cfab65b2e3ede9c103c94c37cc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fmed.1015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.1015%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DG.%2BR.%26aulast%3DHarris%26aufirst%3DR.%2BZ.%26aulast%3DLau%26aufirst%3DD.%2BT.%26atitle%3DPharmacokinetics%2520and%2520its%2520role%2520in%2520small%2520molecule%2520drug%2520discovery%2520research%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2001%26volume%3D21%26spage%3D382%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Thompson, T. N.</span><span> </span><span class="NLM_article-title">Optimization of metabolic stability as a goal of modern drug design</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1002%2Fmed.1017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=11579441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=412-449&author=T.+N.+Thompson&title=Optimization+of+metabolic+stability+as+a+goal+of+modern+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of metabolic stability as a goal of modern drug design</span></div><div class="casAuthors">Thompson, Thomas N.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">412-449</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Metab. and other pharmacokinetic (PK) studies have always played a crit. role in helping to optimize the bioavailability and duration of action of new drugs thereby increasing their success rate.  With the advent of automated combinatorial synthesis, high-throughput pharmacol. testing, and the ability to create extensive databases in the past decade, drug discovery has undergone an amazing evolution.  With the increased throughput of drug discovery, metab. and other PK studies have evolved to keep pace.  Often called "early ADME" studies, these studies are characterized by parallel processing and higher throughput than before.  This article focuses on a particular class of early ADME (absorption, distribution mechanism and excretion) studies known as "metabolic stability" studies.  The theor. basis for metabolic stability and its relationship to the concept of metabolic intrinsic clearance is briefly presented.  Some key relationships between structure and metab. are summarized.  Several case studies from recent medicinal chem. literature are reviewed to exemplify how metabolic stability studies influenced drug design and led to improvements in bioavailability and half-life.  Finally, future trends in drug metab. and anal. chem. and how they may influence metabolic stability studies are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHQRXfzgmH9rVg90H21EOLACvtfcHk0lgVNa0bqXfg1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbk%253D&md5=405716d9371bea565c4422a5cfabe40d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fmed.1017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.1017%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DT.%2BN.%26atitle%3DOptimization%2520of%2520metabolic%2520stability%2520as%2520a%2520goal%2520of%2520modern%2520drug%2520design%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2001%26volume%3D21%26spage%3D412%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pritchard, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurima-Romet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimer, M. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortimer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cayen, M. N.</span><span> </span><span class="NLM_article-title">A guide to drug discovery: making better drugs: decision gates in non-clinical drug development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=542-553&author=J.+F.+Pritchardauthor=M.+Jurima-Rometauthor=M.+L.+J.+Reimerauthor=E.+Mortimerauthor=B.+Rolfeauthor=M.+N.+Cayen&title=A+guide+to+drug+discovery%3A+making+better+drugs%3A+decision+gates+in+non-clinical+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPritchard%26aufirst%3DJ.%2BF.%26aulast%3DJurima-Romet%26aufirst%3DM.%26aulast%3DReimer%26aufirst%3DM.%2BL.%2BJ.%26aulast%3DMortimer%26aufirst%3DE.%26aulast%3DRolfe%26aufirst%3DB.%26aulast%3DCayen%26aufirst%3DM.%2BN.%26atitle%3DA%2520guide%2520to%2520drug%2520discovery%253A%2520making%2520better%2520drugs%253A%2520decision%2520gates%2520in%2520non-clinical%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D542%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Shu, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T. J.</span><span> </span><span class="NLM_article-title">Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1208%2Fs12248-008-9016-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=18446518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWrsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=178-192&author=Y.-Z.+Shuauthor=B.+M.+Johnsonauthor=T.+J.+Yang&title=Role+of+biotransformation+studies+in+minimizing+metabolism-related+liabilities+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery</span></div><div class="casAuthors">Shu, Yue-Zhong; Johnson, Benjamin M.; Yang, Tian J.</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">178-192</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Metab.-related liabilities continue to be a major cause of attrition for drug candidates in clin. development.  Such problems may arise from the bioactivation of the parent compd. to a reactive metabolite capable of modifying biol. materials covalently or engaging in redox-cycling reactions leading to the formation of other toxicants.  Alternatively, they may result from the formation of a major metabolite with systemic exposure and adverse pharmacol. activity.  To avert such problems, biotransformation studies are becoming increasingly important in guiding the refinement of a lead series during drug discovery and in characterizing lead candidates prior to clin. evaluation.  This article provides an overview of the methods that are used to uncover metab.-related liabilities in a preclin. setting and offers suggestions for reducing such liabilities via the modification of structural features that are used commonly in drug-like mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreD31HEIXrHLVg90H21EOLACvtfcHk0lgVNa0bqXfg1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWrsLvO&md5=f271983898661cb2b6d91ba274ddac97</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1208%2Fs12248-008-9016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-008-9016-9%26sid%3Dliteratum%253Aachs%26aulast%3DShu%26aufirst%3DY.-Z.%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26aulast%3DYang%26aufirst%3DT.%2BJ.%26atitle%3DRole%2520of%2520biotransformation%2520studies%2520in%2520minimizing%2520metabolism-related%2520liabilities%2520in%2520drug%2520discovery%26jtitle%3DAAPS%2520J.%26date%3D2008%26volume%3D10%26spage%3D178%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, J.</span><span> </span><span class="NLM_article-title">Opinion: Can the pharmaceutical industry reduce attrition rates?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=711-716&author=I.+Kolaauthor=J.+Landis&title=Opinion%3A+Can+the+pharmaceutical+industry+reduce+attrition+rates%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKola%26aufirst%3DI.%26aulast%3DLandis%26aufirst%3DJ.%26atitle%3DOpinion%253A%2520Can%2520the%2520pharmaceutical%2520industry%2520reduce%2520attrition%2520rates%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D711%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lhy0JbMxRJRSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kerns, E. H.; Di, L.</span> <span class="citation_source-book">Drug-like Properties: Concepts, Structure, Design and Methods</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1016%2FB978-012369520-8.50008-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=E.+H.+Kerns&author=L.+Di&title=Drug-like+Properties%3A+Concepts%2C+Structure%2C+Design+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FB978-012369520-8.50008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012369520-8.50008-5%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26btitle%3DDrug-like%2520Properties%253A%2520Concepts%252C%2520Structure%252C%2520Design%2520and%2520Methods%26pub%3DAcademic%2520Press%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Smith, D. A.</span><span> </span><span class="NLM_article-title">Discovery and ADMET: Where are we now?</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.2174%2F156802611794480909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=21320070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=467-481&author=D.+A.+Smith&title=Discovery+and+ADMET%3A+Where+are+we+now%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and ADMET: where are we now</span></div><div class="casAuthors">Smith, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-481</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The gradual alignment with all of drug metab. with all aspects of drug discovery and development has led to a complete realignment of the way the work is conducted.  From a background of conducting bespoke in vivo studies much of the work is now in a high throughput screening mode.  Large technol. advances were made, but the nature of drug metab. processes, being multi-system and promiscuous means that much of the help provided to the medicinal chem. is reactive rather than based on fundamental disposition structure-activity relationships.  Lessons learned around the chem. and physicochem. properties more often assocd. with successful discovery and development projects are only moderately helpful when the high value pharmacol. targets of today only yield potent ligands outside of the boundaries these properties describe.  Pivotal to the impact of these properties is the intrinsic permeability of a mol., something not as widely recognized as perhaps it should be.  Metabolic lability is still a problem and the tactics employed are unchanged in 20 years: attempt to lower lipophilicity, if it is too high overall or introduce blocking groups, particularly halogens, after identifying the sites of metab.  Perhaps the greatest success drug metab. science has had over the last fifteen years is it's pivotal role in characterizing drug-drug interactions and providing screening systems and computational models to investigate them.  It still has many undeveloped areas of the science such as the role of metabolites in drug activity and why compds. vary in their extent of biliary excretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEw_2VMNc--bVg90H21EOLACvtfcHk0lhy0JbMxRJRSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSnurs%253D&md5=b4e1b937f2f048a3ec9b97df98b339e6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F156802611794480909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794480909%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26atitle%3DDiscovery%2520and%2520ADMET%253A%2520Where%2520are%2520we%2520now%253F%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2011%26volume%3D11%26spage%3D467%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Warr, W.</span><span> </span><span class="NLM_article-title">ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI)</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1007%2Fs10822-009-9260-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=19194660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVWrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=195-198&author=W.+Warr&title=ChEMBL.+An+interview+with+John+Overington%2C+team+leader%2C+chemogenomics+at+the+European+Bioinformatics+Institute+Outstation+of+the+European+Molecular+Biology+Laboratory+%28EMBL-EBI%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI)</span></div><div class="casAuthors">Warr, Wendy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">195-198</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSOSkQaZrKbLVg90H21EOLACvtfcHk0lhy0JbMxRJRSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVWrtLc%253D&md5=500f68457aff5958db205e63fd6fa00e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs10822-009-9260-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-009-9260-9%26sid%3Dliteratum%253Aachs%26aulast%3DWarr%26aufirst%3DW.%26atitle%3DChEMBL.%2520An%2520interview%2520with%2520John%2520Overington%252C%2520team%2520leader%252C%2520chemogenomics%2520at%2520the%2520European%2520Bioinformatics%2520Institute%2520Outstation%2520of%2520the%2520European%2520Molecular%2520Biology%2520Laboratory%2520%2528EMBL-EBI%2529%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2009%26volume%3D23%26spage%3D195%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span> </span><span class="NLM_article-title">Biotransformation reactions of five-membered aromatic heterocyclic rings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+reactions+of+five-membered+aromatic+heterocyclic+rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0lhy0JbMxRJRSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520reactions%2520of%2520five-membered%2520aromatic%2520heterocyclic%2520rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Drug–protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034170b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=3-16&author=D.+C.+Evansauthor=A.+P.+Wattauthor=D.+A.+Nicoll-Griffithauthor=T.+A.+Baillie&title=Drug%E2%80%93protein+adducts%3A+an+industry+perspective+on+minimizing+the+potential+for+drug+bioactivation+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Ftx034170b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034170b%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DDrug%25E2%2580%2593protein%2520adducts%253A%2520an%2520industry%2520perspective%2520on%2520minimizing%2520the%2520potential%2520for%2520drug%2520bioactivation%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Nassar, A.-E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarimont, C.</span><span> </span><span class="NLM_article-title">Improving the decision-making process in structural modification of drug candidates: reducing toxicity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1055-1064&author=A.-E.+F.+Nassarauthor=A.+M.+Kamelauthor=C.+Clarimont&title=Improving+the+decision-making+process+in+structural+modification+of+drug+candidates%3A+reducing+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA.-E.%2BF.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DClarimont%26aufirst%3DC.%26atitle%3DImproving%2520the%2520decision-making%2520process%2520in%2520structural%2520modification%2520of%2520drug%2520candidates%253A%2520reducing%2520toxicity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D1055%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahakian, D. C.</span><span> </span><span class="NLM_article-title">On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.2174%2F1389200023337360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=12093357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlCqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=379-424&author=A.+S.+Kalgutkarauthor=D.+K.+Dalvieauthor=J.+P.+O%E2%80%99Donnellauthor=T.+J.+Taylorauthor=D.+C.+Sahakian&title=On+the+diversity+of+oxidative+bioactivation+reactions+on+nitrogen-containing+xenobiotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics</span></div><div class="casAuthors">Kalgutkar, Amit S.; Dalvie, Deepak K.; O'Donnell, John P.; Taylor, Timothy J.; Sahakian, Diana C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-424</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The unexpected occurrence of idiosyncratic drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use or failure to release/withdrawal.  This leads to considerable uncertainty in drug development and has led to attempts to try to predict a drug's potential to cause such reactions.  The biotransformation of relatively inert drugs to highly reactive metabolites, commonly referred to as "bioactivation", is now recognized to be an obligatory step in several kinds of drug-induced adverse reactions.  Reactive metabolites can be formed by most, if not all, of the enzymes that are involved in drug metab.  A major theme explored in this review includes the diversity of oxidative bioactivation reactions on nitrogen-contg. xenobiotics including drugs.  A variety of Phase I enzymes including P 450, MAO, and peroxidases bioactivate nitrogen-contg. xenobiotics via direct oxidns. on the nitrogen atom leading to reactive intermediates or by oxidn. at an alternate site in the mol.; for the metabolite to be reactive via the latter sequence nitrogen participation in required.  Examples of direct oxidns. on nitrogen include the N-oxidn. of arom. amines (e.g. procainamide), single electron N-oxidn. of imides (e.g. phenytoin), or α-carbon oxidns. of arylalkyl- or alkylamines (e.g. mianserin), to reactive nitroso, nitrogen free radical and iminium species, resp.  Examples of indirect bioactivation are highlighted with arom. amines (e.g. diclofenac) that undergo p-hydroxylation resulting in the formation of p-aminophenols, two-electron oxidn. of which results in the formation of reactive quinone imines.  Potential strategies that could be utilized in the screening of novel bioactivation pathways are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN5v38ETA3R7Vg90H21EOLACvtfcHk0lhjol4QKBcthQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlCqtrk%253D&md5=957229c769ed130bdcc3083d2d89066a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1389200023337360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200023337360%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DTaylor%26aufirst%3DT.%2BJ.%26aulast%3DSahakian%26aufirst%3DD.%2BC.%26atitle%3DOn%2520the%2520diversity%2520of%2520oxidative%2520bioactivation%2520reactions%2520on%2520nitrogen-containing%2520xenobiotics%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2002%26volume%3D3%26spage%3D379%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span> </span><span class="NLM_article-title">Minimising the potential for metabolic activation in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1517%2F17425255.1.1.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=16922655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=91-142&author=A.+S.+Kalgutkarauthor=J.+R.+Soglia&title=Minimising+the+potential+for+metabolic+activation+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Minimising the potential for metabolic activation in drug discovery</span></div><div class="casAuthors">Kalgutkar, Amit S.; Soglia, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-142</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Investigations into the role of bioactivation in the pathogenesis of xeno-biotic-induced toxicity have been a major area of research since the link between reactive metabolites and carcinogenesis was first reported in the 1930s.  Circumstantial evidence suggests that bioactivation of relatively inert functional groups to reactive metabolites may contribute towards certain drug-induced adverse reactions.  Reactive metabolites, if not detoxified, can covalently modify essential cellular targets.  The identity of the susceptible biomacromol.(s), and the physiol. consequence of its covalent modification, will dictate the resulting toxicol. response (e.g., covalent modification of DNA by reactive intermediates derived from procarcinogens that potentially leads to carcinogenesis).  The formation of drug-protein adducts often carries a potential risk of clin. toxicities that may not be predicted from preclin. safety studies.  Animal models used to reliably predict idio-syncratic drug toxicity are unavailable at present.  Furthermore, considering that the frequency of occurrence of idiosyncratic adverse drug reactions (IADRs) is fairly rare (1 in 1000 to 1 in 10,000), it is impossible to detect such phenomena in early clin. trials.  Thus, the occurrence of IADRs during late clin. trials or after a drug has been released can lead to an unanticipated restriction in its use and even in its withdrawal.  Major themes explored in this review include a comprehensive cataloguing of bioactivation pathways of functional groups commonly utilized in drug design efforts with appropriate strategies towards detection of corresponding reactive intermediates.  Several instances wherein replacement of putative structural alerts in drugs assocd. with IADRs with a latent functionality eliminates the underlying liability are also presented.  Examples of where bioactivation phenomenon in drug candidates can be successfully abrogated via iterative chem. interventions are also discussed.  Finally, appropriate strategies that aid in potentially mitigating the risk of IADRs are explored, esp. in circumstances in which the structural alert is also responsible for the primary pharmacol. of the drug candidate and cannot be replaced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryrPwGKBtP3rVg90H21EOLACvtfcHk0lhjol4QKBcthQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVGhs7s%253D&md5=15a3312335273663b6ef1222534f5428</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.1.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.1.91%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26atitle%3DMinimising%2520the%2520potential%2520for%2520metabolic%2520activation%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D91%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0lhAKeAzHA8Ddg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0lhAKeAzHA8Ddg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-D.</span><span> </span><span class="NLM_article-title">Aldehyde oxidase: an enzyme of emerging importance in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8441</span><span class="NLM_x">–</span> <span class="NLM_lpage">8460</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100888d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8441-8460&author=D.+C.+Prydeauthor=D.+Dalvieauthor=Q.+Huauthor=P.+Jonesauthor=R.+S.+Obachauthor=T.-D.+Tran&title=Aldehyde+oxidase%3A+an+enzyme+of+emerging+importance+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span></div><div class="casAuthors">Pryde, David C.; Dalvie, Deepak; Hu, Qiyue; Jones, Peter; Obach, R. Scott; Tran, Thien-Duc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8441-8460</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidase has for many years been recognized as a metabolizing enzyme contained within the cytosolic compartment of many tissues and in many species.  The first literature ref. to AO dates from the 1930s, but literature citations to this enzyme have been steadily growing ever since, esp. in the past decade.  It has been increasingly recognized in this past decade that AO, through its unique structure, distribution, and substrate recognition, has an important role to play in the metab. of drugs.  In this timely Perspective, we present the current knowledge of the enzyme's expression, its structure, and its distribution across species.  We offer an anal. of substrates recognized by AO and highlight clin. examples where metab. by this enzyme has had significant clin. impact or led to the termination of a drug development program.  Finally, through anal. of the structure of known substrates, we present data to suggest the significant impact AO could play on future drug discovery programs along with strategies that could be employed to mitigate this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALwFS70G6tLVg90H21EOLACvtfcHk0lhAKeAzHA8Ddg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N&md5=972eb9862a7dc7bff024b530ab40de7f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm100888d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100888d%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTran%26aufirst%3DT.-D.%26atitle%3DAldehyde%2520oxidase%253A%2520an%2520enzyme%2520of%2520emerging%2520importance%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8441%26epage%3D8460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Argikar, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">Strategies and chemical design approaches to reduce the potential for formation of reactive metabolic species</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.2174%2F156802611794480891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=21320068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=419-449&author=U.+A.+Argikarauthor=J.+B.+Mangoldauthor=S.+P.+Harriman&title=Strategies+and+chemical+design+approaches+to+reduce+the+potential+for+formation+of+reactive+metabolic+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies and chemical design approaches to reduce the potential for formation of reactive metabolic species</span></div><div class="casAuthors">Argikar, Upendra A.; Mangold, James B.; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-449</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Metabolic activation of new chem. entities to reactive intermediates is routinely monitored in drug discovery and development.  Reactive intermediates may bind to cellular macromols. such as proteins, DNA and may eventually lead to cell death via necrosis, apoptosis or oxidative stress.  The evidence that the ultimate outcome of metabolic activation is an adverse drug reaction manifested as in vivo toxicity, is at best circumstantial.  However, understanding the process of bioactivation of structural alerts by trapping the reactive intermediates is crit. to guide medicinal chem. efforts in quest for safer and potent mols.  This commentary provides a brief introduction to adverse drug reactions and mechanisms of reactive intermediate formation for various functional groups, followed by a review of chem. design approaches, examples of such strategies, possible isosteric replacements for structural alerts and rationalization of lab. approaches to det. reactive intermediates, as a guide to today's medicinal chemist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJn3HGMykr8LVg90H21EOLACvtfcHk0ljOVrp_l-FeMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSnur0%253D&md5=85942dff291aaf4221ff156b6bc5a902</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F156802611794480891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794480891%26sid%3Dliteratum%253Aachs%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DMangold%26aufirst%3DJ.%2BB.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DStrategies%2520and%2520chemical%2520design%2520approaches%2520to%2520reduce%2520the%2520potential%2520for%2520formation%2520of%2520reactive%2520metabolic%2520species%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2011%26volume%3D11%26spage%3D419%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassahun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Approaches for minimizing metabolic activation of new drug candidates in drug discovery</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1007%2F978-3-642-00663-0_19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=20020275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVymsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2010&pages=511-544&author=S.+Kumarauthor=K.+Mitraauthor=K.+Kassahunauthor=T.+A.+Baillie&title=Approaches+for+minimizing+metabolic+activation+of+new+drug+candidates+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Approaches for minimizing metabolic activation of new drug candidates in drug discovery</span></div><div class="casAuthors">Kumar, Sanjeev; Mitra, Kaushik; Kassahun, Kelem; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">Adverse Drug Reactions</span>),
    <span class="NLM_cas:pages">511-544</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  A large body of circumstantial evidence suggests that metabolic activation of drug candidates to chem. reactive electrophilic metabolites that are capable of covalently modifying cellular macromols. may result in acute and/or immune system-mediated idiosyncratic toxicities in humans.  Thus, minimizing the potential for metabolic activation of new drug candidates during the drug discovery and lead optimization stage represents a prudent strategy to help discover and develop the next generation of safe and effective therapeutic agents.  In the present chapter, we discuss the scientific methodologies that currently are available to industrial pharmaceutical scientists for assessing and minimizing metabolic activation during drug discovery, their attributes and limitations, and future scientific directions that have the potential to help advance progress in this field.  We also propose a roadmap that should help utilize the armamentarium of available scientific tools in a logical way and contribute to addressing metabolic activation issues in the drug discovery-setting in a rapid, scientifically appropriate, and resource-conscious manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsUn4AeXY6DLVg90H21EOLACvtfcHk0ljOVrp_l-FeMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVymsrk%253D&md5=ec89af3cdc07079ec24aedb7b94f051f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-00663-0_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-00663-0_19%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DKassahun%26aufirst%3DK.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DApproaches%2520for%2520minimizing%2520metabolic%2520activation%2520of%2520new%2520drug%2520candidates%2520in%2520drug%2520discovery%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2010%26volume%3D196%26spage%3D511%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Parkinson, A.; Ogilvie, B. W.</span><span> </span><span class="NLM_article-title">Biotransformation of Xenobiotics</span>. In  <span class="citation_source-book">Casarett & Doull’s Essentials of Toxicology</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Klaassen, C. D.; Watkins, J. B.,  III</span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+Parkinson&author=B.+W.+Ogilvieauthor=C.+D.+Klaassen&author=J.+B.+Watkins&title=Casarett+%26+Doull%E2%80%99s+Essentials+of+Toxicology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DA.%26atitle%3DBiotransformation%2520of%2520Xenobiotics%26btitle%3DCasarett%2520%2526%2520Doull%25E2%2580%2599s%2520Essentials%2520of%2520Toxicology%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26pub%3DMcGraw-Hill%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">Unless noted otherwise, all cLogP and cLogD<sub>7.4</sub> data were calculated using ACD/Labs software, version 11.02, 1994–2011.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Eicher, T.; Hauptmann, S.</span> <span class="citation_source-book">The Chemistry of Heterocycles: Structure, Reactions, Syntheses, and Applications</span>; <span class="NLM_publisher-name">Thieme Verlag</span>: <span class="NLM_publisher-loc">Stuttgart, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=T.+Eicher&author=S.+Hauptmann&title=The+Chemistry+of+Heterocycles%3A+Structure%2C+Reactions%2C+Syntheses%2C+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEicher%26aufirst%3DT.%26btitle%3DThe%2520Chemistry%2520of%2520Heterocycles%253A%2520Structure%252C%2520Reactions%252C%2520Syntheses%252C%2520and%2520Applications%26pub%3DThieme%2520Verlag%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">D’Anna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenna, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noto, R.</span><span> </span><span class="NLM_article-title">Effect of ionic liquid organizing ability and amine structure on the rate and mechanism of base induced elimination of 1,1,1-tribromo-2,2-bis(phenyl-substituted)ethanes</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1690</span><span class="NLM_x">–</span> <span class="NLM_lpage">1698</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=1690-1698&author=F.+D%E2%80%99Annaauthor=V.+Frennaauthor=V.+Paceauthor=R.+Noto&title=Effect+of+ionic+liquid+organizing+ability+and+amine+structure+on+the+rate+and+mechanism+of+base+induced+elimination+of+1%2C1%2C1-tribromo-2%2C2-bis%28phenyl-substituted%29ethanes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Anna%26aufirst%3DF.%26aulast%3DFrenna%26aufirst%3DV.%26aulast%3DPace%26aufirst%3DV.%26aulast%3DNoto%26aufirst%3DR.%26atitle%3DEffect%2520of%2520ionic%2520liquid%2520organizing%2520ability%2520and%2520amine%2520structure%2520on%2520the%2520rate%2520and%2520mechanism%2520of%2520base%2520induced%2520elimination%2520of%25201%252C1%252C1-tribromo-2%252C2-bis%2528phenyl-substituted%2529ethanes%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D1690%26epage%3D1698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Pierson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fettes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freichel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatti-McArthur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwyler, J. r.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plancher, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez Sarmiento, R. M. a.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, R.</span><span> </span><span class="NLM_article-title">5-Hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3855</span><span class="NLM_x">–</span> <span class="NLM_lpage">3868</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900409x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3855-3868&author=P.+D.+Piersonauthor=A.+Fettesauthor=C.+Freichelauthor=S.+Gatti-McArthurauthor=C.+Hertelauthor=J.+r.+Huwylerauthor=P.+Mohrauthor=T.+Nakagawaauthor=M.+Nettekovenauthor=J.-M.+Plancherauthor=S.+Raabauthor=H.+Richterauthor=O.+Rocheauthor=R.+M.+a.+Rodr%C3%ADguez+Sarmientoauthor=M.+Schmittauthor=F.+Schulerauthor=T.+Takahashiauthor=S.+Taylorauthor=C.+Ullmerauthor=R.+Wiegand&title=5-Hydroxyindole-2-carboxylic+acid+amides%3A+novel+histamine-3+receptor+inverse+agonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900409x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900409x%26sid%3Dliteratum%253Aachs%26aulast%3DPierson%26aufirst%3DP.%2BD.%26aulast%3DFettes%26aufirst%3DA.%26aulast%3DFreichel%26aufirst%3DC.%26aulast%3DGatti-McArthur%26aufirst%3DS.%26aulast%3DHertel%26aufirst%3DC.%26aulast%3DHuwyler%26aufirst%3DJ.%2Br.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DPlancher%26aufirst%3DJ.-M.%26aulast%3DRaab%26aufirst%3DS.%26aulast%3DRichter%26aufirst%3DH.%26aulast%3DRoche%26aufirst%3DO.%26aulast%3DRodr%25C3%25ADguez%2BSarmiento%26aufirst%3DR.%2BM.%2Ba.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DUllmer%26aufirst%3DC.%26aulast%3DWiegand%26aufirst%3DR.%26atitle%3D5-Hydroxyindole-2-carboxylic%2520acid%2520amides%253A%2520novel%2520histamine-3%2520receptor%2520inverse%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3855%26epage%3D3868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Adams, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeng, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ksander, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaSala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung-Chu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigel, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span> </span><span class="NLM_article-title">The discovery of potent inhibitors of aldosterone synthase that exhibit selectivity over 11-β-hydroxylase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4324</span><span class="NLM_x">–</span> <span class="NLM_lpage">4327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4324-4327&author=C.+M.+Adamsauthor=C.-W.+Huauthor=A.+Y.+Jengauthor=R.+Karkiauthor=G.+Ksanderauthor=D.+LaSalaauthor=J.+Leung-Chuauthor=G.+Liangauthor=Q.+Liuauthor=E.+Meredithauthor=C.+Raoauthor=D.+F.+Rigelauthor=J.+Shiauthor=S.+Smithauthor=C.+Springerauthor=C.+Zhang&title=The+discovery+of+potent+inhibitors+of+aldosterone+synthase+that+exhibit+selectivity+over+11-%CE%B2-hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DC.%2BM.%26aulast%3DHu%26aufirst%3DC.-W.%26aulast%3DJeng%26aufirst%3DA.%2BY.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKsander%26aufirst%3DG.%26aulast%3DLaSala%26aufirst%3DD.%26aulast%3DLeung-Chu%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMeredith%26aufirst%3DE.%26aulast%3DRao%26aufirst%3DC.%26aulast%3DRigel%26aufirst%3DD.%2BF.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DThe%2520discovery%2520of%2520potent%2520inhibitors%2520of%2520aldosterone%2520synthase%2520that%2520exhibit%2520selectivity%2520over%252011-%25CE%25B2-hydroxylase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4324%26epage%3D4327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Zbinden, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anselm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Décoret, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panday, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricklin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haap, W.</span><span> </span><span class="NLM_article-title">Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2787</span><span class="NLM_x">–</span> <span class="NLM_lpage">2795</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=2787-2795&author=K.+G.+Zbindenauthor=L.+Anselmauthor=D.+W.+Bannerauthor=J.+Benzauthor=F.+Blascoauthor=G.+D%C3%A9coretauthor=J.+Himberauthor=B.+Kuhnauthor=N.+Pandayauthor=F.+Ricklinauthor=P.+Rischauthor=D.+Schlatterauthor=M.+Stahlauthor=S.+Thomiauthor=R.+Ungerauthor=W.+Haap&title=Design+of+novel+aminopyrrolidine+factor+Xa+inhibitors+from+a+screening+hit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZbinden%26aufirst%3DK.%2BG.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DBlasco%26aufirst%3DF.%26aulast%3DD%25C3%25A9coret%26aufirst%3DG.%26aulast%3DHimber%26aufirst%3DJ.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DPanday%26aufirst%3DN.%26aulast%3DRicklin%26aufirst%3DF.%26aulast%3DRisch%26aufirst%3DP.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DThomi%26aufirst%3DS.%26aulast%3DUnger%26aufirst%3DR.%26aulast%3DHaap%26aufirst%3DW.%26atitle%3DDesign%2520of%2520novel%2520aminopyrrolidine%2520factor%2520Xa%2520inhibitors%2520from%2520a%2520screening%2520hit%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D2787%26epage%3D2795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blazel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissinger, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBrun, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruebsam, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergeeva, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkovsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span> </span><span class="NLM_article-title">Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′[lambda]6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2<i>H</i>-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5635</span><span class="NLM_x">–</span> <span class="NLM_lpage">5639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5635-5639&author=P.+S.+Dragovichauthor=J.+K.+Blazelauthor=D.+A.+Ellisauthor=Q.+Hanauthor=R.+Kamranauthor=C.+R.+Kissingerauthor=L.+A.+LeBrunauthor=L.-S.+Liauthor=D.+E.+Murphyauthor=M.+Nobleauthor=R.+A.+Patelauthor=F.+Ruebsamauthor=M.+V.+Sergeevaauthor=A.+M.+Shahauthor=R.+E.+Showalterauthor=C.+V.+Tranauthor=M.+Tsanauthor=S.+E.+Webberauthor=L.+Kirkovskyauthor=Y.+Zhou&title=Novel+HCV+NS5B+polymerase+inhibitors+derived+from+4-%281%E2%80%B2%2C1%E2%80%B2-dioxo-1%E2%80%B2%2C4%E2%80%B2-dihydro-1%E2%80%B2%5Blambda%5D6-benzo%5B1%E2%80%B2%2C2%E2%80%B2%2C4%E2%80%B2%5Dthiadiazin-3%E2%80%B2-yl%29-5-hydroxy-2H-pyridazin-3-ones.+Part+5%3A+Exploration+of+pyridazinones+containing+6-amino-substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DBlazel%26aufirst%3DJ.%2BK.%26aulast%3DEllis%26aufirst%3DD.%2BA.%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DKamran%26aufirst%3DR.%26aulast%3DKissinger%26aufirst%3DC.%2BR.%26aulast%3DLeBrun%26aufirst%3DL.%2BA.%26aulast%3DLi%26aufirst%3DL.-S.%26aulast%3DMurphy%26aufirst%3DD.%2BE.%26aulast%3DNoble%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DRuebsam%26aufirst%3DF.%26aulast%3DSergeeva%26aufirst%3DM.%2BV.%26aulast%3DShah%26aufirst%3DA.%2BM.%26aulast%3DShowalter%26aufirst%3DR.%2BE.%26aulast%3DTran%26aufirst%3DC.%2BV.%26aulast%3DTsan%26aufirst%3DM.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DKirkovsky%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DNovel%2520HCV%2520NS5B%2520polymerase%2520inhibitors%2520derived%2520from%25204-%25281%25E2%2580%25B2%252C1%25E2%2580%25B2-dioxo-1%25E2%2580%25B2%252C4%25E2%2580%25B2-dihydro-1%25E2%2580%25B2%255Blambda%255D6-benzo%255B1%25E2%2580%25B2%252C2%25E2%2580%25B2%252C4%25E2%2580%25B2%255Dthiadiazin-3%25E2%2580%25B2-yl%2529-5-hydroxy-2H-pyridazin-3-ones.%2520Part%25205%253A%2520Exploration%2520of%2520pyridazinones%2520containing%25206-amino-substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5635%26epage%3D5639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, L. R.</span><span> </span><span class="NLM_article-title">7-Sulfonamido-3-benzazepines as potent and selective 5-HT2C receptor agonists: hit-to-lead optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1871</span><span class="NLM_x">–</span> <span class="NLM_lpage">1875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1871-1875&author=P.+V.+Fishauthor=A.+D.+Brownauthor=E.+Evrardauthor=L.+R.+Roberts&title=7-Sulfonamido-3-benzazepines+as+potent+and+selective+5-HT2C+receptor+agonists%3A+hit-to-lead+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DL.%2BR.%26atitle%3D7-Sulfonamido-3-benzazepines%2520as%2520potent%2520and%2520selective%25205-HT2C%2520receptor%2520agonists%253A%2520hit-to-lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1871%26epage%3D1875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Pescatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecchetti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonsi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz-Fademrecht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkühler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span> </span><span class="NLM_article-title">Optimization of a series of potent and selective ketone histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5528</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5528-5532&author=G.+Pescatoreauthor=O.+Kinzelauthor=B.+Attenniauthor=O.+Cecchettiauthor=F.+Fioreauthor=M.+Fonsiauthor=M.+Rowleyauthor=C.+Schultz-Fademrechtauthor=S.+Serafiniauthor=C.+Steink%C3%BChlerauthor=P.+Jones&title=Optimization+of+a+series+of+potent+and+selective+ketone+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DAttenni%26aufirst%3DB.%26aulast%3DCecchetti%26aufirst%3DO.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DFonsi%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DS.%26aulast%3DSteink%25C3%25BChler%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DP.%26atitle%3DOptimization%2520of%2520a%2520series%2520of%2520potent%2520and%2520selective%2520ketone%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5528%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wan, Z.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenail, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ipek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qadri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiah, E.</span><span> </span><span class="NLM_article-title">Efficacious 11β-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5449</span><span class="NLM_x">–</span> <span class="NLM_lpage">5461</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900639u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5449-5461&author=Z.-K.+Wanauthor=E.+Chenailauthor=J.+Xiangauthor=H.-Q.+Liauthor=M.+Ipekauthor=J.+Bardauthor=K.+Svensonauthor=T.+S.+Mansourauthor=X.+Xuauthor=X.+Tianauthor=V.+Suriauthor=S.+Hahmauthor=Y.+Xingauthor=C.+E.+Johnsonauthor=X.+Liauthor=A.+Qadriauthor=D.+Panzaauthor=M.+Perreaultauthor=J.+F.+Tobinauthor=E.+Saiah&title=Efficacious+11%CE%B2-hydroxysteroid+dehydrogenase+type+I+inhibitors+in+the+diet-induced+obesity+mouse+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm900639u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900639u%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DZ.-K.%26aulast%3DChenail%26aufirst%3DE.%26aulast%3DXiang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DIpek%26aufirst%3DM.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DSuri%26aufirst%3DV.%26aulast%3DHahm%26aufirst%3DS.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DC.%2BE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DQadri%26aufirst%3DA.%26aulast%3DPanza%26aufirst%3DD.%26aulast%3DPerreault%26aufirst%3DM.%26aulast%3DTobin%26aufirst%3DJ.%2BF.%26aulast%3DSaiah%26aufirst%3DE.%26atitle%3DEfficacious%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%2520I%2520inhibitors%2520in%2520the%2520diet-induced%2520obesity%2520mouse%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5449%26epage%3D5461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kerekes, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposite, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doll, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagat, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tevar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. B.</span><span> </span><span class="NLM_article-title">Aurora kinase inhibitors based on the imidazo[1,2-<i>a</i>]pyrazine core: fluorine and deuterium incorporation improve oral absorption and exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1010995" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=201-210&author=A.+D.+Kerekesauthor=S.+J.+Espositeauthor=R.+J.+Dollauthor=J.+R.+Tagatauthor=T.+Yuauthor=Y.+Xiaoauthor=Y.+Zhangauthor=D.+B.+Preluskyauthor=S.+Tevarauthor=K.+Grayauthor=G.+A.+Terracinaauthor=S.+Leeauthor=J.+Jonesauthor=M.+Liuauthor=A.+D.+Bassoauthor=E.+B.+Smith&title=Aurora+kinase+inhibitors+based+on+the+imidazo%5B1%2C2-a%5Dpyrazine+core%3A+fluorine+and+deuterium+incorporation+improve+oral+absorption+and+exposure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora Kinase Inhibitors Based on the Imidazo[1,2-a]pyrazine Core: Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure</span></div><div class="casAuthors">Kerekes, Angela D.; Esposite, Sara J.; Doll, Ronald J.; Tagat, Jayaram R.; Yu, Tao; Xiao, Yushi; Zhang, Yonglian; Prelusky, Dan B.; Tevar, Seema; Gray, Kimberly; Terracina, Gaby A.; Lee, Suining; Jones, Jennifer; Liu, Ming; Basso, Andrea D.; Smith, Elizabeth B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">201-210</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aurora kinases are cell cycle regulated serine/threonine kinases that have been linked to cancer.  Compd. 1 was identified as a potent Aurora inhibitor but lacked oral bioavailability.  Optimization of 1 led to the discovery of a series of fluoroamine and deuterated analogs, exemplified by compd. 25 (I), with an improved pharmacokinetic profile.  We found that blocking oxidative metab. at the benzylic position and decreasing the basicity of the amine are important to obtaining compds. with good biol. profiles and oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3YIdBKno7NLVg90H21EOLACvtfcHk0lgQDuQww_KJuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbzP&md5=af7c338866058e7d63116c8c8aa2d3fd</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm1010995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1010995%26sid%3Dliteratum%253Aachs%26aulast%3DKerekes%26aufirst%3DA.%2BD.%26aulast%3DEsposite%26aufirst%3DS.%2BJ.%26aulast%3DDoll%26aufirst%3DR.%2BJ.%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPrelusky%26aufirst%3DD.%2BB.%26aulast%3DTevar%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DTerracina%26aufirst%3DG.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DBasso%26aufirst%3DA.%2BD.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26atitle%3DAurora%2520kinase%2520inhibitors%2520based%2520on%2520the%2520imidazo%255B1%252C2-a%255Dpyrazine%2520core%253A%2520fluorine%2520and%2520deuterium%2520incorporation%2520improve%2520oral%2520absorption%2520and%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D201%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Melander, L.; Saunders, W. H.,  Jr.</span> <span class="citation_source-book">Reaction Rates of Isotopic Molecules</span>; <span class="NLM_publisher-name">John Wiley and Sons</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1979</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1979&author=L.+Melander&author=W.+H.+Saunders&title=Reaction+Rates+of+Isotopic+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMelander%26aufirst%3DL.%26btitle%3DReaction%2520Rates%2520of%2520Isotopic%2520Molecules%26pub%3DJohn%2520Wiley%2520and%2520Sons%26date%3D1979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Shao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span> </span><span class="NLM_article-title">The kinetic isotope effect in the search for deuterated drugs</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=20697607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KrurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=398-404&author=L.+Shaoauthor=M.+C.+Hewitt&title=The+kinetic+isotope+effect+in+the+search+for+deuterated+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetic isotope effect in the search for deuterated drugs</span></div><div class="casAuthors">Shao, Liming; Hewitt, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">398-404</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The kinetic isotope effect has long been exploited by phys. org. chemists to study reaction mechanisms due to its effect on reaction rates when cleavage of a C-isotope bond is rate detg.  Medicinal chemists have also used the deuterium kinetic isotope effect to slow the cytochrome P 450 metab. of the deuterated versions of drug candidates, with the first in vitro microsome studies of deuterated morphine appearing in the literature in the 1960s, and a deuterated alanine compd. from Merck going all the way to phase IIb in the 1970s.  The recent emergence of companies such as Concert Pharmaceuticals and Auspex Pharmaceuticals, based solely on the idea of deuterium-for-hydrogen versions of existing drugs, has reinvigorated the backers of the deuterium camp, and established the strategy as a viable low-risk approach to drug development.  A history of the deuterium kinetic isotope effect is presented, along with examples of deuterated drugs that span 50 years, from 1960 to present day.  Specific examples of compds. from the Concert and Auspex pipelines are also analyzed and the pros and cons of their approach are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAuGgibLHqTrVg90H21EOLACvtfcHk0lgQDuQww_KJuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KrurnO&md5=0cb101283dcec55ddef2603292b95811</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DL.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26atitle%3DThe%2520kinetic%2520isotope%2520effect%2520in%2520the%2520search%2520for%2520deuterated%2520drugs%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2010%26volume%3D23%26spage%3D398%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Gleave, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, G. M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haslam, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roomans, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingsby, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swarbrick, M. E.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB2 agonists for the treatment of inflammatory pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=465-468&author=R.+J.+Gleaveauthor=P.+J.+Beswickauthor=A.+J.+Brownauthor=G.+M.+P.+Giblinauthor=P.+Goldsmithauthor=C.+P.+Haslamauthor=W.+L.+Mitchellauthor=N.+H.+Nicholsonauthor=L.+W.+Pageauthor=S.+Patelauthor=S.+Roomansauthor=B.+P.+Slingsbyauthor=M.+E.+Swarbrick&title=Synthesis+and+evaluation+of+3-amino-6-aryl-pyridazines+as+selective+CB2+agonists+for+the+treatment+of+inflammatory+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGleave%26aufirst%3DR.%2BJ.%26aulast%3DBeswick%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DGiblin%26aufirst%3DG.%2BM.%2BP.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DHaslam%26aufirst%3DC.%2BP.%26aulast%3DMitchell%26aufirst%3DW.%2BL.%26aulast%3DNicholson%26aufirst%3DN.%2BH.%26aulast%3DPage%26aufirst%3DL.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRoomans%26aufirst%3DS.%26aulast%3DSlingsby%26aufirst%3DB.%2BP.%26aulast%3DSwarbrick%26aufirst%3DM.%2BE.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25203-amino-6-aryl-pyridazines%2520as%2520selective%2520CB2%2520agonists%2520for%2520the%2520treatment%2520of%2520inflammatory%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D465%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Peglion, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goument, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Despaux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraud, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekeyne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genissel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Improvement in the selectivity and metabolic stability of the serotonin 5-HT1A ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010975%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=165-176&author=J.-L.+Peglionauthor=B.+Goumentauthor=N.+Despauxauthor=V.+Charlotauthor=H.+Giraudauthor=C.+Nisoleauthor=A.+Newman-Tancrediauthor=A.+Dekeyneauthor=M.+Bertrandauthor=P.+Genisselauthor=M.+J.+Millan&title=Improvement+in+the+selectivity+and+metabolic+stability+of+the+serotonin+5-HT1A+ligand%2C+S+15535%3A+a+series+of+cis-+and+trans-2-%28arylcycloalkylamine%29+1-indanols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm010975%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010975%252B%26sid%3Dliteratum%253Aachs%26aulast%3DPeglion%26aufirst%3DJ.-L.%26aulast%3DGoument%26aufirst%3DB.%26aulast%3DDespaux%26aufirst%3DN.%26aulast%3DCharlot%26aufirst%3DV.%26aulast%3DGiraud%26aufirst%3DH.%26aulast%3DNisole%26aufirst%3DC.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DDekeyne%26aufirst%3DA.%26aulast%3DBertrand%26aufirst%3DM.%26aulast%3DGenissel%26aufirst%3DP.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DImprovement%2520in%2520the%2520selectivity%2520and%2520metabolic%2520stability%2520of%2520the%2520serotonin%25205-HT1A%2520ligand%252C%2520S%252015535%253A%2520a%2520series%2520of%2520cis-%2520and%2520trans-2-%2528arylcycloalkylamine%2529%25201-indanols%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D165%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainer, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span> </span><span class="NLM_article-title">Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6122</span><span class="NLM_x">–</span> <span class="NLM_lpage">6126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6122-6126&author=L.+Qiaoauthor=S.+Choiauthor=A.+Caseauthor=T.+G.+Gainerauthor=K.+Seybauthor=M.+A.+Glicksmanauthor=D.+C.+Loauthor=R.+L.+Steinauthor=G.+D.+Cuny&title=Structure%E2%80%93activity+relationship+study+of+EphB3+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DCase%26aufirst%3DA.%26aulast%3DGainer%26aufirst%3DT.%2BG.%26aulast%3DSeyb%26aufirst%3DK.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DStein%26aufirst%3DR.%2BL.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520study%2520of%2520EphB3%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6122%26epage%3D6126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Cramp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockey, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porres, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leggate, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, R.</span><span> </span><span class="NLM_article-title">Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2516</span><span class="NLM_x">–</span> <span class="NLM_lpage">2519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2516-2519&author=S.+Crampauthor=H.+J.+Dykeauthor=C.+Higgsauthor=D.+E.+Clarkauthor=M.+Gillauthor=P.+Savyauthor=N.+Jenningsauthor=S.+Priceauthor=P.+M.+Lockeyauthor=D.+Normanauthor=S.+Porresauthor=F.+Wilsonauthor=A.+Jonesauthor=N.+Ramsdenauthor=R.+Manganoauthor=D.+Leggateauthor=M.+Anderssonauthor=R.+Hale&title=Identification+and+hit-to-lead+exploration+of+a+novel+series+of+histamine+H4+receptor+inverse+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCramp%26aufirst%3DS.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DHiggs%26aufirst%3DC.%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DGill%26aufirst%3DM.%26aulast%3DSavy%26aufirst%3DP.%26aulast%3DJennings%26aufirst%3DN.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DLockey%26aufirst%3DP.%2BM.%26aulast%3DNorman%26aufirst%3DD.%26aulast%3DPorres%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DF.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DMangano%26aufirst%3DR.%26aulast%3DLeggate%26aufirst%3DD.%26aulast%3DAndersson%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520hit-to-lead%2520exploration%2520of%2520a%2520novel%2520series%2520of%2520histamine%2520H4%2520receptor%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2516%26epage%3D2519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Omura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, K.</span><span> </span><span class="NLM_article-title">The SAR studies of novel CB2 selective agonists, benzimidazolone derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3310</span><span class="NLM_x">–</span> <span class="NLM_lpage">3314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3310-3314&author=H.+Omuraauthor=M.+Kawaiauthor=A.+Shimaauthor=Y.+Iwataauthor=F.+Itoauthor=T.+Masudaauthor=A.+Ohtaauthor=N.+Makitaauthor=K.+Omotoauthor=H.+Sugimotoauthor=A.+Kikuchiauthor=H.+Iwataauthor=K.+Ando&title=The+SAR+studies+of+novel+CB2+selective+agonists%2C+benzimidazolone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOmura%26aufirst%3DH.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DShima%26aufirst%3DA.%26aulast%3DIwata%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DF.%26aulast%3DMasuda%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DA.%26aulast%3DMakita%26aufirst%3DN.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DA.%26aulast%3DIwata%26aufirst%3DH.%26aulast%3DAndo%26aufirst%3DK.%26atitle%3DThe%2520SAR%2520studies%2520of%2520novel%2520CB2%2520selective%2520agonists%252C%2520benzimidazolone%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3310%26epage%3D3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorff, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiRico, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capetta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallgren, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as gamma-secretase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7772</span><span class="NLM_x">–</span> <span class="NLM_lpage">7783</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200893p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7772-7783&author=A.+F.+Stepanauthor=K.+Karkiauthor=W.+S.+McDonaldauthor=P.+H.+Dorffauthor=J.+K.+Dutraauthor=K.+J.+DiRicoauthor=A.+Wonauthor=C.+Subramanyamauthor=I.+V.+Efremovauthor=C.+J.+O%E2%80%99Donnellauthor=C.+E.+Nolanauthor=S.+L.+Beckerauthor=L.+R.+Pustilnikauthor=B.+Sneedauthor=H.+Sunauthor=Y.+Luauthor=A.+E.+Robshawauthor=D.+Riddellauthor=T.+J.+O%E2%80%99Sullivanauthor=E.+Sibleyauthor=S.+Capettaauthor=K.+Atchisonauthor=A.+J.+Hallgrenauthor=E.+Millerauthor=A.+Woodauthor=R.+S.+Obach&title=Metabolism-directed+design+of+oxetane-containing+arylsulfonamide+derivatives+as+gamma-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm200893p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200893p%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DW.%2BS.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DDiRico%26aufirst%3DK.%2BJ.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSneed%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DCapetta%26aufirst%3DS.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DHallgren%26aufirst%3DA.%2BJ.%26aulast%3DMiller%26aufirst%3DE.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DMetabolism-directed%2520design%2520of%2520oxetane-containing%2520arylsulfonamide%2520derivatives%2520as%2520gamma-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7772%26epage%3D7783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogDoct: A tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+A+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neutral+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520A%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neutral%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Rotstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filonova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton-Pleiss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trejo-Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankuratri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deRosier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dioszegi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilek, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jekle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mau, C.-I.</span><span> </span><span class="NLM_article-title">Spiropiperidine CCR5 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5401</span><span class="NLM_x">–</span> <span class="NLM_lpage">5406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5401-5406&author=D.+M.+Rotsteinauthor=S.+D.+Gabrielauthor=F.+Makraauthor=L.+Filonovaauthor=S.+Gleasonauthor=C.+Brotherton-Pleissauthor=L.+Q.+Settiauthor=A.+Trejo-Martinauthor=E.+K.+Leeauthor=S.+Sankuratriauthor=C.+Jiauthor=A.+deRosierauthor=M.+Dioszegiauthor=G.+Heilekauthor=A.+Jekleauthor=P.+Berryauthor=P.+Wellerauthor=C.-I.+Mau&title=Spiropiperidine+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRotstein%26aufirst%3DD.%2BM.%26aulast%3DGabriel%26aufirst%3DS.%2BD.%26aulast%3DMakra%26aufirst%3DF.%26aulast%3DFilonova%26aufirst%3DL.%26aulast%3DGleason%26aufirst%3DS.%26aulast%3DBrotherton-Pleiss%26aufirst%3DC.%26aulast%3DSetti%26aufirst%3DL.%2BQ.%26aulast%3DTrejo-Martin%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DE.%2BK.%26aulast%3DSankuratri%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DdeRosier%26aufirst%3DA.%26aulast%3DDioszegi%26aufirst%3DM.%26aulast%3DHeilek%26aufirst%3DG.%26aulast%3DJekle%26aufirst%3DA.%26aulast%3DBerry%26aufirst%3DP.%26aulast%3DWeller%26aufirst%3DP.%26aulast%3DMau%26aufirst%3DC.-I.%26atitle%3DSpiropiperidine%2520CCR5%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5401%26epage%3D5406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Pierson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freichel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatti-MacArthur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwyler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plancher, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarmiento, R. M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, R.</span><span> </span><span class="NLM_article-title">Histamine-3 receptor inverse agonists for the treatment of obesity: validation of the target and identification of novel series</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2009&pages=275-278&author=P.+D.+Piersonauthor=C.+Freichelauthor=S.+Gatti-MacArthurauthor=C.+Hertelauthor=J.+Huwylerauthor=P.+Mohrauthor=T.+Nakagawaauthor=M.+Nettekovenauthor=J.-M.+Plancherauthor=S.+Raabauthor=H.+Richterauthor=O.+Rocheauthor=R.+M.+R.+Sarmientoauthor=M.+Schmittauthor=F.+Schulerauthor=T.+Takahashiauthor=S.+Taylorauthor=C.+Ullmerauthor=R.+Wiegand&title=Histamine-3+receptor+inverse+agonists+for+the+treatment+of+obesity%3A+validation+of+the+target+and+identification+of+novel+series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierson%26aufirst%3DP.%2BD.%26aulast%3DFreichel%26aufirst%3DC.%26aulast%3DGatti-MacArthur%26aufirst%3DS.%26aulast%3DHertel%26aufirst%3DC.%26aulast%3DHuwyler%26aufirst%3DJ.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DPlancher%26aufirst%3DJ.-M.%26aulast%3DRaab%26aufirst%3DS.%26aulast%3DRichter%26aufirst%3DH.%26aulast%3DRoche%26aufirst%3DO.%26aulast%3DSarmiento%26aufirst%3DR.%2BM.%2BR.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DUllmer%26aufirst%3DC.%26aulast%3DWiegand%26aufirst%3DR.%26atitle%3DHistamine-3%2520receptor%2520inverse%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity%253A%2520validation%2520of%2520the%2520target%2520and%2520identification%2520of%2520novel%2520series%26jtitle%3DChimia%26date%3D2009%26volume%3D63%26spage%3D275%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stotz, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. a. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Díaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title">Lead Optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7099</span><span class="NLM_x">–</span> <span class="NLM_lpage">7110</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800851u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7099-7110&author=X.+Zhangauthor=J.+E.+Tellewauthor=Z.+Luoauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+P.+Williamsauthor=J.+Saundersauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=T.+Joswigauthor=R.+Petroskiauthor=J.+Pierceyauthor=W.+Kargoauthor=S.+Malanyauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+Wenauthor=K.+Jalaliauthor=Z.+O%E2%80%99Brienauthor=C.+E.+Stotzauthor=M.+a.+I.+Crespoauthor=J.-L.+D%C3%ADazauthor=D.+H.+Slee&title=Lead+Optimization+of+4-acetylamino-2-%283%2C5-dimethylpyrazol-1-yl%29-6-pyridylpyrimidines+as+A2A+adenosine+receptor+antagonists+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm800851u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800851u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DPiercey%26aufirst%3DJ.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DStotz%26aufirst%3DC.%2BE.%26aulast%3DCrespo%26aufirst%3DM.%2Ba.%2BI.%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.-L.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3DLead%2520Optimization%2520of%25204-acetylamino-2-%25283%252C5-dimethylpyrazol-1-yl%2529-6-pyridylpyrimidines%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7099%26epage%3D7110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddershaw, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P. A.</span><span> </span><span class="NLM_article-title">Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands—Part II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=428-432&author=S.+E.+Wardauthor=P.+Eddershawauthor=S.+T.+Flynnauthor=L.+Gordonauthor=P.+J.+Lovellauthor=S.+H.+Mooreauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+M.+Thewlisauthor=P.+A.+Wyman&title=Studies+on+a+series+of+potent%2C+orally+bioavailable%2C+5-HT1+receptor+ligands%E2%80%94Part+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DEddershaw%26aufirst%3DP.%26aulast%3DFlynn%26aufirst%3DS.%2BT.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%2BH.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DWyman%26aufirst%3DP.%2BA.%26atitle%3DStudies%2520on%2520a%2520series%2520of%2520potent%252C%2520orally%2520bioavailable%252C%25205-HT1%2520receptor%2520ligands%25E2%2580%2594Part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D428%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Fujimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Textor, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, K.</span><span> </span><span class="NLM_article-title">Discovery of a tetrahydropyrimidin-2(1<i>H</i>)-one derivative (TAK-442) as a potent, selective, and orally active factor Xa inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3517</span><span class="NLM_x">–</span> <span class="NLM_lpage">3531</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901699j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFert7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3517-3531&author=T.+Fujimotoauthor=Y.+Imaedaauthor=N.+Konishiauthor=K.+Hiroeauthor=M.+Kawamuraauthor=G.+P.+Textorauthor=K.+Aertgeertsauthor=K.+Kubo&title=Discovery+of+a+tetrahydropyrimidin-2%281H%29-one+derivative+%28TAK-442%29+as+a+potent%2C+selective%2C+and+orally+active+factor+Xa+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Tetrahydropyrimidin-2(1H)-one Derivative (TAK-442) as a Potent, Selective, and Orally Active Factor Xa Inhibitor</span></div><div class="casAuthors">Fujimoto, Takuya; Imaeda, Yasuhiro; Konishi, Noriko; Hiroe, Katsuhiko; Kawamura, Masaki; Textor, Garret P.; Aertgeerts, Kathleen; Kubo, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3517-3531</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coagulation enzyme factor Xa (FXa) is a particularly promising target for the development of new anticoagulant agents.  We previously reported the imidazo[1,5-c]imidazol-3-one deriv. 1 (I) as a potent and orally active FXa inhibitor.  However, it was found that 1 predominantly undergoes hydrolysis upon incubation with human liver microsomes, and the human specific metabolic pathway made it difficult to predict the human pharmacokinetics.  To address this issue, our synthetic efforts were focused on modification of the imidazo[1,5-c]imidazol-3-one moiety of the active metabolite 3a (II), derived from 1, which resulted in the discovery of the tetrahydropyrimidin-2(1H)-one deriv. 5k as a highly potent and selective FXa inhibitor.  Compd. 5k (III) showed no detectable amide bond cleavage in human liver microsomes, exhibited a good pharmacokinetic profile in monkeys, and had a potent antithrombotic efficacy in a rabbit model without prolongation of bleeding time.  Compd. 5k is currently under clin. development with the code name TAK-442.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZmn8Ml1JItbVg90H21EOLACvtfcHk0lhVTRrGOnn0ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFert7o%253D&md5=73df2272ff6b5889b3667e9859186ee3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm901699j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901699j%26sid%3Dliteratum%253Aachs%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DKonishi%26aufirst%3DN.%26aulast%3DHiroe%26aufirst%3DK.%26aulast%3DKawamura%26aufirst%3DM.%26aulast%3DTextor%26aufirst%3DG.%2BP.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DKubo%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520a%2520tetrahydropyrimidin-2%25281H%2529-one%2520derivative%2520%2528TAK-442%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520factor%2520Xa%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3517%26epage%3D3531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Discovery and optimization of 2-(4-substituted-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)methylene-4-hydroxybenzofuran-3(2<i>H</i>)-ones as potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2321</span><span class="NLM_x">–</span> <span class="NLM_lpage">2325</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2321-2325&author=H.-R.+Tsouauthor=G.+MacEwanauthor=G.+Birnbergauthor=G.+Grosuauthor=M.+G.+Bursavichauthor=J.+Bardauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=T.+S.+Mansourauthor=S.+Ayral-Kaloustianauthor=K.+Yu&title=Discovery+and+optimization+of+2-%284-substituted-pyrrolo%5B2%2C3-b%5Dpyridin-3-yl%29methylene-4-hydroxybenzofuran-3%282H%29-ones+as+potent+and+selective+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DMacEwan%26aufirst%3DG.%26aulast%3DBirnberg%26aufirst%3DG.%26aulast%3DGrosu%26aufirst%3DG.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25202-%25284-substituted-pyrrolo%255B2%252C3-b%255Dpyridin-3-yl%2529methylene-4-hydroxybenzofuran-3%25282H%2529-ones%2520as%2520potent%2520and%2520selective%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2321%26epage%3D2325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Martignoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moscone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Lack of strain-related differences in drug metabolism and efflux transporter characteristics between CD-1 and athymic nude mice</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1007%2Fs00280-004-0898-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=15592720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGgtLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=129-135&author=M.+Martignoniauthor=R.+Kanterauthor=A.+Mosconeauthor=P.+Grossiauthor=M.+Monshouwer&title=Lack+of+strain-related+differences+in+drug+metabolism+and+efflux+transporter+characteristics+between+CD-1+and+athymic+nude+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of strain-related differences in drug metabolism and efflux transporter characteristics between CD-1 and athymic nude mice</span></div><div class="casAuthors">Martignoni, Marcella; Kanter, Ruben; Moscone, Anna; Grossi, Pietro; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-135</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">CD-1 mice are commonly used in oncol. metab. and toxicity to support drug discovery and development and to examine drug metab. and toxicity properties of new chem. entities.  On the other hand, athymic nude mice are the preferred animals to investigate tumor growth inhibition.  Therefore, a frequently asked question is: are the metabolic and pharmacokinetic characteristics of xenobiotics in these two mouse strains comparable or not To address this issue, we characterized drug metab. and efflux transporter properties in both strains and in different organs.  The metabolic stability of a set of 20 compds. and metabolite formation of cytochrome P 450 (CYP) marker substrates (testosterone, ethoxyresorufin and pentoxyresorufin) were measured in liver microsomes.  Drug conjugation was studied by following the disappearance of 7-hydroxycoumarin and the formation of its glucuronide and sulfate conjugates in freshly prepd. liver slices.  In addn., mRNA expression levels of the main cyp genes and drug efflux transporters were investigated by real-time RT-PCR in the liver, kidney, intestine and adrenal glands.  No significant differences in enzymic activities and metabolite formation were obsd. between the two strains.  Also mRNA expression profiles of cyp and drug transporter genes were similar between CD-1 and nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoklQPjI9WZ6bVg90H21EOLACvtfcHk0lhVTRrGOnn0ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGgtLzF&md5=ec86251064dc852d94d1819addc0045a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00280-004-0898-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-004-0898-7%26sid%3Dliteratum%253Aachs%26aulast%3DMartignoni%26aufirst%3DM.%26aulast%3DKanter%26aufirst%3DR.%26aulast%3DMoscone%26aufirst%3DA.%26aulast%3DGrossi%26aufirst%3DP.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DLack%2520of%2520strain-related%2520differences%2520in%2520drug%2520metabolism%2520and%2520efflux%2520transporter%2520characteristics%2520between%2520CD-1%2520and%2520athymic%2520nude%2520mice%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D55%26spage%3D129%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Mastalerz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vite, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span> </span><span class="NLM_article-title">Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2828</span><span class="NLM_x">–</span> <span class="NLM_lpage">2833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2828-2833&author=H.+Mastalerzauthor=M.+Changauthor=A.+Gavaiauthor=W.+Johnsonauthor=D.+Langleyauthor=F.+Y.+Leeauthor=P.+Maratheauthor=A.+Mathurauthor=S.+Oppenheimerauthor=J.+Tarrantauthor=J.+S.+Tokarskiauthor=G.+D.+Viteauthor=D.+M.+Vyasauthor=H.+Wongauthor=T.+W.+Wongauthor=H.+Zhangauthor=G.+Zhang&title=Novel+C-5+aminomethyl+pyrrolotriazine+dual+inhibitors+of+EGFR+and+HER2+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMastalerz%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DGavai%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DW.%26aulast%3DLangley%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DVite%26aufirst%3DG.%2BD.%26aulast%3DVyas%26aufirst%3DD.%2BM.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DT.%2BW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DNovel%2520C-5%2520aminomethyl%2520pyrrolotriazine%2520dual%2520inhibitors%2520of%2520EGFR%2520and%2520HER2%2520protein%2520tyrosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2828%26epage%3D2833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Geng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basarab, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comita-Prevoir, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowravaram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiely, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacPherson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morningstar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osimboni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundqvist, T.</span><span> </span><span class="NLM_article-title">Potent and selective inhibitors of <i>Helicobacter pylori</i> glutamate racemase (MurI): pyridodiazepine amines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=930-936&author=B.+Gengauthor=G.+Basarabauthor=J.+Comita-Prevoirauthor=M.+Gowravaramauthor=P.+Hillauthor=A.+Kielyauthor=J.+Lochauthor=L.+MacPhersonauthor=M.+Morningstarauthor=G.+Mullenauthor=E.+Osimboniauthor=A.+Satzauthor=C.+Eyermannauthor=T.+Lundqvist&title=Potent+and+selective+inhibitors+of+Helicobacter+pylori+glutamate+racemase+%28MurI%29%3A+pyridodiazepine+amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DB.%26aulast%3DBasarab%26aufirst%3DG.%26aulast%3DComita-Prevoir%26aufirst%3DJ.%26aulast%3DGowravaram%26aufirst%3DM.%26aulast%3DHill%26aufirst%3DP.%26aulast%3DKiely%26aufirst%3DA.%26aulast%3DLoch%26aufirst%3DJ.%26aulast%3DMacPherson%26aufirst%3DL.%26aulast%3DMorningstar%26aufirst%3DM.%26aulast%3DMullen%26aufirst%3DG.%26aulast%3DOsimboni%26aufirst%3DE.%26aulast%3DSatz%26aufirst%3DA.%26aulast%3DEyermann%26aufirst%3DC.%26aulast%3DLundqvist%26aufirst%3DT.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520Helicobacter%2520pylori%2520glutamate%2520racemase%2520%2528MurI%2529%253A%2520pyridodiazepine%2520amines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D930%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Riether, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noya-Marino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albaugh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemkow, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grbic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löbbe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, D.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D. S.</span><span> </span><span class="NLM_article-title">1,4-Diazepane compounds as potent and selective CB2 agonists: optimization of metabolic stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2011</span><span class="NLM_x">–</span> <span class="NLM_lpage">2016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2011-2016&author=D.+Rietherauthor=L.+Wuauthor=P.+F.+Cirilloauthor=A.+Berryauthor=E.+R.+Walkerauthor=M.+Ermannauthor=B.+Noya-Marinoauthor=J.+E.+Jenkinsauthor=D.+Albaughauthor=C.+Albrechtauthor=M.+Fisherauthor=M.+J.+Gemkowauthor=H.+Grbicauthor=S.+L%C3%B6bbeauthor=C.+M%C3%B6llerauthor=K.+O%E2%80%99Sheaauthor=A.+Sauerauthor=D.-T.+Shihauthor=D.+S.+Thomson&title=1%2C4-Diazepane+compounds+as+potent+and+selective+CB2+agonists%3A+optimization+of+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiether%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DE.%2BR.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DNoya-Marino%26aufirst%3DB.%26aulast%3DJenkins%26aufirst%3DJ.%2BE.%26aulast%3DAlbaugh%26aufirst%3DD.%26aulast%3DAlbrecht%26aufirst%3DC.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DGemkow%26aufirst%3DM.%2BJ.%26aulast%3DGrbic%26aufirst%3DH.%26aulast%3DL%25C3%25B6bbe%26aufirst%3DS.%26aulast%3DM%25C3%25B6ller%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DK.%26aulast%3DSauer%26aufirst%3DA.%26aulast%3DShih%26aufirst%3DD.-T.%26aulast%3DThomson%26aufirst%3DD.%2BS.%26atitle%3D1%252C4-Diazepane%2520compounds%2520as%2520potent%2520and%2520selective%2520CB2%2520agonists%253A%2520optimization%2520of%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2011%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevena, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span> </span><span class="NLM_article-title">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1954</span><span class="NLM_x">–</span> <span class="NLM_lpage">1965</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700270r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1954-1965&author=A.+S.+Kalgutkarauthor=J.+Driscollauthor=S.+X.+Zhaoauthor=G.+S.+Walkerauthor=R.+M.+Shepardauthor=J.+R.+Sogliaauthor=J.+Athertonauthor=L.+Yuauthor=A.+E.+Mutlibauthor=M.+J.+Munchhofauthor=L.+A.+Reiterauthor=C.+S.+Jonesauthor=J.+L.+Dotyauthor=K.+A.+Trevenaauthor=C.+L.+Shafferauthor=S.+L.+Ripp&title=A+rational+chemical+intervention+strategy+to+circumvent+bioactivation+liabilities+associated+with+a+nonpeptidyl+thrombopoietin+receptor+agonist+containing+a+2-amino-4-arylthiazole+motif"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span></div><div class="casAuthors">Kalgutkar, Amit S.; Driscoll, James; Zhao, Sabrina X.; Walker, Gregory S.; Shepard, Richard M.; Soglia, John R.; Atherton, James; Yu, Linning; Mutlib, Abdul E.; Munchhof, Michael J.; Reiter, Lawrence A.; Jones, Christopher S.; Doty, Johnathan L.; Trevena, Kristen A.; Shaffer, Christopher L.; Ripp, Sharon L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1954-1965</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The current study examd. the bioactivation potential of a nonpeptidyl thrombopoietin receptor agonist, 1-(3-chloro-5-((4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-yl)carbamoyl)pyridine-2-yl)piperidine-4-carboxylic acid (1), contg. a 2-carboxamido-4-arylthiazole moiety in the core structure.  Toxicol. risks arising from P 450-catalyzed C4-C5 thiazole ring opening in 1 via the epoxidn. diol sequence were alleviated, since mass spectrometric anal. of human liver microsome and/or hepatocyte incubations of 1 did not reveal the formation of reactive acylthiourea and/or glyoxal metabolites, which are prototypic products derived from thiazole ring scission.  However, 4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-amine (2), the product of hydrolysis of 1 in human liver microsomes, hepatocytes, and plasma, underwent oxidative bioactivation in human liver microsomes, since trapping studies with glutathione led to the formation of two conjugates derived from the addn. of the thiol nucleophile to 2 and a thiazole-S-oxide metabolite of 2.  Mass spectral fragmentation and NMR anal. indicated that the site of attachment of the glutathionyl moiety in both conjugates was the C5 position in the thiazole ring.  Based on the structures of the glutathione conjugates, two bioactivation pathways are proposed, one involving β-elimination of an initially formed hydroxylamine metabolite and the other involving direct two-electron oxidn. of the electron-rich 2-aminothiazole system to electrophilic intermediates.  This mechanistic insight into the bioactivation process allowed the development of a rational chem. intervention strategy that involved blocking the C5 position with a fluorine atom or replacing the thiazole ring with a 1,2,4-thiadiazole group.  These structural changes not only abrogated the bioactivation liability assocd. with 1 but also resulted in compds. that retained the attractive pharmacol. and pharmacokinetic attributes of the prototype agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxi1Bp9ve-TLVg90H21EOLACvtfcHk0liExcwNTXg4tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM&md5=97c144c6d3c621dcef18a76b63f1806e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Ftx700270r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700270r%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDriscoll%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DShepard%26aufirst%3DR.%2BM.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DAtherton%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DReiter%26aufirst%3DL.%2BA.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DTrevena%26aufirst%3DK.%2BA.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26atitle%3DA%2520rational%2520chemical%2520intervention%2520strategy%2520to%2520circumvent%2520bioactivation%2520liabilities%2520associated%2520with%2520a%2520nonpeptidyl%2520thrombopoietin%2520receptor%2520agonist%2520containing%2520a%25202-amino-4-arylthiazole%2520motif%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1954%26epage%3D1965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span> </span><span class="NLM_article-title">In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1890</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800185b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvFSls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1890-1899&author=R.+S.+Obachauthor=A.+S.+Kalgutkarauthor=T.+F.+Ryderauthor=G.+S.+Walker&title=In+vitro+metabolism+and+covalent+binding+of+enol-carboxamide+derivatives+and+anti-inflammatory+agents+sudoxicam+and+meloxicam%3A+insights+into+the+hepatotoxicity+of+sudoxicam"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Metabolism and Covalent Binding of Enol-Carboxamide Derivatives and Anti-Inflammatory Agents Sudoxicam and Meloxicam: Insights into the Hepatotoxicity of Sudoxicam</span></div><div class="casAuthors">Obach, R. Scott; Kalgutkar, Amit S.; Ryder, Tim F.; Walker, Gregory S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1890-1899</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sudoxicam and meloxicam are nonsteroidal anti-inflammatory drugs (NSAIDs) from the enol-carboxamide class.  While the only structural difference between the two NSAIDs is the presence of a Me group on the C5-position of the 2-carboxamidothiazole motif in meloxicam, a marked difference in their toxicol. profile in humans has been discerned.  In clin. trials, sudoxicam was assocd. with several cases of severe hepatotoxicity that led to its discontinuation, while meloxicam has been in the market for over a decade and is devoid of hepatotoxicity.  In an attempt to understand the biochem. basis for the differences in safety profile, an in vitro investigation of the metabolic pathways and covalent binding of the two NSAIDs was conducted in NADPH-supplemented human liver microsomes.  Both compds. demonstrated NADPH-dependent covalent binding to human liver microsomes; however, the extent of binding of [14C]-meloxicam was ∼2-fold greater than that of [14C]-sudoxicam.  While inclusion of glutathione (GSH) in microsomal incubations resulted in a decrease in covalent binding for both NSAIDs, the redn. in binding was more pronounced for meloxicam.  Metabolite identification studies on [14C]-sudoxicam in NADPH-supplemented human liver microsomes indicated that the primary route of metab. involved a P 450-mediated thiazole ring scission to the corresponding acylthiourea metabolite (S3), a well-established pro-toxin.  The mechanism of formation of S3 presumably proceeds via (a) epoxidn. of the C4-C5-thiazole ring double bond, (b) epoxide hydrolysis to the corresponding thiazole-4,5-dihydrodiol deriv., which was obsd. as a stable metabolite (S2), (c) ring opening of the thiazole-4,5-dihydrodiol to an 2-oxoethylidene thiourea intermediate, and (d) hydrolysis of the imine bond within this intermediate to yield S3.  In the case of meloxicam, the corresponding acylthiourea metabolite M3 was also obsd., but to a lesser extent; the main route of meloxicam metab. involved hydroxylation of the 5'-Me group, a finding that is consistent with the known metabolic fate of this NSAID.  Inclusion of GSH led to a decrease in the formation of M3 with the concomitant formation of an unusual two-electron redn. product (metabolite M7).  The formation of M7 is proposed to arise via redn. of the imine bond in 2-oxopropylidene thiourea, an intermediate in the thiazole ring scission pathway in meloxicam.  In conclusion, the results of our anal. suggest that if the covalent binding of the two NSAIDs is important to the overall hepatotoxicity risk, the differences in metab. (differential preponderance of formation of the acylthiourea relative to total metab.), differential effects of GSH on covalent binding, and finally differences in daily doses of the two NSAIDs may serve as a plausible explanation for the marked differences in toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr41ErheTuDvLVg90H21EOLACvtfcHk0lijGkTrzkw21w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvFSls7o%253D&md5=af142bb2df6107277dcbbb82b0907c21</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Ftx800185b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800185b%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26atitle%3DIn%2520vitro%2520metabolism%2520and%2520covalent%2520binding%2520of%2520enol-carboxamide%2520derivatives%2520and%2520anti-inflammatory%2520agents%2520sudoxicam%2520and%2520meloxicam%253A%2520insights%2520into%2520the%2520hepatotoxicity%2520of%2520sudoxicam%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1890%26epage%3D1899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Roth, S. H.</span><span> </span><span class="NLM_article-title">Arthritis therapy: a better time, a better day</span> <span class="citation_source-journal">Rheumatology (Oxford, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1093%2Frheumatology%2F40.6.603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=11426014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A280%3ADC%252BD3MzmsFeqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=603-606&author=S.+H.+Roth&title=Arthritis+therapy%3A+a+better+time%2C+a+better+day"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Arthritis therapy: a better time, a better day</span></div><div class="casAuthors">Roth S H</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology (Oxford, England)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">603-6</span>
        ISSN:<span class="NLM_cas:issn">1462-0324</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS27AnCJ_qcAYFEOhA_Im3cfW6udTcc2ebkCjPjpzwFsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzmsFeqtw%253D%253D&md5=e0a817946815c16609e655a5f535b922</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2F40.6.603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252F40.6.603%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DS.%2BH.%26atitle%3DArthritis%2520therapy%253A%2520a%2520better%2520time%252C%2520a%2520better%2520day%26jtitle%3DRheumatology%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2001%26volume%3D40%26spage%3D603%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furst, D. E.</span><span> </span><span class="NLM_article-title">Meloxicam in rheumatoid arthritis</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1517%2F17425255.1.4.739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=16863437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1GksL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=739-751&author=M.+Ahmedauthor=D.+Khannaauthor=D.+E.+Furst&title=Meloxicam+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Meloxicam in rheumatoid arthritis</span></div><div class="casAuthors">Ahmed, Mansoor; Khanna, Dinesh; Furst, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">739-751</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Rheumatoid arthritis (RA), a chronic inflammatory multisystem disorder marked by joint pain, stiffness, swelling and multiple systemic involvements, requires a multifaceted approach for its management.  It includes symptomatic treatment with analgesics as well as disease-modifying medications to alter the course of RA over time.  NSAIDS have been widely used for their symptomatic effects, but their use is not free from adverse effects, which may include life-threatening adverse events such as gastrointestinal (GI) bleeding and perforation.  Meloxicam, an oxicam deriv. that is a member of the enolic acid group of NSAIDs, has recently been approved by the US FDA for use in RA and osteoarthritis.  At the FDA-recommended doses meloxicam is COX-2 preferential.  By virtue of this COX-2 preferential activity it is expected to have lower GI toxicity as compared with COX-2 nonselective NSAIDs.  Clin. trials have shown that meloxicam at 7.5 - 15 mg/day is as effective as diclofenac, piroxicam and naproxen as an anti-inflammatory and analgesic, and was assocd. with fewer GI adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW-OerMn56aLVg90H21EOLACvtfcHk0lijGkTrzkw21w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1GksL%252FM&md5=c88a6d17b9dedba14feec2dc55bdb4d7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.4.739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.4.739%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DFurst%26aufirst%3DD.%2BE.%26atitle%3DMeloxicam%2520in%2520rheumatoid%2520arthritis%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D739%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Rostom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldkind, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, L.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients</span> <span class="citation_source-journal">Clin. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1016%2FS1542-3565%2804%2900777-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=15880319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVWqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=489-498&author=A.+Rostomauthor=L.+Goldkindauthor=L.+Laine&title=Nonsteroidal+anti-inflammatory+drugs+and+hepatic+toxicity%3A+a+systematic+review+of+randomized+controlled+trials+in+arthritis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients</span></div><div class="casAuthors">Rostom, Alaa; Goldkind, Lawrence; Laine, Loren</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">489-498</span>CODEN:
                <span class="NLM_cas:coden">CGHLAW</span>;
        ISSN:<span class="NLM_cas:issn">1542-3565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Nonsteroidal anti-inflammatory drugs (NSAIDs) might cause hepatic side effects, but the frequency of these lab. and clin. side effects is uncertain.  Searches of bibliog. databases MEDLINE and EMBASE and of public archives of the Food and Drug Administration were conducted to identify randomized controlled trials of diclofenac, naproxen, ibuprofen, celecoxib, rofecoxib, valdecoxib, or meloxicam in adults with osteoarthritis or rheumatoid arthritis that provided information on aminotransferase elevations >3× upper limit of normal, liver-related discontinuations, hepatic serious adverse events, liver-related hospitalizations, or liver-related deaths.  The proportion of patients with each of the hepatic toxicity outcomes was calcd. sep. by using sample size weighted pooling for each NSAID.  Sixty-seven articles from the bibliog. database and 65 studies from the Food and Drug Administration archives met inclusion criteria.  Diclofenac (3.55%; 95% confidence interval [CI], 3.21-4.03%) and rofecoxib (1.80%; 95% CI, 1.52-2.13%) had higher rates of aminotransferase >3× upper limit of normal than placebo (0.29; 95% CI, 0.17-0.51) and the other NSAIDs (all ≤ 0.43%).  The 95% Cls for liver-related discontinuations of all NSAIDs except diclofenac (2.17%; 95% CI, 1.78-2.64%) overlapped with placebo.  Only 1 liver-related hospitalization (among 37,671 patients) and 1 liver-related death (among 51,942 patients) occurred, with naproxen.  Diclofenac and rofecoxib had higher rates of aminotransferase elevations than placebo and other NSAIDs studied.  No NSAID studied had increased rates of liver-related serious adverse events, hospitalizations, or deaths.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvFih_b5xkhLVg90H21EOLACvtfcHk0lijGkTrzkw21w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVWqtbc%253D&md5=305d405e9bf758363506343f2ea14665</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS1542-3565%2804%2900777-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1542-3565%252804%252900777-3%26sid%3Dliteratum%253Aachs%26aulast%3DRostom%26aufirst%3DA.%26aulast%3DGoldkind%26aufirst%3DL.%26aulast%3DLaine%26aufirst%3DL.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520and%2520hepatic%2520toxicity%253A%2520a%2520systematic%2520review%2520of%2520randomized%2520controlled%2520trials%2520in%2520arthritis%2520patients%26jtitle%3DClin.%2520Gastroenterol.%2520Hepatol.%26date%3D2005%26volume%3D3%26spage%3D489%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: discovery of potent and selective JAK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1016%2Fj.bmcl.2010.01.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=20144546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlehsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1669-1673&author=S.+Ioannidisauthor=M.+L.+Lambauthor=L.+Almeidaauthor=H.+Guanauthor=B.+Pengauthor=G.+Bebernitzauthor=K.+Bellauthor=M.+Alimzhanovauthor=M.+Zinda&title=Replacement+of+pyrazol-3-yl+amine+hinge+binder+with+thiazol-2-yl+amine%3A+discovery+of+potent+and+selective+JAK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: Discovery of potent and selective JAK2 inhibitors</span></div><div class="casAuthors">Ioannidis, Stephanos; Lamb, Michelle L.; Almeida, Lynsie; Guan, Huiping; Peng, Bo; Bebernitz, Geraldine; Bell, Kirsten; Alimzhanov, Marat; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1669-1673</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thiazol-2-yl amine was identified as an isosteric replacement for pyrazol-3-yl amine during the efforts to identify potent and selective JAK2 inhibitors.  The rationale, synthesis and biol. evaluation of several analogs I (X = N, CH; R1 = MeO, 4-morpholinyl, 4-methyl-1-piperazinyl; R2 = H, F; R3 = Me, CN) is reported, along with the in vivo evaluation of the lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE4-bwWDreyrVg90H21EOLACvtfcHk0lhWWBGc6UE_vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlehsbY%253D&md5=a9b1f0cdc19311aca0a314325a1cbc56</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.091%26sid%3Dliteratum%253Aachs%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DReplacement%2520of%2520pyrazol-3-yl%2520amine%2520hinge%2520binder%2520with%2520thiazol-2-yl%2520amine%253A%2520discovery%2520of%2520potent%2520and%2520selective%2520JAK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1669%26epage%3D1673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Tremblay, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lescarbeau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austad, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Diez, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushing, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGovern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A. C.</span><span> </span><span class="NLM_article-title">Discovery of a potent and orally active Hedgehog pathway antagonist (IPI-926)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4400</span><span class="NLM_x">–</span> <span class="NLM_lpage">4418</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900305z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFygs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4400-4418&author=M.+R.+Tremblayauthor=A.+Lescarbeauauthor=M.+J.+Groganauthor=E.+Tanauthor=G.+Linauthor=B.+C.+Austadauthor=L.-C.+Yuauthor=M.+L.+Behnkeauthor=S.+J.+Nairauthor=M.+Hagelauthor=K.+Whiteauthor=J.+Conleyauthor=J.+D.+Mannaauthor=T.+M.+Alvarez-Diezauthor=J.+Hoytauthor=C.+N.+Woodwardauthor=J.+R.+Sydorauthor=M.+Pinkauthor=J.+MacDougallauthor=M.+J.+Campbellauthor=J.+Cushingauthor=J.+Fergusonauthor=M.+S.+Curtisauthor=K.+McGovernauthor=M.+A.+Readauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=A.+C.+Castro&title=Discovery+of+a+potent+and+orally+active+Hedgehog+pathway+antagonist+%28IPI-926%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)</span></div><div class="casAuthors">Tremblay, Martin R.; Lescarbeau, Andre; Grogan, Michael J.; Tan, Eddy; Lin, Grace; Austad, Brian C.; Yu, Lin-Chen; Behnke, Mark L.; Nair, Somarajan J.; Hagel, Margit; White, Kerry; Conley, James; Manna, Joseph D.; Alvarez-Diez, Teresa M.; Hoyt, Jennifer; Woodward, Caroline N.; Sydor, Jens R.; Pink, Melissa; MacDougall, John; Campbell, Matthew J.; Cushing, Jill; Ferguson, Jeanne; Curtis, Michael S.; McGovern, Karen; Read, Margaret A.; Palombella, Vito J.; Adams, Julian; Castro, Alfredo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4400-4418</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent evidence suggests that blocking aberrant hedgehog pathway signaling may be a promising therapeutic strategy for the treatment of several types of cancer.  Cyclopamine, a plant Veratrum alkaloid, is a natural product antagonist of the hedgehog pathway.  In a previous report, a seven-membered D-ring semisynthetic analog of cyclopamine, IPI-269609 (2), was shown to have greater acid stability and better aq. soly. compared to cyclopamine.  Further modifications of the A-ring system generated three series of analogs with improved potency and/or soly.  Lead compds. from each series were characterized in vitro and evaluated in vivo for biol. activity and pharmacokinetic properties.  These studies led to the discovery of IPI-926 (compd. 28), a novel semisynthetic cyclopamine analog with substantially improved pharmaceutical properties and potency and a favorable pharmacokinetic profile relative to cyclopamine and compd. 2.  As a result, complete tumor regression was obsd. in a Hh-dependent medulloblastoma allograft model after daily oral administration of 40 mg/kg of compd. 28.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-f15bWq7kM7Vg90H21EOLACvtfcHk0lhWWBGc6UE_vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFygs7g%253D&md5=9455ee5eadb8293fdb3bd5cdec0e5d67</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm900305z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900305z%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DM.%2BR.%26aulast%3DLescarbeau%26aufirst%3DA.%26aulast%3DGrogan%26aufirst%3DM.%2BJ.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DAustad%26aufirst%3DB.%2BC.%26aulast%3DYu%26aufirst%3DL.-C.%26aulast%3DBehnke%26aufirst%3DM.%2BL.%26aulast%3DNair%26aufirst%3DS.%2BJ.%26aulast%3DHagel%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DK.%26aulast%3DConley%26aufirst%3DJ.%26aulast%3DManna%26aufirst%3DJ.%2BD.%26aulast%3DAlvarez-Diez%26aufirst%3DT.%2BM.%26aulast%3DHoyt%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%2BN.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DMacDougall%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DM.%2BJ.%26aulast%3DCushing%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DJ.%26aulast%3DCurtis%26aufirst%3DM.%2BS.%26aulast%3DMcGovern%26aufirst%3DK.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DA.%2BC.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520orally%2520active%2520Hedgehog%2520pathway%2520antagonist%2520%2528IPI-926%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4400%26epage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><div class="note"><p class="first last">For an example of metabolic ring-opening of an isoxazole ring see the following: </p></div><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, A. D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span> </span><span class="NLM_article-title">In vitro metabolism studies of the isoxazole ring scission in the anti-inflammatory agent leflunomide to its active α-cyanoenol metabolite A771726: mechanistic similarities with cytochrome P450-catalyzed dehydration of aldoximes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">–</span> <span class="NLM_lpage">1250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1240-1250&author=A.+S.+Kalgutkarauthor=H.+T.+Nguyenauthor=A.+D.+N.+Vazauthor=A.+Doanauthor=D.+K.+Dalvieauthor=D.+G.+McLeodauthor=J.+C.+Murray&title=In+vitro+metabolism+studies+of+the+isoxazole+ring+scission+in+the+anti-inflammatory+agent+leflunomide+to+its+active+%CE%B1-cyanoenol+metabolite+A771726%3A+mechanistic+similarities+with+cytochrome+P450-catalyzed+dehydration+of+aldoximes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DVaz%26aufirst%3DA.%2BD.%2BN.%26aulast%3DDoan%26aufirst%3DA.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DMcLeod%26aufirst%3DD.%2BG.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26atitle%3DIn%2520vitro%2520metabolism%2520studies%2520of%2520the%2520isoxazole%2520ring%2520scission%2520in%2520the%2520anti-inflammatory%2520agent%2520leflunomide%2520to%2520its%2520active%2520%25CE%25B1-cyanoenol%2520metabolite%2520A771726%253A%2520mechanistic%2520similarities%2520with%2520cytochrome%2520P450-catalyzed%2520dehydration%2520of%2520aldoximes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26spage%3D1240%26epage%3D1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><div class="note"><p class="first last">For an example where the 1,2,5-oxadiazole ring was unchanged in a metabolism study see the following: </p></div><span class="NLM_contrib-group">Takegoshi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, G.</span><span> </span><span class="NLM_article-title">Steroids. XII. Metabolites of furazabol (17beta -hydroxy-17alpha-methyl-5alpha-androstano[2,3-c]furazan) administered to rats</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1243</span><span class="NLM_x">–</span> <span class="NLM_lpage">1259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1972&pages=1243-1259&author=T.+Takegoshiauthor=H.+Tachizawaauthor=G.+Ohta&title=Steroids.+XII.+Metabolites+of+furazabol+%2817beta+-hydroxy-17alpha-methyl-5alpha-androstano%5B2%2C3-c%5Dfurazan%29+administered+to+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakegoshi%26aufirst%3DT.%26aulast%3DTachizawa%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DG.%26atitle%3DSteroids.%2520XII.%2520Metabolites%2520of%2520furazabol%2520%252817beta%2520-hydroxy-17alpha-methyl-5alpha-androstano%255B2%252C3-c%255Dfurazan%2529%2520administered%2520to%2520rats%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1972%26volume%3D20%26spage%3D1243%26epage%3D1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Thomson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackaby, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. T.</span><span> </span><span class="NLM_article-title">Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2235</span><span class="NLM_x">–</span> <span class="NLM_lpage">2239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2235-2239&author=J.+L.+Thomsonauthor=W.+P.+Blackabyauthor=A.+S.+R.+Jenningsauthor=S.+C.+Goodacreauthor=A.+Pikeauthor=S.+Thomasauthor=T.+A.+Brownauthor=A.+Smithauthor=G.+Pillaiauthor=L.+J.+Streetauthor=R.+T.+Lewis&title=Optimisation+of+a+series+of+potent%2C+selective+and+orally+bioavailable+GlyT1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DJ.%2BL.%26aulast%3DBlackaby%26aufirst%3DW.%2BP.%26aulast%3DJennings%26aufirst%3DA.%2BS.%2BR.%26aulast%3DGoodacre%26aufirst%3DS.%2BC.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DPillai%26aufirst%3DG.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DLewis%26aufirst%3DR.%2BT.%26atitle%3DOptimisation%2520of%2520a%2520series%2520of%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520GlyT1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2235%26epage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Neitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konradi, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zmolek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorentzen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chereau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yednock, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold-Prenner, I.</span><span> </span><span class="NLM_article-title">Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3726</span><span class="NLM_x">–</span> <span class="NLM_lpage">3729</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3726-3729&author=R.+J.+Neitzauthor=A.+W.+Konradiauthor=H.+L.+Shamauthor=W.+Zmolekauthor=K.+Wongauthor=A.+Qinauthor=C.+Lorentzenauthor=D.+Nakamuraauthor=K.+P.+Quinnauthor=J.-M.+Sauerauthor=K.+Powellauthor=L.+Ruslimauthor=D.+Chereauauthor=Z.+Renauthor=J.+Andersonauthor=F.+Bardauthor=T.+A.+Yednockauthor=I.+Griswold-Prenner&title=Highly+selective+c-Jun+N-terminal+kinase+%28JNK%29+3+inhibitors+with+in+vitro+CNS-like+pharmacokinetic+properties+II.+Central+core+replacement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeitz%26aufirst%3DR.%2BJ.%26aulast%3DKonradi%26aufirst%3DA.%2BW.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DZmolek%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DK.%26aulast%3DQin%26aufirst%3DA.%26aulast%3DLorentzen%26aufirst%3DC.%26aulast%3DNakamura%26aufirst%3DD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DSauer%26aufirst%3DJ.-M.%26aulast%3DPowell%26aufirst%3DK.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DChereau%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DYednock%26aufirst%3DT.%2BA.%26aulast%3DGriswold-Prenner%26aufirst%3DI.%26atitle%3DHighly%2520selective%2520c-Jun%2520N-terminal%2520kinase%2520%2528JNK%2529%25203%2520inhibitors%2520with%2520in%2520vitro%2520CNS-like%2520pharmacokinetic%2520properties%2520II.%2520Central%2520core%2520replacement%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3726%26epage%3D3729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Barber, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakemore, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiva, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastwood, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paradowski, K. A.</span><span> </span><span class="NLM_article-title">1-Amido-1-phenyl-3-piperidinylbutanes—CCR5 antagonists for the treatment of HIV. Part 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1079</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1075-1079&author=C.+G.+Barberauthor=D.+C.+Blakemoreauthor=J.-Y.+Chivaauthor=R.+L.+Eastwoodauthor=D.+S.+Middletonauthor=K.+A.+Paradowski&title=1-Amido-1-phenyl-3-piperidinylbutanes%E2%80%94CCR5+antagonists+for+the+treatment+of+HIV.+Part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarber%26aufirst%3DC.%2BG.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DChiva%26aufirst%3DJ.-Y.%26aulast%3DEastwood%26aufirst%3DR.%2BL.%26aulast%3DMiddleton%26aufirst%3DD.%2BS.%26aulast%3DParadowski%26aufirst%3DK.%2BA.%26atitle%3D1-Amido-1-phenyl-3-piperidinylbutanes%25E2%2580%2594CCR5%2520antagonists%2520for%2520the%2520treatment%2520of%2520HIV.%2520Part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1075%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><div class="note"><p class="first last">For an example of metabolic ring-opening of a 1,2,4-oxadiazole ring see the following: </p></div><span class="NLM_contrib-group">Tsalta, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madatian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardesty, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorycki, P. D.</span><span> </span><span class="NLM_article-title">Metabolism of [<sup>14</sup>C]GSK977779 in rats and its implication with the observed covalent binding</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1620</span><span class="NLM_x">–</span> <span class="NLM_lpage">1632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1620-1632&author=C.+D.+Tsaltaauthor=A.+Madatianauthor=E.+M.+Schubertauthor=F.+Xiaauthor=W.+M.+Hardestyauthor=Y.+Dengauthor=J.+L.+Seymourauthor=P.+D.+Gorycki&title=Metabolism+of+%5B14C%5DGSK977779+in+rats+and+its+implication+with+the+observed+covalent+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsalta%26aufirst%3DC.%2BD.%26aulast%3DMadatian%26aufirst%3DA.%26aulast%3DSchubert%26aufirst%3DE.%2BM.%26aulast%3DXia%26aufirst%3DF.%26aulast%3DHardesty%26aufirst%3DW.%2BM.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DSeymour%26aufirst%3DJ.%2BL.%26aulast%3DGorycki%26aufirst%3DP.%2BD.%26atitle%3DMetabolism%2520of%2520%255B14C%255DGSK977779%2520in%2520rats%2520and%2520its%2520implication%2520with%2520the%2520observed%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1620%26epage%3D1632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><div class="note"><p class="first last">Metabolic ring opening of 2-amino-1,3,4-oxadiazole at the C–O bond has been observed: </p></div><span class="NLM_contrib-group">Maciolek, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laliberte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krolikowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, C. R.</span><span> </span><span class="NLM_article-title">Novel cytochrome P450-mediated ring opening of the 1,3,4-oxadiazole in setileuton, a 5-lipoxygenase inhibitor</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=763-770&author=C.+M.+Maciolekauthor=B.+Maauthor=K.+Menzelauthor=S.+Laliberteauthor=K.+Batemanauthor=P.+Krolikowskiauthor=C.+R.+Gibson&title=Novel+cytochrome+P450-mediated+ring+opening+of+the+1%2C3%2C4-oxadiazole+in+setileuton%2C+a+5-lipoxygenase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaciolek%26aufirst%3DC.%2BM.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DMenzel%26aufirst%3DK.%26aulast%3DLaliberte%26aufirst%3DS.%26aulast%3DBateman%26aufirst%3DK.%26aulast%3DKrolikowski%26aufirst%3DP.%26aulast%3DGibson%26aufirst%3DC.%2BR.%26atitle%3DNovel%2520cytochrome%2520P450-mediated%2520ring%2520opening%2520of%2520the%25201%252C3%252C4-oxadiazole%2520in%2520setileuton%252C%2520a%25205-lipoxygenase%2520inhibitor%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D763%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Nordhoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerezo-Gálvez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann-Enger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Canet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rummey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiemann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feurer, A.</span><span> </span><span class="NLM_article-title">The design of potent and selective inhibitors of DPP-4: optimization of ADME properties by amide replacements</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6340</span><span class="NLM_x">–</span> <span class="NLM_lpage">6345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6340-6345&author=S.+Nordhoffauthor=S.+Bulatauthor=S.+Cerezo-G%C3%A1lvezauthor=O.+Hillauthor=B.+Hoffmann-Engerauthor=M.+L%C3%B3pez-Canetauthor=C.+Rosenbaumauthor=C.+Rummeyauthor=M.+Thiemannauthor=V.+G.+Matassaauthor=P.+J.+Edwardsauthor=A.+Feurer&title=The+design+of+potent+and+selective+inhibitors+of+DPP-4%3A+optimization+of+ADME+properties+by+amide+replacements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNordhoff%26aufirst%3DS.%26aulast%3DBulat%26aufirst%3DS.%26aulast%3DCerezo-G%25C3%25A1lvez%26aufirst%3DS.%26aulast%3DHill%26aufirst%3DO.%26aulast%3DHoffmann-Enger%26aufirst%3DB.%26aulast%3DL%25C3%25B3pez-Canet%26aufirst%3DM.%26aulast%3DRosenbaum%26aufirst%3DC.%26aulast%3DRummey%26aufirst%3DC.%26aulast%3DThiemann%26aufirst%3DM.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26aulast%3DFeurer%26aufirst%3DA.%26atitle%3DThe%2520design%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520DPP-4%253A%2520optimization%2520of%2520ADME%2520properties%2520by%2520amide%2520replacements%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6340%26epage%3D6345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Eastwood, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonquerna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiguade, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carranco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenech, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miralpeix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordoba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godessart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prats, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadavid, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nueda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, B.</span><span> </span><span class="NLM_article-title">Discovery of LAS101057: a potent, selective, and orally efficacious A2B adenosine receptor antagonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100249e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=213-218&author=P.+Eastwoodauthor=C.+Esteveauthor=J.+Gonzalezauthor=S.+Fonquernaauthor=J.+Aiguadeauthor=I.+Carrancoauthor=T.+Domenechauthor=M.+Apariciauthor=M.+Miralpeixauthor=J.+Albertiauthor=M.+Cordobaauthor=R.+Fernandezauthor=M.+Pontauthor=N.+Godessartauthor=N.+Pratsauthor=M.+I.+Lozaauthor=M.+I.+Cadavidauthor=A.+Nuedaauthor=B.+Vidal&title=Discovery+of+LAS101057%3A+a+potent%2C+selective%2C+and+orally+efficacious+A2B+adenosine+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fml100249e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100249e%26sid%3Dliteratum%253Aachs%26aulast%3DEastwood%26aufirst%3DP.%26aulast%3DEsteve%26aufirst%3DC.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DFonquerna%26aufirst%3DS.%26aulast%3DAiguade%26aufirst%3DJ.%26aulast%3DCarranco%26aufirst%3DI.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DAparici%26aufirst%3DM.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DAlberti%26aufirst%3DJ.%26aulast%3DCordoba%26aufirst%3DM.%26aulast%3DFernandez%26aufirst%3DR.%26aulast%3DPont%26aufirst%3DM.%26aulast%3DGodessart%26aufirst%3DN.%26aulast%3DPrats%26aufirst%3DN.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DVidal%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520LAS101057%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520A2B%2520adenosine%2520receptor%2520antagonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D213%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Ishida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umehara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajita, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuse, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyoi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span> </span><span class="NLM_article-title">Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5472</span><span class="NLM_x">–</span> <span class="NLM_lpage">5477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5472-5477&author=H.+Ishidaauthor=S.+Isamiauthor=T.+Matsumuraauthor=H.+Umeharaauthor=Y.+Yamashitaauthor=J.+Kajitaauthor=E.+Fuseauthor=H.+Kiyoiauthor=T.+Naoeauthor=S.+Akinagaauthor=Y.+Shiotsuauthor=H.+Arai&title=Novel+and+orally+active+5-%281%2C3%2C4-oxadiazol-2-yl%29pyrimidine+derivatives+as+selective+FLT3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DIsami%26aufirst%3DS.%26aulast%3DMatsumura%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DH.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DKajita%26aufirst%3DJ.%26aulast%3DFuse%26aufirst%3DE.%26aulast%3DKiyoi%26aufirst%3DH.%26aulast%3DNaoe%26aufirst%3DT.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DNovel%2520and%2520orally%2520active%25205-%25281%252C3%252C4-oxadiazol-2-yl%2529pyrimidine%2520derivatives%2520as%2520selective%2520FLT3%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5472%26epage%3D5477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Bailey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farre-Gutierrez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayhow, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seow, H.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takle, A. K.</span><span> </span><span class="NLM_article-title">Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-<i>a</i>]pyridine acid pump antagonists (APAs)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3602</span><span class="NLM_x">–</span> <span class="NLM_lpage">3606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3602-3606&author=N.+Baileyauthor=M.+J.+Bamfordauthor=D.+Brissyauthor=J.+Brookfieldauthor=E.+Demontauthor=R.+Elliottauthor=N.+Gartonauthor=I.+Farre-Gutierrezauthor=T.+Hayhowauthor=G.+Hutleyauthor=A.+Naylorauthor=T.+A.+Panchalauthor=H.-X.+Seowauthor=D.+Spaldingauthor=A.+K.+Takle&title=Orally+active+C-6+heteroaryl-+and+heterocyclyl-substituted+imidazo%5B1%2C2-a%5Dpyridine+acid+pump+antagonists+%28APAs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DN.%26aulast%3DBamford%26aufirst%3DM.%2BJ.%26aulast%3DBrissy%26aufirst%3DD.%26aulast%3DBrookfield%26aufirst%3DJ.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DElliott%26aufirst%3DR.%26aulast%3DGarton%26aufirst%3DN.%26aulast%3DFarre-Gutierrez%26aufirst%3DI.%26aulast%3DHayhow%26aufirst%3DT.%26aulast%3DHutley%26aufirst%3DG.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DPanchal%26aufirst%3DT.%2BA.%26aulast%3DSeow%26aufirst%3DH.-X.%26aulast%3DSpalding%26aufirst%3DD.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26atitle%3DOrally%2520active%2520C-6%2520heteroaryl-%2520and%2520heterocyclyl-substituted%2520imidazo%255B1%252C2-a%255Dpyridine%2520acid%2520pump%2520antagonists%2520%2528APAs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3602%26epage%3D3606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Gao, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim-Riether, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amodeo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccarelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haverty, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill-Drzewi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margarit, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaraja, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proudfoot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellenzohn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedenmayer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrow, N. A.</span><span> </span><span class="NLM_article-title">SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5039</span><span class="NLM_x">–</span> <span class="NLM_lpage">5043</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5039-5043&author=D.+A.+Gaoauthor=Z.+Xiongauthor=A.+Heim-Rietherauthor=L.+Amodeoauthor=E.+M.+Augustauthor=X.+Caoauthor=L.+Ciccarelliauthor=B.+K.+Collinsauthor=K.+Harringtonauthor=K.+Havertyauthor=M.+Hill-Drzewiauthor=X.+Liauthor=S.+Liangauthor=S.+M.+Margaritauthor=N.+Mossauthor=N.+Nagarajaauthor=J.+Proudfootauthor=R.+Romanauthor=S.+Schlyerauthor=L.+S.+Keenanauthor=S.+Taylorauthor=B.+Wellenzohnauthor=D.+Wiedenmayerauthor=J.+Liauthor=N.+A.+Farrow&title=SAR+studies+of+non-zinc-chelating+MMP-13+inhibitors%3A+improving+selectivity+and+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DD.%2BA.%26aulast%3DXiong%26aufirst%3DZ.%26aulast%3DHeim-Riether%26aufirst%3DA.%26aulast%3DAmodeo%26aufirst%3DL.%26aulast%3DAugust%26aufirst%3DE.%2BM.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DCiccarelli%26aufirst%3DL.%26aulast%3DCollins%26aufirst%3DB.%2BK.%26aulast%3DHarrington%26aufirst%3DK.%26aulast%3DHaverty%26aufirst%3DK.%26aulast%3DHill-Drzewi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DMargarit%26aufirst%3DS.%2BM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DNagaraja%26aufirst%3DN.%26aulast%3DProudfoot%26aufirst%3DJ.%26aulast%3DRoman%26aufirst%3DR.%26aulast%3DSchlyer%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DL.%2BS.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWellenzohn%26aufirst%3DB.%26aulast%3DWiedenmayer%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DFarrow%26aufirst%3DN.%2BA.%26atitle%3DSAR%2520studies%2520of%2520non-zinc-chelating%2520MMP-13%2520inhibitors%253A%2520improving%2520selectivity%2520and%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5039%26epage%3D5043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Morwick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büttner, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplita, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paw, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, C.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, E.</span><span> </span><span class="NLM_article-title">Hit to lead account of the discovery of bisbenzamide and related ureidobenzamide inhibitors of Rho kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9014263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=759-777&author=T.+Morwickauthor=F.+H.+B%C3%BCttnerauthor=C.+L.+Cywinauthor=G.+Dahmannauthor=E.+Hickeyauthor=S.+Jakesauthor=P.+Kaplitaauthor=M.+A.+Kashemauthor=S.+Kerrauthor=S.+Kuglerauthor=W.+Maoauthor=D.+Marshallauthor=Z.+Pawauthor=C.-K.+Shihauthor=F.+Wuauthor=E.+Young&title=Hit+to+lead+account+of+the+discovery+of+bisbenzamide+and+related+ureidobenzamide+inhibitors+of+Rho+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm9014263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014263%26sid%3Dliteratum%253Aachs%26aulast%3DMorwick%26aufirst%3DT.%26aulast%3DB%25C3%25BCttner%26aufirst%3DF.%2BH.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DDahmann%26aufirst%3DG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKaplita%26aufirst%3DP.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DKerr%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DPaw%26aufirst%3DZ.%26aulast%3DShih%26aufirst%3DC.-K.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DYoung%26aufirst%3DE.%26atitle%3DHit%2520to%2520lead%2520account%2520of%2520the%2520discovery%2520of%2520bisbenzamide%2520and%2520related%2520ureidobenzamide%2520inhibitors%2520of%2520Rho%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D759%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Ceccarelli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlotterbeck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boissin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettelmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanlon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolczewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupfer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stampfli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span> </span><span class="NLM_article-title">Metabolite identification via LC-SPE-NMR-MS of the in vitro biooxidation products of a lead mGlu5 allosteric antagonist and impact on the improvement of metabolic stability in the series</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=136-144&author=S.+M.+Ceccarelliauthor=G.+Schlotterbeckauthor=P.+Boissinauthor=M.+Binderauthor=B.+Buettelmannauthor=S.+Hanlonauthor=G.+Jaeschkeauthor=S.+Kolczewskiauthor=E.+Kupferauthor=J.-U.+Petersauthor=R.+H.+P.+Porterauthor=E.+P.+Prinssenauthor=M.+Rueherauthor=I.+Rufauthor=W.+Spoorenauthor=A.+Stampfliauthor=E.+Vieira&title=Metabolite+identification+via+LC-SPE-NMR-MS+of+the+in+vitro+biooxidation+products+of+a+lead+mGlu5+allosteric+antagonist+and+impact+on+the+improvement+of+metabolic+stability+in+the+series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCeccarelli%26aufirst%3DS.%2BM.%26aulast%3DSchlotterbeck%26aufirst%3DG.%26aulast%3DBoissin%26aufirst%3DP.%26aulast%3DBinder%26aufirst%3DM.%26aulast%3DBuettelmann%26aufirst%3DB.%26aulast%3DHanlon%26aufirst%3DS.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DKupfer%26aufirst%3DE.%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26aulast%3DPrinssen%26aufirst%3DE.%2BP.%26aulast%3DRueher%26aufirst%3DM.%26aulast%3DRuf%26aufirst%3DI.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DStampfli%26aufirst%3DA.%26aulast%3DVieira%26aufirst%3DE.%26atitle%3DMetabolite%2520identification%2520via%2520LC-SPE-NMR-MS%2520of%2520the%2520in%2520vitro%2520biooxidation%2520products%2520of%2520a%2520lead%2520mGlu5%2520allosteric%2520antagonist%2520and%2520impact%2520on%2520the%2520improvement%2520of%2520metabolic%2520stability%2520in%2520the%2520series%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D136%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preville, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohrt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, P.</span><span> </span><span class="NLM_article-title">Intrinsic electrophilicity of a 4-substituted-5-cyano-6-(2-methylpyridin-3-yloxy)pyrimidine derivative: structural characterization of glutathione conjugates in vitro</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx100429x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=269-278&author=A.+S.+Kalgutkarauthor=V.+Mascittiauthor=R.+Sharmaauthor=G.+W.+Walkerauthor=T.+Ryderauthor=T.+S.+McDonaldauthor=Y.+Chenauthor=C.+Previlleauthor=A.+Basakauthor=K.+F.+McClureauthor=J.+T.+Kohrtauthor=R.+P.+Robinsonauthor=M.+J.+Munchhofauthor=P.+Cornelius&title=Intrinsic+electrophilicity+of+a+4-substituted-5-cyano-6-%282-methylpyridin-3-yloxy%29pyrimidine+derivative%3A+structural+characterization+of+glutathione+conjugates+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Ftx100429x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx100429x%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DG.%2BW.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPreville%26aufirst%3DC.%26aulast%3DBasak%26aufirst%3DA.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DKohrt%26aufirst%3DJ.%2BT.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DCornelius%26aufirst%3DP.%26atitle%3DIntrinsic%2520electrophilicity%2520of%2520a%25204-substituted-5-cyano-6-%25282-methylpyridin-3-yloxy%2529pyrimidine%2520derivative%253A%2520structural%2520characterization%2520of%2520glutathione%2520conjugates%2520in%2520vitro%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D269%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darout, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes, C. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNinno, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohrt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samp, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futatsugi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Activation of the G-protein-coupled receptor 119: a conformation-based hypothesis for understanding agonist response</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1948</span><span class="NLM_x">–</span> <span class="NLM_lpage">1952</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200003p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1948-1952&author=K.+F.+McClureauthor=E.+Daroutauthor=C.+R.+W.+Guimaraesauthor=M.+P.+DeNinnoauthor=V.+Mascittiauthor=M.+J.+Munchhofauthor=R.+P.+Robinsonauthor=J.+Kohrtauthor=A.+R.+Harrisauthor=D.+E.+Mooreauthor=B.+Liauthor=L.+Sampauthor=B.+A.+Lefkerauthor=K.+Futatsugiauthor=D.+Kungauthor=P.+D.+Boninauthor=P.+Corneliusauthor=R.-D.+Wangauthor=E.+Salterauthor=S.+Hornbyauthor=A.+S.+Kalgutkarauthor=Y.+Chen&title=Activation+of+the+G-protein-coupled+receptor+119%3A+a+conformation-based+hypothesis+for+understanding+agonist+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm200003p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200003p%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DDarout%26aufirst%3DE.%26aulast%3DGuimaraes%26aufirst%3DC.%2BR.%2BW.%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DKohrt%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DMoore%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DSamp%26aufirst%3DL.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DKung%26aufirst%3DD.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DCornelius%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DR.-D.%26aulast%3DSalter%26aufirst%3DE.%26aulast%3DHornby%26aufirst%3DS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DActivation%2520of%2520the%2520G-protein-coupled%2520receptor%2520119%253A%2520a%2520conformation-based%2520hypothesis%2520for%2520understanding%2520agonist%2520response%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1948%26epage%3D1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Hartz, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvanitis, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafalski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditta, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deskus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molski, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian-Cutrone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span> </span><span class="NLM_article-title">Synthesis, structure–activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4173</span><span class="NLM_x">–</span> <span class="NLM_lpage">4191</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900301y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4173-4191&author=R.+A.+Hartzauthor=V.+T.+Ahujaauthor=A.+G.+Arvanitisauthor=M.+Rafalskiauthor=E.+W.+Yueauthor=D.+J.+Denhartauthor=W.+D.+Schmitzauthor=J.+L.+Dittaauthor=J.+A.+Deskusauthor=A.+B.+Brennerauthor=F.+W.+Hobbsauthor=J.+Payneauthor=S.+Lelasauthor=Y.-W.+Liauthor=T.+F.+Molskiauthor=G.+K.+Mattsonauthor=Y.+Pengauthor=H.+Wongauthor=J.+E.+Graceauthor=K.+A.+Lentzauthor=J.+Qian-Cutroneauthor=X.+Zhuoauthor=Y.-Z.+Shuauthor=N.+J.+Lodgeauthor=R.+Zaczekauthor=A.+P.+Combsauthor=R.+E.+Olsonauthor=J.+J.+Bronsonauthor=R.+J.+Mattsonauthor=J.+E.+Macor&title=Synthesis%2C+structure%E2%80%93activity+relationships%2C+and+in+vivo+evaluation+of+N3-phenylpyrazinones+as+novel+corticotropin-releasing+factor-1+%28CRF1%29+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm900301y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900301y%26sid%3Dliteratum%253Aachs%26aulast%3DHartz%26aufirst%3DR.%2BA.%26aulast%3DAhuja%26aufirst%3DV.%2BT.%26aulast%3DArvanitis%26aufirst%3DA.%2BG.%26aulast%3DRafalski%26aufirst%3DM.%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DDenhart%26aufirst%3DD.%2BJ.%26aulast%3DSchmitz%26aufirst%3DW.%2BD.%26aulast%3DDitta%26aufirst%3DJ.%2BL.%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DBrenner%26aufirst%3DA.%2BB.%26aulast%3DHobbs%26aufirst%3DF.%2BW.%26aulast%3DPayne%26aufirst%3DJ.%26aulast%3DLelas%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.-W.%26aulast%3DMolski%26aufirst%3DT.%2BF.%26aulast%3DMattson%26aufirst%3DG.%2BK.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DQian-Cutrone%26aufirst%3DJ.%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DShu%26aufirst%3DY.-Z.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DSynthesis%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520and%2520in%2520vivo%2520evaluation%2520of%2520N3-phenylpyrazinones%2520as%2520novel%2520corticotropin-releasing%2520factor-1%2520%2528CRF1%2529%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4173%26epage%3D4191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Zhuo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartz, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrudhula, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leet, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.-Z.</span><span> </span><span class="NLM_article-title">Comparative biotransformation of pyrazinone-containing corticotropin-releasing factor receptor-1 antagonists: minimizing the reactive metabolite formation</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1124%2Fdmd.109.028910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=19833844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1aru7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=5-15&author=X.+Zhuoauthor=R.+A.+Hartzauthor=J.+J.+Bronsonauthor=H.+Wongauthor=V.+T.+Ahujaauthor=V.+M.+Vrudhulaauthor=J.+E.+Leetauthor=S.+Huangauthor=J.+E.+Macorauthor=Y.-Z.+Shu&title=Comparative+biotransformation+of+pyrazinone-containing+corticotropin-releasing+factor+receptor-1+antagonists%3A+minimizing+the+reactive+metabolite+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative biotransformation of pyrazinone-containing corticotropin-releasing factor receptor-1 antagonists: minimizing the reactive metabolite formation</span></div><div class="casAuthors">Zhuo, Xiaoliang; Hartz, Richard A.; Bronson, Joanne J.; Wong, Harvey; Ahuja, Vijay T.; Vrudhula, Vivekananda M.; Leet, John E.; Huang, Stella; Macor, John E.; Shu, Yue-Zhong</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-15</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(S)-5-Chloro-1-(1-cyclopropylethyl)-3-(2,6-dichloro-4-(trifluoromethyl)-phenylamino)pyrazin-2(1H)-one (BMS-665053), a pyrazinone-contg. compd., is a potent and selective antagonist of corticotropin-releasing factor receptor-1 (CRF-R1) that showed efficacy in the defensive withdrawal model for anxiety in rats, suggesting its use as a potential treatment for anxiety and depression.  In vitro metab. studies of BMS-665053 in rat and human liver microsomes revealed cytochrome P 450-mediated oxidn. of the pyrazinone moiety, followed by ring opening, as the primary metabolic pathway.  Detection of a series of GSH adducts in trapping expts. suggested the formation of a reactive intermediate, probably as a result of epoxidn. of the pyrazinone moiety.  In addn., BMS-665053 (20 mg/kg i.v.) underwent extensive metab. in bile duct-cannulated (BDC) rats.  The major drug-related materials in rat plasma were the pyrazinone oxidn. products.  In rat bile and urine (0-7 h), only a trace amt. of the parent drug was recovered, whereas significant levels of the pyrazinone epoxide-derived metabolites and GSH-related conjugates were detected.  Further evidence suggested that GSH-related conjugates also formed at the dichloroarylamine moiety possibly via an epoxide or a quinone imine intermediate.  Other major metabolites in BDC rat bile and urine included glucuronide conjugates.  To reduce potential liability due to metabolic activation of BMS-665053, a no. of pyrazinone analogs with different substituents were synthesized and investigated for reactive metabolite formation, leading to the discovery of a CRF-R1 antagonist with diminished in vitro metabolic activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKSmCnHe221LVg90H21EOLACvtfcHk0lhyXRvlYEsLlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1aru7fE&md5=ce4d9c5f99f96cbc018968130b068e81</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.028910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.028910%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DHartz%26aufirst%3DR.%2BA.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DAhuja%26aufirst%3DV.%2BT.%26aulast%3DVrudhula%26aufirst%3DV.%2BM.%26aulast%3DLeet%26aufirst%3DJ.%2BE.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DShu%26aufirst%3DY.-Z.%26atitle%3DComparative%2520biotransformation%2520of%2520pyrazinone-containing%2520corticotropin-releasing%2520factor%2520receptor-1%2520antagonists%253A%2520minimizing%2520the%2520reactive%2520metabolite%2520formation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D5%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Hartz, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafalski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditta, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deskus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvanitis, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molski, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span> </span><span class="NLM_article-title">In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4161</span><span class="NLM_x">–</span> <span class="NLM_lpage">4172</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900302q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1Ogurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4161-4172&author=R.+A.+Hartzauthor=V.+T.+Ahujaauthor=M.+Rafalskiauthor=W.+D.+Schmitzauthor=A.+B.+Brennerauthor=D.+J.+Denhartauthor=J.+L.+Dittaauthor=J.+A.+Deskusauthor=E.+W.+Yueauthor=A.+G.+Arvanitisauthor=S.+Lelasauthor=Y.-W.+Liauthor=T.+F.+Molskiauthor=H.+Wongauthor=J.+E.+Graceauthor=K.+A.+Lentzauthor=J.+Liauthor=N.+J.+Lodgeauthor=R.+Zaczekauthor=A.+P.+Combsauthor=R.+E.+Olsonauthor=R.+J.+Mattsonauthor=J.+J.+Bronsonauthor=J.+E.+Macor&title=In+vitro+intrinsic+clearance-based+optimization+of+N3-phenylpyrazinones+as+corticotropin-releasing+factor-1+%28CRF1%29+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Intrinsic Clearance-Based Optimization of N3-Phenylpyrazinones as Corticotropin-Releasing Factor-1 (CRF1) Receptor Antagonists</span></div><div class="casAuthors">Hartz, Richard A.; Ahuja, Vijay T.; Rafalski, Maria; Schmitz, William D.; Brenner, Allison B.; Denhart, Derek J.; Ditta, Jonathan L.; Deskus, Jeffrey A.; Yue, Eddy W.; Arvanitis, Argyrios G.; Lelas, Snjezana; Li, Yu-Wen; Molski, Thaddeus F.; Wong, Harvey; Grace, James E.; Lentz, Kimberley A.; Li, Jianqing; Lodge, Nicholas J.; Zaczek, Robert; Combs, Andrew P.; Olson, Richard E.; Mattson, Ronald J.; Bronson, Joanne J.; Macor, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4161-4172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of pyrazinone-based heterocycles was identified as potent and orally active corticotropin-releasing factor-1 (CRF1) receptor antagonists.  Selected compds., e.g. I, proved efficacious in an anxiety model in rats; however, pharmacokinetic properties were not optimal.  In this article, an in vitro intrinsic clearance-based approach is described to the optimization of pyrazinone-based CRF1 receptor antagonists wherein sites of metab. were identified by incubation with human liver microsomes.  It was found that the rate of metab. could be decreased by incorporation of appropriate substituents at the primary sites of metab.  This led to the discovery of I, a highly potent (IC50 = 1.0 nM) and selective CRF1 receptor antagonist with good oral bioavailability (F = 52%) in rats and efficacy in the defensive withdrawal anxiety test in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSxtlvZCt7vrVg90H21EOLACvtfcHk0lhyXRvlYEsLlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1Ogurk%253D&md5=9ed4f4c2001a832dcb9fdcceb6ce0067</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm900302q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900302q%26sid%3Dliteratum%253Aachs%26aulast%3DHartz%26aufirst%3DR.%2BA.%26aulast%3DAhuja%26aufirst%3DV.%2BT.%26aulast%3DRafalski%26aufirst%3DM.%26aulast%3DSchmitz%26aufirst%3DW.%2BD.%26aulast%3DBrenner%26aufirst%3DA.%2BB.%26aulast%3DDenhart%26aufirst%3DD.%2BJ.%26aulast%3DDitta%26aufirst%3DJ.%2BL.%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DArvanitis%26aufirst%3DA.%2BG.%26aulast%3DLelas%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.-W.%26aulast%3DMolski%26aufirst%3DT.%2BF.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DIn%2520vitro%2520intrinsic%2520clearance-based%2520optimization%2520of%2520N3-phenylpyrazinones%2520as%2520corticotropin-releasing%2520factor-1%2520%2528CRF1%2529%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4161%26epage%3D4172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Marriott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taft, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topsom, R. D.</span><span> </span><span class="NLM_article-title">Substituent electronegativity parameters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00180a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=959-965&author=S.+Marriottauthor=W.+F.+Reynoldsauthor=R.+W.+Taftauthor=R.+D.+Topsom&title=Substituent+electronegativity+parameters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjo00180a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00180a002%26sid%3Dliteratum%253Aachs%26aulast%3DMarriott%26aufirst%3DS.%26aulast%3DReynolds%26aufirst%3DW.%2BF.%26aulast%3DTaft%26aufirst%3DR.%2BW.%26aulast%3DTopsom%26aufirst%3DR.%2BD.%26atitle%3DSubstituent%2520electronegativity%2520parameters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D959%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Ceppi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, C. A.</span><span> </span><span class="NLM_article-title">4-Substituted quinuclidinium perchlorates in the determination of polar substituent effects</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_fpage">3627</span><span class="NLM_x">–</span> <span class="NLM_lpage">3630</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&pages=3627-3630&author=E.+Ceppiauthor=W.+Eckhardtauthor=C.+A.+Grob&title=4-Substituted+quinuclidinium+perchlorates+in+the+determination+of+polar+substituent+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCeppi%26aufirst%3DE.%26aulast%3DEckhardt%26aufirst%3DW.%26aulast%3DGrob%26aufirst%3DC.%2BA.%26atitle%3D4-Substituted%2520quinuclidinium%2520perchlorates%2520in%2520the%2520determination%2520of%2520polar%2520substituent%2520effects%26jtitle%3DTetrahedron%2520Lett.%26date%3D1973%26spage%3D3627%26epage%3D3630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Bannwart, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenhouse, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaime-Figueroa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madera, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozboya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raptova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roetz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfeld, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weikert, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span> </span><span class="NLM_article-title">Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6062</span><span class="NLM_x">–</span> <span class="NLM_lpage">6066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6062-6066&author=L.+M.+Bannwartauthor=D.+S.+Carterauthor=H.-Y.+Caiauthor=J.+C.+Choyauthor=R.+Greenhouseauthor=S.+Jaime-Figueroaauthor=P.+S.+Iyerauthor=C.+J.+Linauthor=E.+K.+Leeauthor=M.+C.+Lucasauthor=S.+M.+Lynchauthor=A.+M.+Maderaauthor=A.+Mooreauthor=K.+Ozboyaauthor=L.+Raptovaauthor=R.+Roetzauthor=R.+C.+Schoenfeldauthor=K.+A.+Steinauthor=S.+Steinerauthor=M.+Villaauthor=R.+J.+Weikertauthor=Y.+Zhai&title=Novel+3%2C3-disubstituted+pyrrolidines+as+selective+triple+serotonin%2Fnorepinephrine%2Fdopamine+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBannwart%26aufirst%3DL.%2BM.%26aulast%3DCarter%26aufirst%3DD.%2BS.%26aulast%3DCai%26aufirst%3DH.-Y.%26aulast%3DChoy%26aufirst%3DJ.%2BC.%26aulast%3DGreenhouse%26aufirst%3DR.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DLin%26aufirst%3DC.%2BJ.%26aulast%3DLee%26aufirst%3DE.%2BK.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLynch%26aufirst%3DS.%2BM.%26aulast%3DMadera%26aufirst%3DA.%2BM.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DOzboya%26aufirst%3DK.%26aulast%3DRaptova%26aufirst%3DL.%26aulast%3DRoetz%26aufirst%3DR.%26aulast%3DSchoenfeld%26aufirst%3DR.%2BC.%26aulast%3DStein%26aufirst%3DK.%2BA.%26aulast%3DSteiner%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DWeikert%26aufirst%3DR.%2BJ.%26aulast%3DZhai%26aufirst%3DY.%26atitle%3DNovel%25203%252C3-disubstituted%2520pyrrolidines%2520as%2520selective%2520triple%2520serotonin%252Fnorepinephrine%252Fdopamine%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6062%26epage%3D6066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanchar, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburgh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staton, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(3<i>R</i>)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide, an agonist of the alpha 7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure–activity relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4425</span><span class="NLM_x">–</span> <span class="NLM_lpage">4436</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0602413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4425-4436&author=D.+G.+Wishkaauthor=D.+P.+Walkerauthor=K.+M.+Yatesauthor=S.+C.+Reitzauthor=S.+Jiaauthor=J.+K.+Myersauthor=K.+L.+Olsonauthor=E.+J.+Jacobsenauthor=M.+L.+Wolfeauthor=V.+E.+Groppiauthor=A.+J.+Hancharauthor=B.+A.+Thornburghauthor=L.+A.+Cortes-Burgosauthor=E.+H.+F.+Wongauthor=B.+A.+Statonauthor=T.+J.+Raubauthor=N.+R.+Higdonauthor=T.+M.+Wallauthor=R.+S.+Hurstauthor=R.+R.+Waltersauthor=W.+E.+Hoffmannauthor=M.+Hajosauthor=S.+Franklinauthor=G.+Careyauthor=L.+H.+Goldauthor=K.+K.+Cookauthor=S.+B.+Sandsauthor=S.+X.+Zhaoauthor=J.+R.+Sogliaauthor=A.+S.+Kalgutkarauthor=S.+P.+Arnericauthor=B.+N.+Rogers&title=Discovery+of+N-%5B%283R%29-1-azabicyclo%5B2.2.2%5Doct-3-yl%5Dfuro%5B2%2C3-c%5Dpyridine-5-carboxamide%2C+an+agonist+of+the+alpha+7+nicotinic+acetylcholine+receptor%2C+for+the+potential+treatment+of+cognitive+deficits+in+schizophrenia%3A+synthesis+and+structure%E2%80%93activity+relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm0602413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0602413%26sid%3Dliteratum%253Aachs%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DYates%26aufirst%3DK.%2BM.%26aulast%3DReitz%26aufirst%3DS.%2BC.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DOlson%26aufirst%3DK.%2BL.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DHanchar%26aufirst%3DA.%2BJ.%26aulast%3DThornburgh%26aufirst%3DB.%2BA.%26aulast%3DCortes-Burgos%26aufirst%3DL.%2BA.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DStaton%26aufirst%3DB.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWalters%26aufirst%3DR.%2BR.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DCarey%26aufirst%3DG.%26aulast%3DGold%26aufirst%3DL.%2BH.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DDiscovery%2520of%2520N-%255B%25283R%2529-1-azabicyclo%255B2.2.2%255Doct-3-yl%255Dfuro%255B2%252C3-c%255Dpyridine-5-carboxamide%252C%2520an%2520agonist%2520of%2520the%2520alpha%25207%2520nicotinic%2520acetylcholine%2520receptor%252C%2520for%2520the%2520potential%2520treatment%2520of%2520cognitive%2520deficits%2520in%2520schizophrenia%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4425%26epage%3D4436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Linton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornelas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kephart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, C.</span><span> </span><span class="NLM_article-title">Systematic structure modifications of imidazo[1,2-<i>a</i>]pyrimidine to reduce metabolism mediated by aldehyde oxidase (AO)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7705</span><span class="NLM_x">–</span> <span class="NLM_lpage">7712</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2010942" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7705-7712&author=A.+Lintonauthor=P.+Kangauthor=M.+Ornelasauthor=S.+Kephartauthor=Q.+Huauthor=M.+Pairishauthor=Y.+Jiangauthor=C.+Guo&title=Systematic+structure+modifications+of+imidazo%5B1%2C2-a%5Dpyrimidine+to+reduce+metabolism+mediated+by+aldehyde+oxidase+%28AO%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm2010942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010942%26sid%3Dliteratum%253Aachs%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DP.%26aulast%3DOrnelas%26aufirst%3DM.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DC.%26atitle%3DSystematic%2520structure%2520modifications%2520of%2520imidazo%255B1%252C2-a%255Dpyrimidine%2520to%2520reduce%2520metabolism%2520mediated%2520by%2520aldehyde%2520oxidase%2520%2528AO%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7705%26epage%3D7712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Garattini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romao, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terao, M.</span><span> </span><span class="NLM_article-title">Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2003&pages=15-32&author=E.+Garattiniauthor=R.+Mendelauthor=M.+J.+Romaoauthor=R.+Wrightauthor=M.+Terao&title=Mammalian+molybdo-flavoenzymes%2C+an+expanding+family+of+proteins%3A+structure%2C+genetics%2C+regulation%2C+function+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DMendel%26aufirst%3DR.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26aulast%3DWright%26aufirst%3DR.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DMammalian%2520molybdo-flavoenzymes%252C%2520an%2520expanding%2520family%2520of%2520proteins%253A%2520structure%252C%2520genetics%252C%2520regulation%252C%2520function%2520and%2520pathophysiology%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D372%26spage%3D15%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Torres, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korzekwa, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4642</span><span class="NLM_x">–</span> <span class="NLM_lpage">4647</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0703690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4642-4647&author=R.+A.+Torresauthor=K.+R.+Korzekwaauthor=D.+R.+McMastersauthor=C.+M.+Fandozziauthor=J.+P.+Jones&title=Use+of+density+functional+calculations+to+predict+the+regioselectivity+of+drugs+and+molecules+metabolized+by+aldehyde+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm0703690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703690%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DR.%2BA.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DUse%2520of%2520density%2520functional%2520calculations%2520to%2520predict%2520the%2520regioselectivity%2520of%2520drugs%2520and%2520molecules%2520metabolized%2520by%2520aldehyde%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4642%26epage%3D4647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Lunniss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldred, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aston, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohil, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judkins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranshaw, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span> </span><span class="NLM_article-title">Addressing species specific metabolism and solubility issues in a quinoline series of oral PDE4 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=137-140&author=C.+Lunnissauthor=C.+Eldredauthor=N.+Astonauthor=A.+Cravenauthor=K.+Gohilauthor=B.+Judkinsauthor=S.+Keelingauthor=L.+Ranshawauthor=E.+Robinsonauthor=T.+Shipleyauthor=N.+Trivedi&title=Addressing+species+specific+metabolism+and+solubility+issues+in+a+quinoline+series+of+oral+PDE4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLunniss%26aufirst%3DC.%26aulast%3DEldred%26aufirst%3DC.%26aulast%3DAston%26aufirst%3DN.%26aulast%3DCraven%26aufirst%3DA.%26aulast%3DGohil%26aufirst%3DK.%26aulast%3DJudkins%26aufirst%3DB.%26aulast%3DKeeling%26aufirst%3DS.%26aulast%3DRanshaw%26aufirst%3DL.%26aulast%3DRobinson%26aufirst%3DE.%26aulast%3DShipley%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26atitle%3DAddressing%2520species%2520specific%2520metabolism%2520and%2520solubility%2520issues%2520in%2520a%2520quinoline%2520series%2520of%2520oral%2520PDE4%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D137%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Boström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowright, A. T.</span><span> </span><span class="NLM_article-title">Oxadiazoles in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1830</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostr%C3%B6mauthor=A.+Hognerauthor=A.+Llin%C3%A0sauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlin%25C3%25A0s%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':[],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 122 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Li Ding, Christophe Pannecouque, Erik De Clercq, Chunlin Zhuang, <span class="NLM_string-name hlFld-ContribAuthor">Fen-Er Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Improving Druggability of Novel Diarylpyrimidine NNRTIs by a Fragment-Based Replacement Strategy: From Biphenyl-DAPYs to Heteroaromatic-Biphenyl-DAPYs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10297-10311. <a href="https://doi.org/10.1021/acs.jmedchem.1c00708" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00708%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImproving%252BDruggability%252Bof%252BNovel%252BDiarylpyrimidine%252BNNRTIs%252Bby%252Ba%252BFragment-Based%252BReplacement%252BStrategy%25253A%252BFrom%252BBiphenyl-DAPYs%252Bto%252BHeteroaromatic-Biphenyl-DAPYs%26aulast%3DDing%26aufirst%3DLi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19042021%26date%3D01072021%26volume%3D64%26issue%3D14%26spage%3D10297%26epage%3D10311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wenjun Luo, Zhenguo Wang, Xiaohui Cao, Dacheng Liang, Mingjie Wei, Keshu Yin, <span class="NLM_string-name hlFld-ContribAuthor">Le Li</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of Benzo-1,2,3-thiazaphosphole Heterocycles by Annulations of ortho-Phosphinoarenesulfonyl Fluorides with Trimethylsilyl Azide. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (22)
                                     , 14785-14794. <a href="https://doi.org/10.1021/acs.joc.0c01309" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01309%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConstruction%252Bof%252BBenzo-1%25252C2%25252C3-thiazaphosphole%252BHeterocycles%252Bby%252BAnnulations%252Bof%252Bortho-Phosphinoarenesulfonyl%252BFluorides%252Bwith%252BTrimethylsilyl%252BAzide%26aulast%3DLuo%26aufirst%3DWenjun%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02062020%26date%3D04092020%26volume%3D85%26issue%3D22%26spage%3D14785%26epage%3D14794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Randy R. Miller, Maria Madeira, Harold B. Wood, Wayne M. Geissler, Conrad E. Raab, <span class="NLM_string-name hlFld-ContribAuthor">Iain J. Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12156-12170. <a href="https://doi.org/10.1021/acs.jmedchem.9b01813" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01813</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01813%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntegrating%252Bthe%252BImpact%252Bof%252BLipophilicity%252Bon%252BPotency%252Band%252BPharmacokinetic%252BParameters%252BEnables%252Bthe%252BUse%252Bof%252BDiverse%252BChemical%252BSpace%252Bduring%252BSmall%252BMolecule%252BDrug%252BOptimization%26aulast%3DMiller%26aufirst%3DRandy%2BR.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D01112019%26date%3D07072020%26volume%3D63%26issue%3D21%26spage%3D12156%26epage%3D12170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Taeho Kang, Tuğçe G. Erbay, Kane L. Xu, Gary M. Gallego, Alexander Burtea, Sajiv K. Nair, Ryan L. Patman, Ru Zhou, Scott C. Sutton, Indrawan J. McAlpine, Peng Liu, <span class="NLM_string-name hlFld-ContribAuthor">Keary M. Engle</span>. </span><span class="cited-content_cbyCitation_article-title">Multifaceted Substrate–Ligand Interactions Promote the Copper-Catalyzed Hydroboration of Benzylidenecyclobutanes and Related Compounds. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (21)
                                     , 13075-13083. <a href="https://doi.org/10.1021/acscatal.0c03622" title="DOI URL">https://doi.org/10.1021/acscatal.0c03622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c03622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c03622%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DMultifaceted%252BSubstrate%2525E2%252580%252593Ligand%252BInteractions%252BPromote%252Bthe%252BCopper-Catalyzed%252BHydroboration%252Bof%252BBenzylidenecyclobutanes%252Band%252BRelated%252BCompounds%26aulast%3DKang%26aufirst%3DTaeho%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19082020%26date%3D05102020%26date%3D27102020%26volume%3D10%26issue%3D21%26spage%3D13075%26epage%3D13083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ervin Kovács, Ferenc Faigl, <span class="NLM_string-name hlFld-ContribAuthor">Zoltán Mucsi</span>. </span><span class="cited-content_cbyCitation_article-title">Regio- and Diastereoselective Synthesis of 2-Arylazetidines: Quantum Chemical Explanation of Baldwin’s Rules for the Ring-Formation Reactions of Oxiranes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (17)
                                     , 11226-11239. <a href="https://doi.org/10.1021/acs.joc.0c01310" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01310</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01310%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegio-%252Band%252BDiastereoselective%252BSynthesis%252Bof%252B2-Arylazetidines%25253A%252BQuantum%252BChemical%252BExplanation%252Bof%252BBaldwin%2525E2%252580%252599s%252BRules%252Bfor%252Bthe%252BRing-Formation%252BReactions%252Bof%252BOxiranes%26aulast%3DKov%25C3%25A1cs%26aufirst%3DErvin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02062020%26date%3D24082020%26date%3D10082020%26volume%3D85%26issue%3D17%26spage%3D11226%26epage%3D11239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ana Mallo-Abreu, Rubén Prieto-Díaz, Willem Jespers, Jhonny Azuaje, Maria Majellaro, Carmen Velando, Xerardo García-Mera, Olga Caamaño, José Brea, María I. Loza, Hugo Gutiérrez-de-Terán, <span class="NLM_string-name hlFld-ContribAuthor">Eddy Sotelo</span>. </span><span class="cited-content_cbyCitation_article-title">Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7721-7739. <a href="https://doi.org/10.1021/acs.jmedchem.0c00564" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00564%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNitrogen-Walk%252BApproach%252Bto%252BExplore%252BBioisosteric%252BReplacements%252Bin%252Ba%252BSeries%252Bof%252BPotent%252BA2B%252BAdenosine%252BReceptor%252BAntagonists%26aulast%3DMallo-Abreu%26aufirst%3DAna%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06042020%26date%3D07072020%26date%3D23062020%26volume%3D63%26issue%3D14%26spage%3D7721%26epage%3D7739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Manjinder S. Lall, Asser Bassyouni, James Bradow, Maria Brown, Mark Bundesmann, Jinshan Chen, Gregory Ciszewski, Anne E. Hagen, Dennis Hyek, Stephen Jenkinson, Bo Liu, R. Scott Obach, Senliang Pan, Usa Reilly, Neal Sach, Daniel J. Smaltz, Douglas K. Spracklin, Jeremy Starr, Melissa Wagenaar, <span class="NLM_string-name hlFld-ContribAuthor">Gregory S. Walker</span>. </span><span class="cited-content_cbyCitation_article-title">Late-Stage Lead Diversification Coupled with Quantitative Nuclear Magnetic Resonance Spectroscopy to Identify New Structure–Activity Relationship Vectors at Nanomole-Scale Synthesis: Application to Loratadine, a Human Histamine H1 Receptor Inverse Agonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (13)
                                     , 7268-7292. <a href="https://doi.org/10.1021/acs.jmedchem.0c00483" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00483</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00483%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLate-Stage%252BLead%252BDiversification%252BCoupled%252Bwith%252BQuantitative%252BNuclear%252BMagnetic%252BResonance%252BSpectroscopy%252Bto%252BIdentify%252BNew%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BVectors%252Bat%252BNanomole-Scale%252BSynthesis%25253A%252BApplication%252Bto%252BLoratadine%25252C%252Ba%252BHuman%252BHistamine%252BH1%252BReceptor%252BInverse%252BAgonist%26aulast%3DLall%26aufirst%3DManjinder%2BS.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22032020%26date%3D08062020%26date%3D28052020%26volume%3D63%26issue%3D13%26spage%3D7268%26epage%3D7292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">James P. Driscoll, Corinne M. Sadlowski, Nina R. Shah, <span class="NLM_string-name hlFld-ContribAuthor">Antonio Feula</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism and Bioactivation: It’s Time to Expect the Unexpected. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6303-6314. <a href="https://doi.org/10.1021/acs.jmedchem.0c00026" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00026%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetabolism%252Band%252BBioactivation%25253A%252BIt%2525E2%252580%252599s%252BTime%252Bto%252BExpect%252Bthe%252BUnexpected%26aulast%3DDriscoll%26aufirst%3DJames%2BP.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07012020%26date%3D21042020%26date%3D08042020%26volume%3D63%26issue%3D12%26spage%3D6303%26epage%3D6314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ze Dong, Zhen Wang, Zhong-Qiang Guo, Shouzhe Gong, Tao Zhang, Jiang Liu, Cheng Luo, Hualiang Jiang, <span class="NLM_string-name hlFld-ContribAuthor">Cai-Guang Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship of SPOP Inhibitors against Kidney Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4849-4866. <a href="https://doi.org/10.1021/acs.jmedchem.0c00161" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00161%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252Bof%252BSPOP%252BInhibitors%252Bagainst%252BKidney%252BCancer%26aulast%3DDong%26aufirst%3DZe%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29012020%26date%3D27042020%26date%3D16042020%26volume%3D63%26issue%3D9%26spage%3D4849%26epage%3D4866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wayland E. Noland, Honnaiah Vijay Kumar, Yernaidu Reddi, Christopher J. Cramer, Alexei V. Novikov, Hyejin Kim, Yumeng Zhu, Yoke Ching Chin, Yuqi Zhou, Predrag Radakovic, Anjola Uprety, Jun Xie, <span class="NLM_string-name hlFld-ContribAuthor">Grant C. Flick</span>. </span><span class="cited-content_cbyCitation_article-title">Diels–Alder/Ene Reactivities of 2-(1′-Cycloalkenyl)thiophenes and 2-(1′-Cycloalkenyl)benzo[b]thiophenes with N-Phenylmaleimides: Role of Cycloalkene Ring Size on Benzothiophene and Dibenzothiophene Product Distributions. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (8)
                                     , 5265-5287. <a href="https://doi.org/10.1021/acs.joc.9b03363" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03363</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03363%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDiels%2525E2%252580%252593Alder%25252FEne%252BReactivities%252Bof%252B2-%2525281%2525E2%252580%2525B2-Cycloalkenyl%252529thiophenes%252Band%252B2-%2525281%2525E2%252580%2525B2-Cycloalkenyl%252529benzo%25255Bb%25255Dthiophenes%252Bwith%252BN-Phenylmaleimides%25253A%252BRole%252Bof%252BCycloalkene%252BRing%252BSize%252Bon%252BBenzothiophene%252Band%252BDibenzothiophene%252BProduct%252BDistributions%26aulast%3DNoland%26aufirst%3DWayland%2BE.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D14122019%26date%3D31032020%26date%3D16032020%26volume%3D85%26issue%3D8%26spage%3D5265%26epage%3D5287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jennifer A. Borthwick, Carlos Alemparte, Ian Wall, Benjamin C. Whitehurst, Argyrides Argyrou, Glenn Burley, Paco de Dios-Anton, Laura Guijarro, Maria Candida Monteiro, Fatima Ortega, Colin J Suckling, Julia Castro Pichel, Monica Cacho, <span class="NLM_string-name hlFld-ContribAuthor">Robert J. Young</span>. </span><span class="cited-content_cbyCitation_article-title">Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase Inhibitors: Expeditious Reconstruction of Suboptimal Hits into a Series with Potent in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2557-2576. <a href="https://doi.org/10.1021/acs.jmedchem.9b01561" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01561%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMycobacterium%252Btuberculosis%252BDecaprenylphosphoryl-%2525CE%2525B2-d-ribose%252BOxidase%252BInhibitors%25253A%252BExpeditious%252BReconstruction%252Bof%252BSuboptimal%252BHits%252Binto%252Ba%252BSeries%252Bwith%252BPotent%252Bin%252BVivo%252BActivity%26aulast%3DBorthwick%26aufirst%3DJennifer%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D19092019%26date%3D22012020%26date%3D10012020%26volume%3D63%26issue%3D5%26spage%3D2557%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Swapna Varghese, Raphaël Rahmani, Stephanie Russell, Girdhar Singh Deora, Lori Ferrins, Arthur Toynton, Amy Jones, Melissa Sykes, Albane Kessler, Amanda Eufrásio, Artur Torres Cordeiro, Julian Sherman, Ana Rodriguez, Vicky M. Avery, Matthew J. Piggott, <span class="NLM_string-name hlFld-ContribAuthor">Jonathan B. Baell</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent N-Ethylurea Pyrazole Derivatives as Dual Inhibitors of Trypanosoma brucei and Trypanosoma cruzi. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 278-285. <a href="https://doi.org/10.1021/acsmedchemlett.9b00218" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00218%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BPotent%252BN-Ethylurea%252BPyrazole%252BDerivatives%252Bas%252BDual%252BInhibitors%252Bof%252BTrypanosoma%252Bbrucei%252Band%252BTrypanosoma%252Bcruzi%26aulast%3DVarghese%26aufirst%3DSwapna%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29052019%26date%3D09092019%26date%3D11092019%26date%3D09092019%26volume%3D11%26issue%3D3%26spage%3D278%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Darren Conboy, Styliana I. Mirallai, Austin Craig, Patrick McArdle, Ali A. Al-Kinani, Stephen Barton, <span class="NLM_string-name hlFld-ContribAuthor">Fawaz Aldabbagh</span>. </span><span class="cited-content_cbyCitation_article-title">Incorporating Morpholine and Oxetane into Benzimidazolequinone Antitumor Agents: The Discovery of 1,4,6,9-Tetramethoxyphenazine from Hydrogen Peroxide and Hydroiodic Acid-Mediated Oxidative Cyclizations. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (15)
                                     , 9811-9818. <a href="https://doi.org/10.1021/acs.joc.9b01427" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01427%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIncorporating%252BMorpholine%252Band%252BOxetane%252Binto%252BBenzimidazolequinone%252BAntitumor%252BAgents%25253A%252BThe%252BDiscovery%252Bof%252B1%25252C4%25252C6%25252C9-Tetramethoxyphenazine%252Bfrom%252BHydrogen%252BPeroxide%252Band%252BHydroiodic%252BAcid-Mediated%252BOxidative%252BCyclizations%26aulast%3DConboy%26aufirst%3DDarren%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30052019%26date%3D24072019%26date%3D11072019%26volume%3D84%26issue%3D15%26spage%3D9811%26epage%3D9818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lara Amini-Rentsch, Ennio Vanoli, Sylvia Richard-Bildstein, Roger Marti, <span class="NLM_string-name hlFld-ContribAuthor">Gianvito Vilé</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel and Efficient Continuous-Flow Route To Prepare Trifluoromethylated N-Fused Heterocycles for Drug Discovery and Pharmaceutical Manufacturing. </span><span class="cited-content_cbyCitation_journal-name">Industrial & Engineering Chemistry Research</span><span> <strong>2019,</strong> <em>58 </em>
                                    (24)
                                     , 10164-10171. <a href="https://doi.org/10.1021/acs.iecr.9b01906" title="DOI URL">https://doi.org/10.1021/acs.iecr.9b01906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.iecr.9b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.iecr.9b01906%26sid%3Dliteratum%253Aachs%26jtitle%3DIndustrial%2520%2526%2520Engineering%2520Chemistry%2520Research%26atitle%3DA%252BNovel%252Band%252BEfficient%252BContinuous-Flow%252BRoute%252BTo%252BPrepare%252BTrifluoromethylated%252BN-Fused%252BHeterocycles%252Bfor%252BDrug%252BDiscovery%252Band%252BPharmaceutical%252BManufacturing%26aulast%3DAmini-Rentsch%26aufirst%3DLara%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D09042019%26date%3D27052019%26date%3D27052019%26date%3D11062019%26date%3D27052019%26volume%3D58%26issue%3D24%26spage%3D10164%26epage%3D10171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Oliver F. Brandenberg, Kai Chen, <span class="NLM_string-name hlFld-ContribAuthor">Frances H. Arnold</span>. </span><span class="cited-content_cbyCitation_article-title">Directed Evolution of a Cytochrome P450 Carbene Transferase for Selective Functionalization of Cyclic Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (22)
                                     , 8989-8995. <a href="https://doi.org/10.1021/jacs.9b02931" title="DOI URL">https://doi.org/10.1021/jacs.9b02931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b02931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b02931%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DDirected%252BEvolution%252Bof%252Ba%252BCytochrome%252BP450%252BCarbene%252BTransferase%252Bfor%252BSelective%252BFunctionalization%252Bof%252BCyclic%252BCompounds%26aulast%3DBrandenberg%26aufirst%3DOliver%2BF.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17032019%26date%3D22052019%26date%3D09052019%26volume%3D141%26issue%3D22%26spage%3D8989%26epage%3D8995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alexander Fawcett, Amna Murtaza, Charlotte H. U. Gregson, <span class="NLM_string-name hlFld-ContribAuthor">Varinder K. Aggarwal</span>. </span><span class="cited-content_cbyCitation_article-title">Strain-Release-Driven Homologation of Boronic Esters: Application to the Modular Synthesis of Azetidines. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (11)
                                     , 4573-4578. <a href="https://doi.org/10.1021/jacs.9b01513" title="DOI URL">https://doi.org/10.1021/jacs.9b01513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b01513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b01513%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DStrain-Release-Driven%252BHomologation%252Bof%252BBoronic%252BEsters%25253A%252BApplication%252Bto%252Bthe%252BModular%252BSynthesis%252Bof%252BAzetidines%26aulast%3DFawcett%26aufirst%3DAlexander%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08022019%26date%3D11032019%26date%3D05032019%26volume%3D141%26issue%3D11%26spage%3D4573%26epage%3D4578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ha T. Do, Huiying Li, Georges Chreifi, Thomas L. Poulos, <span class="NLM_string-name hlFld-ContribAuthor">Richard B. Silverman</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Blood–Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (5)
                                     , 2690-2707. <a href="https://doi.org/10.1021/acs.jmedchem.8b02032" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b02032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b02032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b02032%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BBlood%2525E2%252580%252593Brain%252BBarrier%252BPermeability%252Bwith%252BPotent%252Band%252BSelective%252BHuman%252BNeuronal%252BNitric%252BOxide%252BSynthase%252BInhibitors%252BHaving%252Ba%252B2-Aminopyridine%252BScaffold%26aulast%3DDo%26aufirst%3DHa%2BT.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D29122018%26date%3D25022019%26volume%3D62%26issue%3D5%26spage%3D2690%26epage%3D2707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Illia
O. Feskov, Anton V. Chernykh, Yuliya O. Kuchkovska, Constantin G. Daniliuc, Ivan S. Kondratov, <span class="NLM_string-name hlFld-ContribAuthor">Oleksandr O. Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">3-((Hetera)cyclobutyl)azetidines, “Stretched” Analogues of Piperidine, Piperazine, and Morpholine: Advanced Building Blocks for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (3)
                                     , 1363-1371. <a href="https://doi.org/10.1021/acs.joc.8b02822" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02822%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D3-%252528%252528Hetera%252529cyclobutyl%252529azetidines%25252C%252B%2525E2%252580%25259CStretched%2525E2%252580%25259D%252BAnalogues%252Bof%252BPiperidine%25252C%252BPiperazine%25252C%252Band%252BMorpholine%25253A%252BAdvanced%252BBuilding%252BBlocks%252Bfor%252BDrug%252BDiscovery%26aulast%3DFeskov%26aufirst%3DIllia%2BO.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D05112018%26date%3D08012019%26date%3D24122018%26volume%3D84%26issue%3D3%26spage%3D1363%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mihirbaran Mandal, Kaushik Mitra, Diane Grotz, Xinjie Lin, Jairam Palamanda, Pramila Kumari, Alexei Buevich, John P. Caldwell, Xia Chen, Kathleen Cox, Leonard Favreau, Lynn Hyde, Matthew E. Kennedy, Reshma Kuvelkar, Xiaoxiang Liu, Robert D. Mazzola, Eric Parker, Diane Rindgen, Edward Sherer, Hongwu Wang, Zhaoning Zhu, Andrew W. Stamford, <span class="NLM_string-name hlFld-ContribAuthor">Jared N. Cumming</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming Time-Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (23)
                                     , 10700-10708. <a href="https://doi.org/10.1021/acs.jmedchem.8b01326" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01326%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOvercoming%252BTime-Dependent%252BInhibition%252B%252528TDI%252529%252Bof%252BCytochrome%252BP450%252B3A4%252B%252528CYP3A4%252529%252BResulting%252Bfrom%252BBioactivation%252Bof%252Ba%252BFluoropyrimidine%252BMoiety%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22082018%26date%3D15112018%26date%3D02112018%26volume%3D61%26issue%3D23%26spage%3D10700%26epage%3D10708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alf Claesson, <span class="NLM_string-name hlFld-ContribAuthor">Alexander Minidis</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic Approach to Organizing Structural Alerts for Reactive Metabolite Formation from Potential Drugs. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2018,</strong> <em>31 </em>
                                    (6)
                                     , 389-411. <a href="https://doi.org/10.1021/acs.chemrestox.8b00046" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.8b00046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.8b00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.8b00046%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DSystematic%252BApproach%252Bto%252BOrganizing%252BStructural%252BAlerts%252Bfor%252BReactive%252BMetabolite%252BFormation%252Bfrom%252BPotential%252BDrugs%26aulast%3DClaesson%26aufirst%3DAlf%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21022018%26date%3D21052018%26date%3D10052018%26volume%3D31%26issue%3D6%26spage%3D389%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew M.  Thompson</span>, <span class="hlFld-ContribAuthor ">Patrick D.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Marshall</span>, <span class="hlFld-ContribAuthor ">Vanessa  Yardley</span>, <span class="hlFld-ContribAuthor ">Louis  Maes</span>, <span class="hlFld-ContribAuthor ">Suman  Gupta</span>, <span class="hlFld-ContribAuthor ">Delphine  Launay</span>, <span class="hlFld-ContribAuthor ">Stephanie  Braillard</span>, <span class="hlFld-ContribAuthor ">Eric  Chatelain</span>, <span class="hlFld-ContribAuthor ">Scott G.  Franzblau</span>, <span class="hlFld-ContribAuthor ">Baojie  Wan</span>, <span class="hlFld-ContribAuthor ">Yuehong  Wang</span>, <span class="hlFld-ContribAuthor ">Zhenkun  Ma</span>, <span class="hlFld-ContribAuthor ">Christopher B.  Cooper</span>, and <span class="hlFld-ContribAuthor ">William A.  Denny</span>  . </span><span class="cited-content_cbyCitation_article-title">7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (10)
                                     , 4212-4233. <a href="https://doi.org/10.1021/acs.jmedchem.7b00034" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00034%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D7-Substituted%252B2-Nitro-5%25252C6-dihydroimidazo%25255B2%25252C1-b%25255D%25255B1%25252C3%25255Doxazines%25253A%252BNovel%252BAntitubercular%252BAgents%252BLead%252Bto%252Ba%252BNew%252BPreclinical%252BCandidate%252Bfor%252BVisceral%252BLeishmaniasis%26aulast%3DThompson%26aufirst%3DAndrew%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08012017%26date%3D11052017%26date%3D25052017%26date%3D01052017%26volume%3D60%26issue%3D10%26spage%3D4212%26epage%3D4233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span> and <span class="hlFld-ContribAuthor ">Demetri T.  Moustakas</span>  . </span><span class="cited-content_cbyCitation_article-title">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3552-3579. <a href="https://doi.org/10.1021/acs.jmedchem.6b01807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BNecessary%252BNitrogen%252BAtom%25253A%252BA%252BVersatile%252BHigh-Impact%252BDesign%252BElement%252Bfor%252BMultiparameter%252BOptimization%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D09122016%26date%3D08022017%26date%3D11052017%26volume%3D60%26issue%3D9%26spage%3D3552%26epage%3D3579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  Bull</span>, <span class="hlFld-ContribAuthor ">Rosemary A.  Croft</span>, <span class="hlFld-ContribAuthor ">Owen A.  Davis</span>, <span class="hlFld-ContribAuthor ">Robert  Doran</span>, and <span class="hlFld-ContribAuthor ">Kate F.  Morgan</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12150-12233. <a href="https://doi.org/10.1021/acs.chemrev.6b00274" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00274%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DOxetanes%25253A%252BRecent%252BAdvances%252Bin%252BSynthesis%25252C%252BReactivity%25252C%252Band%252BMedicinal%252BChemistry%26aulast%3DBull%26aufirst%3DJames%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28042016%26date%3D15092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12150%26epage%3D12233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (4)
                                     , 564-616. <a href="https://doi.org/10.1021/acs.chemrestox.6b00043" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.6b00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DImproving%252BDrug%252BDesign%25253A%252BAn%252BUpdate%252Bon%252BRecent%252BApplications%252Bof%252BEfficiency%252BMetrics%25252C%252BStrategies%252Bfor%252BReplacing%252BProblematic%252BElements%25252C%252Band%252BCompounds%252Bin%252BNontraditional%252BDrug%252BSpace%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03022016%26date%3D14032016%26date%3D18042016%26volume%3D29%26issue%3D4%26spage%3D564%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew S.  Dowling</span>, <span class="hlFld-ContribAuthor ">Dilinie P.  Fernando</span>, <span class="hlFld-ContribAuthor ">Jie  Hou</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, and <span class="hlFld-ContribAuthor ">Aaron C.  Smith</span>  . </span><span class="cited-content_cbyCitation_article-title">Two Scalable Syntheses of (S)-2-Methylazetidine. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (7)
                                     , 3031-3036. <a href="https://doi.org/10.1021/acs.joc.6b00149" title="DOI URL">https://doi.org/10.1021/acs.joc.6b00149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b00149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b00149%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTwo%252BScalable%252BSyntheses%252Bof%252B%252528S%252529-2-Methylazetidine%26aulast%3DDowling%26aufirst%3DMatthew%2BS.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D22012016%26date%3D11032016%26date%3D01042016%26date%3D19022016%26volume%3D81%26issue%3D7%26spage%3D3031%26epage%3D3036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huaming  Sheng</span>, <span class="hlFld-ContribAuthor ">Weijuan  Tang</span>, <span class="hlFld-ContribAuthor ">Ravikiran  Yerabolu</span>, <span class="hlFld-ContribAuthor ">Joann  Max</span>, <span class="hlFld-ContribAuthor ">Raghavendhar R.  Kotha</span>, <span class="hlFld-ContribAuthor ">James S.  Riedeman</span>, <span class="hlFld-ContribAuthor ">John J.  Nash</span>, <span class="hlFld-ContribAuthor ">Minli  Zhang</span>, and <span class="hlFld-ContribAuthor ">Hilkka. I.  Kenttämaa</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of N-Oxide and Sulfoxide Functionalities in Protonated Drug Metabolites by Using  Ion–Molecule Reactions Followed by Collisionally Activated Dissociation in a Linear Quadrupole Ion Trap Mass Spectrometer. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>81 </em>
                                    (2)
                                     , 575-586. <a href="https://doi.org/10.1021/acs.joc.5b02409" title="DOI URL">https://doi.org/10.1021/acs.joc.5b02409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b02409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b02409%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIdentification%252Bof%252BN-Oxide%252Band%252BSulfoxide%252BFunctionalities%252Bin%252BProtonated%252BDrug%252BMetabolites%252Bby%252BUsing%252BIon%2525E2%252580%252593Molecule%252BReactions%252BFollowed%252Bby%252BCollisionally%252BActivated%252BDissociation%252Bin%252Ba%252BLinear%252BQuadrupole%252BIon%252BTrap%252BMass%252BSpectrometer%26aulast%3DSheng%26aufirst%3DHuaming%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D17102015%26date%3D29122015%26date%3D15012016%26date%3D11122015%26volume%3D81%26issue%3D2%26spage%3D575%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter G.  Ruminski</span>, <span class="hlFld-ContribAuthor ">Mark  Massa</span>, <span class="hlFld-ContribAuthor ">Joseph  Strohbach</span>, <span class="hlFld-ContribAuthor ">Cathleen E.  Hanau</span>, <span class="hlFld-ContribAuthor ">Michelle  Schmidt</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Scholten</span>, <span class="hlFld-ContribAuthor ">Theresa R.  Fletcher</span>, <span class="hlFld-ContribAuthor ">Bruce C.  Hamper</span>, <span class="hlFld-ContribAuthor ">Jeffery N.  Carroll</span>, <span class="hlFld-ContribAuthor ">Huey S.  Shieh</span>, <span class="hlFld-ContribAuthor ">Nicole  Caspers</span>, <span class="hlFld-ContribAuthor ">Brandon  Collins</span>, <span class="hlFld-ContribAuthor ">Margaret  Grapperhaus</span>, <span class="hlFld-ContribAuthor ">Katherine E.  Palmquist</span>, <span class="hlFld-ContribAuthor ">Joe  Collins</span>, <span class="hlFld-ContribAuthor ">John E.  Baldus</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Hitchcock</span>, <span class="hlFld-ContribAuthor ">H. Peter  Kleine</span>, <span class="hlFld-ContribAuthor ">Michael D.  Rogers</span>, <span class="hlFld-ContribAuthor ">Joseph  McDonald</span>, <span class="hlFld-ContribAuthor ">Grace E.  Munie</span>, <span class="hlFld-ContribAuthor ">Dean M.  Messing</span>, <span class="hlFld-ContribAuthor ">Silvia  Portolan</span>, <span class="hlFld-ContribAuthor ">Laurence O.  Whiteley</span>, <span class="hlFld-ContribAuthor ">Teresa  Sunyer</span>, and <span class="hlFld-ContribAuthor ">Mark E.  Schnute</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (1)
                                     , 313-327. <a href="https://doi.org/10.1021/acs.jmedchem.5b01434" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01434%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525284-Fluoro-3-methoxybenzyl%252529-6-%2525282-%252528%252528%2525282S%25252C5R%252529-5-%252528hydroxymethyl%252529-1%25252C4-dioxan-2-yl%252529methyl%252529-2H-tetrazol-5-yl%252529-2-methylpyrimidine-4-carboxamide.%252BA%252BHighly%252BSelective%252Band%252BOrally%252BBioavailable%252BMatrix%252BMetalloproteinase-13%252BInhibitor%252Bfor%252Bthe%252BPotential%252BTreatment%252Bof%252BOsteoarthritis%26aulast%3DRuminski%26aufirst%3DPeter%2BG.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D15092015%26date%3D24122015%26date%3D14012016%26date%3D12122015%26volume%3D59%26issue%3D1%26spage%3D313%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Michael D.  Croghan</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Kate S.  Ashton</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Bourbeau</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Samer  Chmait</span>, <span class="hlFld-ContribAuthor ">Rod  Cupples</span>, <span class="hlFld-ContribAuthor ">Christopher  Fotsch</span>, <span class="hlFld-ContribAuthor ">Joan  Helmering</span>, <span class="hlFld-ContribAuthor ">Fang-Tsao  Hong</span>, <span class="hlFld-ContribAuthor ">Randall W.  Hungate</span>, <span class="hlFld-ContribAuthor ">Steven R.  Jordan</span>, <span class="hlFld-ContribAuthor ">Ke  Kong</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Klaus  Michelsen</span>, <span class="hlFld-ContribAuthor ">Carolyn  Moyer</span>, <span class="hlFld-ContribAuthor ">Nobuko  Nishimura</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">Andreas  Reichelt</span>, <span class="hlFld-ContribAuthor ">Aaron C.  Siegmund</span>, <span class="hlFld-ContribAuthor ">Glenn  Sivits</span>, <span class="hlFld-ContribAuthor ">Seifu  Tadesse</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Tegley</span>, <span class="hlFld-ContribAuthor ">Gwyneth  Van</span>, <span class="hlFld-ContribAuthor ">Kevin C.  Yang</span>, <span class="hlFld-ContribAuthor ">Guomin  Yao</span>, <span class="hlFld-ContribAuthor ">Jiandong  Zhang</span>, <span class="hlFld-ContribAuthor ">David J.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Clarence  Hale</span>, and <span class="hlFld-ContribAuthor ">David J.  St. Jean, Jr.</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Structure-Guided Optimization of Diarylmethanesulfonamide Disrupters of Glucokinase–Glucokinase Regulatory Protein (GK–GKRP) Binding: Strategic Use of a N → S (nN → σ*S–X) Interaction for Conformational Constraint. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (24)
                                     , 9663-9679. <a href="https://doi.org/10.1021/acs.jmedchem.5b01367" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01367%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BStructure-Guided%252BOptimization%252Bof%252BDiarylmethanesulfonamide%252BDisrupters%252Bof%252BGlucokinase%2525E2%252580%252593Glucokinase%252BRegulatory%252BProtein%252B%252528GK%2525E2%252580%252593GKRP%252529%252BBinding%25253A%252BStrategic%252BUse%252Bof%252Ba%252BN%252B%2525E2%252586%252592%252BS%252B%252528nN%252B%2525E2%252586%252592%252B%2525CF%252583%252AS%2525E2%252580%252593X%252529%252BInteraction%252Bfor%252BConformational%252BConstraint%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D04092015%26date%3D01122015%26date%3D24122015%26date%3D09112015%26volume%3D58%26issue%3D24%26spage%3D9663%26epage%3D9679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Snahel  Patel</span>, <span class="hlFld-ContribAuthor ">Seth F.  Harris</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Amy  Gustafson</span>, <span class="hlFld-ContribAuthor ">Terry  Kellar</span>, <span class="hlFld-ContribAuthor ">Han  Lin</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Yanzhou  Liu</span>, <span class="hlFld-ContribAuthor ">Yichin  Liu</span>, <span class="hlFld-ContribAuthor ">Changyou  Ma</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Arundhati Sengupta  Ghosh</span>, <span class="hlFld-ContribAuthor ">Young G.  Shin</span>, <span class="hlFld-ContribAuthor ">Hilda  Solanoy</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Bei  Wang</span>, <span class="hlFld-ContribAuthor ">Jianping  Yin</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, and <span class="hlFld-ContribAuthor ">Joseph W.  Lewcock</span>  . </span><span class="cited-content_cbyCitation_article-title">Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (20)
                                     , 8182-8199. <a href="https://doi.org/10.1021/acs.jmedchem.5b01072" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01072%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DScaffold-Hopping%252Band%252BStructure-Based%252BDiscovery%252Bof%252BPotent%25252C%252BSelective%25252C%252BAnd%252BBrain%252BPenetrant%252BN-%2525281H-Pyrazol-3-yl%252529pyridin-2-amine%252BInhibitors%252Bof%252BDual%252BLeucine%252BZipper%252BKinase%252B%252528DLK%25252C%252BMAP3K12%252529%26aulast%3DPatel%26aufirst%3DSnahel%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09072015%26date%3D02102015%26date%3D22102015%26volume%3D58%26issue%3D20%26spage%3D8182%26epage%3D8199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien P. N.  Papillon</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Adams</span>, <span class="hlFld-ContribAuthor ">Qi-Ying  Hu</span>, <span class="hlFld-ContribAuthor ">Changgang  Lou</span>, <span class="hlFld-ContribAuthor ">Alok K.  Singh</span>, <span class="hlFld-ContribAuthor ">Chun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jose  Carvalho</span>, <span class="hlFld-ContribAuthor ">Srinivan  Rajan</span>, <span class="hlFld-ContribAuthor ">Adam  Amaral</span>, <span class="hlFld-ContribAuthor ">Michael E.  Beil</span>, <span class="hlFld-ContribAuthor ">Fumin  Fu</span>, <span class="hlFld-ContribAuthor ">Eric  Gangl</span>, <span class="hlFld-ContribAuthor ">Chii-Whei  Hu</span>, <span class="hlFld-ContribAuthor ">Arco Y.  Jeng</span>, <span class="hlFld-ContribAuthor ">Daniel  LaSala</span>, <span class="hlFld-ContribAuthor ">Guiqing  Liang</span>, <span class="hlFld-ContribAuthor ">Michael  Logman</span>, <span class="hlFld-ContribAuthor ">Wieslawa M.  Maniara</span>, <span class="hlFld-ContribAuthor ">Dean F.  Rigel</span>, <span class="hlFld-ContribAuthor ">Sherri A.  Smith</span>, and <span class="hlFld-ContribAuthor ">Gary M.  Ksander</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships, Pharmacokinetics, and in Vivo Activity of CYP11B2 and CYP11B1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4749-4770. <a href="https://doi.org/10.1021/acs.jmedchem.5b00407" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00407%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%25252C%252BPharmacokinetics%25252C%252Band%252Bin%252BVivo%252BActivity%252Bof%252BCYP11B2%252Band%252BCYP11B1%252BInhibitors%26aulast%3DPapillon%26aufirst%3DJulien%2BP.%2BN.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13032015%26date%3D21052015%26date%3D11062015%26date%3D08052015%26volume%3D58%26issue%3D11%26spage%3D4749%26epage%3D4770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brett R.  Beno</span>, <span class="hlFld-ContribAuthor ">Kap-Sun  Yeung</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4383-4438. <a href="https://doi.org/10.1021/jm501853m" title="DOI URL">https://doi.org/10.1021/jm501853m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501853m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501853m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BSurvey%252Bof%252Bthe%252BRole%252Bof%252BNoncovalent%252BSulfur%252BInteractions%252Bin%252BDrug%252BDesign%26aulast%3DBeno%26aufirst%3DBrett%2BR.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D01122014%26date%3D03032015%26date%3D11062015%26volume%3D58%26issue%3D11%26spage%3D4383%26epage%3D4438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Concepción  Alonso</span>, <span class="hlFld-ContribAuthor ">Eduardo  Martínez de Marigorta</span>, <span class="hlFld-ContribAuthor ">Gloria  Rubiales</span>, and <span class="hlFld-ContribAuthor ">Francisco  Palacios</span>  . </span><span class="cited-content_cbyCitation_article-title">Carbon Trifluoromethylation Reactions of Hydrocarbon Derivatives and Heteroarenes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2015,</strong> <em>115 </em>
                                    (4)
                                     , 1847-1935. <a href="https://doi.org/10.1021/cr500368h" title="DOI URL">https://doi.org/10.1021/cr500368h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500368h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500368h%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DCarbon%252BTrifluoromethylation%252BReactions%252Bof%252BHydrocarbon%252BDerivatives%252Band%252BHeteroarenes%26aulast%3DAlonso%26aufirst%3DConcepci%25C3%25B3n%26date%3D2015%26date%3D2015%26date%3D2013%26date%3D27062013%26date%3D30012015%26date%3D25022015%26volume%3D115%26issue%3D4%26spage%3D1847%26epage%3D1935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benoit  Pasquier</span>, <span class="hlFld-ContribAuthor ">Youssef  El-Ahmad</span>, <span class="hlFld-ContribAuthor ">Bruno  Filoche-Rommé</span>, <span class="hlFld-ContribAuthor ">Christine  Dureuil</span>, <span class="hlFld-ContribAuthor ">Florence  Fassy</span>, <span class="hlFld-ContribAuthor ">Pierre-Yves  Abecassis</span>, <span class="hlFld-ContribAuthor ">Magali  Mathieu</span>, <span class="hlFld-ContribAuthor ">Thomas  Bertrand</span>, <span class="hlFld-ContribAuthor ">Tsiala  Benard</span>, <span class="hlFld-ContribAuthor ">Cédric  Barrière</span>, <span class="hlFld-ContribAuthor ">Samira  El Batti</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Letallec</span>, <span class="hlFld-ContribAuthor ">Véronique  Sonnefraud</span>, <span class="hlFld-ContribAuthor ">Maurice  Brollo</span>, <span class="hlFld-ContribAuthor ">Laurence  Delbarre</span>, <span class="hlFld-ContribAuthor ">Véronique  Loyau</span>, <span class="hlFld-ContribAuthor ">Fabienne  Pilorge</span>, <span class="hlFld-ContribAuthor ">Luc  Bertin</span>, <span class="hlFld-ContribAuthor ">Patrick  Richepin</span>, <span class="hlFld-ContribAuthor ">Jérôme  Arigon</span>, <span class="hlFld-ContribAuthor ">Jean-Robert  Labrosse</span>, <span class="hlFld-ContribAuthor ">Jacques  Clément</span>, <span class="hlFld-ContribAuthor ">Florence  Durand</span>, <span class="hlFld-ContribAuthor ">Romain  Combet</span>, <span class="hlFld-ContribAuthor ">Pierre  Perraut</span>, <span class="hlFld-ContribAuthor ">Vincent  Leroy</span>, <span class="hlFld-ContribAuthor ">Frédéric  Gay</span>, <span class="hlFld-ContribAuthor ">Dominique  Lefrançois</span>, <span class="hlFld-ContribAuthor ">François  Bretin</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Marquette</span>, <span class="hlFld-ContribAuthor ">Nadine  Michot</span>, <span class="hlFld-ContribAuthor ">Anne  Caron</span>, <span class="hlFld-ContribAuthor ">Christelle  Castell</span>, <span class="hlFld-ContribAuthor ">Laurent  Schio</span>, <span class="hlFld-ContribAuthor ">Gary  McCort</span>, <span class="hlFld-ContribAuthor ">Hélène  Goulaouic</span>, <span class="hlFld-ContribAuthor ">Carlos  Garcia-Echeverria</span>, and <span class="hlFld-ContribAuthor ">Baptiste  Ronan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (2S)-8-[(3R)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 376-400. <a href="https://doi.org/10.1021/jm5013352" title="DOI URL">https://doi.org/10.1021/jm5013352</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5013352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5013352%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525282S%252529-8-%25255B%2525283R%252529-3-Methylmorpholin-4-yl%25255D-1-%2525283-methyl-2-oxobutyl%252529-2-%252528trifluoromethyl%252529-3%25252C4-dihydro-2H-pyrimido%25255B1%25252C2-a%25255Dpyrimidin-6-one%25253A%252BA%252BNovel%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252BVps34%252Bfor%252Bthe%252BTreatment%252Bof%252BSolid%252BTumors%26aulast%3DPasquier%26aufirst%3DBenoit%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D01092014%26date%3D26112014%26date%3D08012015%26date%3D17112014%26volume%3D58%26issue%3D1%26spage%3D376%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Debra  Hunter</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Michael A.  Stashko</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Minson</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Cummings</span>, <span class="hlFld-ContribAuthor ">Minjung  Lee</span>, <span class="hlFld-ContribAuthor ">Trevor G.  Glaros</span>, <span class="hlFld-ContribAuthor ">Dianne L.  Newton</span>, <span class="hlFld-ContribAuthor ">Susan  Sather</span>, <span class="hlFld-ContribAuthor ">Dehui  Zhang</span>, <span class="hlFld-ContribAuthor ">Dmitri  Kireev</span>, <span class="hlFld-ContribAuthor ">William P.  Janzen</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, and <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (16)
                                     , 7031-7041. <a href="https://doi.org/10.1021/jm500749d" title="DOI URL">https://doi.org/10.1021/jm500749d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500749d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500749d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUNC2025%25252C%252Ba%252BPotent%252Band%252BOrally%252BBioavailable%252BMER%25252FFLT3%252BDual%252BInhibitor%26aulast%3DZhang%26aufirst%3DWeihe%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D14052014%26date%3D06082014%26date%3D28082014%26date%3D28072014%26volume%3D57%26issue%3D16%26spage%3D7031%26epage%3D7041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunkyung  Jeong</span>, <span class="hlFld-ContribAuthor ">Bom-I  Kim</span>, <span class="hlFld-ContribAuthor ">Jae Kyun  Lee</span>, and <span class="hlFld-ContribAuthor ">Jae-Sang  Ryu</span>  . </span><span class="cited-content_cbyCitation_article-title">Direct Synthesis of 4-Fluoroisoxazoles through Gold-Catalyzed Cascade Cyclization–Fluorination of 2-Alkynone O-Methyl Oximes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (14)
                                     , 6444-6455. <a href="https://doi.org/10.1021/jo5008702" title="DOI URL">https://doi.org/10.1021/jo5008702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo5008702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo5008702%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDirect%252BSynthesis%252Bof%252B4-Fluoroisoxazoles%252Bthrough%252BGold-Catalyzed%252BCascade%252BCyclization%2525E2%252580%252593Fluorination%252Bof%252B2-Alkynone%252BO-Methyl%252BOximes%26aulast%3DJeong%26aufirst%3DYunkyung%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18042014%26date%3D07072014%26date%3D18072014%26date%3D30062014%26volume%3D79%26issue%3D14%26spage%3D6444%26epage%3D6455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fionn  O’Hara</span>, <span class="hlFld-ContribAuthor ">Aaron C.  Burns</span>, <span class="hlFld-ContribAuthor ">Michael R.  Collins</span>, <span class="hlFld-ContribAuthor ">Deepak  Dalvie</span>, <span class="hlFld-ContribAuthor ">Martha A.  Ornelas</span>, <span class="hlFld-ContribAuthor ">Alfin D. N.  Vaz</span>, <span class="hlFld-ContribAuthor ">Yuta  Fujiwara</span>, and <span class="hlFld-ContribAuthor ">Phil S.  Baran</span>  . </span><span class="cited-content_cbyCitation_article-title">A Simple Litmus Test for Aldehyde Oxidase Metabolism of Heteroarenes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1616-1620. <a href="https://doi.org/10.1021/jm4017976" title="DOI URL">https://doi.org/10.1021/jm4017976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4017976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4017976%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BSimple%252BLitmus%252BTest%252Bfor%252BAldehyde%252BOxidase%252BMetabolism%252Bof%252BHeteroarenes%26aulast%3DO%25E2%2580%2599Hara%26aufirst%3DFionn%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D20112013%26date%3D05022014%26date%3D27022014%26date%3D28012014%26volume%3D57%26issue%3D4%26spage%3D1616%26epage%3D1620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kentaro  Kawai</span>, <span class="hlFld-ContribAuthor ">Naoya  Nagata</span>, and <span class="hlFld-ContribAuthor ">Yoshimasa  Takahashi</span>  . </span><span class="cited-content_cbyCitation_article-title">De Novo Design of Drug-Like Molecules by a Fragment-Based Molecular Evolutionary Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (1)
                                     , 49-56. <a href="https://doi.org/10.1021/ci400418c" title="DOI URL">https://doi.org/10.1021/ci400418c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400418c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400418c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDe%252BNovo%252BDesign%252Bof%252BDrug-Like%252BMolecules%252Bby%252Ba%252BFragment-Based%252BMolecular%252BEvolutionary%252BApproach%26aulast%3DKawai%26aufirst%3DKentaro%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D17072013%26date%3D13012014%26date%3D27012014%26date%3D28122013%26volume%3D54%26issue%3D1%26spage%3D49%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  St. Jean, Jr.</span>, <span class="hlFld-ContribAuthor ">Kate S.  Ashton</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Samer  Chmait</span>, <span class="hlFld-ContribAuthor ">Rod  Cupples</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Galbreath</span>, <span class="hlFld-ContribAuthor ">Joan  Helmering</span>, <span class="hlFld-ContribAuthor ">Fang-Tsao  Hong</span>, <span class="hlFld-ContribAuthor ">Steven R.  Jordan</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Roxanne K.  Kunz</span>, <span class="hlFld-ContribAuthor ">Klaus  Michelsen</span>, <span class="hlFld-ContribAuthor ">Nobuko  Nishimura</span>, <span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Steve F.  Poon</span>, <span class="hlFld-ContribAuthor ">Darren  Reid</span>, <span class="hlFld-ContribAuthor ">Glenn  Sivits</span>, <span class="hlFld-ContribAuthor ">Markian M.  Stec</span>, <span class="hlFld-ContribAuthor ">Seifu  Tadesse</span>, <span class="hlFld-ContribAuthor ">Nuria  Tamayo</span>, <span class="hlFld-ContribAuthor ">Gwyneth  Van</span>, <span class="hlFld-ContribAuthor ">Kevin C.  Yang</span>, <span class="hlFld-ContribAuthor ">Jiandong  Zhang</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">Christopher  Fotsch</span>, <span class="hlFld-ContribAuthor ">David J.  Lloyd</span>, and <span class="hlFld-ContribAuthor ">Clarence  Hale</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Disruptors of the Glucokinase–Glucokinase Regulatory Protein Interaction: 2. Leveraging Structure-Based Drug Design to Identify Analogues with Improved Pharmacokinetic Profiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (2)
                                     , 325-338. <a href="https://doi.org/10.1021/jm4016747" title="DOI URL">https://doi.org/10.1021/jm4016747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4016747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4016747%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BDisruptors%252Bof%252Bthe%252BGlucokinase%2525E2%252580%252593Glucokinase%252BRegulatory%252BProtein%252BInteraction%25253A%252B2.%252BLeveraging%252BStructure-Based%252BDrug%252BDesign%252Bto%252BIdentify%252BAnalogues%252Bwith%252BImproved%252BPharmacokinetic%252BProfiles%26aulast%3DSt.%2BJean%26aufirst%3DDavid%2BJ.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D28102013%26date%3D09012014%26date%3D23012014%26volume%3D57%26issue%3D2%26spage%3D325%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengcheng P.  Shao</span>, <span class="hlFld-ContribAuthor ">Feng  Ye</span>, <span class="hlFld-ContribAuthor ">Prasun K.  Chakravarty</span>, <span class="hlFld-ContribAuthor ">James B.  Herrington</span>, <span class="hlFld-ContribAuthor ">Ge  Dai</span>, <span class="hlFld-ContribAuthor ">Randal M.  Bugianesi</span>, <span class="hlFld-ContribAuthor ">Rodolfo J.  Haedo</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Swensen</span>, <span class="hlFld-ContribAuthor ">Vivien A.  Warren</span>, <span class="hlFld-ContribAuthor ">McHardy M.  Smith</span>, <span class="hlFld-ContribAuthor ">Maria L.  Garcia</span>, <span class="hlFld-ContribAuthor ">Owen B.  McManus</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Lyons</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Li</span>, <span class="hlFld-ContribAuthor ">Mitchell  Green</span>, <span class="hlFld-ContribAuthor ">Nina  Jochnowitz</span>, <span class="hlFld-ContribAuthor ">Erin  McGowan</span>, <span class="hlFld-ContribAuthor ">Shruti  Mistry</span>, <span class="hlFld-ContribAuthor ">Shu-Yu  Sun</span>, <span class="hlFld-ContribAuthor ">Catherine  Abbadie</span>, <span class="hlFld-ContribAuthor ">Gregory J.  Kaczorowski</span>, and <span class="hlFld-ContribAuthor ">Joseph L.  Duffy</span>  . </span><span class="cited-content_cbyCitation_article-title">Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile Sulfonamide. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (11)
                                     , 1064-1068. <a href="https://doi.org/10.1021/ml4002612" title="DOI URL">https://doi.org/10.1021/ml4002612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml4002612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml4002612%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImproved%252BCav2.2%252BChannel%252BInhibitors%252Bthrough%252Ba%252Bgem-Dimethylsulfone%252BBioisostere%252BReplacement%252Bof%252Ba%252BLabile%252BSulfonamide%26aulast%3DShao%26aufirst%3DPengcheng%2BP.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D09072013%26date%3D08092013%26date%3D13092013%26date%3D14112013%26date%3D08092013%26volume%3D4%26issue%3D11%26spage%3D1064%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonia F.  Stepan</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, <span class="hlFld-ContribAuthor ">Christopher E.  Keefer</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, and <span class="hlFld-ContribAuthor ">Martin  Edwards</span>  . </span><span class="cited-content_cbyCitation_article-title">Evaluating the Differences in Cycloalkyl Ether Metabolism Using the Design Parameter “Lipophilic Metabolism Efficiency” (LipMetE) and a Matched Molecular Pairs Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (17)
                                     , 6985-6990. <a href="https://doi.org/10.1021/jm4008642" title="DOI URL">https://doi.org/10.1021/jm4008642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4008642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4008642%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEvaluating%252Bthe%252BDifferences%252Bin%252BCycloalkyl%252BEther%252BMetabolism%252BUsing%252Bthe%252BDesign%252BParameter%252B%2525E2%252580%25259CLipophilic%252BMetabolism%252BEfficiency%2525E2%252580%25259D%252B%252528LipMetE%252529%252Band%252Ba%252BMatched%252BMolecular%252BPairs%252BAnalysis%26aulast%3DStepan%26aufirst%3DAntonia%2BF.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D28052013%26date%3D21082013%26date%3D12092013%26date%3D25072013%26volume%3D56%26issue%3D17%26spage%3D6985%26epage%3D6990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Sheng</span>, <span class="hlFld-ContribAuthor ">Bo  Chao</span>, <span class="hlFld-ContribAuthor ">Hong  Chen</span>, and <span class="hlFld-ContribAuthor ">Youhong  Hu</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Chromeno[2,3-d]imidazol-9(1H)-ones via Tandem Reactions of 3-Iodochromones with Amidines Involving Copper-Catalyzed C–H Functionalization and C–O Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2013,</strong> <em>15 </em>
                                    (17)
                                     , 4508-4511. <a href="https://doi.org/10.1021/ol401966y" title="DOI URL">https://doi.org/10.1021/ol401966y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol401966y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol401966y%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BChromeno%25255B2%25252C3-d%25255Dimidazol-9%2525281H%252529-ones%252Bvia%252BTandem%252BReactions%252Bof%252B3-Iodochromones%252Bwith%252BAmidines%252BInvolving%252BCopper-Catalyzed%252BC%2525E2%252580%252593H%252BFunctionalization%252Band%252BC%2525E2%252580%252593O%252BBond%252BFormation%26aulast%3DSheng%26aufirst%3DJia%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D22072013%26date%3D14082013%26date%3D06092013%26volume%3D15%26issue%3D17%26spage%3D4508%26epage%3D4511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Genovino</span>, <span class="hlFld-ContribAuthor ">Stephan  Lütz</span>, <span class="hlFld-ContribAuthor ">Dalibor  Sames</span>, and <span class="hlFld-ContribAuthor ">B. Barry  Touré</span>  . </span><span class="cited-content_cbyCitation_article-title">Complementation of Biotransformations with Chemical C–H Oxidation: Copper-Catalyzed Oxidation of Tertiary Amines in Complex Pharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2013,</strong> <em>135 </em>
                                    (33)
                                     , 12346-12352. <a href="https://doi.org/10.1021/ja405471h" title="DOI URL">https://doi.org/10.1021/ja405471h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja405471h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja405471h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DComplementation%252Bof%252BBiotransformations%252Bwith%252BChemical%252BC%2525E2%252580%252593H%252BOxidation%25253A%252BCopper-Catalyzed%252BOxidation%252Bof%252BTertiary%252BAmines%252Bin%252BComplex%252BPharmaceuticals%26aulast%3DGenovino%26aufirst%3DJulien%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D31052013%26date%3D12082013%26date%3D21082013%26date%3D22072013%26volume%3D135%26issue%3D33%26spage%3D12346%26epage%3D12352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Nilewski</span>, <span class="hlFld-ContribAuthor ">Theodore D.  Michels</span>, <span class="hlFld-ContribAuthor ">Garrick K.  Packard</span>, <span class="hlFld-ContribAuthor ">Alan X.  Xiang</span>, <span class="hlFld-ContribAuthor ">Paul A.  Sprengeler</span>, <span class="hlFld-ContribAuthor ">Boreth  Eam</span>, <span class="hlFld-ContribAuthor ">Sarah  Fish</span>, <span class="hlFld-ContribAuthor ">Peggy A.  Thompson</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Wegerski</span>, <span class="hlFld-ContribAuthor ">Andres  Nevarez</span>, <span class="hlFld-ContribAuthor ">Jeff  Clarine</span>, <span class="hlFld-ContribAuthor ">Samuel  Sperry</span>, <span class="hlFld-ContribAuthor ">Justin T.  Ernst</span>, <span class="hlFld-ContribAuthor ">Siegfried H.  Reich</span>. </span><span class="cited-content_cbyCitation_article-title">1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>47 </em>, 128111. <a href="https://doi.org/10.1016/j.bmcl.2021.128111" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128111%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D1-Aminomethyl%252BSAR%252Bin%252Ba%252Bnovel%252Bseries%252Bof%252Bflavagline-inspired%252BeIF4A%252Binhibitors%25253A%252BEffects%252Bof%252Bamine%252Bsubstitution%252Bon%252Bcell%252Bpotency%252Band%252Bin%252Bvitro%252BPK%252Bproperties%26aulast%3DNilewski%26aufirst%3DChristian%26date%3D2021%26volume%3D47%26spage%3D128111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yinran  Wang</span>, <span class="hlFld-ContribAuthor ">Fang  Guo</span>, <span class="hlFld-ContribAuthor ">Zhaomin  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">N
              ‐Monomethylation of Amines with Methanol by Syndiotactic Poly(aminostyrene)‐supported Palladium Nanoparticle Catalyst. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>59 </em><a href="https://doi.org/10.1002/ajoc.202100339" title="DOI URL">https://doi.org/10.1002/ajoc.202100339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100339%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DN%252B%2525E2%252580%252590Monomethylation%252Bof%252BAmines%252Bwith%252BMethanol%252Bby%252BSyndiotactic%252BPoly%252528aminostyrene%252529%2525E2%252580%252590supported%252BPalladium%252BNanoparticle%252BCatalyst%26aulast%3DJiang%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Hill</span>, <span class="hlFld-ContribAuthor ">Haiquan  Fang</span>, <span class="hlFld-ContribAuthor ">John  Tokarski</span>, <span class="hlFld-ContribAuthor ">Carolynn  Fanslau</span>, <span class="hlFld-ContribAuthor ">Zuzana  Haarhoff</span>, <span class="hlFld-ContribAuthor ">Christine  Huang</span>, <span class="hlFld-ContribAuthor ">Melissa  Kramer</span>, <span class="hlFld-ContribAuthor ">Krista  Menard</span>, <span class="hlFld-ContribAuthor ">Laura  Monereau</span>, <span class="hlFld-ContribAuthor ">John  Morrison</span>, <span class="hlFld-ContribAuthor ">Asoka  Ranasinghe</span>, <span class="hlFld-ContribAuthor ">Eric E.  Shields</span>, <span class="hlFld-ContribAuthor ">Ching Kim  Tye</span>, <span class="hlFld-ContribAuthor ">Richard  Westhouse</span>, <span class="hlFld-ContribAuthor ">Gerry  Everlof</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Chunhong  Yan</span>, <span class="hlFld-ContribAuthor ">Frank  Marsilio</span>, <span class="hlFld-ContribAuthor ">Lisa  Zhang</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Francis  Lee</span>, <span class="hlFld-ContribAuthor ">Ashvinikumar V.  Gavai</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Degnan</span>. </span><span class="cited-content_cbyCitation_article-title">Development of BET inhibitors as potential treatments for cancer: A search for structural diversity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>44 </em>, 128108. <a href="https://doi.org/10.1016/j.bmcl.2021.128108" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128108%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252BBET%252Binhibitors%252Bas%252Bpotential%252Btreatments%252Bfor%252Bcancer%25253A%252BA%252Bsearch%252Bfor%252Bstructural%252Bdiversity%26aulast%3DHill%26aufirst%3DMatthew%2BD.%26date%3D2021%26volume%3D44%26spage%3D128108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlotte H. U.  Gregson</span>, <span class="hlFld-ContribAuthor ">Adam  Noble</span>, <span class="hlFld-ContribAuthor ">Varinder K.  Aggarwal</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent, Strain‐Release Reactions of Azabicyclo[1.1.0]butyl Carbinols: Semipinacol or Spiroepoxy Azetidine Formation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (13)
                                     , 7436-7441. <a href="https://doi.org/10.1002/ange.202100583" title="DOI URL">https://doi.org/10.1002/ange.202100583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202100583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202100583%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DDivergent%25252C%252BStrain%2525E2%252580%252590Release%252BReactions%252Bof%252BAzabicyclo%25255B1.1.0%25255Dbutyl%252BCarbinols%25253A%252BSemipinacol%252Bor%252BSpiroepoxy%252BAzetidine%252BFormation%26aulast%3DGregson%26aufirst%3DCharlotte%2BH.%2BU.%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D13%26spage%3D7436%26epage%3D7441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlotte H. U.  Gregson</span>, <span class="hlFld-ContribAuthor ">Adam  Noble</span>, <span class="hlFld-ContribAuthor ">Varinder K.  Aggarwal</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent, Strain‐Release Reactions of Azabicyclo[1.1.0]butyl Carbinols: Semipinacol or Spiroepoxy Azetidine Formation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (13)
                                     , 7360-7365. <a href="https://doi.org/10.1002/anie.202100583" title="DOI URL">https://doi.org/10.1002/anie.202100583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202100583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202100583%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DDivergent%25252C%252BStrain%2525E2%252580%252590Release%252BReactions%252Bof%252BAzabicyclo%25255B1.1.0%25255Dbutyl%252BCarbinols%25253A%252BSemipinacol%252Bor%252BSpiroepoxy%252BAzetidine%252BFormation%26aulast%3DGregson%26aufirst%3DCharlotte%2BH.%2BU.%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D13%26spage%3D7360%26epage%3D7365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dustyn A.  Barnette</span>, <span class="hlFld-ContribAuthor ">Mary A.  Schleiff</span>, <span class="hlFld-ContribAuthor ">Arghya  Datta</span>, <span class="hlFld-ContribAuthor ">Noah  Flynn</span>, <span class="hlFld-ContribAuthor ">S. Joshua  Swamidass</span>, <span class="hlFld-ContribAuthor ">Grover P.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam. </span><span class="cited-content_cbyCitation_journal-name">Toxicology Letters</span><span> <strong>2021,</strong> <em>338 </em>, 10-20. <a href="https://doi.org/10.1016/j.toxlet.2020.11.015" title="DOI URL">https://doi.org/10.1016/j.toxlet.2020.11.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.toxlet.2020.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.toxlet.2020.11.015%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520Letters%26atitle%3DMeloxicam%252Bmethyl%252Bgroup%252Bdetermines%252Benzyme%252Bspecificity%252Bfor%252Bthiazole%252Bbioactivation%252Bcompared%252Bto%252Bsudoxicam%26aulast%3DBarnette%26aufirst%3DDustyn%2BA.%26date%3D2021%26volume%3D338%26spage%3D10%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aisha A.  Alsfouk</span>, <span class="hlFld-ContribAuthor ">Hanan M.  Alshibl</span>, <span class="hlFld-ContribAuthor ">Najla A.  Altwaijry</span>, <span class="hlFld-ContribAuthor ">Bshra A.  Alsfouk</span>, <span class="hlFld-ContribAuthor ">Ebtehal S.  Al-Abdullah</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of seliciclib derivatives as potent and selective CDK9 inhibitors for prostate cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2021,</strong> <em>152 </em>
                                    (1)
                                     , 109-120. <a href="https://doi.org/10.1007/s00706-020-02727-x" title="DOI URL">https://doi.org/10.1007/s00706-020-02727-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-020-02727-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-020-02727-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bseliciclib%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BCDK9%252Binhibitors%252Bfor%252Bprostate%252Bcancer%252Btherapy%26aulast%3DAlsfouk%26aufirst%3DAisha%2BA.%26date%3D2021%26date%3D2021%26volume%3D152%26issue%3D1%26spage%3D109%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro ADME and in vivo pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 305-369. <a href="https://doi.org/10.1016/B978-0-12-817214-8.00006-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-817214-8.00006-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817214-8.00006-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817214-8.00006-3%26sid%3Dliteratum%253Aachs%26atitle%3DIn%252Bvitro%252BADME%252Band%252Bin%252Bvivo%252Bpharmacokinetics%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2021%26spage%3D305%26epage%3D369%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2021%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liezel A.  Lumangtad</span>, <span class="hlFld-ContribAuthor ">Elisa  Claeys</span>, <span class="hlFld-ContribAuthor ">Sunil  Hamal</span>, <span class="hlFld-ContribAuthor ">Amarawan  Intasiri</span>, <span class="hlFld-ContribAuthor ">Courtney  Basrai</span>, <span class="hlFld-ContribAuthor ">Expedite  Yen-Pon</span>, <span class="hlFld-ContribAuthor ">Davison  Beenfeldt</span>, <span class="hlFld-ContribAuthor ">Kurt  Vermeire</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Bell</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (24)
                                     , 115816. <a href="https://doi.org/10.1016/j.bmc.2020.115816" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115816</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115816%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSyntheses%252Band%252Banti-HIV%252Band%252Bhuman%252Bcluster%252Bof%252Bdifferentiation%252B4%252B%252528CD4%252529%252Bdown-modulating%252Bpotencies%252Bof%252Bpyridine-fused%252Bcyclotriazadisulfonamide%252B%252528CADA%252529%252Bcompounds%26aulast%3DLumangtad%26aufirst%3DLiezel%2BA.%26date%3D2020%26volume%3D28%26issue%3D24%26spage%3D115816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc R.  Becker</span>, <span class="hlFld-ContribAuthor ">Emily R.  Wearing</span>, <span class="hlFld-ContribAuthor ">Corinna S.  Schindler</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of azetidines via visible-light-mediated intermolecular [2+2] photocycloadditions. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 898-905. <a href="https://doi.org/10.1038/s41557-020-0541-1" title="DOI URL">https://doi.org/10.1038/s41557-020-0541-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41557-020-0541-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41557-020-0541-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bazetidines%252Bvia%252Bvisible-light-mediated%252Bintermolecular%252B%25255B2%25252B2%25255D%252Bphotocycloadditions%26aulast%3DBecker%26aufirst%3DMarc%2BR.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D898%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Savitha  Bhaskaran</span>, <span class="hlFld-ContribAuthor ">M. Syed Ali  Padusha</span>, <span class="hlFld-ContribAuthor ">Ayyiliath M  Sajith</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Palladium Based Precatalytic Systems in the Suzuki‐Miyaura Cross‐Coupling Reactions of Chloro‐ Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (29)
                                     , 9005-9016. <a href="https://doi.org/10.1002/slct.202002357" title="DOI URL">https://doi.org/10.1002/slct.202002357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202002357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202002357%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DApplication%252Bof%252BPalladium%252BBased%252BPrecatalytic%252BSystems%252Bin%252Bthe%252BSuzuki%2525E2%252580%252590Miyaura%252BCross%2525E2%252580%252590Coupling%252BReactions%252Bof%252BChloro%2525E2%252580%252590%252BHeterocycles%26aulast%3DBhaskaran%26aufirst%3DSavitha%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D29%26spage%3D9005%26epage%3D9016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Andresini</span>, <span class="hlFld-ContribAuthor ">Leonardo  Degennaro</span>, <span class="hlFld-ContribAuthor ">Renzo  Luisi</span>. </span><span class="cited-content_cbyCitation_article-title">The renaissance of strained 1-azabicyclo[1.1.0]butanes as useful reagents for the synthesis of functionalized azetidines. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (30)
                                     , 5798-5810. <a href="https://doi.org/10.1039/D0OB01251C" title="DOI URL">https://doi.org/10.1039/D0OB01251C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB01251C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB01251C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Brenaissance%252Bof%252Bstrained%252B1-azabicyclo%25255B1.1.0%25255Dbutanes%252Bas%252Buseful%252Breagents%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bfunctionalized%252Bazetidines%26aulast%3DAndresini%26aufirst%3DMichael%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D30%26spage%3D5798%26epage%3D5810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alistair D.  Richardson</span>, <span class="hlFld-ContribAuthor ">Marc R.  Becker</span>, <span class="hlFld-ContribAuthor ">Corinna S.  Schindler</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of azetidines by aza Paternò–Büchi reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (29)
                                     , 7553-7561. <a href="https://doi.org/10.1039/D0SC01017K" title="DOI URL">https://doi.org/10.1039/D0SC01017K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC01017K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC01017K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DSynthesis%252Bof%252Bazetidines%252Bby%252Baza%252BPatern%2525C3%2525B2%2525E2%252580%252593B%2525C3%2525BCchi%252Breactions%26aulast%3DRichardson%26aufirst%3DAlistair%2BD.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D29%26spage%3D7553%26epage%3D7561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dustyn A.  Barnette</span>, <span class="hlFld-ContribAuthor ">Mary A.  Schleiff</span>, <span class="hlFld-ContribAuthor ">Laura R.  Osborn</span>, <span class="hlFld-ContribAuthor ">Noah  Flynn</span>, <span class="hlFld-ContribAuthor ">Matthew  Matlock</span>, <span class="hlFld-ContribAuthor ">S. Joshua  Swamidass</span>, <span class="hlFld-ContribAuthor ">Grover P.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam. </span><span class="cited-content_cbyCitation_journal-name">Toxicology</span><span> <strong>2020,</strong> <em>440 </em>, 152478. <a href="https://doi.org/10.1016/j.tox.2020.152478" title="DOI URL">https://doi.org/10.1016/j.tox.2020.152478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tox.2020.152478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tox.2020.152478%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%26atitle%3DDual%252Bmechanisms%252Bsuppress%252Bmeloxicam%252Bbioactivation%252Brelative%252Bto%252Bsudoxicam%26aulast%3DBarnette%26aufirst%3DDustyn%2BA.%26date%3D2020%26volume%3D440%26spage%3D152478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew D.  Chen</span>, <span class="hlFld-ContribAuthor ">James H.  Herbort</span>, <span class="hlFld-ContribAuthor ">Ethan A.  Wappes</span>, <span class="hlFld-ContribAuthor ">Kohki M.  Nakafuku</span>, <span class="hlFld-ContribAuthor ">Darsheed N.  Mustafa</span>, <span class="hlFld-ContribAuthor ">David A.  Nagib</span>. </span><span class="cited-content_cbyCitation_article-title">Radical cascade synthesis of azoles
              via
              tandem hydrogen atom transfer. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 2479-2486. <a href="https://doi.org/10.1039/C9SC06239D" title="DOI URL">https://doi.org/10.1039/C9SC06239D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9SC06239D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9SC06239D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DRadical%252Bcascade%252Bsynthesis%252Bof%252Bazoles%252Bvia%252Btandem%252Bhydrogen%252Batom%252Btransfer%26aulast%3DChen%26aufirst%3DAndrew%2BD.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D9%26spage%3D2479%26epage%3D2486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phillip R.  Lazzara</span>, <span class="hlFld-ContribAuthor ">Terry W.  Moore</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 18-29. <a href="https://doi.org/10.1039/C9MD00396G" title="DOI URL">https://doi.org/10.1039/C9MD00396G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00396G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00396G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DScaffold-hopping%252Bas%252Ba%252Bstrategy%252Bto%252Baddress%252Bmetabolic%252Bliabilities%252Bof%252Baromatic%252Bcompounds%26aulast%3DLazzara%26aufirst%3DPhillip%2BR.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D18%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc R.  Becker</span>, <span class="hlFld-ContribAuthor ">Alistair D.  Richardson</span>, <span class="hlFld-ContribAuthor ">Corinna S.  Schindler</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalized azetidines via visible light-enabled aza Paternò-Büchi reactions. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-13072-x" title="DOI URL">https://doi.org/10.1038/s41467-019-13072-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-13072-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-13072-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DFunctionalized%252Bazetidines%252Bvia%252Bvisible%252Blight-enabled%252Baza%252BPatern%2525C3%2525B2-B%2525C3%2525BCchi%252Breactions%26aulast%3DBecker%26aufirst%3DMarc%2BR.%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Jiang</span>, <span class="hlFld-ContribAuthor ">Fang  Guo</span>, <span class="hlFld-ContribAuthor ">Yinran  Wang</span>, <span class="hlFld-ContribAuthor ">Jialin  Jiang</span>, <span class="hlFld-ContribAuthor ">Yangzhi  Duan</span>, <span class="hlFld-ContribAuthor ">Zhaomin  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Selective
              N
              ‐Monomethylation of Anilines with Methanol Catalyzed by Commercial Pd/C as an Efficient and Reusable Catalyst. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>8 </em>
                                    (11)
                                     , 2046-2049. <a href="https://doi.org/10.1002/ajoc.201900509" title="DOI URL">https://doi.org/10.1002/ajoc.201900509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201900509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201900509%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSelective%252BN%252B%2525E2%252580%252590Monomethylation%252Bof%252BAnilines%252Bwith%252BMethanol%252BCatalyzed%252Bby%252BCommercial%252BPd%25252FC%252Bas%252Ban%252BEfficient%252Band%252BReusable%252BCatalyst%26aulast%3DJiang%26aufirst%3DLei%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D11%26spage%3D2046%26epage%3D2049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. Cyrus  Khojasteh</span>, <span class="hlFld-ContribAuthor ">Namandjé N.  Bumpus</span>, <span class="hlFld-ContribAuthor ">James P.  Driscoll</span>, <span class="hlFld-ContribAuthor ">Grover P.  Miller</span>, <span class="hlFld-ContribAuthor ">Kaushik  Mitra</span>, <span class="hlFld-ContribAuthor ">Ivonne M. C. M.  Rietjens</span>, <span class="hlFld-ContribAuthor ">Donglu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Biotransformation and bioactivation reactions – 2018 literature highlights. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2019,</strong> <em>51 </em>
                                    (2)
                                     , 121-161. <a href="https://doi.org/10.1080/03602532.2019.1615937" title="DOI URL">https://doi.org/10.1080/03602532.2019.1615937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03602532.2019.1615937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03602532.2019.1615937%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DBiotransformation%252Band%252Bbioactivation%252Breactions%252B%2525E2%252580%252593%252B2018%252Bliterature%252Bhighlights%26aulast%3DKhojasteh%26aufirst%3DS.%2BCyrus%26date%3D2019%26date%3D2019%26volume%3D51%26issue%3D2%26spage%3D121%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jordan K.  Zjawiony</span>, <span class="hlFld-ContribAuthor ">Antônio S.  Machado</span>, <span class="hlFld-ContribAuthor ">Ricardo  Menegatti</span>, <span class="hlFld-ContribAuthor ">Paulo C.  Ghedini</span>, <span class="hlFld-ContribAuthor ">Elson A.  Costa</span>, <span class="hlFld-ContribAuthor ">Gustavo R.  Pedrino</span>, <span class="hlFld-ContribAuthor ">Scott E.  Lukas</span>, <span class="hlFld-ContribAuthor ">Octávio L.  Franco</span>, <span class="hlFld-ContribAuthor ">Osmar N.  Silva</span>, <span class="hlFld-ContribAuthor ">James O.  Fajemiroye</span>. </span><span class="cited-content_cbyCitation_article-title">Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Psychiatry</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fpsyt.2019.00157" title="DOI URL">https://doi.org/10.3389/fpsyt.2019.00157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fpsyt.2019.00157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffpsyt.2019.00157%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Psychiatry%26atitle%3DCutting-Edge%252BSearch%252Bfor%252BSafer%252BOpioid%252BPain%252BRelief%25253A%252BRetrospective%252BReview%252Bof%252BSalvinorin%252BA%252Band%252BIts%252BAnalogs%26aulast%3DZjawiony%26aufirst%3DJordan%2BK.%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel K.  Mykhailiuk</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated bioisosteres of benzene: where to go next?. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (11)
                                     , 2839-2849. <a href="https://doi.org/10.1039/C8OB02812E" title="DOI URL">https://doi.org/10.1039/C8OB02812E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02812E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02812E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSaturated%252Bbioisosteres%252Bof%252Bbenzene%25253A%252Bwhere%252Bto%252Bgo%252Bnext%25253F%26aulast%3DMykhailiuk%26aufirst%3DPavel%2BK.%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D11%26spage%3D2839%26epage%3D2849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grzegorz  Ślifirski</span>, <span class="hlFld-ContribAuthor ">Marek  Król</span>, <span class="hlFld-ContribAuthor ">Jerzy  Kleps</span>, <span class="hlFld-ContribAuthor ">Szymon  Ulenberg</span>, <span class="hlFld-ContribAuthor ">Mariusz  Belka</span>, <span class="hlFld-ContribAuthor ">Tomasz  Bączek</span>, <span class="hlFld-ContribAuthor ">Agata  Siwek</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Stachowicz</span>, <span class="hlFld-ContribAuthor ">Bernadeta  Szewczyk</span>, <span class="hlFld-ContribAuthor ">Gabriel  Nowak</span>, <span class="hlFld-ContribAuthor ">Andrzej  Bojarski</span>, <span class="hlFld-ContribAuthor ">Anna E.  Kozioł</span>, <span class="hlFld-ContribAuthor ">Jadwiga  Turło</span>, <span class="hlFld-ContribAuthor ">Franciszek  Herold</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT1A receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 144-158. <a href="https://doi.org/10.1016/j.ejmech.2019.01.031" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.031%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnovel%252Bpyrido%25255B1%25252C2-c%25255Dpyrimidine%252Bderivatives%252Bwith%252Brigidized%252Btryptamine%252Bmoiety%252Bas%252Bpotential%252BSSRI%252Band%252B5-HT1A%252Breceptor%252Bligands%26aulast%3D%25C5%259Alifirski%26aufirst%3DGrzegorz%26date%3D2019%26volume%3D166%26spage%3D144%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Boutard</span>, <span class="hlFld-ContribAuthor ">Arkadiusz  Białas</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Sabiniarz</span>, <span class="hlFld-ContribAuthor ">Paweł  Guzik</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Banaszak</span>, <span class="hlFld-ContribAuthor ">Artur  Biela</span>, <span class="hlFld-ContribAuthor ">Marcin  Bień</span>, <span class="hlFld-ContribAuthor ">Anna  Buda</span>, <span class="hlFld-ContribAuthor ">Barbara  Bugaj</span>, <span class="hlFld-ContribAuthor ">Ewelina  Cieluch</span>, <span class="hlFld-ContribAuthor ">Anna  Cierpich</span>, <span class="hlFld-ContribAuthor ">Łukasz  Dudek</span>, <span class="hlFld-ContribAuthor ">Hans-Michael  Eggenweiler</span>, <span class="hlFld-ContribAuthor ">Joanna  Fogt</span>, <span class="hlFld-ContribAuthor ">Monika  Gaik</span>, <span class="hlFld-ContribAuthor ">Andrzej  Gondela</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Jakubiec</span>, <span class="hlFld-ContribAuthor ">Mirek  Jurzak</span>, <span class="hlFld-ContribAuthor ">Agata  Kitlińska</span>, <span class="hlFld-ContribAuthor ">Piotr  Kowalczyk</span>, <span class="hlFld-ContribAuthor ">Maciej  Kujawa</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kwiecińska</span>, <span class="hlFld-ContribAuthor ">Marcin  Leś</span>, <span class="hlFld-ContribAuthor ">Ralph  Lindemann</span>, <span class="hlFld-ContribAuthor ">Monika  Maciuszek</span>, <span class="hlFld-ContribAuthor ">Maciej  Mikulski</span>, <span class="hlFld-ContribAuthor ">Paulina  Niedziejko</span>, <span class="hlFld-ContribAuthor ">Alicja  Obara</span>, <span class="hlFld-ContribAuthor ">Henryk  Pawlik</span>, <span class="hlFld-ContribAuthor ">Tomasz  Rzymski</span>, <span class="hlFld-ContribAuthor ">Magdalena  Sieprawska-Lupa</span>, <span class="hlFld-ContribAuthor ">Marta  Sowińska</span>, <span class="hlFld-ContribAuthor ">Joanna  Szeremeta-Spisak</span>, <span class="hlFld-ContribAuthor ">Agata  Stachowicz</span>, <span class="hlFld-ContribAuthor ">Mateusz M.  Tomczyk</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Wiklik</span>, <span class="hlFld-ContribAuthor ">Łukasz  Włoszczak</span>, <span class="hlFld-ContribAuthor ">Sylwia  Ziemiańska</span>, <span class="hlFld-ContribAuthor ">Adrian  Zarębski</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Brzózka</span>, <span class="hlFld-ContribAuthor ">Mateusz  Nowak</span>, <span class="hlFld-ContribAuthor ">Charles-Henry  Fabritius</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amide and sulfonamide substituted N-aryl 6-aminoquinoxalines as PFKFB3 inhibitors with improved physicochemical properties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 646-653. <a href="https://doi.org/10.1016/j.bmcl.2018.12.034" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bamide%252Band%252Bsulfonamide%252Bsubstituted%252BN-aryl%252B6-aminoquinoxalines%252Bas%252BPFKFB3%252Binhibitors%252Bwith%252Bimproved%252Bphysicochemical%252Bproperties%26aulast%3DBoutard%26aufirst%3DNicolas%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D646%26epage%3D653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingyun  Xing</span>, <span class="hlFld-ContribAuthor ">Tongfei  Jing</span>, <span class="hlFld-ContribAuthor ">Junlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Xiuqi  Miao</span>, <span class="hlFld-ContribAuthor ">Feng  Jiang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation N2-(2-alkyoxy-6-aliphatic aminopyridin-3-yl)-2,4-diaminepyrimidine derivatives bearing acylamino or DBTD ‘head’ as potential ALK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>81 </em>, 689-699. <a href="https://doi.org/10.1016/j.bioorg.2018.09.019" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.09.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.09.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252BN2-%2525282-alkyoxy-6-aliphatic%252Baminopyridin-3-yl%252529-2%25252C4-diaminepyrimidine%252Bderivatives%252Bbearing%252Bacylamino%252Bor%252BDBTD%252B%2525E2%252580%252598head%2525E2%252580%252599%252Bas%252Bpotential%252BALK%252Binhibitors%26aulast%3DXing%26aufirst%3DLingyun%26date%3D2018%26volume%3D81%26spage%3D689%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tina P.  Andrejević</span>, <span class="hlFld-ContribAuthor ">Andrea M.  Nikolić</span>, <span class="hlFld-ContribAuthor ">Biljana Đ.  Glišić</span>, <span class="hlFld-ContribAuthor ">Hubert  Wadepohl</span>, <span class="hlFld-ContribAuthor ">Sandra  Vojnovic</span>, <span class="hlFld-ContribAuthor ">Mario  Zlatović</span>, <span class="hlFld-ContribAuthor ">Miloš  Petković</span>, <span class="hlFld-ContribAuthor ">Jasmina  Nikodinovic-Runic</span>, <span class="hlFld-ContribAuthor ">Igor M.  Opsenica</span>, <span class="hlFld-ContribAuthor ">Miloš I.  Djuran</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, structural characterization and antimicrobial activity of silver(I) complexes with 1-benzyl-1H-tetrazoles. </span><span class="cited-content_cbyCitation_journal-name">Polyhedron</span><span> <strong>2018,</strong> <em>154 </em>, 325-333. <a href="https://doi.org/10.1016/j.poly.2018.08.001" title="DOI URL">https://doi.org/10.1016/j.poly.2018.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.poly.2018.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.poly.2018.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DPolyhedron%26atitle%3DSynthesis%25252C%252Bstructural%252Bcharacterization%252Band%252Bantimicrobial%252Bactivity%252Bof%252Bsilver%252528I%252529%252Bcomplexes%252Bwith%252B1-benzyl-1H-tetrazoles%26aulast%3DAndrejevi%25C4%2587%26aufirst%3DTina%2BP.%26date%3D2018%26volume%3D154%26spage%3D325%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasser Fakri  Mustafa</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and antibacterial activity of novel heterocycle, coumacine, and two of its derivatives. </span><span class="cited-content_cbyCitation_journal-name">Saudi Pharmaceutical Journal</span><span> <strong>2018,</strong> <em>26 </em>
                                    (6)
                                     , 870-875. <a href="https://doi.org/10.1016/j.jsps.2018.03.010" title="DOI URL">https://doi.org/10.1016/j.jsps.2018.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsps.2018.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsps.2018.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DSaudi%2520Pharmaceutical%2520Journal%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Bantibacterial%252Bactivity%252Bof%252Bnovel%252Bheterocycle%25252C%252Bcoumacine%25252C%252Band%252Btwo%252Bof%252Bits%252Bderivatives%26aulast%3DMustafa%26aufirst%3DYasser%2BFakri%26date%3D2018%26volume%3D26%26issue%3D6%26spage%3D870%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoki  Takaoka</span>, <span class="hlFld-ContribAuthor ">Seigo  Sanoh</span>, <span class="hlFld-ContribAuthor ">Katsuhiro  Okuda</span>, <span class="hlFld-ContribAuthor ">Yaichiro  Kotake</span>, <span class="hlFld-ContribAuthor ">Go  Sugahara</span>, <span class="hlFld-ContribAuthor ">Ami  Yanagi</span>, <span class="hlFld-ContribAuthor ">Yuji  Ishida</span>, <span class="hlFld-ContribAuthor ">Chise  Tateno</span>, <span class="hlFld-ContribAuthor ">Yoshitaka  Tayama</span>, <span class="hlFld-ContribAuthor ">Kazumi  Sugihara</span>, <span class="hlFld-ContribAuthor ">Shigeyuki  Kitamura</span>, <span class="hlFld-ContribAuthor ">Mami  Kurosaki</span>, <span class="hlFld-ContribAuthor ">Mineko  Terao</span>, <span class="hlFld-ContribAuthor ">Enrico  Garattini</span>, <span class="hlFld-ContribAuthor ">Shigeru  Ohta</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug–drug interactions. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2018,</strong> <em>154 </em>, 28-38. <a href="https://doi.org/10.1016/j.bcp.2018.04.017" title="DOI URL">https://doi.org/10.1016/j.bcp.2018.04.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2018.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2018.04.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DInhibitory%252Beffects%252Bof%252Bdrugs%252Bon%252Bthe%252Bmetabolic%252Bactivity%252Bof%252Bmouse%252Band%252Bhuman%252Baldehyde%252Boxidases%252Band%252Binfluence%252Bon%252Bdrug%2525E2%252580%252593drug%252Binteractions%26aulast%3DTakaoka%26aufirst%3DNaoki%26date%3D2018%26volume%3D154%26spage%3D28%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy J.  Roach</span>, <span class="hlFld-ContribAuthor ">Ryan A.  Shenvi</span>. </span><span class="cited-content_cbyCitation_article-title">A review of salvinorin analogs and their kappa-opioid receptor activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (9)
                                     , 1436-1445. <a href="https://doi.org/10.1016/j.bmcl.2018.03.029" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.03.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.03.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Breview%252Bof%252Bsalvinorin%252Banalogs%252Band%252Btheir%252Bkappa-opioid%252Breceptor%252Bactivity%26aulast%3DRoach%26aufirst%3DJeremy%2BJ.%26date%3D2018%26volume%3D28%26issue%3D9%26spage%3D1436%26epage%3D1445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William F.  Vernier</span>, <span class="hlFld-ContribAuthor ">Laurent  Gomez</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective palladium-catalyzed C H arylation of 4-alkoxy and 4-thioalkyl pyrazoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (49)
                                     , 4587-4590. <a href="https://doi.org/10.1016/j.tetlet.2017.10.047" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.10.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.10.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.10.047%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DRegioselective%252Bpalladium-catalyzed%252BC%252BH%252Barylation%252Bof%252B4-alkoxy%252Band%252B4-thioalkyl%252Bpyrazoles%26aulast%3DVernier%26aufirst%3DWilliam%2BF.%26date%3D2017%26volume%3D58%26issue%3D49%26spage%3D4587%26epage%3D4590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Badr  Jismy</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Hassan  Allouchi</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abarbri</span>. </span><span class="cited-content_cbyCitation_article-title">Concise and Efficient Access to 5,7-Disubstituted Pyrazolo[1,5-
              a
              ]pyrimidines by Pd-Catalyzed Sequential Arylation, Alkynylation and SN
              Ar
              Reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (41)
                                     , 6168-6178. <a href="https://doi.org/10.1002/ejoc.201701024" title="DOI URL">https://doi.org/10.1002/ejoc.201701024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConcise%252Band%252BEfficient%252BAccess%252Bto%252B5%25252C7-Disubstituted%252BPyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrimidines%252Bby%252BPd-Catalyzed%252BSequential%252BArylation%25252C%252BAlkynylation%252Band%252BSN%252BAr%252BReaction%26aulast%3DJismy%26aufirst%3DBadr%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D41%26spage%3D6168%26epage%3D6178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohit  Misra</span>, <span class="hlFld-ContribAuthor ">Maximilian  Kuhn</span>, <span class="hlFld-ContribAuthor ">Mark  Löbel</span>, <span class="hlFld-ContribAuthor ">Heeseon  An</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Statsyuk</span>, <span class="hlFld-ContribAuthor ">Christoph  Sotriffer</span>, <span class="hlFld-ContribAuthor ">Hermann  Schindelin</span>. </span><span class="cited-content_cbyCitation_article-title">Dissecting the Specificity of Adenosyl Sulfamate Inhibitors Targeting the Ubiquitin-Activating Enzyme. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2017,</strong> <em>25 </em>
                                    (7)
                                     , 1120-1129.e3. <a href="https://doi.org/10.1016/j.str.2017.05.001" title="DOI URL">https://doi.org/10.1016/j.str.2017.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2017.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2017.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DDissecting%252Bthe%252BSpecificity%252Bof%252BAdenosyl%252BSulfamate%252BInhibitors%252BTargeting%252Bthe%252BUbiquitin-Activating%252BEnzyme%26aulast%3DMisra%26aufirst%3DMohit%26date%3D2017%26volume%3D25%26issue%3D7%26spage%3D1120%26epage%3D1129.e3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danielle M.  Hurzy</span>, <span class="hlFld-ContribAuthor ">Darrell A.  Henze</span>, <span class="hlFld-ContribAuthor ">Tamara D.  Cabalu</span>, <span class="hlFld-ContribAuthor ">Kartik  Narayan</span>, <span class="hlFld-ContribAuthor ">Amanda  Heller</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Cooke</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and SAR of substituted indoles as selective TrkA inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (12)
                                     , 2695-2701. <a href="https://doi.org/10.1016/j.bmcl.2017.04.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252BSAR%252Bof%252Bsubstituted%252Bindoles%252Bas%252Bselective%252BTrkA%252Binhibitors%26aulast%3DHurzy%26aufirst%3DDanielle%2BM.%26date%3D2017%26volume%3D27%26issue%3D12%26spage%3D2695%26epage%3D2701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Buyu  Kou</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">Haixia  Liu</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Jie  Wu</span>, <span class="hlFld-ContribAuthor ">Taishan  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Bridged Bicyclic Morpholine Amino Acids as Compact Modules for Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemistry Letters</span><span> <strong>2017,</strong> <em>46 </em>
                                    (4)
                                     , 566-568. <a href="https://doi.org/10.1246/cl.170011" title="DOI URL">https://doi.org/10.1246/cl.170011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1246/cl.170011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1246%2Fcl.170011%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520Letters%26atitle%3DSynthesis%252Bof%252BBridged%252BBicyclic%252BMorpholine%252BAmino%252BAcids%252Bas%252BCompact%252BModules%252Bfor%252BMedicinal%252BChemistry%26aulast%3DKou%26aufirst%3DBuyu%26date%3D2017%26volume%3D46%26issue%3D4%26spage%3D566%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhiro  Nakano</span>, <span class="hlFld-ContribAuthor ">Sen  Takeshita</span>, <span class="hlFld-ContribAuthor ">Noriko  Kawasaki</span>, <span class="hlFld-ContribAuthor ">Wataru  Miyanaga</span>, <span class="hlFld-ContribAuthor ">Yoriko  Okamatsu</span>, <span class="hlFld-ContribAuthor ">Mizuki  Dohi</span>, <span class="hlFld-ContribAuthor ">Tadakiyo  Nakagawa</span>. </span><span class="cited-content_cbyCitation_article-title">AJS1669, a novel small-molecule muscle glycogen synthase activator, improves glucose metabolism and reduces body fat mass in mice. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Medicine</span><span> <strong>2017,</strong> <em>39 </em>
                                    (4)
                                     , 841-850. <a href="https://doi.org/10.3892/ijmm.2017.2909" title="DOI URL">https://doi.org/10.3892/ijmm.2017.2909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijmm.2017.2909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijmm.2017.2909%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Medicine%26atitle%3DAJS1669%25252C%252Ba%252Bnovel%252Bsmall-molecule%252Bmuscle%252Bglycogen%252Bsynthase%252Bactivator%25252C%252Bimproves%252Bglucose%252Bmetabolism%252Band%252Breduces%252Bbody%252Bfat%252Bmass%252Bin%252Bmice%26aulast%3DNakano%26aufirst%3DKazuhiro%26date%3D2017%26date%3D2017%26volume%3D39%26issue%3D4%26spage%3D841%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George N.  Pairas</span>, <span class="hlFld-ContribAuthor ">Fereniki  Perperopoulou</span>, <span class="hlFld-ContribAuthor ">Petros G.  Tsoungas</span>, <span class="hlFld-ContribAuthor ">George  Varvounis</span>. </span><span class="cited-content_cbyCitation_article-title">The Isoxazole Ring and Its
              N
              -Oxide: A Privileged Core Structure in Neuropsychiatric Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (6)
                                     , 408-419. <a href="https://doi.org/10.1002/cmdc.201700023" title="DOI URL">https://doi.org/10.1002/cmdc.201700023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700023%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BIsoxazole%252BRing%252Band%252BIts%252BN%252B-Oxide%25253A%252BA%252BPrivileged%252BCore%252BStructure%252Bin%252BNeuropsychiatric%252BTherapeutics%26aulast%3DPairas%26aufirst%3DGeorge%2BN.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D6%26spage%3D408%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-An  Guo</span>, <span class="hlFld-ContribAuthor ">Wonchul  Lee</span>, <span class="hlFld-ContribAuthor ">Michael J.  Krische</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of Oxetanes Bearing All-Carbon Quaternary Stereocenters via Iridium-Catalyzed C−C Bond-Forming Transfer Hydrogenation. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2017,</strong> <em>23 </em>
                                    (11)
                                     , 2557-2559. <a href="https://doi.org/10.1002/chem.201606046" title="DOI URL">https://doi.org/10.1002/chem.201606046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201606046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201606046%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DEnantioselective%252BSynthesis%252Bof%252BOxetanes%252BBearing%252BAll-Carbon%252BQuaternary%252BStereocenters%252Bvia%252BIridium-Catalyzed%252BC%2525E2%252588%252592C%252BBond-Forming%252BTransfer%252BHydrogenation%26aulast%3DGuo%26aufirst%3DYi-An%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D11%26spage%3D2557%26epage%3D2559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guolin  Wu</span>, <span class="hlFld-ContribAuthor ">Yazhen  Li</span>, <span class="hlFld-ContribAuthor ">Xuemei  Yu</span>, <span class="hlFld-ContribAuthor ">Yu  Gao</span>, <span class="hlFld-ContribAuthor ">Haijun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Acetic Acid Accelerated Visible-Light Photoredox Catalyzed
              N
              -Demethylation of
              N,N
              -Dimethylaminophenyl Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2017,</strong> <em>359 </em>
                                    (4)
                                     , 687-692. <a href="https://doi.org/10.1002/adsc.201601108" title="DOI URL">https://doi.org/10.1002/adsc.201601108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201601108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201601108%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DAcetic%252BAcid%252BAccelerated%252BVisible-Light%252BPhotoredox%252BCatalyzed%252BN%252B-Demethylation%252Bof%252BN%25252CN%252B-Dimethylaminophenyl%252BDerivatives%26aulast%3DWu%26aufirst%3DGuolin%26date%3D2017%26date%3D2016%26volume%3D359%26issue%3D4%26spage%3D687%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">A Synopsis of the Properties and Applications of Heteroaromatic Rings in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 245-361. <a href="https://doi.org/10.1016/bs.aihch.2016.11.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.11.002%26sid%3Dliteratum%253Aachs%26atitle%3DA%252BSynopsis%252Bof%252Bthe%252BProperties%252Band%252BApplications%252Bof%252BHeteroaromatic%252BRings%252Bin%252BMedicinal%252BChemistry%26aulast%3DMeanwell%26aufirst%3DN.A.%26date%3D2017%26spage%3D245%26epage%3D361%26pub%3DElsevier%26date%3D2017%26volume%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjie  Shao</span>, <span class="hlFld-ContribAuthor ">Sherif J.  Kaldas</span>, <span class="hlFld-ContribAuthor ">Andrei K.  Yudin</span>. </span><span class="cited-content_cbyCitation_article-title">3-Cyanoallyl boronates are versatile building blocks in the synthesis of polysubstituted thiophenes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 4431-4436. <a href="https://doi.org/10.1039/C7SC00831G" title="DOI URL">https://doi.org/10.1039/C7SC00831G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7SC00831G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7SC00831G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3D3-Cyanoallyl%252Bboronates%252Bare%252Bversatile%252Bbuilding%252Bblocks%252Bin%252Bthe%252Bsynthesis%252Bof%252Bpolysubstituted%252Bthiophenes%26aulast%3DShao%26aufirst%3DWenjie%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D6%26spage%3D4431%26epage%3D4436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huagang  Lu</span>, <span class="hlFld-ContribAuthor ">John  Rogowskyj</span>, <span class="hlFld-ContribAuthor ">Wenquan  Yu</span>, <span class="hlFld-ContribAuthor ">Anu  Venkatesh</span>, <span class="hlFld-ContribAuthor ">Noshena  Khan</span>, <span class="hlFld-ContribAuthor ">Shigeki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Nicolas  Goossens</span>, <span class="hlFld-ContribAuthor ">Anna P.  Koh</span>, <span class="hlFld-ContribAuthor ">Takaaki  Higashi</span>, <span class="hlFld-ContribAuthor ">Ganesh  Gunasekaran</span>, <span class="hlFld-ContribAuthor ">Myron E.  Schwarz</span>, <span class="hlFld-ContribAuthor ">Spiros P.  Hiotis</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Xu</span>, <span class="hlFld-ContribAuthor ">William  Kinney</span>, <span class="hlFld-ContribAuthor ">Yujin  Hoshida</span>, <span class="hlFld-ContribAuthor ">Timothy  Block</span>, <span class="hlFld-ContribAuthor ">Andrea  Cuconati</span>, <span class="hlFld-ContribAuthor ">Yanming  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (23)
                                     , 5819-5824. <a href="https://doi.org/10.1016/j.bmcl.2016.10.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.10.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.10.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bsubstituted%252Baminothiazoles%252Bas%252Bpotent%252Band%252Bselective%252Banti-hepatocellular%252Bcarcinoma%252Bagents%26aulast%3DLu%26aufirst%3DHuagang%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5819%26epage%3D5824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arnaud  Chevalier</span>, <span class="hlFld-ContribAuthor ">Mohammad Parvez  Alam</span>, <span class="hlFld-ContribAuthor ">Omar M.  Khdour</span>, <span class="hlFld-ContribAuthor ">Margaret  Schmierer</span>, <span class="hlFld-ContribAuthor ">Pablo M.  Arce</span>, <span class="hlFld-ContribAuthor ">Cameron D.  Cripe</span>, <span class="hlFld-ContribAuthor ">Sidney M.  Hecht</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of pyrimidinol antioxidants as mitochondrial protective agents: ATP production and metabolic stability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (21)
                                     , 5206-5220. <a href="https://doi.org/10.1016/j.bmc.2016.08.039" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.08.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.08.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Bpyrimidinol%252Bantioxidants%252Bas%252Bmitochondrial%252Bprotective%252Bagents%25253A%252BATP%252Bproduction%252Band%252Bmetabolic%252Bstability%26aulast%3DChevalier%26aufirst%3DArnaud%26date%3D2016%26volume%3D24%26issue%3D21%26spage%3D5206%26epage%3D5220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin  Han</span>, <span class="hlFld-ContribAuthor ">Silje  Henriksen</span>, <span class="hlFld-ContribAuthor ">Kristin G.  Nørsett</span>, <span class="hlFld-ContribAuthor ">Eirik  Sundby</span>, <span class="hlFld-ContribAuthor ">Bård Helge  Hoff</span>. </span><span class="cited-content_cbyCitation_article-title">Balancing potency, metabolic stability and permeability in pyrrolopyrimidine-based EGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>124 </em>, 583-607. <a href="https://doi.org/10.1016/j.ejmech.2016.08.068" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.08.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.08.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.08.068%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBalancing%252Bpotency%25252C%252Bmetabolic%252Bstability%252Band%252Bpermeability%252Bin%252Bpyrrolopyrimidine-based%252BEGFR%252Binhibitors%26aulast%3DHan%26aufirst%3DJin%26date%3D2016%26volume%3D124%26spage%3D583%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Li</span>, <span class="hlFld-ContribAuthor ">Qianqian  Qiu</span>, <span class="hlFld-ContribAuthor ">Xue  Xu</span>, <span class="hlFld-ContribAuthor ">Xuekun  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Jiao</span>, <span class="hlFld-ContribAuthor ">Xin  Su</span>, <span class="hlFld-ContribAuthor ">Miaobo  Pan</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and Structure–activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>113 </em>, 246-257. <a href="https://doi.org/10.1016/j.ejmech.2016.02.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.02.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.02.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252BStructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%252Bof%252Bnew%252Bthiazole-based%252Bfree%252Bfatty%252Bacid%252Breceptor%252B1%252Bagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Btype%252B2%252Bdiabetes%26aulast%3DLi%26aufirst%3DZheng%26date%3D2016%26volume%3D113%26spage%3D246%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serge  Mignani</span>, <span class="hlFld-ContribAuthor ">Scot  Huber</span>, <span class="hlFld-ContribAuthor ">Helena  Tomás</span>, <span class="hlFld-ContribAuthor ">João  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Majoral</span>. </span><span class="cited-content_cbyCitation_article-title">Compound high-quality criteria: a new vision to guide the development of drugs, current situation. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2016,</strong> <em>21 </em>
                                    (4)
                                     , 573-584. <a href="https://doi.org/10.1016/j.drudis.2016.01.005" title="DOI URL">https://doi.org/10.1016/j.drudis.2016.01.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2016.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2016.01.005%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DCompound%252Bhigh-quality%252Bcriteria%25253A%252Ba%252Bnew%252Bvision%252Bto%252Bguide%252Bthe%252Bdevelopment%252Bof%252Bdrugs%25252C%252Bcurrent%252Bsituation%26aulast%3DMignani%26aufirst%3DSerge%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D573%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibtissam  Bassoude</span>, <span class="hlFld-ContribAuthor ">Zahira  Tber</span>, <span class="hlFld-ContribAuthor ">El Mokhtar  Essassi</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Sabine  Berteina-Raboin</span>. </span><span class="cited-content_cbyCitation_article-title">A one-pot process for the microwave-assisted synthesis of 7-substituted pyrazolo[1,5-a]pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (4)
                                     , 3301-3306. <a href="https://doi.org/10.1039/C5RA23417D" title="DOI URL">https://doi.org/10.1039/C5RA23417D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA23417D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA23417D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bone-pot%252Bprocess%252Bfor%252Bthe%252Bmicrowave-assisted%252Bsynthesis%252Bof%252B7-substituted%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%26aulast%3DBassoude%26aufirst%3DIbtissam%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D4%26spage%3D3301%26epage%3D3306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengju  Feng</span>, <span class="hlFld-ContribAuthor ">Katarzyna N.  Lee</span>, <span class="hlFld-ContribAuthor ">Johnny W.  Lee</span>, <span class="hlFld-ContribAuthor ">Chengbo  Zhan</span>, <span class="hlFld-ContribAuthor ">Ming-Yu  Ngai</span>. </span><span class="cited-content_cbyCitation_article-title">Access to a new class of synthetic building blocks via trifluoromethoxylation of pyridines and pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , 424-429. <a href="https://doi.org/10.1039/C5SC02983J" title="DOI URL">https://doi.org/10.1039/C5SC02983J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5SC02983J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5SC02983J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DAccess%252Bto%252Ba%252Bnew%252Bclass%252Bof%252Bsynthetic%252Bbuilding%252Bblocks%252Bvia%252Btrifluoromethoxylation%252Bof%252Bpyridines%252Band%252Bpyrimidines%26aulast%3DFeng%26aufirst%3DPengju%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D1%26spage%3D424%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandria P.  Taylor</span>, <span class="hlFld-ContribAuthor ">Ralph P.  Robinson</span>, <span class="hlFld-ContribAuthor ">Yvette M.  Fobian</span>, <span class="hlFld-ContribAuthor ">David C.  Blakemore</span>, <span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>, <span class="hlFld-ContribAuthor ">Olugbeminiyi  Fadeyi</span>. </span><span class="cited-content_cbyCitation_article-title">Modern advances in heterocyclic chemistry in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (28)
                                     , 6611-6637. <a href="https://doi.org/10.1039/C6OB00936K" title="DOI URL">https://doi.org/10.1039/C6OB00936K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00936K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00936K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DModern%252Badvances%252Bin%252Bheterocyclic%252Bchemistry%252Bin%252Bdrug%252Bdiscovery%26aulast%3DTaylor%26aufirst%3DAlexandria%2BP.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D28%26spage%3D6611%26epage%3D6637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edgar  Jacoby</span>. </span><span class="cited-content_cbyCitation_article-title">Elements for the Development of Strategies for Compound Library Enhancement. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 11-36. <a href="https://doi.org/10.1002/9781118771723.ch1" title="DOI URL">https://doi.org/10.1002/9781118771723.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118771723.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118771723.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DElements%252Bfor%252Bthe%252BDevelopment%252Bof%252BStrategies%252Bfor%252BCompound%252BLibrary%252BEnhancement%26aulast%3DJacoby%26aufirst%3DEdgar%26date%3D2015%26date%3D2015%26spage%3D11%26epage%3D36%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DSmall%252BMolecule%252BMedicinal%252BChemistry%26aulast%3DCzechtizky%26aufirst%3DWerngard%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mina  Saeedi</span>, <span class="hlFld-ContribAuthor ">Fereshteh  Goli</span>, <span class="hlFld-ContribAuthor ">Mohammad  Mahdavi</span>, <span class="hlFld-ContribAuthor ">Ali  Asadipour</span>, <span class="hlFld-ContribAuthor ">Abbas  Shafiee</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Novel Thiazol-2-ylidene-amides Using Carbonylthiourea Building Blocks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2015,</strong> <em>52 </em>
                                    (4)
                                     , 1150-1153. <a href="https://doi.org/10.1002/jhet.2144" title="DOI URL">https://doi.org/10.1002/jhet.2144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2144%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DEfficient%252BSynthesis%252Bof%252BNovel%252BThiazol-2-ylidene-amides%252BUsing%252BCarbonylthiourea%252BBuilding%252BBlocks%26aulast%3DSaeedi%26aufirst%3DMina%26date%3D2015%26date%3D2014%26volume%3D52%26issue%3D4%26spage%3D1150%26epage%3D1153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Genovino</span>, <span class="hlFld-ContribAuthor ">Dalibor  Sames</span>, <span class="hlFld-ContribAuthor ">B. Barry  Touré</span>. </span><span class="cited-content_cbyCitation_article-title">Access to drug metabolites via C–H functionalization: copper-catalyzed aerobic oxidation of  N , N -dimethylalkylamines in complex pharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (23)
                                     , 3066-3069. <a href="https://doi.org/10.1016/j.tetlet.2014.11.037" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.11.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.11.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.11.037%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAccess%252Bto%252Bdrug%252Bmetabolites%252Bvia%252BC%2525E2%252580%252593H%252Bfunctionalization%25253A%252Bcopper-catalyzed%252Baerobic%252Boxidation%252Bof%252BN%252B%25252C%252BN%252B-dimethylalkylamines%252Bin%252Bcomplex%252Bpharmaceuticals%26aulast%3DGenovino%26aufirst%3DJulien%26date%3D2015%26volume%3D56%26issue%3D23%26spage%3D3066%26epage%3D3069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thibault  Gendron</span>, <span class="hlFld-ContribAuthor ">Hripsimée  Kessedjian</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Davioud-Charvet</span>, <span class="hlFld-ContribAuthor ">Don Antoine  Lanfranchi</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective Synthesis of 2,6-Diaryltetrahydrothiopyran-4-ones by Phase-Transfer Catalysis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (8)
                                     , 1790-1796. <a href="https://doi.org/10.1002/ejoc.201403516" title="DOI URL">https://doi.org/10.1002/ejoc.201403516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201403516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201403516%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDiastereoselective%252BSynthesis%252Bof%252B2%25252C6-Diaryltetrahydrothiopyran-4-ones%252Bby%252BPhase-Transfer%252BCatalysis%26aulast%3DGendron%26aufirst%3DThibault%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D8%26spage%3D1790%26epage%3D1796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro ADME and In vivo Pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 245-306. <a href="https://doi.org/10.1016/B978-0-12-411508-8.00006-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-411508-8.00006-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-411508-8.00006-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-411508-8.00006-2%26sid%3Dliteratum%253Aachs%26atitle%3DIn%2525C2%2525A0vitro%252BADME%252Band%252BIn%2525C2%2525A0vivo%252BPharmacokinetics%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2015%26spage%3D245%26epage%3D306%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2015%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen'kii</span>, <span class="hlFld-ContribAuthor ">Yu B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The Literature of Heterocyclic Chemistry, Part XIII, 2012–2013. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 193-363. <a href="https://doi.org/10.1016/bs.aihch.2015.04.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2015.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2015.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2015.04.002%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BLiterature%252Bof%252BHeterocyclic%252BChemistry%25252C%252BPart%252BXIII%25252C%252B2012%2525E2%252580%2525932013%26aulast%3DBelen%2527kii%26aufirst%3DLeonid%2BI.%26date%3D2015%26spage%3D193%26epage%3D363%26pub%3DElsevier%26date%3D2015%26volume%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederick W.  Goldberg</span>, <span class="hlFld-ContribAuthor ">Jason G.  Kettle</span>, <span class="hlFld-ContribAuthor ">Thierry  Kogej</span>, <span class="hlFld-ContribAuthor ">Matthew W.D.  Perry</span>, <span class="hlFld-ContribAuthor ">Nick P.  Tomkinson</span>. </span><span class="cited-content_cbyCitation_article-title">Designing novel building blocks is an overlooked strategy to improve compound quality. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2015,</strong> <em>20 </em>
                                    (1)
                                     , 11-17. <a href="https://doi.org/10.1016/j.drudis.2014.09.023" title="DOI URL">https://doi.org/10.1016/j.drudis.2014.09.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2014.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2014.09.023%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DDesigning%252Bnovel%252Bbuilding%252Bblocks%252Bis%252Ban%252Boverlooked%252Bstrategy%252Bto%252Bimprove%252Bcompound%252Bquality%26aulast%3DGoldberg%26aufirst%3DFrederick%2BW.%26date%3D2015%26volume%3D20%26issue%3D1%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tegan P.  Stockdale</span>, <span class="hlFld-ContribAuthor ">Craig M.  Williams</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmaceuticals that contain polycyclic hydrocarbon scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2015,</strong> <em>44 </em>
                                    (21)
                                     , 7737-7763. <a href="https://doi.org/10.1039/C4CS00477A" title="DOI URL">https://doi.org/10.1039/C4CS00477A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4CS00477A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4CS00477A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DPharmaceuticals%252Bthat%252Bcontain%252Bpolycyclic%252Bhydrocarbon%252Bscaffolds%26aulast%3DStockdale%26aufirst%3DTegan%2BP.%26date%3D2015%26date%3D2015%26volume%3D44%26issue%3D21%26spage%3D7737%26epage%3D7763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zongjun  Qiao</span>, <span class="hlFld-ContribAuthor ">Nanyang  Ge</span>, <span class="hlFld-ContribAuthor ">Xuefeng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">CO
              2
              -promoted oxidative cross-coupling reaction for C–S bond formation via masked strategy in an odourless way. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2015,</strong> <em>51 </em>
                                    (51)
                                     , 10295-10298. <a href="https://doi.org/10.1039/C5CC03038B" title="DOI URL">https://doi.org/10.1039/C5CC03038B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CC03038B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CC03038B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DCO%252B2%252B-promoted%252Boxidative%252Bcross-coupling%252Breaction%252Bfor%252BC%2525E2%252580%252593S%252Bbond%252Bformation%252Bvia%252Bmasked%252Bstrategy%252Bin%252Ban%252Bodourless%252Bway%26aulast%3DQiao%26aufirst%3DZongjun%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D51%26spage%3D10295%26epage%3D10298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Massarotti</span>, <span class="hlFld-ContribAuthor ">Silvio  Aprile</span>, <span class="hlFld-ContribAuthor ">Valentina  Mercalli</span>, <span class="hlFld-ContribAuthor ">Erika  Del Grosso</span>, <span class="hlFld-ContribAuthor ">Giorgio  Grosa</span>, <span class="hlFld-ContribAuthor ">Giovanni  Sorba</span>, <span class="hlFld-ContribAuthor ">Gian Cesare  Tron</span>. </span><span class="cited-content_cbyCitation_article-title">Are 1,4- and 1,5-Disubstituted 1,2,3-Triazoles Good Pharmacophoric Groups?. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (11)
                                     , 2497-2508. <a href="https://doi.org/10.1002/cmdc.201402233" title="DOI URL">https://doi.org/10.1002/cmdc.201402233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402233%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAre%252B1%25252C4-%252Band%252B1%25252C5-Disubstituted%252B1%25252C2%25252C3-Triazoles%252BGood%252BPharmacophoric%252BGroups%25253F%26aulast%3DMassarotti%26aufirst%3DAlberto%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D11%26spage%3D2497%26epage%3D2508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuele M.  Gargano</span>, <span class="hlFld-ContribAuthor ">Enrico  Perspicace</span>, <span class="hlFld-ContribAuthor ">Nina  Hanke</span>, <span class="hlFld-ContribAuthor ">Angelo  Carotti</span>, <span class="hlFld-ContribAuthor ">Sandrine  Marchais-Oberwinkler</span>, <span class="hlFld-ContribAuthor ">Rolf W.  Hartmann</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>87 </em>, 203-219. <a href="https://doi.org/10.1016/j.ejmech.2014.09.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMetabolic%252Bstability%252Boptimization%252Band%252Bmetabolite%252Bidentification%252Bof%252B2%25252C5-thiophene%252Bamide%252B17%2525CE%2525B2-hydroxysteroid%252Bdehydrogenase%252Btype%252B2%252Binhibitors%26aulast%3DGargano%26aufirst%3DEmanuele%2BM.%26date%3D2014%26volume%3D87%26spage%3D203%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm300343m&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm300343m%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=122&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. In vitro potency and PK properties of selected H<sub>3</sub>R inverse antagonists. The log <i>D</i><sub>7.4</sub> and p<i>K</i><sub>a</sub> values were experimentally determined by Pierson et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. In vitro potency and PK properties of selected aldosterone synthase inhibitors.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vitro potency and PK properties of selected FXa inhibitors.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vitro potency and in vitro PKDM profile for selected HCV NS5B polymerase inhibitors.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro potency and in vitro PKDM profile for selected 5-HT<sub>2C</sub> agonists. The log <i>D</i><sub>7.4</sub> values were experimental determined by Fish et al.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vitro potency and RLM data for selected HDAC1 inhibitors.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vitro potency and PK properties of selected 11β-HSD1 inhibitors. PK experiments were conducted with C57B6 mice at 2 mg/kg (iv) and at 10 mg/kg (for <b>23</b>) or 30 mg/kg (for <b>19</b>) (po).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Rat PK of selected aurora kinase inhibitors.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> All compounds had IC<sub>50</sub> at Aurora A and Aurora B of ≤4 and ≤13 nM, respectively. The po AUC was determined in SD rats from 0–6 h after a 10 mg/kg oral dose. The iv PK was run at 10 mg/kg and % <i>F</i> determined from 30 mg/kg po.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. In vitro potency and metabolic stability of selected CB2 agonists.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. In vitro potency and metabolic stability for selected 5-HT<sub>1A</sub> receptor agonists.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The metabolic bioavailability prediction (MF%) was determined from the stability of test compound (concentration of 0.1 μM) in human liver microsomes where MF% = 100% is equal to no metabolism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. In vitro potency and metabolic stability of selected EphB3 inhibitors. Half-life and CL<sub>int</sub> were determined in MLM.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. In vitro potency and RLM stability for selected human H4R inverse agonists. The percent remaining in RLM was measured after a 10 min incubation.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. In vitro potency and metabolic stability of selected CB2 agonists.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. In vitro potency and metabolic stability of selected γ-secretase inhibitors.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The log <i>D</i><sub>7.4</sub> was determined experimentally by Stepan et al. using the method of Lombardo et al.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. In vitro potency and metabolic stability of selected CCR5 receptor antagonists.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. In vitro potency and PK properties of selected H<sub>3</sub>R inverse agonists. In vivo PK experiments were run with Wistar rats at 1 mL/kg (iv) and 4 mL/kg (po). The log <i>D</i><sub>7.4</sub> values were experimentally determined by Pierson et al.<a onclick="showRef(event, 'ref27 ref45'); return false;" href="javascript:void(0);" class="ref ref27 ref45">(27, 45)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. In vitro potency and metabolic stability for selected human A<sub>2A</sub> receptor antagonists.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. In vitro potency and metabolic profile for selected 5-HT<sub>1A,B,D</sub> receptor ligands.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Rat in vivo PK was determined after 1 mg/kg dosing iv.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. In vitro potency and metabolic stability for selected FXa inhibitors. The percent eliminated data were determined after 20 min incubations with NADPH and LM. The log <i>D</i><sub>7.4</sub> data were determined experimentally by Fujimoto et al.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> (MoLM = monkey liver microsomes).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0021.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. In vitro potency and metabolic stability for selected mTOR inhibitors. MLM studies were conducted with MLM from nude mice. Phase I metabolism studies were conducted with NADPH, while phase I/II studies were conducted with both NADPH and uridine 5′-diphosphoglucuronic acid (UDPGA).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0022.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. In vitro potency and metabolic stability of selected dual EGFR/HER2 inhibitors.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0023.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. In vitro potency, HLM, and MLM data for selected MurI inhibitors.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0024.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. In vitro potency and HLM data for select CB2 agonists.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> All compounds displayed weak activity against CB1 (EC<sub>50</sub> > 20 μM). Rat in vivo PK experiments were performed using Wistar rats at 1 μmol/kg (iv) and 10 μmol/kg (po).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0025.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. In vivo PK data for selected Tpo receptor antagonists. NuH is protein nucleophile or glutathione (GSH). In vivo PK was measured in male SD rats (1 mg/kg iv, 5 mg/kg po).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0026.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Metabolism of sudoxicam and meloxicam.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0027.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. In vitro potency and RLM stability for selected JAK2 inhibitors.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0028.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. In vitro potency and HLM data for selected orally active Hh pathway antagonists. In vivo PK experiments were conducted with SD rats (iv dose of 1 mg/kg, po dose of 5 mg/kg).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0029.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. In vitro potency and LM data for selected GlyT1 receptor antagonists<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> (%TO = percent turnover).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0030.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. In vitro potency, MLM, and glucuronidation data for select JNK inhibitors.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0031.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. In vitro potency and HLM data for selected CCR5 antagonists. The log <i>D</i><sub>7.4</sub> values were experimentally determined by Barber et al.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0032.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. In vitro potency and LM data for selected DPP-4 inhibitors.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig32" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Figure 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0033.jpeg" id="rightTab-gr32" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 32. In vitro potency and microsomal stability for selected A<sub>2B</sub> receptor antagonists.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig33" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Figure 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0034.jpeg" id="rightTab-gr33" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 33. In vitro potency and metabolic stability of selected FLT3 inhibitors<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> (MOLM-13 cells are from the human acute myeloid leukemia cell line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig34" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Figure 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0035.jpeg" id="rightTab-gr34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 34. In vitro potency and metabolic stability for selected APAs.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig35" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Figure 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0036.jpeg" id="rightTab-gr35" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 35. In vitro potency and metabolic stability of selected MMP-13 inhibitors.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> %QH is the percent of hepatic clearance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig36" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Figure 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0037.jpeg" id="rightTab-gr36" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 36. In vitro potency and metabolic stability of selected ROCK2 inhibitors.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig37" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Figure 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0038.jpeg" id="rightTab-gr37" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 37. In vitro potency and metabolic stability of selected mGlu5 antagonists.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Arrows indicate sites of oxidation observed on metabolites generated with HLM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig38" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Figure 38</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0039.jpeg" id="rightTab-gr38" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 38. GPR119 agonists containing 5-substituted pyrimidines: propensity for GSH adduct formation.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75, 76)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig38"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig39" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Figure 39</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0040.jpeg" id="rightTab-gr39" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 39. CRF<sub>1</sub> antagonists containing pyrazin-2(1<i>H</i>)-ones: propensity for ring oxidation and GSH adduct formation.<a onclick="showRef(event, 'ref77 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref79">(77-79)</a> A single bracket on the structure of the metabolites indicates that the regiochemistry has not been assigned. Arrows indicate sites of metabolism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig39"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig40" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Figure 40</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0041.jpeg" id="rightTab-gr40" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 40. Monoamine reuptake <i>K</i><sub>i</sub> values and in vitro metabolism data for selected TRI.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> SERT, NET, DAT are the serotonin transporter, norepinephrine transporter, and dopamine transporter, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig40"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig41" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Figure 41</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0042.jpeg" id="rightTab-gr41" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 41. In vitro activity and rat liver microsomal profiles for selected α7 nAChR agonists. RLM data are expressed as percent parent remaining after 1 h.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The reactive metabolite assay (RMA) was conducted in the presence of HLM and GSH-EE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig41"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig42" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Figure 42</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0043.jpeg" id="rightTab-gr42" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 42. SAR of selected AR antagonists toward oxidation by AO. A “yes” indicates that qualitative formation was observed in human S9 fraction (HS9) without NADPH which suggests AO oxidation. HLM is measured as extraction ratio (ER). cLogP values in this figure are those reported by Linton et al.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig42"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig43" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Figure 43</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/medium/jm-2012-00343m_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0044.jpeg" id="rightTab-gr43" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 43. In vitro activity and in vivo PK parameters for selected PDE4 inhibitors.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The potency data are reported as the inhibition of LPS induced TNF-α production in human whole blood (hWB).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-13/jm300343m/production/images/large/jm-2012-00343m_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300343m&amp;id=fig43"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i21">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 88 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A. Y. H.</span><span> </span><span class="NLM_article-title">Role of pharmacokinetics and metabolism in drug discovery and development</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=9443165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADyaK1cXjslSrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1997&pages=403-449&author=J.+H.+Linauthor=A.+Y.+H.+Lu&title=Role+of+pharmacokinetics+and+metabolism+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Role of pharmacokinetics and metabolism in drug discovery and development</span></div><div class="casAuthors">Lin, Jiunn H.; Lu, Anthony Y. H.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-449</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with approx. 500 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVCGyQIHSc8rVg90H21EOLACvtfcHk0ljPQl49CvzJlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslSrtQ%253D%253D&md5=6478056298f03045d8be510faa053221</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26aulast%3DLu%26aufirst%3DA.%2BY.%2BH.%26atitle%3DRole%2520of%2520pharmacokinetics%2520and%2520metabolism%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DPharmacol.%2520Rev.%26date%3D1997%26volume%3D49%26spage%3D403%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kumar, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surapaneni, S.</span><span> </span><span class="NLM_article-title">Role of drug metabolism in drug discovery and development</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1002%2Fmed.1016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=11579440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=397-411&author=G.+N.+Kumarauthor=S.+Surapaneni&title=Role+of+drug+metabolism+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Role of drug metabolism in drug discovery and development</span></div><div class="casAuthors">Kumar, Gondi N.; Surapaneni, Sekhar</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">397-411</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  This article reviews the role of drug metab. in drug discovery and development.  Metab. by the host organism is 1 of the most important determinants of the pharmacokinetic profile of a drug.  High metabolic lability usually leads to poor bioavailability and high clearance.  Formation of active or toxic metabolites will have an impact on the pharmacol. and toxicol. outcomes.  There is also potential for drug-drug interactions with coadministered drugs due to inhibition and/or induction of drug metab. pathways.  Hence, optimization of the metabolic liability and drug-drug interaction potential of the new chem. entities are some of the most important steps during the drug discovery process.  The rate and site(s) of metab. of new chem. entities by drug metabolizing enzymes is amenable to modulation by appropriate structural changes.  Similarly, the potential for drug-drug interactions can also be minimized by appropriate structural modifications to the drug candidate.  However, the optimization of the metabolic stability and drug-drug interaction potential during drug discovery stage was largely by empirical methods and by trial and error.  Recently, a lot of effort was applied to develop predictive methods to aid the optimization process during drug discovery and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnXC3CBCcCZbVg90H21EOLACvtfcHk0lj2MJdRtSvGbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbg%253D&md5=1ec2b0c0cb720ffd2be45f59145f9b70</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fmed.1016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.1016%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DG.%2BN.%26aulast%3DSurapaneni%26aufirst%3DS.%26atitle%3DRole%2520of%2520drug%2520metabolism%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2001%26volume%3D21%26spage%3D397%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">van de Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaumont, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. K.</span><span> </span><span class="NLM_article-title">Property-based design: optimization of drug absorption and pharmacokinetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1313</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000407e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1313-1333&author=H.+van+de+Waterbeemdauthor=D.+A.+Smithauthor=K.+Beaumontauthor=D.+K.+Walker&title=Property-based+design%3A+optimization+of+drug+absorption+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Property-based design: optimization of drug absorption and pharmacokinetics</span></div><div class="casAuthors">van de Waterbeemd, Han; Smith, Dennis A.; Beaumont, Kevin; Walker, Don K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1313-1333</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 223 refs.  The authors discuss some aspects of the properties of biol. barriers.  In different sections the estn. of drug absorption via important barriers including gastrointestinal tract, blood-brain barrier, and skin are reviewed.  Various approaches for the measurement and computation of physicochem. and mol. properties currently used in the optimization of absorption as well as the use of physicochem. properties in the design of optimal pharmacokinetic profiles are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQwsmoX0-mbVg90H21EOLACvtfcHk0lj2MJdRtSvGbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1Whu7c%253D&md5=3183baedca70020f4ce27f306ba0997e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm000407e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000407e%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bde%2BWaterbeemd%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26atitle%3DProperty-based%2520design%253A%2520optimization%2520of%2520drug%2520absorption%2520and%2520pharmacokinetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1313%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Jang, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, D. T.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and its role in small molecule drug discovery research</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1002%2Fmed.1015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=11579439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=382-396&author=G.+R.+Jangauthor=R.+Z.+Harrisauthor=D.+T.+Lau&title=Pharmacokinetics+and+its+role+in+small+molecule+drug+discovery+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and its role in small molecule drug discovery research</span></div><div class="casAuthors">Jang, Graham R.; Harris, Robert Z.; Lau, David T.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">382-396</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Pharmacokinetics (PK), which describes the disposition of a drug in the body, should be a primary consideration in the selection of a drug candidate, ultimately contributing to its eventual clin. success or failure.  Accordingly, a sound understanding of PK concepts and an appreciation of the judicious use of PK and related (e.g., metab., transporter) data in drug discovery can be beneficial to those involved in the process.  This review defines important PK parameters (e.g., clearance, vol. of distribution, half-life), describes methods of PK data anal. (noncompartmental vs. compartmental) and provides an overview of addnl. concepts such as allometric scaling, PK/pharmacodynamic modeling, and nonlinear PK.  Furthermore, the role and strategic use of PK screens in drug discovery are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6ZQgdKuejILVg90H21EOLACvtfcHk0lhtKh0uW82Vbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbs%253D&md5=b976d2cfab65b2e3ede9c103c94c37cc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fmed.1015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.1015%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DG.%2BR.%26aulast%3DHarris%26aufirst%3DR.%2BZ.%26aulast%3DLau%26aufirst%3DD.%2BT.%26atitle%3DPharmacokinetics%2520and%2520its%2520role%2520in%2520small%2520molecule%2520drug%2520discovery%2520research%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2001%26volume%3D21%26spage%3D382%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Thompson, T. N.</span><span> </span><span class="NLM_article-title">Optimization of metabolic stability as a goal of modern drug design</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1002%2Fmed.1017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=11579441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=412-449&author=T.+N.+Thompson&title=Optimization+of+metabolic+stability+as+a+goal+of+modern+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of metabolic stability as a goal of modern drug design</span></div><div class="casAuthors">Thompson, Thomas N.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">412-449</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Metab. and other pharmacokinetic (PK) studies have always played a crit. role in helping to optimize the bioavailability and duration of action of new drugs thereby increasing their success rate.  With the advent of automated combinatorial synthesis, high-throughput pharmacol. testing, and the ability to create extensive databases in the past decade, drug discovery has undergone an amazing evolution.  With the increased throughput of drug discovery, metab. and other PK studies have evolved to keep pace.  Often called "early ADME" studies, these studies are characterized by parallel processing and higher throughput than before.  This article focuses on a particular class of early ADME (absorption, distribution mechanism and excretion) studies known as "metabolic stability" studies.  The theor. basis for metabolic stability and its relationship to the concept of metabolic intrinsic clearance is briefly presented.  Some key relationships between structure and metab. are summarized.  Several case studies from recent medicinal chem. literature are reviewed to exemplify how metabolic stability studies influenced drug design and led to improvements in bioavailability and half-life.  Finally, future trends in drug metab. and anal. chem. and how they may influence metabolic stability studies are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHQRXfzgmH9rVg90H21EOLACvtfcHk0lhtKh0uW82Vbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFCmtbk%253D&md5=405716d9371bea565c4422a5cfabe40d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fmed.1017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.1017%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DT.%2BN.%26atitle%3DOptimization%2520of%2520metabolic%2520stability%2520as%2520a%2520goal%2520of%2520modern%2520drug%2520design%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2001%26volume%3D21%26spage%3D412%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pritchard, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurima-Romet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimer, M. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortimer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cayen, M. N.</span><span> </span><span class="NLM_article-title">A guide to drug discovery: making better drugs: decision gates in non-clinical drug development</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=542-553&author=J.+F.+Pritchardauthor=M.+Jurima-Rometauthor=M.+L.+J.+Reimerauthor=E.+Mortimerauthor=B.+Rolfeauthor=M.+N.+Cayen&title=A+guide+to+drug+discovery%3A+making+better+drugs%3A+decision+gates+in+non-clinical+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPritchard%26aufirst%3DJ.%2BF.%26aulast%3DJurima-Romet%26aufirst%3DM.%26aulast%3DReimer%26aufirst%3DM.%2BL.%2BJ.%26aulast%3DMortimer%26aufirst%3DE.%26aulast%3DRolfe%26aufirst%3DB.%26aulast%3DCayen%26aufirst%3DM.%2BN.%26atitle%3DA%2520guide%2520to%2520drug%2520discovery%253A%2520making%2520better%2520drugs%253A%2520decision%2520gates%2520in%2520non-clinical%2520drug%2520development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D542%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Shu, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T. J.</span><span> </span><span class="NLM_article-title">Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery</span> <span class="citation_source-journal">AAPS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1208%2Fs12248-008-9016-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=18446518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWrsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=178-192&author=Y.-Z.+Shuauthor=B.+M.+Johnsonauthor=T.+J.+Yang&title=Role+of+biotransformation+studies+in+minimizing+metabolism-related+liabilities+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery</span></div><div class="casAuthors">Shu, Yue-Zhong; Johnson, Benjamin M.; Yang, Tian J.</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">178-192</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Metab.-related liabilities continue to be a major cause of attrition for drug candidates in clin. development.  Such problems may arise from the bioactivation of the parent compd. to a reactive metabolite capable of modifying biol. materials covalently or engaging in redox-cycling reactions leading to the formation of other toxicants.  Alternatively, they may result from the formation of a major metabolite with systemic exposure and adverse pharmacol. activity.  To avert such problems, biotransformation studies are becoming increasingly important in guiding the refinement of a lead series during drug discovery and in characterizing lead candidates prior to clin. evaluation.  This article provides an overview of the methods that are used to uncover metab.-related liabilities in a preclin. setting and offers suggestions for reducing such liabilities via the modification of structural features that are used commonly in drug-like mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreD31HEIXrHLVg90H21EOLACvtfcHk0lhHouLlWZS-xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWrsLvO&md5=f271983898661cb2b6d91ba274ddac97</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1208%2Fs12248-008-9016-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-008-9016-9%26sid%3Dliteratum%253Aachs%26aulast%3DShu%26aufirst%3DY.-Z.%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26aulast%3DYang%26aufirst%3DT.%2BJ.%26atitle%3DRole%2520of%2520biotransformation%2520studies%2520in%2520minimizing%2520metabolism-related%2520liabilities%2520in%2520drug%2520discovery%26jtitle%3DAAPS%2520J.%26date%3D2008%26volume%3D10%26spage%3D178%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, J.</span><span> </span><span class="NLM_article-title">Opinion: Can the pharmaceutical industry reduce attrition rates?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=711-716&author=I.+Kolaauthor=J.+Landis&title=Opinion%3A+Can+the+pharmaceutical+industry+reduce+attrition+rates%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKola%26aufirst%3DI.%26aulast%3DLandis%26aufirst%3DJ.%26atitle%3DOpinion%253A%2520Can%2520the%2520pharmaceutical%2520industry%2520reduce%2520attrition%2520rates%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D711%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lhHouLlWZS-xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kerns, E. H.; Di, L.</span> <span class="citation_source-book">Drug-like Properties: Concepts, Structure, Design and Methods</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1016%2FB978-012369520-8.50008-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=E.+H.+Kerns&author=L.+Di&title=Drug-like+Properties%3A+Concepts%2C+Structure%2C+Design+and+Methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FB978-012369520-8.50008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-012369520-8.50008-5%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26btitle%3DDrug-like%2520Properties%253A%2520Concepts%252C%2520Structure%252C%2520Design%2520and%2520Methods%26pub%3DAcademic%2520Press%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Smith, D. A.</span><span> </span><span class="NLM_article-title">Discovery and ADMET: Where are we now?</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">481</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.2174%2F156802611794480909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=21320070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=467-481&author=D.+A.+Smith&title=Discovery+and+ADMET%3A+Where+are+we+now%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and ADMET: where are we now</span></div><div class="casAuthors">Smith, Dennis A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">467-481</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The gradual alignment with all of drug metab. with all aspects of drug discovery and development has led to a complete realignment of the way the work is conducted.  From a background of conducting bespoke in vivo studies much of the work is now in a high throughput screening mode.  Large technol. advances were made, but the nature of drug metab. processes, being multi-system and promiscuous means that much of the help provided to the medicinal chem. is reactive rather than based on fundamental disposition structure-activity relationships.  Lessons learned around the chem. and physicochem. properties more often assocd. with successful discovery and development projects are only moderately helpful when the high value pharmacol. targets of today only yield potent ligands outside of the boundaries these properties describe.  Pivotal to the impact of these properties is the intrinsic permeability of a mol., something not as widely recognized as perhaps it should be.  Metabolic lability is still a problem and the tactics employed are unchanged in 20 years: attempt to lower lipophilicity, if it is too high overall or introduce blocking groups, particularly halogens, after identifying the sites of metab.  Perhaps the greatest success drug metab. science has had over the last fifteen years is it's pivotal role in characterizing drug-drug interactions and providing screening systems and computational models to investigate them.  It still has many undeveloped areas of the science such as the role of metabolites in drug activity and why compds. vary in their extent of biliary excretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEw_2VMNc--bVg90H21EOLACvtfcHk0lhHouLlWZS-xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSnurs%253D&md5=b4e1b937f2f048a3ec9b97df98b339e6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F156802611794480909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794480909%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26atitle%3DDiscovery%2520and%2520ADMET%253A%2520Where%2520are%2520we%2520now%253F%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2011%26volume%3D11%26spage%3D467%26epage%3D481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Warr, W.</span><span> </span><span class="NLM_article-title">ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI)</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1007%2Fs10822-009-9260-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=19194660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVWrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=195-198&author=W.+Warr&title=ChEMBL.+An+interview+with+John+Overington%2C+team+leader%2C+chemogenomics+at+the+European+Bioinformatics+Institute+Outstation+of+the+European+Molecular+Biology+Laboratory+%28EMBL-EBI%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI)</span></div><div class="casAuthors">Warr, Wendy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">195-198</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSOSkQaZrKbLVg90H21EOLACvtfcHk0limBBtmCmtfEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVWrtLc%253D&md5=500f68457aff5958db205e63fd6fa00e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs10822-009-9260-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-009-9260-9%26sid%3Dliteratum%253Aachs%26aulast%3DWarr%26aufirst%3DW.%26atitle%3DChEMBL.%2520An%2520interview%2520with%2520John%2520Overington%252C%2520team%2520leader%252C%2520chemogenomics%2520at%2520the%2520European%2520Bioinformatics%2520Institute%2520Outstation%2520of%2520the%2520European%2520Molecular%2520Biology%2520Laboratory%2520%2528EMBL-EBI%2529%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2009%26volume%3D23%26spage%3D195%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span> </span><span class="NLM_article-title">Biotransformation reactions of five-membered aromatic heterocyclic rings</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+reactions+of+five-membered+aromatic+heterocyclic+rings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0limBBtmCmtfEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520reactions%2520of%2520five-membered%2520aromatic%2520heterocyclic%2520rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D269%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Evans, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Drug–protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx034170b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=3-16&author=D.+C.+Evansauthor=A.+P.+Wattauthor=D.+A.+Nicoll-Griffithauthor=T.+A.+Baillie&title=Drug%E2%80%93protein+adducts%3A+an+industry+perspective+on+minimizing+the+potential+for+drug+bioactivation+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Ftx034170b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx034170b%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BC.%26aulast%3DWatt%26aufirst%3DA.%2BP.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DDrug%25E2%2580%2593protein%2520adducts%253A%2520an%2520industry%2520perspective%2520on%2520minimizing%2520the%2520potential%2520for%2520drug%2520bioactivation%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Nassar, A.-E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamel, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarimont, C.</span><span> </span><span class="NLM_article-title">Improving the decision-making process in structural modification of drug candidates: reducing toxicity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1055</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1055-1064&author=A.-E.+F.+Nassarauthor=A.+M.+Kamelauthor=C.+Clarimont&title=Improving+the+decision-making+process+in+structural+modification+of+drug+candidates%3A+reducing+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA.-E.%2BF.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DClarimont%26aufirst%3DC.%26atitle%3DImproving%2520the%2520decision-making%2520process%2520in%2520structural%2520modification%2520of%2520drug%2520candidates%253A%2520reducing%2520toxicity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D1055%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahakian, D. C.</span><span> </span><span class="NLM_article-title">On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.2174%2F1389200023337360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=12093357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlCqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=379-424&author=A.+S.+Kalgutkarauthor=D.+K.+Dalvieauthor=J.+P.+O%E2%80%99Donnellauthor=T.+J.+Taylorauthor=D.+C.+Sahakian&title=On+the+diversity+of+oxidative+bioactivation+reactions+on+nitrogen-containing+xenobiotics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics</span></div><div class="casAuthors">Kalgutkar, Amit S.; Dalvie, Deepak K.; O'Donnell, John P.; Taylor, Timothy J.; Sahakian, Diana C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">379-424</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The unexpected occurrence of idiosyncratic drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use or failure to release/withdrawal.  This leads to considerable uncertainty in drug development and has led to attempts to try to predict a drug's potential to cause such reactions.  The biotransformation of relatively inert drugs to highly reactive metabolites, commonly referred to as "bioactivation", is now recognized to be an obligatory step in several kinds of drug-induced adverse reactions.  Reactive metabolites can be formed by most, if not all, of the enzymes that are involved in drug metab.  A major theme explored in this review includes the diversity of oxidative bioactivation reactions on nitrogen-contg. xenobiotics including drugs.  A variety of Phase I enzymes including P 450, MAO, and peroxidases bioactivate nitrogen-contg. xenobiotics via direct oxidns. on the nitrogen atom leading to reactive intermediates or by oxidn. at an alternate site in the mol.; for the metabolite to be reactive via the latter sequence nitrogen participation in required.  Examples of direct oxidns. on nitrogen include the N-oxidn. of arom. amines (e.g. procainamide), single electron N-oxidn. of imides (e.g. phenytoin), or α-carbon oxidns. of arylalkyl- or alkylamines (e.g. mianserin), to reactive nitroso, nitrogen free radical and iminium species, resp.  Examples of indirect bioactivation are highlighted with arom. amines (e.g. diclofenac) that undergo p-hydroxylation resulting in the formation of p-aminophenols, two-electron oxidn. of which results in the formation of reactive quinone imines.  Potential strategies that could be utilized in the screening of novel bioactivation pathways are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN5v38ETA3R7Vg90H21EOLACvtfcHk0limBBtmCmtfEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlCqtrk%253D&md5=957229c769ed130bdcc3083d2d89066a</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1389200023337360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200023337360%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DTaylor%26aufirst%3DT.%2BJ.%26aulast%3DSahakian%26aufirst%3DD.%2BC.%26atitle%3DOn%2520the%2520diversity%2520of%2520oxidative%2520bioactivation%2520reactions%2520on%2520nitrogen-containing%2520xenobiotics%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2002%26volume%3D3%26spage%3D379%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span> </span><span class="NLM_article-title">Minimising the potential for metabolic activation in drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1517%2F17425255.1.1.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=16922655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvVGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=91-142&author=A.+S.+Kalgutkarauthor=J.+R.+Soglia&title=Minimising+the+potential+for+metabolic+activation+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Minimising the potential for metabolic activation in drug discovery</span></div><div class="casAuthors">Kalgutkar, Amit S.; Soglia, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-142</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Investigations into the role of bioactivation in the pathogenesis of xeno-biotic-induced toxicity have been a major area of research since the link between reactive metabolites and carcinogenesis was first reported in the 1930s.  Circumstantial evidence suggests that bioactivation of relatively inert functional groups to reactive metabolites may contribute towards certain drug-induced adverse reactions.  Reactive metabolites, if not detoxified, can covalently modify essential cellular targets.  The identity of the susceptible biomacromol.(s), and the physiol. consequence of its covalent modification, will dictate the resulting toxicol. response (e.g., covalent modification of DNA by reactive intermediates derived from procarcinogens that potentially leads to carcinogenesis).  The formation of drug-protein adducts often carries a potential risk of clin. toxicities that may not be predicted from preclin. safety studies.  Animal models used to reliably predict idio-syncratic drug toxicity are unavailable at present.  Furthermore, considering that the frequency of occurrence of idiosyncratic adverse drug reactions (IADRs) is fairly rare (1 in 1000 to 1 in 10,000), it is impossible to detect such phenomena in early clin. trials.  Thus, the occurrence of IADRs during late clin. trials or after a drug has been released can lead to an unanticipated restriction in its use and even in its withdrawal.  Major themes explored in this review include a comprehensive cataloguing of bioactivation pathways of functional groups commonly utilized in drug design efforts with appropriate strategies towards detection of corresponding reactive intermediates.  Several instances wherein replacement of putative structural alerts in drugs assocd. with IADRs with a latent functionality eliminates the underlying liability are also presented.  Examples of where bioactivation phenomenon in drug candidates can be successfully abrogated via iterative chem. interventions are also discussed.  Finally, appropriate strategies that aid in potentially mitigating the risk of IADRs are explored, esp. in circumstances in which the structural alert is also responsible for the primary pharmacol. of the drug candidate and cannot be replaced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryrPwGKBtP3rVg90H21EOLACvtfcHk0lhG4EaKHUND8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvVGhs7s%253D&md5=15a3312335273663b6ef1222534f5428</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.1.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.1.91%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26atitle%3DMinimising%2520the%2520potential%2520for%2520metabolic%2520activation%2520in%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D91%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">A comprehensive listing of bioactivation pathways of organic functional groups</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.2174%2F1389200054021799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=15975040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=161-225&author=A.+S.+Kalgutkarauthor=I.+Gardnerauthor=R.+S.+Obachauthor=C.+L.+Shafferauthor=E.+Callegariauthor=K.+R.+Henneauthor=A.+E.+Mutlibauthor=D.+K.+Dalvieauthor=J.+S.+Leeauthor=Y.+Nakaiauthor=J.+P.+O%E2%80%99Donnellauthor=J.+Boerauthor=S.+P.+Harriman&title=A+comprehensive+listing+of+bioactivation+pathways+of+organic+functional+groups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive listing of bioactivation pathways of organic functional groups</span></div><div class="casAuthors">Kalgutkar, Amit S.; Gardner, Iain; Obach, R. Scott; Shaffer, Christopher L.; Callegari, Ernesto; Henne, Kirk R.; Mutlib, Abdul E.; Dalvie, Deepak K.; Lee, Jae S.; Nakai, Yasuhiro; O'Donnell, John P.; Boer, Jason; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-225</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of idiosyncratic adverse drug reactions during late clin. trials or after a drug has been released can lead to a severe restriction in its use and even in its withdrawal.  Metabolic activation of relatively inert functional groups to reactive electrophilic intermediates is considered to be an obligatory event in the etiol. of many drug-induced adverse reactions.  Therefore, a thorough examn. of the biochem. reactivity of functional groups/structural motifs in all new drug candidates is essential from a safety standpoint.  A major theme attempted in this review is the comprehensive cataloging of all of the known bioactivation pathways of functional groups or structural motifs commonly utilized in drug design efforts.  Potential strategies in the detection of reactive intermediates in biochem. systems are also discussed.  The intention of this review is not to "black list" functional groups or to immediately discard compds. based on their potential to form reactive metabolites, but rather to serve as a resource describing the structural diversity of these functionalities as well as exptl. approaches that could be taken to evaluate whether a "structural alert" in a new drug candidate undergoes bioactivation to reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOVj7cmxfwXrVg90H21EOLACvtfcHk0lhG4EaKHUND8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvF2is7k%253D&md5=b16dfc2de97c40a11218ecc3043bed66</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1389200054021799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200054021799%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DGardner%26aufirst%3DI.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DHenne%26aufirst%3DK.%2BR.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26aulast%3DBoer%26aufirst%3DJ.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DA%2520comprehensive%2520listing%2520of%2520bioactivation%2520pathways%2520of%2520organic%2520functional%2520groups%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2005%26volume%3D6%26spage%3D161%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleo, M. D.</span><span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1410</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States</span></div><div class="casAuthors">Stepan, Antonia F.; Walker, Daniel P.; Bauman, Jonathan; Price, David A.; Baillie, Thomas A.; Kalgutkar, Amit S.; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1410</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Because of a preconceived notion that eliminating reactive metabolite (RM) formation with new drug candidates could mitigate the risk of idiosyncratic drug toxicity, the potential for RM formation is routinely examd. as part of lead optimization efforts in drug discovery.  Likewise, avoidance of "structural alerts" is almost a norm in drug design.  However, there is a growing concern that the perceived safety hazards assocd. with structural alerts and/or RM screening tools as standalone predictors of toxicity risks may be over exaggerated.  In addn., the multifactorial nature of idiosyncratic toxicity is now well recognized based upon observations that mechanisms other than RM formation (e.g., mitochondrial toxicity and inhibition of bile salt export pump (BSEP)) also can account for certain target organ toxicities.  Hence, fundamental questions arise such as: When is a mol. that contains a structural alert (RM pos. or neg.) a cause for concern.  Could the mol. in its parent form exert toxicity.  Can a low dose drug candidate truly mitigate metab.-dependent and -independent idiosyncratic toxicity risks.  In an effort to address these questions, we have retrospectively examd. 68 drugs (recalled or assocd. with a black box warning due to idiosyncratic toxicity) and the top 200 drugs (prescription and sales) in the United States in 2009 for trends in physiochem. characteristics, daily doses, presence of structural alerts, evidence for RM formation as well as toxicity mechanism(s) potentially mediated by parent drugs.  Collectively, our anal. revealed that a significant proportion (∼78-86%) of drugs assocd. with toxicity contained structural alerts and evidence indicating that RM formation as a causative factor for toxicity has been presented in 62-69% of these mols.  In several cases, mitochondrial toxicity and BSEP inhibition mediated by parent drugs were also noted as potential causative factors.  Most drugs were administered at daily doses exceeding several hundred milligrams.  There was no obvious link between idiosyncratic toxicity and physicochem. properties such as mol. wt., lipophilicity, etc.  Approx. half of the top 200 drugs for 2009 (prescription and sales) also contained one or more alerts in their chem. architecture, and many were found to be RM-pos.  Several instances of BSEP and mitochondrial liabilities were also noted with agents in the top 200 category.  However, with relatively few exceptions, the vast majority of these drugs are rarely assocd. with idiosyncratic toxicity, despite years of patient use.  The major differentiating factor appeared to be the daily dose; most of the drugs in the top 200 list are administered at low daily doses.  In addn., competing detoxication pathways and/or alternate nonmetabolic clearance routes provided suitable justifications for the safety records of RM-pos. drugs in the top 200 category.  Thus, while RM elimination may be a useful and pragmatic starting point in mitigating idiosyncratic toxicity risks, our anal. suggests a need for a more integrated screening paradigm for chem. hazard identification in drug discovery.  Thus, in addn. to a detailed assessment of RM formation potential (in relationship to the overall elimination mechanisms of the compd.(s)) for lead compds., effects on cellular health (e.g., cytotoxicity assays), BSEP inhibition, and mitochondrial toxicity are the recommended suite of assays to characterize compd. liabilities.  However, the prospective use of such data in compd. selection will require further validation of the cellular assays using marketed agents.  Until we gain a better understanding of the pathophysiol. mechanisms assocd. with idiosyncratic toxicities, improving pharmacokinetics and intrinsic potency as means of decreasing the dose size and the assocd. "body burden" of the parent drug and its metabolites will remain an overarching goal in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3IhczIcvVDLVg90H21EOLACvtfcHk0lhG4EaKHUND8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Whtbo%253D&md5=632b73f755738e49eb233bc8dca1fbcc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D1345%26epage%3D1410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-D.</span><span> </span><span class="NLM_article-title">Aldehyde oxidase: an enzyme of emerging importance in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8441</span><span class="NLM_x">–</span> <span class="NLM_lpage">8460</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100888d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8441-8460&author=D.+C.+Prydeauthor=D.+Dalvieauthor=Q.+Huauthor=P.+Jonesauthor=R.+S.+Obachauthor=T.-D.+Tran&title=Aldehyde+oxidase%3A+an+enzyme+of+emerging+importance+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery</span></div><div class="casAuthors">Pryde, David C.; Dalvie, Deepak; Hu, Qiyue; Jones, Peter; Obach, R. Scott; Tran, Thien-Duc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8441-8460</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aldehyde oxidase has for many years been recognized as a metabolizing enzyme contained within the cytosolic compartment of many tissues and in many species.  The first literature ref. to AO dates from the 1930s, but literature citations to this enzyme have been steadily growing ever since, esp. in the past decade.  It has been increasingly recognized in this past decade that AO, through its unique structure, distribution, and substrate recognition, has an important role to play in the metab. of drugs.  In this timely Perspective, we present the current knowledge of the enzyme's expression, its structure, and its distribution across species.  We offer an anal. of substrates recognized by AO and highlight clin. examples where metab. by this enzyme has had significant clin. impact or led to the termination of a drug development program.  Finally, through anal. of the structure of known substrates, we present data to suggest the significant impact AO could play on future drug discovery programs along with strategies that could be employed to mitigate this.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALwFS70G6tLVg90H21EOLACvtfcHk0lhcCsA_2sa3jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFygt73N&md5=972eb9862a7dc7bff024b530ab40de7f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm100888d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100888d%26sid%3Dliteratum%253Aachs%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTran%26aufirst%3DT.-D.%26atitle%3DAldehyde%2520oxidase%253A%2520an%2520enzyme%2520of%2520emerging%2520importance%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8441%26epage%3D8460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Argikar, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span> </span><span class="NLM_article-title">Strategies and chemical design approaches to reduce the potential for formation of reactive metabolic species</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.2174%2F156802611794480891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=21320068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=419-449&author=U.+A.+Argikarauthor=J.+B.+Mangoldauthor=S.+P.+Harriman&title=Strategies+and+chemical+design+approaches+to+reduce+the+potential+for+formation+of+reactive+metabolic+species"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies and chemical design approaches to reduce the potential for formation of reactive metabolic species</span></div><div class="casAuthors">Argikar, Upendra A.; Mangold, James B.; Harriman, Shawn P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">419-449</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Metabolic activation of new chem. entities to reactive intermediates is routinely monitored in drug discovery and development.  Reactive intermediates may bind to cellular macromols. such as proteins, DNA and may eventually lead to cell death via necrosis, apoptosis or oxidative stress.  The evidence that the ultimate outcome of metabolic activation is an adverse drug reaction manifested as in vivo toxicity, is at best circumstantial.  However, understanding the process of bioactivation of structural alerts by trapping the reactive intermediates is crit. to guide medicinal chem. efforts in quest for safer and potent mols.  This commentary provides a brief introduction to adverse drug reactions and mechanisms of reactive intermediate formation for various functional groups, followed by a review of chem. design approaches, examples of such strategies, possible isosteric replacements for structural alerts and rationalization of lab. approaches to det. reactive intermediates, as a guide to today's medicinal chemist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJn3HGMykr8LVg90H21EOLACvtfcHk0lhcCsA_2sa3jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSnur0%253D&md5=85942dff291aaf4221ff156b6bc5a902</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F156802611794480891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611794480891%26sid%3Dliteratum%253Aachs%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DMangold%26aufirst%3DJ.%2BB.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26atitle%3DStrategies%2520and%2520chemical%2520design%2520approaches%2520to%2520reduce%2520the%2520potential%2520for%2520formation%2520of%2520reactive%2520metabolic%2520species%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2011%26volume%3D11%26spage%3D419%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassahun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baillie, T. A.</span><span> </span><span class="NLM_article-title">Approaches for minimizing metabolic activation of new drug candidates in drug discovery</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">196</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1007%2F978-3-642-00663-0_19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=20020275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvVymsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2010&pages=511-544&author=S.+Kumarauthor=K.+Mitraauthor=K.+Kassahunauthor=T.+A.+Baillie&title=Approaches+for+minimizing+metabolic+activation+of+new+drug+candidates+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Approaches for minimizing metabolic activation of new drug candidates in drug discovery</span></div><div class="casAuthors">Kumar, Sanjeev; Mitra, Kaushik; Kassahun, Kelem; Baillie, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">Adverse Drug Reactions</span>),
    <span class="NLM_cas:pages">511-544</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  A large body of circumstantial evidence suggests that metabolic activation of drug candidates to chem. reactive electrophilic metabolites that are capable of covalently modifying cellular macromols. may result in acute and/or immune system-mediated idiosyncratic toxicities in humans.  Thus, minimizing the potential for metabolic activation of new drug candidates during the drug discovery and lead optimization stage represents a prudent strategy to help discover and develop the next generation of safe and effective therapeutic agents.  In the present chapter, we discuss the scientific methodologies that currently are available to industrial pharmaceutical scientists for assessing and minimizing metabolic activation during drug discovery, their attributes and limitations, and future scientific directions that have the potential to help advance progress in this field.  We also propose a roadmap that should help utilize the armamentarium of available scientific tools in a logical way and contribute to addressing metabolic activation issues in the drug discovery-setting in a rapid, scientifically appropriate, and resource-conscious manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsUn4AeXY6DLVg90H21EOLACvtfcHk0lhcCsA_2sa3jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvVymsrk%253D&md5=ec89af3cdc07079ec24aedb7b94f051f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-00663-0_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-00663-0_19%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMitra%26aufirst%3DK.%26aulast%3DKassahun%26aufirst%3DK.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26atitle%3DApproaches%2520for%2520minimizing%2520metabolic%2520activation%2520of%2520new%2520drug%2520candidates%2520in%2520drug%2520discovery%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2010%26volume%3D196%26spage%3D511%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Parkinson, A.; Ogilvie, B. W.</span><span> </span><span class="NLM_article-title">Biotransformation of Xenobiotics</span>. In  <span class="citation_source-book">Casarett & Doull’s Essentials of Toxicology</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Klaassen, C. D.; Watkins, J. B.,  III</span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+Parkinson&author=B.+W.+Ogilvieauthor=C.+D.+Klaassen&author=J.+B.+Watkins&title=Casarett+%26+Doull%E2%80%99s+Essentials+of+Toxicology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DA.%26atitle%3DBiotransformation%2520of%2520Xenobiotics%26btitle%3DCasarett%2520%2526%2520Doull%25E2%2580%2599s%2520Essentials%2520of%2520Toxicology%26aulast%3DKlaassen%26aufirst%3DC.%2BD.%26pub%3DMcGraw-Hill%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">Unless noted otherwise, all cLogP and cLogD<sub>7.4</sub> data were calculated using ACD/Labs software, version 11.02, 1994–2011.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Eicher, T.; Hauptmann, S.</span> <span class="citation_source-book">The Chemistry of Heterocycles: Structure, Reactions, Syntheses, and Applications</span>; <span class="NLM_publisher-name">Thieme Verlag</span>: <span class="NLM_publisher-loc">Stuttgart, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=T.+Eicher&author=S.+Hauptmann&title=The+Chemistry+of+Heterocycles%3A+Structure%2C+Reactions%2C+Syntheses%2C+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DEicher%26aufirst%3DT.%26btitle%3DThe%2520Chemistry%2520of%2520Heterocycles%253A%2520Structure%252C%2520Reactions%252C%2520Syntheses%252C%2520and%2520Applications%26pub%3DThieme%2520Verlag%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">D’Anna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenna, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noto, R.</span><span> </span><span class="NLM_article-title">Effect of ionic liquid organizing ability and amine structure on the rate and mechanism of base induced elimination of 1,1,1-tribromo-2,2-bis(phenyl-substituted)ethanes</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1690</span><span class="NLM_x">–</span> <span class="NLM_lpage">1698</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=1690-1698&author=F.+D%E2%80%99Annaauthor=V.+Frennaauthor=V.+Paceauthor=R.+Noto&title=Effect+of+ionic+liquid+organizing+ability+and+amine+structure+on+the+rate+and+mechanism+of+base+induced+elimination+of+1%2C1%2C1-tribromo-2%2C2-bis%28phenyl-substituted%29ethanes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Anna%26aufirst%3DF.%26aulast%3DFrenna%26aufirst%3DV.%26aulast%3DPace%26aufirst%3DV.%26aulast%3DNoto%26aufirst%3DR.%26atitle%3DEffect%2520of%2520ionic%2520liquid%2520organizing%2520ability%2520and%2520amine%2520structure%2520on%2520the%2520rate%2520and%2520mechanism%2520of%2520base%2520induced%2520elimination%2520of%25201%252C1%252C1-tribromo-2%252C2-bis%2528phenyl-substituted%2529ethanes%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D1690%26epage%3D1698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Pierson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fettes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freichel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatti-McArthur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwyler, J. r.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plancher, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodríguez Sarmiento, R. M. a.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, R.</span><span> </span><span class="NLM_article-title">5-Hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3855</span><span class="NLM_x">–</span> <span class="NLM_lpage">3868</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900409x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3855-3868&author=P.+D.+Piersonauthor=A.+Fettesauthor=C.+Freichelauthor=S.+Gatti-McArthurauthor=C.+Hertelauthor=J.+r.+Huwylerauthor=P.+Mohrauthor=T.+Nakagawaauthor=M.+Nettekovenauthor=J.-M.+Plancherauthor=S.+Raabauthor=H.+Richterauthor=O.+Rocheauthor=R.+M.+a.+Rodr%C3%ADguez+Sarmientoauthor=M.+Schmittauthor=F.+Schulerauthor=T.+Takahashiauthor=S.+Taylorauthor=C.+Ullmerauthor=R.+Wiegand&title=5-Hydroxyindole-2-carboxylic+acid+amides%3A+novel+histamine-3+receptor+inverse+agonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm900409x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900409x%26sid%3Dliteratum%253Aachs%26aulast%3DPierson%26aufirst%3DP.%2BD.%26aulast%3DFettes%26aufirst%3DA.%26aulast%3DFreichel%26aufirst%3DC.%26aulast%3DGatti-McArthur%26aufirst%3DS.%26aulast%3DHertel%26aufirst%3DC.%26aulast%3DHuwyler%26aufirst%3DJ.%2Br.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DPlancher%26aufirst%3DJ.-M.%26aulast%3DRaab%26aufirst%3DS.%26aulast%3DRichter%26aufirst%3DH.%26aulast%3DRoche%26aufirst%3DO.%26aulast%3DRodr%25C3%25ADguez%2BSarmiento%26aufirst%3DR.%2BM.%2Ba.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DUllmer%26aufirst%3DC.%26aulast%3DWiegand%26aufirst%3DR.%26atitle%3D5-Hydroxyindole-2-carboxylic%2520acid%2520amides%253A%2520novel%2520histamine-3%2520receptor%2520inverse%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3855%26epage%3D3868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Adams, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeng, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ksander, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaSala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung-Chu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meredith, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigel, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span> </span><span class="NLM_article-title">The discovery of potent inhibitors of aldosterone synthase that exhibit selectivity over 11-β-hydroxylase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4324</span><span class="NLM_x">–</span> <span class="NLM_lpage">4327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4324-4327&author=C.+M.+Adamsauthor=C.-W.+Huauthor=A.+Y.+Jengauthor=R.+Karkiauthor=G.+Ksanderauthor=D.+LaSalaauthor=J.+Leung-Chuauthor=G.+Liangauthor=Q.+Liuauthor=E.+Meredithauthor=C.+Raoauthor=D.+F.+Rigelauthor=J.+Shiauthor=S.+Smithauthor=C.+Springerauthor=C.+Zhang&title=The+discovery+of+potent+inhibitors+of+aldosterone+synthase+that+exhibit+selectivity+over+11-%CE%B2-hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DC.%2BM.%26aulast%3DHu%26aufirst%3DC.-W.%26aulast%3DJeng%26aufirst%3DA.%2BY.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKsander%26aufirst%3DG.%26aulast%3DLaSala%26aufirst%3DD.%26aulast%3DLeung-Chu%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMeredith%26aufirst%3DE.%26aulast%3DRao%26aufirst%3DC.%26aulast%3DRigel%26aufirst%3DD.%2BF.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DThe%2520discovery%2520of%2520potent%2520inhibitors%2520of%2520aldosterone%2520synthase%2520that%2520exhibit%2520selectivity%2520over%252011-%25CE%25B2-hydroxylase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4324%26epage%3D4327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Zbinden, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anselm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Décoret, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panday, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricklin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlatter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haap, W.</span><span> </span><span class="NLM_article-title">Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2787</span><span class="NLM_x">–</span> <span class="NLM_lpage">2795</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=2787-2795&author=K.+G.+Zbindenauthor=L.+Anselmauthor=D.+W.+Bannerauthor=J.+Benzauthor=F.+Blascoauthor=G.+D%C3%A9coretauthor=J.+Himberauthor=B.+Kuhnauthor=N.+Pandayauthor=F.+Ricklinauthor=P.+Rischauthor=D.+Schlatterauthor=M.+Stahlauthor=S.+Thomiauthor=R.+Ungerauthor=W.+Haap&title=Design+of+novel+aminopyrrolidine+factor+Xa+inhibitors+from+a+screening+hit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZbinden%26aufirst%3DK.%2BG.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DBlasco%26aufirst%3DF.%26aulast%3DD%25C3%25A9coret%26aufirst%3DG.%26aulast%3DHimber%26aufirst%3DJ.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DPanday%26aufirst%3DN.%26aulast%3DRicklin%26aufirst%3DF.%26aulast%3DRisch%26aufirst%3DP.%26aulast%3DSchlatter%26aufirst%3DD.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DThomi%26aufirst%3DS.%26aulast%3DUnger%26aufirst%3DR.%26aulast%3DHaap%26aufirst%3DW.%26atitle%3DDesign%2520of%2520novel%2520aminopyrrolidine%2520factor%2520Xa%2520inhibitors%2520from%2520a%2520screening%2520hit%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D2787%26epage%3D2795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blazel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissinger, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBrun, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruebsam, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergeeva, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webber, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkovsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span> </span><span class="NLM_article-title">Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′[lambda]6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2<i>H</i>-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5635</span><span class="NLM_x">–</span> <span class="NLM_lpage">5639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5635-5639&author=P.+S.+Dragovichauthor=J.+K.+Blazelauthor=D.+A.+Ellisauthor=Q.+Hanauthor=R.+Kamranauthor=C.+R.+Kissingerauthor=L.+A.+LeBrunauthor=L.-S.+Liauthor=D.+E.+Murphyauthor=M.+Nobleauthor=R.+A.+Patelauthor=F.+Ruebsamauthor=M.+V.+Sergeevaauthor=A.+M.+Shahauthor=R.+E.+Showalterauthor=C.+V.+Tranauthor=M.+Tsanauthor=S.+E.+Webberauthor=L.+Kirkovskyauthor=Y.+Zhou&title=Novel+HCV+NS5B+polymerase+inhibitors+derived+from+4-%281%E2%80%B2%2C1%E2%80%B2-dioxo-1%E2%80%B2%2C4%E2%80%B2-dihydro-1%E2%80%B2%5Blambda%5D6-benzo%5B1%E2%80%B2%2C2%E2%80%B2%2C4%E2%80%B2%5Dthiadiazin-3%E2%80%B2-yl%29-5-hydroxy-2H-pyridazin-3-ones.+Part+5%3A+Exploration+of+pyridazinones+containing+6-amino-substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DBlazel%26aufirst%3DJ.%2BK.%26aulast%3DEllis%26aufirst%3DD.%2BA.%26aulast%3DHan%26aufirst%3DQ.%26aulast%3DKamran%26aufirst%3DR.%26aulast%3DKissinger%26aufirst%3DC.%2BR.%26aulast%3DLeBrun%26aufirst%3DL.%2BA.%26aulast%3DLi%26aufirst%3DL.-S.%26aulast%3DMurphy%26aufirst%3DD.%2BE.%26aulast%3DNoble%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DRuebsam%26aufirst%3DF.%26aulast%3DSergeeva%26aufirst%3DM.%2BV.%26aulast%3DShah%26aufirst%3DA.%2BM.%26aulast%3DShowalter%26aufirst%3DR.%2BE.%26aulast%3DTran%26aufirst%3DC.%2BV.%26aulast%3DTsan%26aufirst%3DM.%26aulast%3DWebber%26aufirst%3DS.%2BE.%26aulast%3DKirkovsky%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DNovel%2520HCV%2520NS5B%2520polymerase%2520inhibitors%2520derived%2520from%25204-%25281%25E2%2580%25B2%252C1%25E2%2580%25B2-dioxo-1%25E2%2580%25B2%252C4%25E2%2580%25B2-dihydro-1%25E2%2580%25B2%255Blambda%255D6-benzo%255B1%25E2%2580%25B2%252C2%25E2%2580%25B2%252C4%25E2%2580%25B2%255Dthiadiazin-3%25E2%2580%25B2-yl%2529-5-hydroxy-2H-pyridazin-3-ones.%2520Part%25205%253A%2520Exploration%2520of%2520pyridazinones%2520containing%25206-amino-substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5635%26epage%3D5639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evrard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, L. R.</span><span> </span><span class="NLM_article-title">7-Sulfonamido-3-benzazepines as potent and selective 5-HT2C receptor agonists: hit-to-lead optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1871</span><span class="NLM_x">–</span> <span class="NLM_lpage">1875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1871-1875&author=P.+V.+Fishauthor=A.+D.+Brownauthor=E.+Evrardauthor=L.+R.+Roberts&title=7-Sulfonamido-3-benzazepines+as+potent+and+selective+5-HT2C+receptor+agonists%3A+hit-to-lead+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DEvrard%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DL.%2BR.%26atitle%3D7-Sulfonamido-3-benzazepines%2520as%2520potent%2520and%2520selective%25205-HT2C%2520receptor%2520agonists%253A%2520hit-to-lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1871%26epage%3D1875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Pescatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecchetti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonsi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz-Fademrecht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serafini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinkühler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span> </span><span class="NLM_article-title">Optimization of a series of potent and selective ketone histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5528</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5528-5532&author=G.+Pescatoreauthor=O.+Kinzelauthor=B.+Attenniauthor=O.+Cecchettiauthor=F.+Fioreauthor=M.+Fonsiauthor=M.+Rowleyauthor=C.+Schultz-Fademrechtauthor=S.+Serafiniauthor=C.+Steink%C3%BChlerauthor=P.+Jones&title=Optimization+of+a+series+of+potent+and+selective+ketone+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DAttenni%26aufirst%3DB.%26aulast%3DCecchetti%26aufirst%3DO.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DFonsi%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSchultz-Fademrecht%26aufirst%3DC.%26aulast%3DSerafini%26aufirst%3DS.%26aulast%3DSteink%25C3%25BChler%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DP.%26atitle%3DOptimization%2520of%2520a%2520series%2520of%2520potent%2520and%2520selective%2520ketone%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5528%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wan, Z.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenail, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ipek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qadri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panza, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perreault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobin, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saiah, E.</span><span> </span><span class="NLM_article-title">Efficacious 11β-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5449</span><span class="NLM_x">–</span> <span class="NLM_lpage">5461</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900639u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5449-5461&author=Z.-K.+Wanauthor=E.+Chenailauthor=J.+Xiangauthor=H.-Q.+Liauthor=M.+Ipekauthor=J.+Bardauthor=K.+Svensonauthor=T.+S.+Mansourauthor=X.+Xuauthor=X.+Tianauthor=V.+Suriauthor=S.+Hahmauthor=Y.+Xingauthor=C.+E.+Johnsonauthor=X.+Liauthor=A.+Qadriauthor=D.+Panzaauthor=M.+Perreaultauthor=J.+F.+Tobinauthor=E.+Saiah&title=Efficacious+11%CE%B2-hydroxysteroid+dehydrogenase+type+I+inhibitors+in+the+diet-induced+obesity+mouse+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm900639u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900639u%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DZ.-K.%26aulast%3DChenail%26aufirst%3DE.%26aulast%3DXiang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DH.-Q.%26aulast%3DIpek%26aufirst%3DM.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DSuri%26aufirst%3DV.%26aulast%3DHahm%26aufirst%3DS.%26aulast%3DXing%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DC.%2BE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DQadri%26aufirst%3DA.%26aulast%3DPanza%26aufirst%3DD.%26aulast%3DPerreault%26aufirst%3DM.%26aulast%3DTobin%26aufirst%3DJ.%2BF.%26aulast%3DSaiah%26aufirst%3DE.%26atitle%3DEfficacious%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%2520I%2520inhibitors%2520in%2520the%2520diet-induced%2520obesity%2520mouse%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5449%26epage%3D5461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kerekes, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposite, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doll, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagat, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tevar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basso, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. B.</span><span> </span><span class="NLM_article-title">Aurora kinase inhibitors based on the imidazo[1,2-<i>a</i>]pyrazine core: fluorine and deuterium incorporation improve oral absorption and exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1010995" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=201-210&author=A.+D.+Kerekesauthor=S.+J.+Espositeauthor=R.+J.+Dollauthor=J.+R.+Tagatauthor=T.+Yuauthor=Y.+Xiaoauthor=Y.+Zhangauthor=D.+B.+Preluskyauthor=S.+Tevarauthor=K.+Grayauthor=G.+A.+Terracinaauthor=S.+Leeauthor=J.+Jonesauthor=M.+Liuauthor=A.+D.+Bassoauthor=E.+B.+Smith&title=Aurora+kinase+inhibitors+based+on+the+imidazo%5B1%2C2-a%5Dpyrazine+core%3A+fluorine+and+deuterium+incorporation+improve+oral+absorption+and+exposure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Aurora Kinase Inhibitors Based on the Imidazo[1,2-a]pyrazine Core: Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure</span></div><div class="casAuthors">Kerekes, Angela D.; Esposite, Sara J.; Doll, Ronald J.; Tagat, Jayaram R.; Yu, Tao; Xiao, Yushi; Zhang, Yonglian; Prelusky, Dan B.; Tevar, Seema; Gray, Kimberly; Terracina, Gaby A.; Lee, Suining; Jones, Jennifer; Liu, Ming; Basso, Andrea D.; Smith, Elizabeth B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">201-210</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aurora kinases are cell cycle regulated serine/threonine kinases that have been linked to cancer.  Compd. 1 was identified as a potent Aurora inhibitor but lacked oral bioavailability.  Optimization of 1 led to the discovery of a series of fluoroamine and deuterated analogs, exemplified by compd. 25 (I), with an improved pharmacokinetic profile.  We found that blocking oxidative metab. at the benzylic position and decreasing the basicity of the amine are important to obtaining compds. with good biol. profiles and oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3YIdBKno7NLVg90H21EOLACvtfcHk0lh51UTENPo5oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWqsbzP&md5=af7c338866058e7d63116c8c8aa2d3fd</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm1010995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1010995%26sid%3Dliteratum%253Aachs%26aulast%3DKerekes%26aufirst%3DA.%2BD.%26aulast%3DEsposite%26aufirst%3DS.%2BJ.%26aulast%3DDoll%26aufirst%3DR.%2BJ.%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26aulast%3DYu%26aufirst%3DT.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPrelusky%26aufirst%3DD.%2BB.%26aulast%3DTevar%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DK.%26aulast%3DTerracina%26aufirst%3DG.%2BA.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DBasso%26aufirst%3DA.%2BD.%26aulast%3DSmith%26aufirst%3DE.%2BB.%26atitle%3DAurora%2520kinase%2520inhibitors%2520based%2520on%2520the%2520imidazo%255B1%252C2-a%255Dpyrazine%2520core%253A%2520fluorine%2520and%2520deuterium%2520incorporation%2520improve%2520oral%2520absorption%2520and%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D201%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Melander, L.; Saunders, W. H.,  Jr.</span> <span class="citation_source-book">Reaction Rates of Isotopic Molecules</span>; <span class="NLM_publisher-name">John Wiley and Sons</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1979</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1979&author=L.+Melander&author=W.+H.+Saunders&title=Reaction+Rates+of+Isotopic+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMelander%26aufirst%3DL.%26btitle%3DReaction%2520Rates%2520of%2520Isotopic%2520Molecules%26pub%3DJohn%2520Wiley%2520and%2520Sons%26date%3D1979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Shao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span> </span><span class="NLM_article-title">The kinetic isotope effect in the search for deuterated drugs</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">398</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=20697607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KrurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=398-404&author=L.+Shaoauthor=M.+C.+Hewitt&title=The+kinetic+isotope+effect+in+the+search+for+deuterated+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetic isotope effect in the search for deuterated drugs</span></div><div class="casAuthors">Shao, Liming; Hewitt, Michael C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">398-404</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The kinetic isotope effect has long been exploited by phys. org. chemists to study reaction mechanisms due to its effect on reaction rates when cleavage of a C-isotope bond is rate detg.  Medicinal chemists have also used the deuterium kinetic isotope effect to slow the cytochrome P 450 metab. of the deuterated versions of drug candidates, with the first in vitro microsome studies of deuterated morphine appearing in the literature in the 1960s, and a deuterated alanine compd. from Merck going all the way to phase IIb in the 1970s.  The recent emergence of companies such as Concert Pharmaceuticals and Auspex Pharmaceuticals, based solely on the idea of deuterium-for-hydrogen versions of existing drugs, has reinvigorated the backers of the deuterium camp, and established the strategy as a viable low-risk approach to drug development.  A history of the deuterium kinetic isotope effect is presented, along with examples of deuterated drugs that span 50 years, from 1960 to present day.  Specific examples of compds. from the Concert and Auspex pipelines are also analyzed and the pros and cons of their approach are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAuGgibLHqTrVg90H21EOLACvtfcHk0lh51UTENPo5oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KrurnO&md5=0cb101283dcec55ddef2603292b95811</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DL.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26atitle%3DThe%2520kinetic%2520isotope%2520effect%2520in%2520the%2520search%2520for%2520deuterated%2520drugs%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2010%26volume%3D23%26spage%3D398%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Gleave, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, G. M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haslam, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roomans, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingsby, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swarbrick, M. E.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB2 agonists for the treatment of inflammatory pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=465-468&author=R.+J.+Gleaveauthor=P.+J.+Beswickauthor=A.+J.+Brownauthor=G.+M.+P.+Giblinauthor=P.+Goldsmithauthor=C.+P.+Haslamauthor=W.+L.+Mitchellauthor=N.+H.+Nicholsonauthor=L.+W.+Pageauthor=S.+Patelauthor=S.+Roomansauthor=B.+P.+Slingsbyauthor=M.+E.+Swarbrick&title=Synthesis+and+evaluation+of+3-amino-6-aryl-pyridazines+as+selective+CB2+agonists+for+the+treatment+of+inflammatory+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGleave%26aufirst%3DR.%2BJ.%26aulast%3DBeswick%26aufirst%3DP.%2BJ.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DGiblin%26aufirst%3DG.%2BM.%2BP.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DHaslam%26aufirst%3DC.%2BP.%26aulast%3DMitchell%26aufirst%3DW.%2BL.%26aulast%3DNicholson%26aufirst%3DN.%2BH.%26aulast%3DPage%26aufirst%3DL.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRoomans%26aufirst%3DS.%26aulast%3DSlingsby%26aufirst%3DB.%2BP.%26aulast%3DSwarbrick%26aufirst%3DM.%2BE.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25203-amino-6-aryl-pyridazines%2520as%2520selective%2520CB2%2520agonists%2520for%2520the%2520treatment%2520of%2520inflammatory%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D465%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Peglion, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goument, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Despaux, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giraud, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman-Tancredi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekeyne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genissel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Improvement in the selectivity and metabolic stability of the serotonin 5-HT1A ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010975%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=165-176&author=J.-L.+Peglionauthor=B.+Goumentauthor=N.+Despauxauthor=V.+Charlotauthor=H.+Giraudauthor=C.+Nisoleauthor=A.+Newman-Tancrediauthor=A.+Dekeyneauthor=M.+Bertrandauthor=P.+Genisselauthor=M.+J.+Millan&title=Improvement+in+the+selectivity+and+metabolic+stability+of+the+serotonin+5-HT1A+ligand%2C+S+15535%3A+a+series+of+cis-+and+trans-2-%28arylcycloalkylamine%29+1-indanols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm010975%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010975%252B%26sid%3Dliteratum%253Aachs%26aulast%3DPeglion%26aufirst%3DJ.-L.%26aulast%3DGoument%26aufirst%3DB.%26aulast%3DDespaux%26aufirst%3DN.%26aulast%3DCharlot%26aufirst%3DV.%26aulast%3DGiraud%26aufirst%3DH.%26aulast%3DNisole%26aufirst%3DC.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DDekeyne%26aufirst%3DA.%26aulast%3DBertrand%26aufirst%3DM.%26aulast%3DGenissel%26aufirst%3DP.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DImprovement%2520in%2520the%2520selectivity%2520and%2520metabolic%2520stability%2520of%2520the%2520serotonin%25205-HT1A%2520ligand%252C%2520S%252015535%253A%2520a%2520series%2520of%2520cis-%2520and%2520trans-2-%2528arylcycloalkylamine%2529%25201-indanols%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D165%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Qiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gainer, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seyb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span> </span><span class="NLM_article-title">Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6122</span><span class="NLM_x">–</span> <span class="NLM_lpage">6126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6122-6126&author=L.+Qiaoauthor=S.+Choiauthor=A.+Caseauthor=T.+G.+Gainerauthor=K.+Seybauthor=M.+A.+Glicksmanauthor=D.+C.+Loauthor=R.+L.+Steinauthor=G.+D.+Cuny&title=Structure%E2%80%93activity+relationship+study+of+EphB3+receptor+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DL.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DCase%26aufirst%3DA.%26aulast%3DGainer%26aufirst%3DT.%2BG.%26aulast%3DSeyb%26aufirst%3DK.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DStein%26aufirst%3DR.%2BL.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520study%2520of%2520EphB3%2520receptor%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6122%26epage%3D6126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Cramp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockey, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porres, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leggate, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, R.</span><span> </span><span class="NLM_article-title">Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2516</span><span class="NLM_x">–</span> <span class="NLM_lpage">2519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2516-2519&author=S.+Crampauthor=H.+J.+Dykeauthor=C.+Higgsauthor=D.+E.+Clarkauthor=M.+Gillauthor=P.+Savyauthor=N.+Jenningsauthor=S.+Priceauthor=P.+M.+Lockeyauthor=D.+Normanauthor=S.+Porresauthor=F.+Wilsonauthor=A.+Jonesauthor=N.+Ramsdenauthor=R.+Manganoauthor=D.+Leggateauthor=M.+Anderssonauthor=R.+Hale&title=Identification+and+hit-to-lead+exploration+of+a+novel+series+of+histamine+H4+receptor+inverse+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCramp%26aufirst%3DS.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DHiggs%26aufirst%3DC.%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DGill%26aufirst%3DM.%26aulast%3DSavy%26aufirst%3DP.%26aulast%3DJennings%26aufirst%3DN.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DLockey%26aufirst%3DP.%2BM.%26aulast%3DNorman%26aufirst%3DD.%26aulast%3DPorres%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DF.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DMangano%26aufirst%3DR.%26aulast%3DLeggate%26aufirst%3DD.%26aulast%3DAndersson%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520hit-to-lead%2520exploration%2520of%2520a%2520novel%2520series%2520of%2520histamine%2520H4%2520receptor%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2516%26epage%3D2519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Omura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, K.</span><span> </span><span class="NLM_article-title">The SAR studies of novel CB2 selective agonists, benzimidazolone derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3310</span><span class="NLM_x">–</span> <span class="NLM_lpage">3314</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3310-3314&author=H.+Omuraauthor=M.+Kawaiauthor=A.+Shimaauthor=Y.+Iwataauthor=F.+Itoauthor=T.+Masudaauthor=A.+Ohtaauthor=N.+Makitaauthor=K.+Omotoauthor=H.+Sugimotoauthor=A.+Kikuchiauthor=H.+Iwataauthor=K.+Ando&title=The+SAR+studies+of+novel+CB2+selective+agonists%2C+benzimidazolone+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOmura%26aufirst%3DH.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DShima%26aufirst%3DA.%26aulast%3DIwata%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DF.%26aulast%3DMasuda%26aufirst%3DT.%26aulast%3DOhta%26aufirst%3DA.%26aulast%3DMakita%26aufirst%3DN.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DSugimoto%26aufirst%3DH.%26aulast%3DKikuchi%26aufirst%3DA.%26aulast%3DIwata%26aufirst%3DH.%26aulast%3DAndo%26aufirst%3DK.%26atitle%3DThe%2520SAR%2520studies%2520of%2520novel%2520CB2%2520selective%2520agonists%252C%2520benzimidazolone%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3310%26epage%3D3314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Stepan, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorff, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiRico, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Won, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pustilnik, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sneed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capetta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallgren, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as gamma-secretase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7772</span><span class="NLM_x">–</span> <span class="NLM_lpage">7783</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200893p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7772-7783&author=A.+F.+Stepanauthor=K.+Karkiauthor=W.+S.+McDonaldauthor=P.+H.+Dorffauthor=J.+K.+Dutraauthor=K.+J.+DiRicoauthor=A.+Wonauthor=C.+Subramanyamauthor=I.+V.+Efremovauthor=C.+J.+O%E2%80%99Donnellauthor=C.+E.+Nolanauthor=S.+L.+Beckerauthor=L.+R.+Pustilnikauthor=B.+Sneedauthor=H.+Sunauthor=Y.+Luauthor=A.+E.+Robshawauthor=D.+Riddellauthor=T.+J.+O%E2%80%99Sullivanauthor=E.+Sibleyauthor=S.+Capettaauthor=K.+Atchisonauthor=A.+J.+Hallgrenauthor=E.+Millerauthor=A.+Woodauthor=R.+S.+Obach&title=Metabolism-directed+design+of+oxetane-containing+arylsulfonamide+derivatives+as+gamma-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm200893p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200893p%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DMcDonald%26aufirst%3DW.%2BS.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DDiRico%26aufirst%3DK.%2BJ.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DSneed%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DCapetta%26aufirst%3DS.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DHallgren%26aufirst%3DA.%2BJ.%26aulast%3DMiller%26aufirst%3DE.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DMetabolism-directed%2520design%2520of%2520oxetane-containing%2520arylsulfonamide%2520derivatives%2520as%2520gamma-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7772%26epage%3D7783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalaeva, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tupper, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">ElogDoct: A tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2497</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0100990" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2490-2497&author=F.+Lombardoauthor=M.+Y.+Shalaevaauthor=K.+A.+Tupperauthor=F.+Gao&title=ElogDoct%3A+A+tool+for+lipophilicity+determination+in+drug+discovery.+2.+Basic+and+neutral+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0100990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0100990%26sid%3Dliteratum%253Aachs%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DShalaeva%26aufirst%3DM.%2BY.%26aulast%3DTupper%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DElogDoct%253A%2520A%2520tool%2520for%2520lipophilicity%2520determination%2520in%2520drug%2520discovery.%25202.%2520Basic%2520and%2520neutral%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2490%26epage%3D2497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Rotstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filonova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton-Pleiss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trejo-Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankuratri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deRosier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dioszegi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilek, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jekle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mau, C.-I.</span><span> </span><span class="NLM_article-title">Spiropiperidine CCR5 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5401</span><span class="NLM_x">–</span> <span class="NLM_lpage">5406</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5401-5406&author=D.+M.+Rotsteinauthor=S.+D.+Gabrielauthor=F.+Makraauthor=L.+Filonovaauthor=S.+Gleasonauthor=C.+Brotherton-Pleissauthor=L.+Q.+Settiauthor=A.+Trejo-Martinauthor=E.+K.+Leeauthor=S.+Sankuratriauthor=C.+Jiauthor=A.+deRosierauthor=M.+Dioszegiauthor=G.+Heilekauthor=A.+Jekleauthor=P.+Berryauthor=P.+Wellerauthor=C.-I.+Mau&title=Spiropiperidine+CCR5+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRotstein%26aufirst%3DD.%2BM.%26aulast%3DGabriel%26aufirst%3DS.%2BD.%26aulast%3DMakra%26aufirst%3DF.%26aulast%3DFilonova%26aufirst%3DL.%26aulast%3DGleason%26aufirst%3DS.%26aulast%3DBrotherton-Pleiss%26aufirst%3DC.%26aulast%3DSetti%26aufirst%3DL.%2BQ.%26aulast%3DTrejo-Martin%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DE.%2BK.%26aulast%3DSankuratri%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DdeRosier%26aufirst%3DA.%26aulast%3DDioszegi%26aufirst%3DM.%26aulast%3DHeilek%26aufirst%3DG.%26aulast%3DJekle%26aufirst%3DA.%26aulast%3DBerry%26aufirst%3DP.%26aulast%3DWeller%26aufirst%3DP.%26aulast%3DMau%26aufirst%3DC.-I.%26atitle%3DSpiropiperidine%2520CCR5%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5401%26epage%3D5406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Pierson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freichel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatti-MacArthur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwyler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettekoven, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plancher, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raab, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarmiento, R. M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand, R.</span><span> </span><span class="NLM_article-title">Histamine-3 receptor inverse agonists for the treatment of obesity: validation of the target and identification of novel series</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2009&pages=275-278&author=P.+D.+Piersonauthor=C.+Freichelauthor=S.+Gatti-MacArthurauthor=C.+Hertelauthor=J.+Huwylerauthor=P.+Mohrauthor=T.+Nakagawaauthor=M.+Nettekovenauthor=J.-M.+Plancherauthor=S.+Raabauthor=H.+Richterauthor=O.+Rocheauthor=R.+M.+R.+Sarmientoauthor=M.+Schmittauthor=F.+Schulerauthor=T.+Takahashiauthor=S.+Taylorauthor=C.+Ullmerauthor=R.+Wiegand&title=Histamine-3+receptor+inverse+agonists+for+the+treatment+of+obesity%3A+validation+of+the+target+and+identification+of+novel+series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPierson%26aufirst%3DP.%2BD.%26aulast%3DFreichel%26aufirst%3DC.%26aulast%3DGatti-MacArthur%26aufirst%3DS.%26aulast%3DHertel%26aufirst%3DC.%26aulast%3DHuwyler%26aufirst%3DJ.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DNakagawa%26aufirst%3DT.%26aulast%3DNettekoven%26aufirst%3DM.%26aulast%3DPlancher%26aufirst%3DJ.-M.%26aulast%3DRaab%26aufirst%3DS.%26aulast%3DRichter%26aufirst%3DH.%26aulast%3DRoche%26aufirst%3DO.%26aulast%3DSarmiento%26aufirst%3DR.%2BM.%2BR.%26aulast%3DSchmitt%26aufirst%3DM.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DUllmer%26aufirst%3DC.%26aulast%3DWiegand%26aufirst%3DR.%26atitle%3DHistamine-3%2520receptor%2520inverse%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity%253A%2520validation%2520of%2520the%2520target%2520and%2520identification%2520of%2520novel%2520series%26jtitle%3DChimia%26date%3D2009%26volume%3D63%26spage%3D275%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stotz, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. a. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Díaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title">Lead Optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7099</span><span class="NLM_x">–</span> <span class="NLM_lpage">7110</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800851u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7099-7110&author=X.+Zhangauthor=J.+E.+Tellewauthor=Z.+Luoauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+P.+Williamsauthor=J.+Saundersauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=T.+Joswigauthor=R.+Petroskiauthor=J.+Pierceyauthor=W.+Kargoauthor=S.+Malanyauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+Wenauthor=K.+Jalaliauthor=Z.+O%E2%80%99Brienauthor=C.+E.+Stotzauthor=M.+a.+I.+Crespoauthor=J.-L.+D%C3%ADazauthor=D.+H.+Slee&title=Lead+Optimization+of+4-acetylamino-2-%283%2C5-dimethylpyrazol-1-yl%29-6-pyridylpyrimidines+as+A2A+adenosine+receptor+antagonists+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm800851u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800851u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DPiercey%26aufirst%3DJ.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DStotz%26aufirst%3DC.%2BE.%26aulast%3DCrespo%26aufirst%3DM.%2Ba.%2BI.%26aulast%3DD%25C3%25ADaz%26aufirst%3DJ.-L.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3DLead%2520Optimization%2520of%25204-acetylamino-2-%25283%252C5-dimethylpyrazol-1-yl%2529-6-pyridylpyrimidines%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7099%26epage%3D7110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddershaw, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyman, P. A.</span><span> </span><span class="NLM_article-title">Studies on a series of potent, orally bioavailable, 5-HT1 receptor ligands—Part II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=428-432&author=S.+E.+Wardauthor=P.+Eddershawauthor=S.+T.+Flynnauthor=L.+Gordonauthor=P.+J.+Lovellauthor=S.+H.+Mooreauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+M.+Thewlisauthor=P.+A.+Wyman&title=Studies+on+a+series+of+potent%2C+orally+bioavailable%2C+5-HT1+receptor+ligands%E2%80%94Part+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DEddershaw%26aufirst%3DP.%26aulast%3DFlynn%26aufirst%3DS.%2BT.%26aulast%3DGordon%26aufirst%3DL.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMoore%26aufirst%3DS.%2BH.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DWyman%26aufirst%3DP.%2BA.%26atitle%3DStudies%2520on%2520a%2520series%2520of%2520potent%252C%2520orally%2520bioavailable%252C%25205-HT1%2520receptor%2520ligands%25E2%2580%2594Part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D428%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Fujimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konishi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Textor, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, K.</span><span> </span><span class="NLM_article-title">Discovery of a tetrahydropyrimidin-2(1<i>H</i>)-one derivative (TAK-442) as a potent, selective, and orally active factor Xa inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3517</span><span class="NLM_x">–</span> <span class="NLM_lpage">3531</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901699j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFert7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3517-3531&author=T.+Fujimotoauthor=Y.+Imaedaauthor=N.+Konishiauthor=K.+Hiroeauthor=M.+Kawamuraauthor=G.+P.+Textorauthor=K.+Aertgeertsauthor=K.+Kubo&title=Discovery+of+a+tetrahydropyrimidin-2%281H%29-one+derivative+%28TAK-442%29+as+a+potent%2C+selective%2C+and+orally+active+factor+Xa+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Tetrahydropyrimidin-2(1H)-one Derivative (TAK-442) as a Potent, Selective, and Orally Active Factor Xa Inhibitor</span></div><div class="casAuthors">Fujimoto, Takuya; Imaeda, Yasuhiro; Konishi, Noriko; Hiroe, Katsuhiko; Kawamura, Masaki; Textor, Garret P.; Aertgeerts, Kathleen; Kubo, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3517-3531</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coagulation enzyme factor Xa (FXa) is a particularly promising target for the development of new anticoagulant agents.  We previously reported the imidazo[1,5-c]imidazol-3-one deriv. 1 (I) as a potent and orally active FXa inhibitor.  However, it was found that 1 predominantly undergoes hydrolysis upon incubation with human liver microsomes, and the human specific metabolic pathway made it difficult to predict the human pharmacokinetics.  To address this issue, our synthetic efforts were focused on modification of the imidazo[1,5-c]imidazol-3-one moiety of the active metabolite 3a (II), derived from 1, which resulted in the discovery of the tetrahydropyrimidin-2(1H)-one deriv. 5k as a highly potent and selective FXa inhibitor.  Compd. 5k (III) showed no detectable amide bond cleavage in human liver microsomes, exhibited a good pharmacokinetic profile in monkeys, and had a potent antithrombotic efficacy in a rabbit model without prolongation of bleeding time.  Compd. 5k is currently under clin. development with the code name TAK-442.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZmn8Ml1JItbVg90H21EOLACvtfcHk0lj5BYSm9xXpnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFert7o%253D&md5=73df2272ff6b5889b3667e9859186ee3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm901699j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901699j%26sid%3Dliteratum%253Aachs%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DImaeda%26aufirst%3DY.%26aulast%3DKonishi%26aufirst%3DN.%26aulast%3DHiroe%26aufirst%3DK.%26aulast%3DKawamura%26aufirst%3DM.%26aulast%3DTextor%26aufirst%3DG.%2BP.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DKubo%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520a%2520tetrahydropyrimidin-2%25281H%2529-one%2520derivative%2520%2528TAK-442%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520factor%2520Xa%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3517%26epage%3D3531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Tsou, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnberg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Discovery and optimization of 2-(4-substituted-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)methylene-4-hydroxybenzofuran-3(2<i>H</i>)-ones as potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2321</span><span class="NLM_x">–</span> <span class="NLM_lpage">2325</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2321-2325&author=H.-R.+Tsouauthor=G.+MacEwanauthor=G.+Birnbergauthor=G.+Grosuauthor=M.+G.+Bursavichauthor=J.+Bardauthor=N.+Brooijmansauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=T.+S.+Mansourauthor=S.+Ayral-Kaloustianauthor=K.+Yu&title=Discovery+and+optimization+of+2-%284-substituted-pyrrolo%5B2%2C3-b%5Dpyridin-3-yl%29methylene-4-hydroxybenzofuran-3%282H%29-ones+as+potent+and+selective+ATP-competitive+inhibitors+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26aulast%3DMacEwan%26aufirst%3DG.%26aulast%3DBirnberg%26aufirst%3DG.%26aulast%3DGrosu%26aufirst%3DG.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25202-%25284-substituted-pyrrolo%255B2%252C3-b%255Dpyridin-3-yl%2529methylene-4-hydroxybenzofuran-3%25282H%2529-ones%2520as%2520potent%2520and%2520selective%2520ATP-competitive%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2321%26epage%3D2325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Martignoni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moscone, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Lack of strain-related differences in drug metabolism and efflux transporter characteristics between CD-1 and athymic nude mice</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1007%2Fs00280-004-0898-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=15592720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVGgtLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=129-135&author=M.+Martignoniauthor=R.+Kanterauthor=A.+Mosconeauthor=P.+Grossiauthor=M.+Monshouwer&title=Lack+of+strain-related+differences+in+drug+metabolism+and+efflux+transporter+characteristics+between+CD-1+and+athymic+nude+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Lack of strain-related differences in drug metabolism and efflux transporter characteristics between CD-1 and athymic nude mice</span></div><div class="casAuthors">Martignoni, Marcella; Kanter, Ruben; Moscone, Anna; Grossi, Pietro; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-135</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">CD-1 mice are commonly used in oncol. metab. and toxicity to support drug discovery and development and to examine drug metab. and toxicity properties of new chem. entities.  On the other hand, athymic nude mice are the preferred animals to investigate tumor growth inhibition.  Therefore, a frequently asked question is: are the metabolic and pharmacokinetic characteristics of xenobiotics in these two mouse strains comparable or not To address this issue, we characterized drug metab. and efflux transporter properties in both strains and in different organs.  The metabolic stability of a set of 20 compds. and metabolite formation of cytochrome P 450 (CYP) marker substrates (testosterone, ethoxyresorufin and pentoxyresorufin) were measured in liver microsomes.  Drug conjugation was studied by following the disappearance of 7-hydroxycoumarin and the formation of its glucuronide and sulfate conjugates in freshly prepd. liver slices.  In addn., mRNA expression levels of the main cyp genes and drug efflux transporters were investigated by real-time RT-PCR in the liver, kidney, intestine and adrenal glands.  No significant differences in enzymic activities and metabolite formation were obsd. between the two strains.  Also mRNA expression profiles of cyp and drug transporter genes were similar between CD-1 and nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoklQPjI9WZ6bVg90H21EOLACvtfcHk0lj5BYSm9xXpnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVGgtLzF&md5=ec86251064dc852d94d1819addc0045a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs00280-004-0898-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-004-0898-7%26sid%3Dliteratum%253Aachs%26aulast%3DMartignoni%26aufirst%3DM.%26aulast%3DKanter%26aufirst%3DR.%26aulast%3DMoscone%26aufirst%3DA.%26aulast%3DGrossi%26aufirst%3DP.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DLack%2520of%2520strain-related%2520differences%2520in%2520drug%2520metabolism%2520and%2520efflux%2520transporter%2520characteristics%2520between%2520CD-1%2520and%2520athymic%2520nude%2520mice%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D55%26spage%3D129%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Mastalerz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheimer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vite, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span> </span><span class="NLM_article-title">Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2828</span><span class="NLM_x">–</span> <span class="NLM_lpage">2833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2828-2833&author=H.+Mastalerzauthor=M.+Changauthor=A.+Gavaiauthor=W.+Johnsonauthor=D.+Langleyauthor=F.+Y.+Leeauthor=P.+Maratheauthor=A.+Mathurauthor=S.+Oppenheimerauthor=J.+Tarrantauthor=J.+S.+Tokarskiauthor=G.+D.+Viteauthor=D.+M.+Vyasauthor=H.+Wongauthor=T.+W.+Wongauthor=H.+Zhangauthor=G.+Zhang&title=Novel+C-5+aminomethyl+pyrrolotriazine+dual+inhibitors+of+EGFR+and+HER2+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMastalerz%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DM.%26aulast%3DGavai%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DW.%26aulast%3DLangley%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DF.%2BY.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DOppenheimer%26aufirst%3DS.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DVite%26aufirst%3DG.%2BD.%26aulast%3DVyas%26aufirst%3DD.%2BM.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DT.%2BW.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DNovel%2520C-5%2520aminomethyl%2520pyrrolotriazine%2520dual%2520inhibitors%2520of%2520EGFR%2520and%2520HER2%2520protein%2520tyrosine%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2828%26epage%3D2833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Geng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basarab, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comita-Prevoir, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowravaram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiely, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacPherson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morningstar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osimboni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundqvist, T.</span><span> </span><span class="NLM_article-title">Potent and selective inhibitors of <i>Helicobacter pylori</i> glutamate racemase (MurI): pyridodiazepine amines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">936</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=930-936&author=B.+Gengauthor=G.+Basarabauthor=J.+Comita-Prevoirauthor=M.+Gowravaramauthor=P.+Hillauthor=A.+Kielyauthor=J.+Lochauthor=L.+MacPhersonauthor=M.+Morningstarauthor=G.+Mullenauthor=E.+Osimboniauthor=A.+Satzauthor=C.+Eyermannauthor=T.+Lundqvist&title=Potent+and+selective+inhibitors+of+Helicobacter+pylori+glutamate+racemase+%28MurI%29%3A+pyridodiazepine+amines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DB.%26aulast%3DBasarab%26aufirst%3DG.%26aulast%3DComita-Prevoir%26aufirst%3DJ.%26aulast%3DGowravaram%26aufirst%3DM.%26aulast%3DHill%26aufirst%3DP.%26aulast%3DKiely%26aufirst%3DA.%26aulast%3DLoch%26aufirst%3DJ.%26aulast%3DMacPherson%26aufirst%3DL.%26aulast%3DMorningstar%26aufirst%3DM.%26aulast%3DMullen%26aufirst%3DG.%26aulast%3DOsimboni%26aufirst%3DE.%26aulast%3DSatz%26aufirst%3DA.%26aulast%3DEyermann%26aufirst%3DC.%26aulast%3DLundqvist%26aufirst%3DT.%26atitle%3DPotent%2520and%2520selective%2520inhibitors%2520of%2520Helicobacter%2520pylori%2520glutamate%2520racemase%2520%2528MurI%2529%253A%2520pyridodiazepine%2520amines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D930%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Riether, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noya-Marino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albaugh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemkow, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grbic, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löbbe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, D.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D. S.</span><span> </span><span class="NLM_article-title">1,4-Diazepane compounds as potent and selective CB2 agonists: optimization of metabolic stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2011</span><span class="NLM_x">–</span> <span class="NLM_lpage">2016</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2011-2016&author=D.+Rietherauthor=L.+Wuauthor=P.+F.+Cirilloauthor=A.+Berryauthor=E.+R.+Walkerauthor=M.+Ermannauthor=B.+Noya-Marinoauthor=J.+E.+Jenkinsauthor=D.+Albaughauthor=C.+Albrechtauthor=M.+Fisherauthor=M.+J.+Gemkowauthor=H.+Grbicauthor=S.+L%C3%B6bbeauthor=C.+M%C3%B6llerauthor=K.+O%E2%80%99Sheaauthor=A.+Sauerauthor=D.-T.+Shihauthor=D.+S.+Thomson&title=1%2C4-Diazepane+compounds+as+potent+and+selective+CB2+agonists%3A+optimization+of+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiether%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DBerry%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DE.%2BR.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DNoya-Marino%26aufirst%3DB.%26aulast%3DJenkins%26aufirst%3DJ.%2BE.%26aulast%3DAlbaugh%26aufirst%3DD.%26aulast%3DAlbrecht%26aufirst%3DC.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DGemkow%26aufirst%3DM.%2BJ.%26aulast%3DGrbic%26aufirst%3DH.%26aulast%3DL%25C3%25B6bbe%26aufirst%3DS.%26aulast%3DM%25C3%25B6ller%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DK.%26aulast%3DSauer%26aufirst%3DA.%26aulast%3DShih%26aufirst%3DD.-T.%26aulast%3DThomson%26aufirst%3DD.%2BS.%26atitle%3D1%252C4-Diazepane%2520compounds%2520as%2520potent%2520and%2520selective%2520CB2%2520agonists%253A%2520optimization%2520of%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D2011%26epage%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atherton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutlib, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiter, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevena, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripp, S. L.</span><span> </span><span class="NLM_article-title">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1954</span><span class="NLM_x">–</span> <span class="NLM_lpage">1965</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700270r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1954-1965&author=A.+S.+Kalgutkarauthor=J.+Driscollauthor=S.+X.+Zhaoauthor=G.+S.+Walkerauthor=R.+M.+Shepardauthor=J.+R.+Sogliaauthor=J.+Athertonauthor=L.+Yuauthor=A.+E.+Mutlibauthor=M.+J.+Munchhofauthor=L.+A.+Reiterauthor=C.+S.+Jonesauthor=J.+L.+Dotyauthor=K.+A.+Trevenaauthor=C.+L.+Shafferauthor=S.+L.+Ripp&title=A+rational+chemical+intervention+strategy+to+circumvent+bioactivation+liabilities+associated+with+a+nonpeptidyl+thrombopoietin+receptor+agonist+containing+a+2-amino-4-arylthiazole+motif"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif</span></div><div class="casAuthors">Kalgutkar, Amit S.; Driscoll, James; Zhao, Sabrina X.; Walker, Gregory S.; Shepard, Richard M.; Soglia, John R.; Atherton, James; Yu, Linning; Mutlib, Abdul E.; Munchhof, Michael J.; Reiter, Lawrence A.; Jones, Christopher S.; Doty, Johnathan L.; Trevena, Kristen A.; Shaffer, Christopher L.; Ripp, Sharon L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1954-1965</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The current study examd. the bioactivation potential of a nonpeptidyl thrombopoietin receptor agonist, 1-(3-chloro-5-((4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-yl)carbamoyl)pyridine-2-yl)piperidine-4-carboxylic acid (1), contg. a 2-carboxamido-4-arylthiazole moiety in the core structure.  Toxicol. risks arising from P 450-catalyzed C4-C5 thiazole ring opening in 1 via the epoxidn. diol sequence were alleviated, since mass spectrometric anal. of human liver microsome and/or hepatocyte incubations of 1 did not reveal the formation of reactive acylthiourea and/or glyoxal metabolites, which are prototypic products derived from thiazole ring scission.  However, 4-(4-fluoro-3-(trifluoromethyl)phenyl)thiazol-2-amine (2), the product of hydrolysis of 1 in human liver microsomes, hepatocytes, and plasma, underwent oxidative bioactivation in human liver microsomes, since trapping studies with glutathione led to the formation of two conjugates derived from the addn. of the thiol nucleophile to 2 and a thiazole-S-oxide metabolite of 2.  Mass spectral fragmentation and NMR anal. indicated that the site of attachment of the glutathionyl moiety in both conjugates was the C5 position in the thiazole ring.  Based on the structures of the glutathione conjugates, two bioactivation pathways are proposed, one involving β-elimination of an initially formed hydroxylamine metabolite and the other involving direct two-electron oxidn. of the electron-rich 2-aminothiazole system to electrophilic intermediates.  This mechanistic insight into the bioactivation process allowed the development of a rational chem. intervention strategy that involved blocking the C5 position with a fluorine atom or replacing the thiazole ring with a 1,2,4-thiadiazole group.  These structural changes not only abrogated the bioactivation liability assocd. with 1 but also resulted in compds. that retained the attractive pharmacol. and pharmacokinetic attributes of the prototype agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxi1Bp9ve-TLVg90H21EOLACvtfcHk0lhakBtg9qzbyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKhtbfM&md5=97c144c6d3c621dcef18a76b63f1806e</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Ftx700270r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700270r%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DDriscoll%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DShepard%26aufirst%3DR.%2BM.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DAtherton%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DReiter%26aufirst%3DL.%2BA.%26aulast%3DJones%26aufirst%3DC.%2BS.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DTrevena%26aufirst%3DK.%2BA.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26atitle%3DA%2520rational%2520chemical%2520intervention%2520strategy%2520to%2520circumvent%2520bioactivation%2520liabilities%2520associated%2520with%2520a%2520nonpeptidyl%2520thrombopoietin%2520receptor%2520agonist%2520containing%2520a%25202-amino-4-arylthiazole%2520motif%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1954%26epage%3D1965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. S.</span><span> </span><span class="NLM_article-title">In vitro metabolism and covalent binding of enol-carboxamide derivatives and anti-inflammatory agents sudoxicam and meloxicam: insights into the hepatotoxicity of sudoxicam</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1890</span><span class="NLM_x">–</span> <span class="NLM_lpage">1899</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800185b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvFSls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1890-1899&author=R.+S.+Obachauthor=A.+S.+Kalgutkarauthor=T.+F.+Ryderauthor=G.+S.+Walker&title=In+vitro+metabolism+and+covalent+binding+of+enol-carboxamide+derivatives+and+anti-inflammatory+agents+sudoxicam+and+meloxicam%3A+insights+into+the+hepatotoxicity+of+sudoxicam"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Metabolism and Covalent Binding of Enol-Carboxamide Derivatives and Anti-Inflammatory Agents Sudoxicam and Meloxicam: Insights into the Hepatotoxicity of Sudoxicam</span></div><div class="casAuthors">Obach, R. Scott; Kalgutkar, Amit S.; Ryder, Tim F.; Walker, Gregory S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1890-1899</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sudoxicam and meloxicam are nonsteroidal anti-inflammatory drugs (NSAIDs) from the enol-carboxamide class.  While the only structural difference between the two NSAIDs is the presence of a Me group on the C5-position of the 2-carboxamidothiazole motif in meloxicam, a marked difference in their toxicol. profile in humans has been discerned.  In clin. trials, sudoxicam was assocd. with several cases of severe hepatotoxicity that led to its discontinuation, while meloxicam has been in the market for over a decade and is devoid of hepatotoxicity.  In an attempt to understand the biochem. basis for the differences in safety profile, an in vitro investigation of the metabolic pathways and covalent binding of the two NSAIDs was conducted in NADPH-supplemented human liver microsomes.  Both compds. demonstrated NADPH-dependent covalent binding to human liver microsomes; however, the extent of binding of [14C]-meloxicam was ∼2-fold greater than that of [14C]-sudoxicam.  While inclusion of glutathione (GSH) in microsomal incubations resulted in a decrease in covalent binding for both NSAIDs, the redn. in binding was more pronounced for meloxicam.  Metabolite identification studies on [14C]-sudoxicam in NADPH-supplemented human liver microsomes indicated that the primary route of metab. involved a P 450-mediated thiazole ring scission to the corresponding acylthiourea metabolite (S3), a well-established pro-toxin.  The mechanism of formation of S3 presumably proceeds via (a) epoxidn. of the C4-C5-thiazole ring double bond, (b) epoxide hydrolysis to the corresponding thiazole-4,5-dihydrodiol deriv., which was obsd. as a stable metabolite (S2), (c) ring opening of the thiazole-4,5-dihydrodiol to an 2-oxoethylidene thiourea intermediate, and (d) hydrolysis of the imine bond within this intermediate to yield S3.  In the case of meloxicam, the corresponding acylthiourea metabolite M3 was also obsd., but to a lesser extent; the main route of meloxicam metab. involved hydroxylation of the 5'-Me group, a finding that is consistent with the known metabolic fate of this NSAID.  Inclusion of GSH led to a decrease in the formation of M3 with the concomitant formation of an unusual two-electron redn. product (metabolite M7).  The formation of M7 is proposed to arise via redn. of the imine bond in 2-oxopropylidene thiourea, an intermediate in the thiazole ring scission pathway in meloxicam.  In conclusion, the results of our anal. suggest that if the covalent binding of the two NSAIDs is important to the overall hepatotoxicity risk, the differences in metab. (differential preponderance of formation of the acylthiourea relative to total metab.), differential effects of GSH on covalent binding, and finally differences in daily doses of the two NSAIDs may serve as a plausible explanation for the marked differences in toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr41ErheTuDvLVg90H21EOLACvtfcHk0ljpai0mOj3lhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvFSls7o%253D&md5=af142bb2df6107277dcbbb82b0907c21</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Ftx800185b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800185b%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DRyder%26aufirst%3DT.%2BF.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26atitle%3DIn%2520vitro%2520metabolism%2520and%2520covalent%2520binding%2520of%2520enol-carboxamide%2520derivatives%2520and%2520anti-inflammatory%2520agents%2520sudoxicam%2520and%2520meloxicam%253A%2520insights%2520into%2520the%2520hepatotoxicity%2520of%2520sudoxicam%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1890%26epage%3D1899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Roth, S. H.</span><span> </span><span class="NLM_article-title">Arthritis therapy: a better time, a better day</span> <span class="citation_source-journal">Rheumatology (Oxford, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1093%2Frheumatology%2F40.6.603" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=11426014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A280%3ADC%252BD3MzmsFeqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=603-606&author=S.+H.+Roth&title=Arthritis+therapy%3A+a+better+time%2C+a+better+day"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Arthritis therapy: a better time, a better day</span></div><div class="casAuthors">Roth S H</div><div class="citationInfo"><span class="NLM_cas:title">Rheumatology (Oxford, England)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">603-6</span>
        ISSN:<span class="NLM_cas:issn">1462-0324</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS27AnCJ_qcAYFEOhA_Im3cfW6udTcc2eaZlMi35mmvBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzmsFeqtw%253D%253D&md5=e0a817946815c16609e655a5f535b922</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1093%2Frheumatology%2F40.6.603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Frheumatology%252F40.6.603%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DS.%2BH.%26atitle%3DArthritis%2520therapy%253A%2520a%2520better%2520time%252C%2520a%2520better%2520day%26jtitle%3DRheumatology%2520%2528Oxford%252C%2520U.%2520K.%2529%26date%3D2001%26volume%3D40%26spage%3D603%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Ahmed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furst, D. E.</span><span> </span><span class="NLM_article-title">Meloxicam in rheumatoid arthritis</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1517%2F17425255.1.4.739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=16863437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1GksL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=739-751&author=M.+Ahmedauthor=D.+Khannaauthor=D.+E.+Furst&title=Meloxicam+in+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Meloxicam in rheumatoid arthritis</span></div><div class="casAuthors">Ahmed, Mansoor; Khanna, Dinesh; Furst, Daniel E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">739-751</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Rheumatoid arthritis (RA), a chronic inflammatory multisystem disorder marked by joint pain, stiffness, swelling and multiple systemic involvements, requires a multifaceted approach for its management.  It includes symptomatic treatment with analgesics as well as disease-modifying medications to alter the course of RA over time.  NSAIDS have been widely used for their symptomatic effects, but their use is not free from adverse effects, which may include life-threatening adverse events such as gastrointestinal (GI) bleeding and perforation.  Meloxicam, an oxicam deriv. that is a member of the enolic acid group of NSAIDs, has recently been approved by the US FDA for use in RA and osteoarthritis.  At the FDA-recommended doses meloxicam is COX-2 preferential.  By virtue of this COX-2 preferential activity it is expected to have lower GI toxicity as compared with COX-2 nonselective NSAIDs.  Clin. trials have shown that meloxicam at 7.5 - 15 mg/day is as effective as diclofenac, piroxicam and naproxen as an anti-inflammatory and analgesic, and was assocd. with fewer GI adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW-OerMn56aLVg90H21EOLACvtfcHk0ljpai0mOj3lhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1GksL%252FM&md5=c88a6d17b9dedba14feec2dc55bdb4d7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.4.739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.4.739%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DKhanna%26aufirst%3DD.%26aulast%3DFurst%26aufirst%3DD.%2BE.%26atitle%3DMeloxicam%2520in%2520rheumatoid%2520arthritis%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D739%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Rostom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldkind, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, L.</span><span> </span><span class="NLM_article-title">Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients</span> <span class="citation_source-journal">Clin. Gastroenterol. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1016%2FS1542-3565%2804%2900777-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=15880319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVWqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=489-498&author=A.+Rostomauthor=L.+Goldkindauthor=L.+Laine&title=Nonsteroidal+anti-inflammatory+drugs+and+hepatic+toxicity%3A+a+systematic+review+of+randomized+controlled+trials+in+arthritis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients</span></div><div class="casAuthors">Rostom, Alaa; Goldkind, Lawrence; Laine, Loren</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">489-498</span>CODEN:
                <span class="NLM_cas:coden">CGHLAW</span>;
        ISSN:<span class="NLM_cas:issn">1542-3565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Nonsteroidal anti-inflammatory drugs (NSAIDs) might cause hepatic side effects, but the frequency of these lab. and clin. side effects is uncertain.  Searches of bibliog. databases MEDLINE and EMBASE and of public archives of the Food and Drug Administration were conducted to identify randomized controlled trials of diclofenac, naproxen, ibuprofen, celecoxib, rofecoxib, valdecoxib, or meloxicam in adults with osteoarthritis or rheumatoid arthritis that provided information on aminotransferase elevations >3× upper limit of normal, liver-related discontinuations, hepatic serious adverse events, liver-related hospitalizations, or liver-related deaths.  The proportion of patients with each of the hepatic toxicity outcomes was calcd. sep. by using sample size weighted pooling for each NSAID.  Sixty-seven articles from the bibliog. database and 65 studies from the Food and Drug Administration archives met inclusion criteria.  Diclofenac (3.55%; 95% confidence interval [CI], 3.21-4.03%) and rofecoxib (1.80%; 95% CI, 1.52-2.13%) had higher rates of aminotransferase >3× upper limit of normal than placebo (0.29; 95% CI, 0.17-0.51) and the other NSAIDs (all ≤ 0.43%).  The 95% Cls for liver-related discontinuations of all NSAIDs except diclofenac (2.17%; 95% CI, 1.78-2.64%) overlapped with placebo.  Only 1 liver-related hospitalization (among 37,671 patients) and 1 liver-related death (among 51,942 patients) occurred, with naproxen.  Diclofenac and rofecoxib had higher rates of aminotransferase elevations than placebo and other NSAIDs studied.  No NSAID studied had increased rates of liver-related serious adverse events, hospitalizations, or deaths.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvFih_b5xkhLVg90H21EOLACvtfcHk0lgQuSrUla5j3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVWqtbc%253D&md5=305d405e9bf758363506343f2ea14665</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2FS1542-3565%2804%2900777-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1542-3565%252804%252900777-3%26sid%3Dliteratum%253Aachs%26aulast%3DRostom%26aufirst%3DA.%26aulast%3DGoldkind%26aufirst%3DL.%26aulast%3DLaine%26aufirst%3DL.%26atitle%3DNonsteroidal%2520anti-inflammatory%2520drugs%2520and%2520hepatic%2520toxicity%253A%2520a%2520systematic%2520review%2520of%2520randomized%2520controlled%2520trials%2520in%2520arthritis%2520patients%26jtitle%3DClin.%2520Gastroenterol.%2520Hepatol.%26date%3D2005%26volume%3D3%26spage%3D489%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: discovery of potent and selective JAK2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1016%2Fj.bmcl.2010.01.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=20144546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitlehsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1669-1673&author=S.+Ioannidisauthor=M.+L.+Lambauthor=L.+Almeidaauthor=H.+Guanauthor=B.+Pengauthor=G.+Bebernitzauthor=K.+Bellauthor=M.+Alimzhanovauthor=M.+Zinda&title=Replacement+of+pyrazol-3-yl+amine+hinge+binder+with+thiazol-2-yl+amine%3A+discovery+of+potent+and+selective+JAK2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: Discovery of potent and selective JAK2 inhibitors</span></div><div class="casAuthors">Ioannidis, Stephanos; Lamb, Michelle L.; Almeida, Lynsie; Guan, Huiping; Peng, Bo; Bebernitz, Geraldine; Bell, Kirsten; Alimzhanov, Marat; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1669-1673</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Thiazol-2-yl amine was identified as an isosteric replacement for pyrazol-3-yl amine during the efforts to identify potent and selective JAK2 inhibitors.  The rationale, synthesis and biol. evaluation of several analogs I (X = N, CH; R1 = MeO, 4-morpholinyl, 4-methyl-1-piperazinyl; R2 = H, F; R3 = Me, CN) is reported, along with the in vivo evaluation of the lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE4-bwWDreyrVg90H21EOLACvtfcHk0lgQuSrUla5j3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitlehsbY%253D&md5=a9b1f0cdc19311aca0a314325a1cbc56</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.091%26sid%3Dliteratum%253Aachs%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DReplacement%2520of%2520pyrazol-3-yl%2520amine%2520hinge%2520binder%2520with%2520thiazol-2-yl%2520amine%253A%2520discovery%2520of%2520potent%2520and%2520selective%2520JAK2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1669%26epage%3D1673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Tremblay, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lescarbeau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austad, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnke, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Diez, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cushing, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGovern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A. C.</span><span> </span><span class="NLM_article-title">Discovery of a potent and orally active Hedgehog pathway antagonist (IPI-926)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4400</span><span class="NLM_x">–</span> <span class="NLM_lpage">4418</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900305z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFygs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4400-4418&author=M.+R.+Tremblayauthor=A.+Lescarbeauauthor=M.+J.+Groganauthor=E.+Tanauthor=G.+Linauthor=B.+C.+Austadauthor=L.-C.+Yuauthor=M.+L.+Behnkeauthor=S.+J.+Nairauthor=M.+Hagelauthor=K.+Whiteauthor=J.+Conleyauthor=J.+D.+Mannaauthor=T.+M.+Alvarez-Diezauthor=J.+Hoytauthor=C.+N.+Woodwardauthor=J.+R.+Sydorauthor=M.+Pinkauthor=J.+MacDougallauthor=M.+J.+Campbellauthor=J.+Cushingauthor=J.+Fergusonauthor=M.+S.+Curtisauthor=K.+McGovernauthor=M.+A.+Readauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=A.+C.+Castro&title=Discovery+of+a+potent+and+orally+active+Hedgehog+pathway+antagonist+%28IPI-926%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)</span></div><div class="casAuthors">Tremblay, Martin R.; Lescarbeau, Andre; Grogan, Michael J.; Tan, Eddy; Lin, Grace; Austad, Brian C.; Yu, Lin-Chen; Behnke, Mark L.; Nair, Somarajan J.; Hagel, Margit; White, Kerry; Conley, James; Manna, Joseph D.; Alvarez-Diez, Teresa M.; Hoyt, Jennifer; Woodward, Caroline N.; Sydor, Jens R.; Pink, Melissa; MacDougall, John; Campbell, Matthew J.; Cushing, Jill; Ferguson, Jeanne; Curtis, Michael S.; McGovern, Karen; Read, Margaret A.; Palombella, Vito J.; Adams, Julian; Castro, Alfredo C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4400-4418</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recent evidence suggests that blocking aberrant hedgehog pathway signaling may be a promising therapeutic strategy for the treatment of several types of cancer.  Cyclopamine, a plant Veratrum alkaloid, is a natural product antagonist of the hedgehog pathway.  In a previous report, a seven-membered D-ring semisynthetic analog of cyclopamine, IPI-269609 (2), was shown to have greater acid stability and better aq. soly. compared to cyclopamine.  Further modifications of the A-ring system generated three series of analogs with improved potency and/or soly.  Lead compds. from each series were characterized in vitro and evaluated in vivo for biol. activity and pharmacokinetic properties.  These studies led to the discovery of IPI-926 (compd. 28), a novel semisynthetic cyclopamine analog with substantially improved pharmaceutical properties and potency and a favorable pharmacokinetic profile relative to cyclopamine and compd. 2.  As a result, complete tumor regression was obsd. in a Hh-dependent medulloblastoma allograft model after daily oral administration of 40 mg/kg of compd. 28.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-f15bWq7kM7Vg90H21EOLACvtfcHk0lgQuSrUla5j3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFygs7g%253D&md5=9455ee5eadb8293fdb3bd5cdec0e5d67</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm900305z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900305z%26sid%3Dliteratum%253Aachs%26aulast%3DTremblay%26aufirst%3DM.%2BR.%26aulast%3DLescarbeau%26aufirst%3DA.%26aulast%3DGrogan%26aufirst%3DM.%2BJ.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DAustad%26aufirst%3DB.%2BC.%26aulast%3DYu%26aufirst%3DL.-C.%26aulast%3DBehnke%26aufirst%3DM.%2BL.%26aulast%3DNair%26aufirst%3DS.%2BJ.%26aulast%3DHagel%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DK.%26aulast%3DConley%26aufirst%3DJ.%26aulast%3DManna%26aufirst%3DJ.%2BD.%26aulast%3DAlvarez-Diez%26aufirst%3DT.%2BM.%26aulast%3DHoyt%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%2BN.%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DMacDougall%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DM.%2BJ.%26aulast%3DCushing%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DJ.%26aulast%3DCurtis%26aufirst%3DM.%2BS.%26aulast%3DMcGovern%26aufirst%3DK.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DA.%2BC.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520orally%2520active%2520Hedgehog%2520pathway%2520antagonist%2520%2528IPI-926%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4400%26epage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><div class="note"><p class="first last">For an example of metabolic ring-opening of an isoxazole ring see the following: </p></div><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, A. D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalvie, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeod, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span> </span><span class="NLM_article-title">In vitro metabolism studies of the isoxazole ring scission in the anti-inflammatory agent leflunomide to its active α-cyanoenol metabolite A771726: mechanistic similarities with cytochrome P450-catalyzed dehydration of aldoximes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">–</span> <span class="NLM_lpage">1250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1240-1250&author=A.+S.+Kalgutkarauthor=H.+T.+Nguyenauthor=A.+D.+N.+Vazauthor=A.+Doanauthor=D.+K.+Dalvieauthor=D.+G.+McLeodauthor=J.+C.+Murray&title=In+vitro+metabolism+studies+of+the+isoxazole+ring+scission+in+the+anti-inflammatory+agent+leflunomide+to+its+active+%CE%B1-cyanoenol+metabolite+A771726%3A+mechanistic+similarities+with+cytochrome+P450-catalyzed+dehydration+of+aldoximes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DVaz%26aufirst%3DA.%2BD.%2BN.%26aulast%3DDoan%26aufirst%3DA.%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DMcLeod%26aufirst%3DD.%2BG.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26atitle%3DIn%2520vitro%2520metabolism%2520studies%2520of%2520the%2520isoxazole%2520ring%2520scission%2520in%2520the%2520anti-inflammatory%2520agent%2520leflunomide%2520to%2520its%2520active%2520%25CE%25B1-cyanoenol%2520metabolite%2520A771726%253A%2520mechanistic%2520similarities%2520with%2520cytochrome%2520P450-catalyzed%2520dehydration%2520of%2520aldoximes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2003%26volume%3D31%26spage%3D1240%26epage%3D1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><div class="note"><p class="first last">For an example where the 1,2,5-oxadiazole ring was unchanged in a metabolism study see the following: </p></div><span class="NLM_contrib-group">Takegoshi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, G.</span><span> </span><span class="NLM_article-title">Steroids. XII. Metabolites of furazabol (17beta -hydroxy-17alpha-methyl-5alpha-androstano[2,3-c]furazan) administered to rats</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1243</span><span class="NLM_x">–</span> <span class="NLM_lpage">1259</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1972&pages=1243-1259&author=T.+Takegoshiauthor=H.+Tachizawaauthor=G.+Ohta&title=Steroids.+XII.+Metabolites+of+furazabol+%2817beta+-hydroxy-17alpha-methyl-5alpha-androstano%5B2%2C3-c%5Dfurazan%29+administered+to+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakegoshi%26aufirst%3DT.%26aulast%3DTachizawa%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DG.%26atitle%3DSteroids.%2520XII.%2520Metabolites%2520of%2520furazabol%2520%252817beta%2520-hydroxy-17alpha-methyl-5alpha-androstano%255B2%252C3-c%255Dfurazan%2529%2520administered%2520to%2520rats%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1972%26volume%3D20%26spage%3D1243%26epage%3D1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Thomson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackaby, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. T.</span><span> </span><span class="NLM_article-title">Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2235</span><span class="NLM_x">–</span> <span class="NLM_lpage">2239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2235-2239&author=J.+L.+Thomsonauthor=W.+P.+Blackabyauthor=A.+S.+R.+Jenningsauthor=S.+C.+Goodacreauthor=A.+Pikeauthor=S.+Thomasauthor=T.+A.+Brownauthor=A.+Smithauthor=G.+Pillaiauthor=L.+J.+Streetauthor=R.+T.+Lewis&title=Optimisation+of+a+series+of+potent%2C+selective+and+orally+bioavailable+GlyT1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DJ.%2BL.%26aulast%3DBlackaby%26aufirst%3DW.%2BP.%26aulast%3DJennings%26aufirst%3DA.%2BS.%2BR.%26aulast%3DGoodacre%26aufirst%3DS.%2BC.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DPillai%26aufirst%3DG.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DLewis%26aufirst%3DR.%2BT.%26atitle%3DOptimisation%2520of%2520a%2520series%2520of%2520potent%252C%2520selective%2520and%2520orally%2520bioavailable%2520GlyT1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2235%26epage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Neitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konradi, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zmolek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorentzen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chereau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yednock, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griswold-Prenner, I.</span><span> </span><span class="NLM_article-title">Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3726</span><span class="NLM_x">–</span> <span class="NLM_lpage">3729</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3726-3729&author=R.+J.+Neitzauthor=A.+W.+Konradiauthor=H.+L.+Shamauthor=W.+Zmolekauthor=K.+Wongauthor=A.+Qinauthor=C.+Lorentzenauthor=D.+Nakamuraauthor=K.+P.+Quinnauthor=J.-M.+Sauerauthor=K.+Powellauthor=L.+Ruslimauthor=D.+Chereauauthor=Z.+Renauthor=J.+Andersonauthor=F.+Bardauthor=T.+A.+Yednockauthor=I.+Griswold-Prenner&title=Highly+selective+c-Jun+N-terminal+kinase+%28JNK%29+3+inhibitors+with+in+vitro+CNS-like+pharmacokinetic+properties+II.+Central+core+replacement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeitz%26aufirst%3DR.%2BJ.%26aulast%3DKonradi%26aufirst%3DA.%2BW.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DZmolek%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DK.%26aulast%3DQin%26aufirst%3DA.%26aulast%3DLorentzen%26aufirst%3DC.%26aulast%3DNakamura%26aufirst%3DD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DSauer%26aufirst%3DJ.-M.%26aulast%3DPowell%26aufirst%3DK.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DChereau%26aufirst%3DD.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DYednock%26aufirst%3DT.%2BA.%26aulast%3DGriswold-Prenner%26aufirst%3DI.%26atitle%3DHighly%2520selective%2520c-Jun%2520N-terminal%2520kinase%2520%2528JNK%2529%25203%2520inhibitors%2520with%2520in%2520vitro%2520CNS-like%2520pharmacokinetic%2520properties%2520II.%2520Central%2520core%2520replacement%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3726%26epage%3D3729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Barber, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakemore, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiva, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastwood, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paradowski, K. A.</span><span> </span><span class="NLM_article-title">1-Amido-1-phenyl-3-piperidinylbutanes—CCR5 antagonists for the treatment of HIV. Part 1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1079</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1075-1079&author=C.+G.+Barberauthor=D.+C.+Blakemoreauthor=J.-Y.+Chivaauthor=R.+L.+Eastwoodauthor=D.+S.+Middletonauthor=K.+A.+Paradowski&title=1-Amido-1-phenyl-3-piperidinylbutanes%E2%80%94CCR5+antagonists+for+the+treatment+of+HIV.+Part+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarber%26aufirst%3DC.%2BG.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DChiva%26aufirst%3DJ.-Y.%26aulast%3DEastwood%26aufirst%3DR.%2BL.%26aulast%3DMiddleton%26aufirst%3DD.%2BS.%26aulast%3DParadowski%26aufirst%3DK.%2BA.%26atitle%3D1-Amido-1-phenyl-3-piperidinylbutanes%25E2%2580%2594CCR5%2520antagonists%2520for%2520the%2520treatment%2520of%2520HIV.%2520Part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1075%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><div class="note"><p class="first last">For an example of metabolic ring-opening of a 1,2,4-oxadiazole ring see the following: </p></div><span class="NLM_contrib-group">Tsalta, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madatian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubert, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardesty, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorycki, P. D.</span><span> </span><span class="NLM_article-title">Metabolism of [<sup>14</sup>C]GSK977779 in rats and its implication with the observed covalent binding</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1620</span><span class="NLM_x">–</span> <span class="NLM_lpage">1632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1620-1632&author=C.+D.+Tsaltaauthor=A.+Madatianauthor=E.+M.+Schubertauthor=F.+Xiaauthor=W.+M.+Hardestyauthor=Y.+Dengauthor=J.+L.+Seymourauthor=P.+D.+Gorycki&title=Metabolism+of+%5B14C%5DGSK977779+in+rats+and+its+implication+with+the+observed+covalent+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsalta%26aufirst%3DC.%2BD.%26aulast%3DMadatian%26aufirst%3DA.%26aulast%3DSchubert%26aufirst%3DE.%2BM.%26aulast%3DXia%26aufirst%3DF.%26aulast%3DHardesty%26aufirst%3DW.%2BM.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DSeymour%26aufirst%3DJ.%2BL.%26aulast%3DGorycki%26aufirst%3DP.%2BD.%26atitle%3DMetabolism%2520of%2520%255B14C%255DGSK977779%2520in%2520rats%2520and%2520its%2520implication%2520with%2520the%2520observed%2520covalent%2520binding%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1620%26epage%3D1632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><div class="note"><p class="first last">Metabolic ring opening of 2-amino-1,3,4-oxadiazole at the C–O bond has been observed: </p></div><span class="NLM_contrib-group">Maciolek, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laliberte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bateman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krolikowski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, C. R.</span><span> </span><span class="NLM_article-title">Novel cytochrome P450-mediated ring opening of the 1,3,4-oxadiazole in setileuton, a 5-lipoxygenase inhibitor</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=763-770&author=C.+M.+Maciolekauthor=B.+Maauthor=K.+Menzelauthor=S.+Laliberteauthor=K.+Batemanauthor=P.+Krolikowskiauthor=C.+R.+Gibson&title=Novel+cytochrome+P450-mediated+ring+opening+of+the+1%2C3%2C4-oxadiazole+in+setileuton%2C+a+5-lipoxygenase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaciolek%26aufirst%3DC.%2BM.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DMenzel%26aufirst%3DK.%26aulast%3DLaliberte%26aufirst%3DS.%26aulast%3DBateman%26aufirst%3DK.%26aulast%3DKrolikowski%26aufirst%3DP.%26aulast%3DGibson%26aufirst%3DC.%2BR.%26atitle%3DNovel%2520cytochrome%2520P450-mediated%2520ring%2520opening%2520of%2520the%25201%252C3%252C4-oxadiazole%2520in%2520setileuton%252C%2520a%25205-lipoxygenase%2520inhibitor%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D763%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Nordhoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerezo-Gálvez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann-Enger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Canet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rummey, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiemann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feurer, A.</span><span> </span><span class="NLM_article-title">The design of potent and selective inhibitors of DPP-4: optimization of ADME properties by amide replacements</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6340</span><span class="NLM_x">–</span> <span class="NLM_lpage">6345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6340-6345&author=S.+Nordhoffauthor=S.+Bulatauthor=S.+Cerezo-G%C3%A1lvezauthor=O.+Hillauthor=B.+Hoffmann-Engerauthor=M.+L%C3%B3pez-Canetauthor=C.+Rosenbaumauthor=C.+Rummeyauthor=M.+Thiemannauthor=V.+G.+Matassaauthor=P.+J.+Edwardsauthor=A.+Feurer&title=The+design+of+potent+and+selective+inhibitors+of+DPP-4%3A+optimization+of+ADME+properties+by+amide+replacements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNordhoff%26aufirst%3DS.%26aulast%3DBulat%26aufirst%3DS.%26aulast%3DCerezo-G%25C3%25A1lvez%26aufirst%3DS.%26aulast%3DHill%26aufirst%3DO.%26aulast%3DHoffmann-Enger%26aufirst%3DB.%26aulast%3DL%25C3%25B3pez-Canet%26aufirst%3DM.%26aulast%3DRosenbaum%26aufirst%3DC.%26aulast%3DRummey%26aufirst%3DC.%26aulast%3DThiemann%26aufirst%3DM.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26aulast%3DFeurer%26aufirst%3DA.%26atitle%3DThe%2520design%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520DPP-4%253A%2520optimization%2520of%2520ADME%2520properties%2520by%2520amide%2520replacements%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6340%26epage%3D6345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Eastwood, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonquerna, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiguade, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carranco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenech, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miralpeix, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordoba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pont, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godessart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prats, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadavid, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nueda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, B.</span><span> </span><span class="NLM_article-title">Discovery of LAS101057: a potent, selective, and orally efficacious A2B adenosine receptor antagonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100249e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=213-218&author=P.+Eastwoodauthor=C.+Esteveauthor=J.+Gonzalezauthor=S.+Fonquernaauthor=J.+Aiguadeauthor=I.+Carrancoauthor=T.+Domenechauthor=M.+Apariciauthor=M.+Miralpeixauthor=J.+Albertiauthor=M.+Cordobaauthor=R.+Fernandezauthor=M.+Pontauthor=N.+Godessartauthor=N.+Pratsauthor=M.+I.+Lozaauthor=M.+I.+Cadavidauthor=A.+Nuedaauthor=B.+Vidal&title=Discovery+of+LAS101057%3A+a+potent%2C+selective%2C+and+orally+efficacious+A2B+adenosine+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fml100249e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100249e%26sid%3Dliteratum%253Aachs%26aulast%3DEastwood%26aufirst%3DP.%26aulast%3DEsteve%26aufirst%3DC.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DFonquerna%26aufirst%3DS.%26aulast%3DAiguade%26aufirst%3DJ.%26aulast%3DCarranco%26aufirst%3DI.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DAparici%26aufirst%3DM.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DAlberti%26aufirst%3DJ.%26aulast%3DCordoba%26aufirst%3DM.%26aulast%3DFernandez%26aufirst%3DR.%26aulast%3DPont%26aufirst%3DM.%26aulast%3DGodessart%26aufirst%3DN.%26aulast%3DPrats%26aufirst%3DN.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DNueda%26aufirst%3DA.%26aulast%3DVidal%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520LAS101057%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520A2B%2520adenosine%2520receptor%2520antagonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D213%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Ishida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umehara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajita, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuse, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiyoi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span> </span><span class="NLM_article-title">Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5472</span><span class="NLM_x">–</span> <span class="NLM_lpage">5477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5472-5477&author=H.+Ishidaauthor=S.+Isamiauthor=T.+Matsumuraauthor=H.+Umeharaauthor=Y.+Yamashitaauthor=J.+Kajitaauthor=E.+Fuseauthor=H.+Kiyoiauthor=T.+Naoeauthor=S.+Akinagaauthor=Y.+Shiotsuauthor=H.+Arai&title=Novel+and+orally+active+5-%281%2C3%2C4-oxadiazol-2-yl%29pyrimidine+derivatives+as+selective+FLT3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DIsami%26aufirst%3DS.%26aulast%3DMatsumura%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DH.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DKajita%26aufirst%3DJ.%26aulast%3DFuse%26aufirst%3DE.%26aulast%3DKiyoi%26aufirst%3DH.%26aulast%3DNaoe%26aufirst%3DT.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DNovel%2520and%2520orally%2520active%25205-%25281%252C3%252C4-oxadiazol-2-yl%2529pyrimidine%2520derivatives%2520as%2520selective%2520FLT3%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5472%26epage%3D5477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Bailey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farre-Gutierrez, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayhow, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutley, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seow, H.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takle, A. K.</span><span> </span><span class="NLM_article-title">Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-<i>a</i>]pyridine acid pump antagonists (APAs)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3602</span><span class="NLM_x">–</span> <span class="NLM_lpage">3606</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3602-3606&author=N.+Baileyauthor=M.+J.+Bamfordauthor=D.+Brissyauthor=J.+Brookfieldauthor=E.+Demontauthor=R.+Elliottauthor=N.+Gartonauthor=I.+Farre-Gutierrezauthor=T.+Hayhowauthor=G.+Hutleyauthor=A.+Naylorauthor=T.+A.+Panchalauthor=H.-X.+Seowauthor=D.+Spaldingauthor=A.+K.+Takle&title=Orally+active+C-6+heteroaryl-+and+heterocyclyl-substituted+imidazo%5B1%2C2-a%5Dpyridine+acid+pump+antagonists+%28APAs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBailey%26aufirst%3DN.%26aulast%3DBamford%26aufirst%3DM.%2BJ.%26aulast%3DBrissy%26aufirst%3DD.%26aulast%3DBrookfield%26aufirst%3DJ.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DElliott%26aufirst%3DR.%26aulast%3DGarton%26aufirst%3DN.%26aulast%3DFarre-Gutierrez%26aufirst%3DI.%26aulast%3DHayhow%26aufirst%3DT.%26aulast%3DHutley%26aufirst%3DG.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DPanchal%26aufirst%3DT.%2BA.%26aulast%3DSeow%26aufirst%3DH.-X.%26aulast%3DSpalding%26aufirst%3DD.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26atitle%3DOrally%2520active%2520C-6%2520heteroaryl-%2520and%2520heterocyclyl-substituted%2520imidazo%255B1%252C2-a%255Dpyridine%2520acid%2520pump%2520antagonists%2520%2528APAs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3602%26epage%3D3606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Gao, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim-Riether, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amodeo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">August, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccarelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haverty, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill-Drzewi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margarit, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaraja, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proudfoot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellenzohn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedenmayer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrow, N. A.</span><span> </span><span class="NLM_article-title">SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5039</span><span class="NLM_x">–</span> <span class="NLM_lpage">5043</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5039-5043&author=D.+A.+Gaoauthor=Z.+Xiongauthor=A.+Heim-Rietherauthor=L.+Amodeoauthor=E.+M.+Augustauthor=X.+Caoauthor=L.+Ciccarelliauthor=B.+K.+Collinsauthor=K.+Harringtonauthor=K.+Havertyauthor=M.+Hill-Drzewiauthor=X.+Liauthor=S.+Liangauthor=S.+M.+Margaritauthor=N.+Mossauthor=N.+Nagarajaauthor=J.+Proudfootauthor=R.+Romanauthor=S.+Schlyerauthor=L.+S.+Keenanauthor=S.+Taylorauthor=B.+Wellenzohnauthor=D.+Wiedenmayerauthor=J.+Liauthor=N.+A.+Farrow&title=SAR+studies+of+non-zinc-chelating+MMP-13+inhibitors%3A+improving+selectivity+and+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DD.%2BA.%26aulast%3DXiong%26aufirst%3DZ.%26aulast%3DHeim-Riether%26aufirst%3DA.%26aulast%3DAmodeo%26aufirst%3DL.%26aulast%3DAugust%26aufirst%3DE.%2BM.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DCiccarelli%26aufirst%3DL.%26aulast%3DCollins%26aufirst%3DB.%2BK.%26aulast%3DHarrington%26aufirst%3DK.%26aulast%3DHaverty%26aufirst%3DK.%26aulast%3DHill-Drzewi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DMargarit%26aufirst%3DS.%2BM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DNagaraja%26aufirst%3DN.%26aulast%3DProudfoot%26aufirst%3DJ.%26aulast%3DRoman%26aufirst%3DR.%26aulast%3DSchlyer%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DL.%2BS.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWellenzohn%26aufirst%3DB.%26aulast%3DWiedenmayer%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DFarrow%26aufirst%3DN.%2BA.%26atitle%3DSAR%2520studies%2520of%2520non-zinc-chelating%2520MMP-13%2520inhibitors%253A%2520improving%2520selectivity%2520and%2520metabolic%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5039%26epage%3D5043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Morwick, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büttner, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplita, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paw, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, C.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, E.</span><span> </span><span class="NLM_article-title">Hit to lead account of the discovery of bisbenzamide and related ureidobenzamide inhibitors of Rho kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9014263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=759-777&author=T.+Morwickauthor=F.+H.+B%C3%BCttnerauthor=C.+L.+Cywinauthor=G.+Dahmannauthor=E.+Hickeyauthor=S.+Jakesauthor=P.+Kaplitaauthor=M.+A.+Kashemauthor=S.+Kerrauthor=S.+Kuglerauthor=W.+Maoauthor=D.+Marshallauthor=Z.+Pawauthor=C.-K.+Shihauthor=F.+Wuauthor=E.+Young&title=Hit+to+lead+account+of+the+discovery+of+bisbenzamide+and+related+ureidobenzamide+inhibitors+of+Rho+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm9014263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014263%26sid%3Dliteratum%253Aachs%26aulast%3DMorwick%26aufirst%3DT.%26aulast%3DB%25C3%25BCttner%26aufirst%3DF.%2BH.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DDahmann%26aufirst%3DG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKaplita%26aufirst%3DP.%26aulast%3DKashem%26aufirst%3DM.%2BA.%26aulast%3DKerr%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DPaw%26aufirst%3DZ.%26aulast%3DShih%26aufirst%3DC.-K.%26aulast%3DWu%26aufirst%3DF.%26aulast%3DYoung%26aufirst%3DE.%26atitle%3DHit%2520to%2520lead%2520account%2520of%2520the%2520discovery%2520of%2520bisbenzamide%2520and%2520related%2520ureidobenzamide%2520inhibitors%2520of%2520Rho%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D759%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Ceccarelli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlotterbeck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boissin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettelmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanlon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolczewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupfer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stampfli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span> </span><span class="NLM_article-title">Metabolite identification via LC-SPE-NMR-MS of the in vitro biooxidation products of a lead mGlu5 allosteric antagonist and impact on the improvement of metabolic stability in the series</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=136-144&author=S.+M.+Ceccarelliauthor=G.+Schlotterbeckauthor=P.+Boissinauthor=M.+Binderauthor=B.+Buettelmannauthor=S.+Hanlonauthor=G.+Jaeschkeauthor=S.+Kolczewskiauthor=E.+Kupferauthor=J.-U.+Petersauthor=R.+H.+P.+Porterauthor=E.+P.+Prinssenauthor=M.+Rueherauthor=I.+Rufauthor=W.+Spoorenauthor=A.+Stampfliauthor=E.+Vieira&title=Metabolite+identification+via+LC-SPE-NMR-MS+of+the+in+vitro+biooxidation+products+of+a+lead+mGlu5+allosteric+antagonist+and+impact+on+the+improvement+of+metabolic+stability+in+the+series"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCeccarelli%26aufirst%3DS.%2BM.%26aulast%3DSchlotterbeck%26aufirst%3DG.%26aulast%3DBoissin%26aufirst%3DP.%26aulast%3DBinder%26aufirst%3DM.%26aulast%3DBuettelmann%26aufirst%3DB.%26aulast%3DHanlon%26aufirst%3DS.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DKupfer%26aufirst%3DE.%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26aulast%3DPrinssen%26aufirst%3DE.%2BP.%26aulast%3DRueher%26aufirst%3DM.%26aulast%3DRuf%26aufirst%3DI.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DStampfli%26aufirst%3DA.%26aulast%3DVieira%26aufirst%3DE.%26atitle%3DMetabolite%2520identification%2520via%2520LC-SPE-NMR-MS%2520of%2520the%2520in%2520vitro%2520biooxidation%2520products%2520of%2520a%2520lead%2520mGlu5%2520allosteric%2520antagonist%2520and%2520impact%2520on%2520the%2520improvement%2520of%2520metabolic%2520stability%2520in%2520the%2520series%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D136%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preville, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohrt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, P.</span><span> </span><span class="NLM_article-title">Intrinsic electrophilicity of a 4-substituted-5-cyano-6-(2-methylpyridin-3-yloxy)pyrimidine derivative: structural characterization of glutathione conjugates in vitro</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx100429x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=269-278&author=A.+S.+Kalgutkarauthor=V.+Mascittiauthor=R.+Sharmaauthor=G.+W.+Walkerauthor=T.+Ryderauthor=T.+S.+McDonaldauthor=Y.+Chenauthor=C.+Previlleauthor=A.+Basakauthor=K.+F.+McClureauthor=J.+T.+Kohrtauthor=R.+P.+Robinsonauthor=M.+J.+Munchhofauthor=P.+Cornelius&title=Intrinsic+electrophilicity+of+a+4-substituted-5-cyano-6-%282-methylpyridin-3-yloxy%29pyrimidine+derivative%3A+structural+characterization+of+glutathione+conjugates+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Ftx100429x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx100429x%26sid%3Dliteratum%253Aachs%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DG.%2BW.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DMcDonald%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DPreville%26aufirst%3DC.%26aulast%3DBasak%26aufirst%3DA.%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DKohrt%26aufirst%3DJ.%2BT.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DCornelius%26aufirst%3DP.%26atitle%3DIntrinsic%2520electrophilicity%2520of%2520a%25204-substituted-5-cyano-6-%25282-methylpyridin-3-yloxy%2529pyrimidine%2520derivative%253A%2520structural%2520characterization%2520of%2520glutathione%2520conjugates%2520in%2520vitro%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26spage%3D269%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">McClure, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darout, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes, C. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNinno, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascitti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohrt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samp, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futatsugi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornelius, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Activation of the G-protein-coupled receptor 119: a conformation-based hypothesis for understanding agonist response</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1948</span><span class="NLM_x">–</span> <span class="NLM_lpage">1952</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200003p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1948-1952&author=K.+F.+McClureauthor=E.+Daroutauthor=C.+R.+W.+Guimaraesauthor=M.+P.+DeNinnoauthor=V.+Mascittiauthor=M.+J.+Munchhofauthor=R.+P.+Robinsonauthor=J.+Kohrtauthor=A.+R.+Harrisauthor=D.+E.+Mooreauthor=B.+Liauthor=L.+Sampauthor=B.+A.+Lefkerauthor=K.+Futatsugiauthor=D.+Kungauthor=P.+D.+Boninauthor=P.+Corneliusauthor=R.-D.+Wangauthor=E.+Salterauthor=S.+Hornbyauthor=A.+S.+Kalgutkarauthor=Y.+Chen&title=Activation+of+the+G-protein-coupled+receptor+119%3A+a+conformation-based+hypothesis+for+understanding+agonist+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm200003p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200003p%26sid%3Dliteratum%253Aachs%26aulast%3DMcClure%26aufirst%3DK.%2BF.%26aulast%3DDarout%26aufirst%3DE.%26aulast%3DGuimaraes%26aufirst%3DC.%2BR.%2BW.%26aulast%3DDeNinno%26aufirst%3DM.%2BP.%26aulast%3DMascitti%26aufirst%3DV.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26aulast%3DKohrt%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DA.%2BR.%26aulast%3DMoore%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DSamp%26aufirst%3DL.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DFutatsugi%26aufirst%3DK.%26aulast%3DKung%26aufirst%3DD.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DCornelius%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DR.-D.%26aulast%3DSalter%26aufirst%3DE.%26aulast%3DHornby%26aufirst%3DS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DActivation%2520of%2520the%2520G-protein-coupled%2520receptor%2520119%253A%2520a%2520conformation-based%2520hypothesis%2520for%2520understanding%2520agonist%2520response%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1948%26epage%3D1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Hartz, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvanitis, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafalski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditta, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deskus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molski, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian-Cutrone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span> </span><span class="NLM_article-title">Synthesis, structure–activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4173</span><span class="NLM_x">–</span> <span class="NLM_lpage">4191</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900301y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4173-4191&author=R.+A.+Hartzauthor=V.+T.+Ahujaauthor=A.+G.+Arvanitisauthor=M.+Rafalskiauthor=E.+W.+Yueauthor=D.+J.+Denhartauthor=W.+D.+Schmitzauthor=J.+L.+Dittaauthor=J.+A.+Deskusauthor=A.+B.+Brennerauthor=F.+W.+Hobbsauthor=J.+Payneauthor=S.+Lelasauthor=Y.-W.+Liauthor=T.+F.+Molskiauthor=G.+K.+Mattsonauthor=Y.+Pengauthor=H.+Wongauthor=J.+E.+Graceauthor=K.+A.+Lentzauthor=J.+Qian-Cutroneauthor=X.+Zhuoauthor=Y.-Z.+Shuauthor=N.+J.+Lodgeauthor=R.+Zaczekauthor=A.+P.+Combsauthor=R.+E.+Olsonauthor=J.+J.+Bronsonauthor=R.+J.+Mattsonauthor=J.+E.+Macor&title=Synthesis%2C+structure%E2%80%93activity+relationships%2C+and+in+vivo+evaluation+of+N3-phenylpyrazinones+as+novel+corticotropin-releasing+factor-1+%28CRF1%29+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm900301y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900301y%26sid%3Dliteratum%253Aachs%26aulast%3DHartz%26aufirst%3DR.%2BA.%26aulast%3DAhuja%26aufirst%3DV.%2BT.%26aulast%3DArvanitis%26aufirst%3DA.%2BG.%26aulast%3DRafalski%26aufirst%3DM.%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DDenhart%26aufirst%3DD.%2BJ.%26aulast%3DSchmitz%26aufirst%3DW.%2BD.%26aulast%3DDitta%26aufirst%3DJ.%2BL.%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DBrenner%26aufirst%3DA.%2BB.%26aulast%3DHobbs%26aufirst%3DF.%2BW.%26aulast%3DPayne%26aufirst%3DJ.%26aulast%3DLelas%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.-W.%26aulast%3DMolski%26aufirst%3DT.%2BF.%26aulast%3DMattson%26aufirst%3DG.%2BK.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DQian-Cutrone%26aufirst%3DJ.%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DShu%26aufirst%3DY.-Z.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DSynthesis%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520and%2520in%2520vivo%2520evaluation%2520of%2520N3-phenylpyrazinones%2520as%2520novel%2520corticotropin-releasing%2520factor-1%2520%2528CRF1%2529%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4173%26epage%3D4191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Zhuo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartz, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrudhula, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leet, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, Y.-Z.</span><span> </span><span class="NLM_article-title">Comparative biotransformation of pyrazinone-containing corticotropin-releasing factor receptor-1 antagonists: minimizing the reactive metabolite formation</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm300343m&amp;key=10.1124%2Fdmd.109.028910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm300343m&amp;key=19833844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1aru7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=5-15&author=X.+Zhuoauthor=R.+A.+Hartzauthor=J.+J.+Bronsonauthor=H.+Wongauthor=V.+T.+Ahujaauthor=V.+M.+Vrudhulaauthor=J.+E.+Leetauthor=S.+Huangauthor=J.+E.+Macorauthor=Y.-Z.+Shu&title=Comparative+biotransformation+of+pyrazinone-containing+corticotropin-releasing+factor+receptor-1+antagonists%3A+minimizing+the+reactive+metabolite+formation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative biotransformation of pyrazinone-containing corticotropin-releasing factor receptor-1 antagonists: minimizing the reactive metabolite formation</span></div><div class="casAuthors">Zhuo, Xiaoliang; Hartz, Richard A.; Bronson, Joanne J.; Wong, Harvey; Ahuja, Vijay T.; Vrudhula, Vivekananda M.; Leet, John E.; Huang, Stella; Macor, John E.; Shu, Yue-Zhong</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-15</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(S)-5-Chloro-1-(1-cyclopropylethyl)-3-(2,6-dichloro-4-(trifluoromethyl)-phenylamino)pyrazin-2(1H)-one (BMS-665053), a pyrazinone-contg. compd., is a potent and selective antagonist of corticotropin-releasing factor receptor-1 (CRF-R1) that showed efficacy in the defensive withdrawal model for anxiety in rats, suggesting its use as a potential treatment for anxiety and depression.  In vitro metab. studies of BMS-665053 in rat and human liver microsomes revealed cytochrome P 450-mediated oxidn. of the pyrazinone moiety, followed by ring opening, as the primary metabolic pathway.  Detection of a series of GSH adducts in trapping expts. suggested the formation of a reactive intermediate, probably as a result of epoxidn. of the pyrazinone moiety.  In addn., BMS-665053 (20 mg/kg i.v.) underwent extensive metab. in bile duct-cannulated (BDC) rats.  The major drug-related materials in rat plasma were the pyrazinone oxidn. products.  In rat bile and urine (0-7 h), only a trace amt. of the parent drug was recovered, whereas significant levels of the pyrazinone epoxide-derived metabolites and GSH-related conjugates were detected.  Further evidence suggested that GSH-related conjugates also formed at the dichloroarylamine moiety possibly via an epoxide or a quinone imine intermediate.  Other major metabolites in BDC rat bile and urine included glucuronide conjugates.  To reduce potential liability due to metabolic activation of BMS-665053, a no. of pyrazinone analogs with different substituents were synthesized and investigated for reactive metabolite formation, leading to the discovery of a CRF-R1 antagonist with diminished in vitro metabolic activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKSmCnHe221LVg90H21EOLACvtfcHk0lhfqe8OzOlALA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1aru7fE&md5=ce4d9c5f99f96cbc018968130b068e81</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.028910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.028910%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DHartz%26aufirst%3DR.%2BA.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DAhuja%26aufirst%3DV.%2BT.%26aulast%3DVrudhula%26aufirst%3DV.%2BM.%26aulast%3DLeet%26aufirst%3DJ.%2BE.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26aulast%3DShu%26aufirst%3DY.-Z.%26atitle%3DComparative%2520biotransformation%2520of%2520pyrazinone-containing%2520corticotropin-releasing%2520factor%2520receptor-1%2520antagonists%253A%2520minimizing%2520the%2520reactive%2520metabolite%2520formation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D5%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Hartz, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafalski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ditta, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deskus, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvanitis, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molski, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grace, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaczek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macor, J. E.</span><span> </span><span class="NLM_article-title">In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4161</span><span class="NLM_x">–</span> <span class="NLM_lpage">4172</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900302q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm300343m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXns1Ogurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4161-4172&author=R.+A.+Hartzauthor=V.+T.+Ahujaauthor=M.+Rafalskiauthor=W.+D.+Schmitzauthor=A.+B.+Brennerauthor=D.+J.+Denhartauthor=J.+L.+Dittaauthor=J.+A.+Deskusauthor=E.+W.+Yueauthor=A.+G.+Arvanitisauthor=S.+Lelasauthor=Y.-W.+Liauthor=T.+F.+Molskiauthor=H.+Wongauthor=J.+E.+Graceauthor=K.+A.+Lentzauthor=J.+Liauthor=N.+J.+Lodgeauthor=R.+Zaczekauthor=A.+P.+Combsauthor=R.+E.+Olsonauthor=R.+J.+Mattsonauthor=J.+J.+Bronsonauthor=J.+E.+Macor&title=In+vitro+intrinsic+clearance-based+optimization+of+N3-phenylpyrazinones+as+corticotropin-releasing+factor-1+%28CRF1%29+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Intrinsic Clearance-Based Optimization of N3-Phenylpyrazinones as Corticotropin-Releasing Factor-1 (CRF1) Receptor Antagonists</span></div><div class="casAuthors">Hartz, Richard A.; Ahuja, Vijay T.; Rafalski, Maria; Schmitz, William D.; Brenner, Allison B.; Denhart, Derek J.; Ditta, Jonathan L.; Deskus, Jeffrey A.; Yue, Eddy W.; Arvanitis, Argyrios G.; Lelas, Snjezana; Li, Yu-Wen; Molski, Thaddeus F.; Wong, Harvey; Grace, James E.; Lentz, Kimberley A.; Li, Jianqing; Lodge, Nicholas J.; Zaczek, Robert; Combs, Andrew P.; Olson, Richard E.; Mattson, Ronald J.; Bronson, Joanne J.; Macor, John E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4161-4172</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of pyrazinone-based heterocycles was identified as potent and orally active corticotropin-releasing factor-1 (CRF1) receptor antagonists.  Selected compds., e.g. I, proved efficacious in an anxiety model in rats; however, pharmacokinetic properties were not optimal.  In this article, an in vitro intrinsic clearance-based approach is described to the optimization of pyrazinone-based CRF1 receptor antagonists wherein sites of metab. were identified by incubation with human liver microsomes.  It was found that the rate of metab. could be decreased by incorporation of appropriate substituents at the primary sites of metab.  This led to the discovery of I, a highly potent (IC50 = 1.0 nM) and selective CRF1 receptor antagonist with good oral bioavailability (F = 52%) in rats and efficacy in the defensive withdrawal anxiety test in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSxtlvZCt7vrVg90H21EOLACvtfcHk0lhfqe8OzOlALA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXns1Ogurk%253D&md5=9ed4f4c2001a832dcb9fdcceb6ce0067</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm900302q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900302q%26sid%3Dliteratum%253Aachs%26aulast%3DHartz%26aufirst%3DR.%2BA.%26aulast%3DAhuja%26aufirst%3DV.%2BT.%26aulast%3DRafalski%26aufirst%3DM.%26aulast%3DSchmitz%26aufirst%3DW.%2BD.%26aulast%3DBrenner%26aufirst%3DA.%2BB.%26aulast%3DDenhart%26aufirst%3DD.%2BJ.%26aulast%3DDitta%26aufirst%3DJ.%2BL.%26aulast%3DDeskus%26aufirst%3DJ.%2BA.%26aulast%3DYue%26aufirst%3DE.%2BW.%26aulast%3DArvanitis%26aufirst%3DA.%2BG.%26aulast%3DLelas%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DY.-W.%26aulast%3DMolski%26aufirst%3DT.%2BF.%26aulast%3DWong%26aufirst%3DH.%26aulast%3DGrace%26aufirst%3DJ.%2BE.%26aulast%3DLentz%26aufirst%3DK.%2BA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLodge%26aufirst%3DN.%2BJ.%26aulast%3DZaczek%26aufirst%3DR.%26aulast%3DCombs%26aufirst%3DA.%2BP.%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMattson%26aufirst%3DR.%2BJ.%26aulast%3DBronson%26aufirst%3DJ.%2BJ.%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26atitle%3DIn%2520vitro%2520intrinsic%2520clearance-based%2520optimization%2520of%2520N3-phenylpyrazinones%2520as%2520corticotropin-releasing%2520factor-1%2520%2528CRF1%2529%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4161%26epage%3D4172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Marriott, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taft, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topsom, R. D.</span><span> </span><span class="NLM_article-title">Substituent electronegativity parameters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">959</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00180a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=959-965&author=S.+Marriottauthor=W.+F.+Reynoldsauthor=R.+W.+Taftauthor=R.+D.+Topsom&title=Substituent+electronegativity+parameters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjo00180a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00180a002%26sid%3Dliteratum%253Aachs%26aulast%3DMarriott%26aufirst%3DS.%26aulast%3DReynolds%26aufirst%3DW.%2BF.%26aulast%3DTaft%26aufirst%3DR.%2BW.%26aulast%3DTopsom%26aufirst%3DR.%2BD.%26atitle%3DSubstituent%2520electronegativity%2520parameters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D959%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Ceppi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckhardt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, C. A.</span><span> </span><span class="NLM_article-title">4-Substituted quinuclidinium perchlorates in the determination of polar substituent effects</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_fpage">3627</span><span class="NLM_x">–</span> <span class="NLM_lpage">3630</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&pages=3627-3630&author=E.+Ceppiauthor=W.+Eckhardtauthor=C.+A.+Grob&title=4-Substituted+quinuclidinium+perchlorates+in+the+determination+of+polar+substituent+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCeppi%26aufirst%3DE.%26aulast%3DEckhardt%26aufirst%3DW.%26aulast%3DGrob%26aufirst%3DC.%2BA.%26atitle%3D4-Substituted%2520quinuclidinium%2520perchlorates%2520in%2520the%2520determination%2520of%2520polar%2520substituent%2520effects%26jtitle%3DTetrahedron%2520Lett.%26date%3D1973%26spage%3D3627%26epage%3D3630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Bannwart, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choy, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenhouse, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaime-Figueroa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madera, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozboya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raptova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roetz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenfeld, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weikert, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span> </span><span class="NLM_article-title">Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6062</span><span class="NLM_x">–</span> <span class="NLM_lpage">6066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6062-6066&author=L.+M.+Bannwartauthor=D.+S.+Carterauthor=H.-Y.+Caiauthor=J.+C.+Choyauthor=R.+Greenhouseauthor=S.+Jaime-Figueroaauthor=P.+S.+Iyerauthor=C.+J.+Linauthor=E.+K.+Leeauthor=M.+C.+Lucasauthor=S.+M.+Lynchauthor=A.+M.+Maderaauthor=A.+Mooreauthor=K.+Ozboyaauthor=L.+Raptovaauthor=R.+Roetzauthor=R.+C.+Schoenfeldauthor=K.+A.+Steinauthor=S.+Steinerauthor=M.+Villaauthor=R.+J.+Weikertauthor=Y.+Zhai&title=Novel+3%2C3-disubstituted+pyrrolidines+as+selective+triple+serotonin%2Fnorepinephrine%2Fdopamine+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBannwart%26aufirst%3DL.%2BM.%26aulast%3DCarter%26aufirst%3DD.%2BS.%26aulast%3DCai%26aufirst%3DH.-Y.%26aulast%3DChoy%26aufirst%3DJ.%2BC.%26aulast%3DGreenhouse%26aufirst%3DR.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DLin%26aufirst%3DC.%2BJ.%26aulast%3DLee%26aufirst%3DE.%2BK.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26aulast%3DLynch%26aufirst%3DS.%2BM.%26aulast%3DMadera%26aufirst%3DA.%2BM.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DOzboya%26aufirst%3DK.%26aulast%3DRaptova%26aufirst%3DL.%26aulast%3DRoetz%26aufirst%3DR.%26aulast%3DSchoenfeld%26aufirst%3DR.%2BC.%26aulast%3DStein%26aufirst%3DK.%2BA.%26aulast%3DSteiner%26aufirst%3DS.%26aulast%3DVilla%26aufirst%3DM.%26aulast%3DWeikert%26aufirst%3DR.%2BJ.%26aulast%3DZhai%26aufirst%3DY.%26atitle%3DNovel%25203%252C3-disubstituted%2520pyrrolidines%2520as%2520selective%2520triple%2520serotonin%252Fnorepinephrine%252Fdopamine%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6062%26epage%3D6066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Wishka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanchar, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornburgh, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E. H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staton, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raub, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sands, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soglia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(3<i>R</i>)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide, an agonist of the alpha 7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure–activity relationship</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4425</span><span class="NLM_x">–</span> <span class="NLM_lpage">4436</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0602413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4425-4436&author=D.+G.+Wishkaauthor=D.+P.+Walkerauthor=K.+M.+Yatesauthor=S.+C.+Reitzauthor=S.+Jiaauthor=J.+K.+Myersauthor=K.+L.+Olsonauthor=E.+J.+Jacobsenauthor=M.+L.+Wolfeauthor=V.+E.+Groppiauthor=A.+J.+Hancharauthor=B.+A.+Thornburghauthor=L.+A.+Cortes-Burgosauthor=E.+H.+F.+Wongauthor=B.+A.+Statonauthor=T.+J.+Raubauthor=N.+R.+Higdonauthor=T.+M.+Wallauthor=R.+S.+Hurstauthor=R.+R.+Waltersauthor=W.+E.+Hoffmannauthor=M.+Hajosauthor=S.+Franklinauthor=G.+Careyauthor=L.+H.+Goldauthor=K.+K.+Cookauthor=S.+B.+Sandsauthor=S.+X.+Zhaoauthor=J.+R.+Sogliaauthor=A.+S.+Kalgutkarauthor=S.+P.+Arnericauthor=B.+N.+Rogers&title=Discovery+of+N-%5B%283R%29-1-azabicyclo%5B2.2.2%5Doct-3-yl%5Dfuro%5B2%2C3-c%5Dpyridine-5-carboxamide%2C+an+agonist+of+the+alpha+7+nicotinic+acetylcholine+receptor%2C+for+the+potential+treatment+of+cognitive+deficits+in+schizophrenia%3A+synthesis+and+structure%E2%80%93activity+relationship"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm0602413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0602413%26sid%3Dliteratum%253Aachs%26aulast%3DWishka%26aufirst%3DD.%2BG.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DYates%26aufirst%3DK.%2BM.%26aulast%3DReitz%26aufirst%3DS.%2BC.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DMyers%26aufirst%3DJ.%2BK.%26aulast%3DOlson%26aufirst%3DK.%2BL.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DWolfe%26aufirst%3DM.%2BL.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DHanchar%26aufirst%3DA.%2BJ.%26aulast%3DThornburgh%26aufirst%3DB.%2BA.%26aulast%3DCortes-Burgos%26aufirst%3DL.%2BA.%26aulast%3DWong%26aufirst%3DE.%2BH.%2BF.%26aulast%3DStaton%26aufirst%3DB.%2BA.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DWalters%26aufirst%3DR.%2BR.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DFranklin%26aufirst%3DS.%26aulast%3DCarey%26aufirst%3DG.%26aulast%3DGold%26aufirst%3DL.%2BH.%26aulast%3DCook%26aufirst%3DK.%2BK.%26aulast%3DSands%26aufirst%3DS.%2BB.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26aulast%3DSoglia%26aufirst%3DJ.%2BR.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26atitle%3DDiscovery%2520of%2520N-%255B%25283R%2529-1-azabicyclo%255B2.2.2%255Doct-3-yl%255Dfuro%255B2%252C3-c%255Dpyridine-5-carboxamide%252C%2520an%2520agonist%2520of%2520the%2520alpha%25207%2520nicotinic%2520acetylcholine%2520receptor%252C%2520for%2520the%2520potential%2520treatment%2520of%2520cognitive%2520deficits%2520in%2520schizophrenia%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4425%26epage%3D4436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Linton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ornelas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kephart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pairish, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, C.</span><span> </span><span class="NLM_article-title">Systematic structure modifications of imidazo[1,2-<i>a</i>]pyrimidine to reduce metabolism mediated by aldehyde oxidase (AO)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7705</span><span class="NLM_x">–</span> <span class="NLM_lpage">7712</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2010942" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7705-7712&author=A.+Lintonauthor=P.+Kangauthor=M.+Ornelasauthor=S.+Kephartauthor=Q.+Huauthor=M.+Pairishauthor=Y.+Jiangauthor=C.+Guo&title=Systematic+structure+modifications+of+imidazo%5B1%2C2-a%5Dpyrimidine+to+reduce+metabolism+mediated+by+aldehyde+oxidase+%28AO%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm2010942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010942%26sid%3Dliteratum%253Aachs%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DP.%26aulast%3DOrnelas%26aufirst%3DM.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DC.%26atitle%3DSystematic%2520structure%2520modifications%2520of%2520imidazo%255B1%252C2-a%255Dpyrimidine%2520to%2520reduce%2520metabolism%2520mediated%2520by%2520aldehyde%2520oxidase%2520%2528AO%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7705%26epage%3D7712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Garattini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romao, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terao, M.</span><span> </span><span class="NLM_article-title">Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2003&pages=15-32&author=E.+Garattiniauthor=R.+Mendelauthor=M.+J.+Romaoauthor=R.+Wrightauthor=M.+Terao&title=Mammalian+molybdo-flavoenzymes%2C+an+expanding+family+of+proteins%3A+structure%2C+genetics%2C+regulation%2C+function+and+pathophysiology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarattini%26aufirst%3DE.%26aulast%3DMendel%26aufirst%3DR.%26aulast%3DRomao%26aufirst%3DM.%2BJ.%26aulast%3DWright%26aufirst%3DR.%26aulast%3DTerao%26aufirst%3DM.%26atitle%3DMammalian%2520molybdo-flavoenzymes%252C%2520an%2520expanding%2520family%2520of%2520proteins%253A%2520structure%252C%2520genetics%252C%2520regulation%252C%2520function%2520and%2520pathophysiology%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D372%26spage%3D15%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Torres, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korzekwa, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. P.</span><span> </span><span class="NLM_article-title">Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4642</span><span class="NLM_x">–</span> <span class="NLM_lpage">4647</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0703690" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4642-4647&author=R.+A.+Torresauthor=K.+R.+Korzekwaauthor=D.+R.+McMastersauthor=C.+M.+Fandozziauthor=J.+P.+Jones&title=Use+of+density+functional+calculations+to+predict+the+regioselectivity+of+drugs+and+molecules+metabolized+by+aldehyde+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm0703690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703690%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DR.%2BA.%26aulast%3DKorzekwa%26aufirst%3DK.%2BR.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DJ.%2BP.%26atitle%3DUse%2520of%2520density%2520functional%2520calculations%2520to%2520predict%2520the%2520regioselectivity%2520of%2520drugs%2520and%2520molecules%2520metabolized%2520by%2520aldehyde%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4642%26epage%3D4647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Lunniss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldred, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aston, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craven, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohil, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judkins, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranshaw, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span> </span><span class="NLM_article-title">Addressing species specific metabolism and solubility issues in a quinoline series of oral PDE4 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=137-140&author=C.+Lunnissauthor=C.+Eldredauthor=N.+Astonauthor=A.+Cravenauthor=K.+Gohilauthor=B.+Judkinsauthor=S.+Keelingauthor=L.+Ranshawauthor=E.+Robinsonauthor=T.+Shipleyauthor=N.+Trivedi&title=Addressing+species+specific+metabolism+and+solubility+issues+in+a+quinoline+series+of+oral+PDE4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLunniss%26aufirst%3DC.%26aulast%3DEldred%26aufirst%3DC.%26aulast%3DAston%26aufirst%3DN.%26aulast%3DCraven%26aufirst%3DA.%26aulast%3DGohil%26aufirst%3DK.%26aulast%3DJudkins%26aufirst%3DB.%26aulast%3DKeeling%26aufirst%3DS.%26aulast%3DRanshaw%26aufirst%3DL.%26aulast%3DRobinson%26aufirst%3DE.%26aulast%3DShipley%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26atitle%3DAddressing%2520species%2520specific%2520metabolism%2520and%2520solubility%2520issues%2520in%2520a%2520quinoline%2520series%2520of%2520oral%2520PDE4%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D137%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Boström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowright, A. T.</span><span> </span><span class="NLM_article-title">Oxadiazoles in medicinal chemistry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1830</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostr%C3%B6mauthor=A.+Hognerauthor=A.+Llin%C3%A0sauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlin%25C3%25A0s%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300343m&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm300343m%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-13%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300343m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991085fa7f2212","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
